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Abstract 
The incidence of paediatric coeliac disease (CD) is rising globally. It is uncertain 
whether this is attributed to improved case ascertainment or signifies a true rise in 
numbers. Geographical variation in incidence has also been reported in some 
European countries, although it is not known whether regional differences present in 
Scotland. Furthermore, data on the management of children diagnosed with CD in 
Scotland is lacking. The cornerstone of CD treatment is a strict gluten-free diet 
(GFD). Adherence may reduce risk of future complications including osteoporosis, 
malignancy and fertility difficulties. Nonetheless, the GFD is known to be 
particularly challenging during adolescence and may be nutritionally inadequate. 
Limited adolescent research addresses factors associated with adherence to the GFD, 
the diet’s nutritional quality or effect on health-related quality of life (HRQoL).  
Retrospective longitudinal and prospective regional trends in age-sex standardised 
incidence of childhood CD (≤16 years) in Scotland were determined. Data on case 
presentation, reasons for diagnosis and the management of newly diagnosed children 
were collected. A cross-sectional study was undertaken to identify adherence to the 
GFD in Scottish adolescents with CD (11-18 years) using a short validated 
questionnaire. A further questionnaire was developed to identify factors associated 
with adherence to the GFD. Teenagers’ energy and nutrient intakes were compared 
to Dietary Reference Values (DRVs) and a healthy, age-matched control group. 
Generic and disease-specific HRQoL indices were compared between adherent 
teenagers, non-adherent teenagers and age-matched controls. 
 
The incidence of paediatric CD in Scotland between 01.09.09 and 31.08.10 was 
10.0/100,000/yr. Incidence in the East was 16.3, West 8.1 and North 7.7. More than 
twice the incidence of cases were diagnosed due to active screening in the East (4.6) 
compared to the West (2.0) and North (1.3), as was the incidence of classical cases. 
Significantly more CD diagnostic antibody tests were performed per head of 
population in the East compared to the West (OR 1.65, 95% CI 1.57-1.73) and North 
(OR 1.81 95% CI 1.70-1.92). The incidence of childhood CD rose from 1.8 (95% CI 
1.1-2.7) to 11.7 (95% CI 9.8-13.9) per 100,000 from 1990-1994 to 2005-2009, 
respectively (p<0.0001). The incidence of non-classical and actively screened cases 
increased 1467% (p<0.05) and 1100% (p<0.001) from 1990-1999 to 2000-2009, 
respectively. A significant rise in the incidence of Oslo classical cases from 1.51 
(95% CI 0.91-2.38) in 1990-1994 to 5.22 (95% CI 3.98-6.75) in 2005-2009 (p<0.01) 
remained. A number of differences in the dietetic management of newly diagnosed 
children were observed between a regional (multidisciplinary team) and a district 
general (dietetic-led) clinic. Differences in the management of dietary concerns as 
well as the type of education and resources provided were reported. Sixteen 
participants were categorised as non-adherent to the GFD in the adolescent study 
(41%; 0/7 boys, 16/32 girls). Male gender, being a member of a CD support group, 
ability to follow a GFD on holiday, when traveling and at social and special events 
were associated with better adherence to the GFD (p<0.05). Never checking food 
labels was associated with poorer adherence. Compared to controls, boys and girls 
with CD had higher median energy intakes (p<0.05). Mean percentage energy intake 
from protein, saturated fat and non-milk extrinsic sugar was significantly higher in 
the CD group compared to controls and DRVs (p<0.05). Ten (34%) girls with CD 
  
II 
had estimated iron intakes below the Lower Reference Nutrient Intake (LRNI). This 
was not significantly different compared to NDNS data (44% <LRNI) (p>0.05). 
Adherent adolescents had significantly better generic HRQoL scores for the domains 
‘physical health’ and ‘self perception’ compared to non-adherent teenagers and 
controls (p<0.05). 
 
Evidence of more actively screened cases and more antibody tests performed in the 
East suggests the higher incidence observed may be due to a lower threshold to test. 
An environmental influence cannot be dismissed since more classic cases were also 
captured. The incidence of pediatric CD increased 6.4-fold over the 20 years studied. 
This rise is significant for classic CD, indicating a true rise in incidence. Further 
research is needed to highlight the role of exogenous factors in CD development and 
whether differences in management affect disease outcomes. A number of factors 
appear to be associated with adherence to the GFD in Scottish adolescents and 
dietary intakes were of concern regarding the distribution from different 
macronutrients. The results imply that HRQoL should be monitored alongside 
adherence in this population. Further studies are required to identify independent 
predictors of adherence, the nutritional status of teenagers following a GFD and to 
ascertain whether poor HRQoL is a cause or effect of non-adherence.  
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Chapter 1: Introduction and background 
Coeliac disease (CD) is a permanent, systemic, immune mediated disorder initiated 
through the ingestion of gluten-containing cereals: wheat, barley and rye, in 
genetically predisposed individuals (Dickey 2009). Although CD is known to affect 
approximately 1% of most childhood populations, including children in the UK 
(Bingley et al. 2004), it is estimated that only 0.1% (1 out of 10 cases) are actually 
diagnosed (Ravikumara et al. 2007). This is largely attributed to CD’s varied 
presentation – ranging from classical symptoms such as diarrhoea and faltering 
growth, more subtle extra-intestinal presentations, to complete absence of any 
external symptoms (NICE 2009). Many countries have observed a rise in childhood 
CD diagnoses over the last few decades (Dydensborg et al. 2012; Hurley et al. 2012; 
McGowan et al. 2009; Roma et al. 2009; Steens et al. 2005; Telega et al. 2008). 
However, reasons behind the rise are not clear. It is important to address whether the 
rise in incidence is due to better awareness of the condition’s heterogeneous 
presentation, improved screening practices or whether a true rise in cases is evident. 
Additionally, certain countries have reported geographical disparity in CD incidence 
rates (Olsson et al. 2009b; Steens et al. 2005). Limited research on the incidence of 
paediatric CD has been carried out in Scotland. A pan-Scottish incidence study will 
enable regional comparisons to be made with regards to not only childhood CD 
diagnoses, but also symptom presentation, screening practices and patient 
management. Such data will help to ascertain whether any inequalities in practice 
exist between regional centres, whether true differences in incidence occur and so 
assist in identifying where additional support should be focused in relation to the 
diagnosis and treatment of childhood CD. 
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Strict life long adherence to a gluten-free diet (GFD) is the current treatment for CD 
(Armstrong et al. 2009). Following the GFD not only helps to alleviate intestinal 
injury; relieving multiple symptoms and normalise nutrient absorption (Jones and 
Sleet 2009; Niewinski 2008), it may further act to prevent serious future 
complications associated with the untreated condition including osteoporosis, 
malignancy and fertility difficulties (Haines et al. 2008). Despite this, there is 
evidence to suggest adherence to the GFD in adolescent populations is poor 
(Chauhan et al. 2010; Roma et al. 2010). Factors associated with teenage adherence 
and non-adherence to the GFD has not been addressed in the UK. Furthermore, it is 
uncertain whether strict adherence to the GFD is associated with a better health-
related quality of life (HRQoL) during adolescence. Identifying factors associated 
with adherence to the GFD in this age group and determining HRQoL in adherent 
and non-adherent teenagers will provide an evidence base for future management 
guidance and support at this stage of unique physiological, psychological and social 
development.  
Although the GFD may play a preventative role in relation to short and longer-term 
health issues, there is evidence to suggest the diet may be nutritionally inadequate 
(Ohlund et al. 2010; Robins et al. 2008a; Wild et al. 2010). However, no study has 
examined the dietary patterns or nutritional intakes of teenagers following a GFD in 
the UK; despite the fact that UK teenagers are a particularly vulnerable population 
nutritionally (Bates et al. 2012; Sheehy et al. 2008). By comparing the dietary intakes 
of adolescents with CD in the UK to a healthy control population and seeing whether 
any inequalities exist, it will help to inform the dietetic management of teenage 
patients. Furthermore, such research could also inform current policy on the 
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fortification of gluten-free (GF) flours which, unlike regular wheat-based flours, are 
not required by law to be fortified with iron, thiamin, niacin and calcium (Codex 
Alimentarius Commission 2008; Ministry of Agriculture, Fisheries and Food 1998) 
and wheat-based products make a significant contribution to micronutrient intakes in 
healthy populations (Bates et al. 2012). 
1.1 Overview of paediatric coeliac disease 
Coeliac disease is a permanent, multi-system, immunological disorder that is 
environmentally precipitated by exposure to gluten in individuals with genetic 
susceptibility (Dickey 2009). Additionally, a secondary environmental trigger is 
necessary to initiate the primary inflammatory response to gluten in the small 
intestine (Kneepkens and Von Blomberg 2012). Factors including infections and 
infant feeding practices have been implicated (Akobeng et al. 2006; Plot and Amital 
2009). However, this area of research is still relatively unexplored and the majority 
of patients do not have a known identifiable trigger (Di Sabatino and Corazza 2009; 
Tack et al. 2010). 
1.1.1 Gluten 
Intestinal inflammation and damage in CD is highly dependant on intestinal wall 
exposure to prolamines (alcohol soluble portion of a plant protein) and/or glutenins 
(alcohol insoluble portion of a plant protein) found in the cereal grains wheat, barley 
and rye (Maki and Lohi 2004). Collectively, these are referred to as ‘gluten’. 
Although oats belong to the same grass subfamily as wheat, barley and rye 
(Festucoideae) and contain prolamin peptide structures known as avenins, they do 
not belong to the same grass tribe as the aforementioned grains (Triticeae) (Maki and 
  
4 
Lohi 2004), and thus share fewer compositional characteristics. The majority of 
individuals with CD tolerate pure oats, uncontaminated by other gluten-containing 
cereals during harvest and production (Pulido et al. 2009). However, a small 
percentage of patients sustain villous atrophy (flattening of the duodenal and jejunal 
villi) after consumption (Lundin et al. 2003). The inclusion and safety of oats within 
a GFD is discussed in more detail in Section 1.1.6. 
1.1.2 Genetics 
Epidemiological studies have exposed CD’s strong genetic component. In their 
systematic review of CD prevalence in Western European populations, Dube and 
colleagues (2005) observed the prevalence of CD in general populations to range 
from 0.5% to 2.26%. In contrast, authors calculated a pooled CD prevalence of 16% 
in first-degree relatives of individuals with CD (Dube et al. 2005). Additionally, two 
Italian twin studies identified a CD concordance rate of 83-86% in monozygotic 
twins (Greco et al. 2002; Nistico et al. 2006), supporting a strong genetic link. 
Wolters and Wijmenga’s (2008) literature review of all genetic susceptibility genes 
that have been identified to play a role in CD development found that four coeliac 
loci have been detected on separate chromosomes, as well as specific candidate 
genes from genetic association studies (Wolters and Wijmenga 2008). Table 1 
summarises the loci and candidate genes identified in the review. The human 
leukocyte antigen (HLA)-DQ2 and HLA-DQ8 genes on the CELIAC1 locus have 
demonstrated the strongest genetic association with CD to date. Approximately 95% 
of CD patients express HLA-DQ2, with isolation of HLA-DQ8 in the predominance 
of remaining patients (Sollid and Thorsby 1993). However, approximately 30% of 
the general population carry the HLA-DQ2 or HLA-DQ8 alleles (Sollid et al. 1989). 
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Therefore, these genes alone are not sufficient to predispose CD. Research into the 
genetics of CD continues to develop and a genome wide association study has 
recently shown convincing evidence of 13 new loci involved in CD risk (Plenge 
2010), although further replication studies are vital to establish true positive 
associations between these loci and CD development.  
Table 1 Coeliac disease genetic susceptibility loci and the genes associated with 
coeliac disease development 
Susceptibility 
locus 
Chromosome 
location 
Role of the locus Coeliac disease  
associated alleles on 
the locus 
CELIAC1 
Locus 
6p21 Codes for human leukocyte 
antigen (HLA) class II 
molecules  
HLA-DQ2 
HLA-DQ8 
CELIAC2 
Locus 
5q31-33 It contains a cytokine gene 
cluster and may play a role in 
immune regulation and 
inflammation 
No functional disease 
triggering gene has 
been identified 
CELIAC3 
Locus 
2q33 Contains the T-lymphocyte 
regulatory genes 
No truly identifiable 
gene, although 
CTLA4 has been 
associated with CD 
at the haplotype level 
CELIAC4 
Locus 
19p13.1 Encodes for an atypical myosin 
molecule likely to play a role in 
actin remodelling of epithelial 
enterocytes 
MYO9B 
Adapted from Wolters and Wijmenga (2008) 
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1.1.3 Pathogenesis 
Although the exact pathogenic mechanism behind CD is not fully understood, the 
vast majority of literature supports a T-cell mediated autoimmune response (Di 
Sabatino and Corazza 2009). In the small intestine, incomplete digestion of gluten 
peptides, due to protease resistance, has been shown to initiate an inflammatory 
reaction typified by pervasion of chronic inflammatory cells in the lamina propria 
and epithelium as well as villous atrophy (Green and Cellier 2007). The mechanism 
by which this cytotoxicity occurs has been attributed to both adaptive and innate 
immune responses (Armstrong et al. 2009; Fasano and Catassi 2012) and 
identification of tissue transglutaminase (tTG) as the major auto-antigen in CD by 
Dieterich and colleagues (Dieterich et al. 1997) has led to a much greater 
understanding of the disease’s aetiology over the last decade.  
In relation to the adaptive immune response, it has been observed that increased 
intestinal permeability in CD results in partially digested gluten proteins reaching the 
lamina propria either via paracellular transport (due to increased release of the 
permeability modulating protein, zonulin) or via interferon-gamma-dependant 
transcytosis (Di Sabatino and Corazza 2009; Schumann et al. 2008). Here, it is 
deaminated by tTG-2 and presented by HLA-DQ2 or HLA-DQ8 molecules on 
antigen presenting cells to CD4 T-cells (Niewinski 2008; Schumann et al. 2008). The 
T-cells produce high levels of inflammatory cytokines; predominately interferon 
gamma (IFN-), leading to degradation of the extracellular matrix and basement 
membranes, increased cytotoxicity of intraepithelial lymphocytes (IELs) and 
increased production of natural killer (NK) cells. Subsequently, enterocyte apoptosis 
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(cell death) and villous flattening occur (Dickey 2009); limiting absorption of 
essential nutrients (see Section 3.1.1).  
The non-T-cell dependent innate response occurs in the intestinal epithelium (Gujral 
et al. 2012). Incomplete digestion of gluten peptides has been shown to trigger 
increased expression of inter-leukin 15 (IL-15) by enterocytes, promoting an IEL 
response which express NK-G2D receptors; NK cell markers (Barker and Liu 2008). 
These activated cells become cytotoxic and cause apoptosis of enterocytes, leading to 
villous atrophy in the duodenum and jejunum (Barker and Liu 2008), and thus 
symptoms such as iron deficiency anaemia (IDA), weight loss, faltering growth, 
diarrhoea and fatigue may occur due to poor absorption of macro and micronutrients 
(NICE 2009). 
1.1.4 Presentation and co-morbidities 
Classically, childhood CD presents before school age with diarrhoea, vomiting, 
abdominal distension, failure to thrive (FTT) and proximal wasting characterising the 
standard symptoms (Maki and Lohi 2004). However, highly sensitive and specific 
screening tools developed in the 1990s (anti-tissue transglutaminase [Anti-tTG] and 
anti-endomysial antibody [Anti-EMA] tests) have enabled conduct of large screening 
studies to identify CD in the general population (Hill 2005). Both the sensitivity and 
specificity of Anti-tTG and Anti-EMA for the diagnosis of CD is above 95% 
(Rostom et al. 2005). Through mass screening it is clear that children frequently 
present with non-classical, often extra-intestinal presentations of CD, and that 
children with overt mucosal villous atrophy may exhibit no external symptoms of the 
condition (Alessio 2005) making reasons for testing varied and wide ranging. 
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Additionally, CD has been identified in children and adolescents of all ages (Rutz et 
al. 2002; Tommasini et al. 2004).  
Although clinicians should have a low threshold to test, due to wide variation in the 
presentation of paediatric CD, diagnosis can be difficult. An ‘iceberg model’ is often 
used to explain the clinical spectrum of CD prevalence (Rubio-Tapia et al. 2009). 
The tip of the iceberg (above the waterline) represents the minority of children with a 
confirmed diagnosis of CD. These cases, more often than not, have classical 
symptoms; although it is becoming more common to capture non-classical and 
asymptomatic cases in practice (Garampazzi et al. 2007; McGowan et al. 2009; 
Ravikumara et al. 2006; Roma et al. 2009). Nonetheless, the majority of cases still 
remain under the waterline as undiagnosed (Ravikumara et al. 2007). These children 
tend to have few or no health complaints and it is estimated that nine out of ten 
childhood cases remain undetected in the UK (Ravikumara et al. 2007). 
The guidelines of both the National Institute of Clinical Excellence (NICE) and 
British Society for Paediatric Gastroenterology, Hepatology and Nutrition 
(BSPGHAN) provide clinical information on the most effective means of 
recognising and diagnosing paediatric CD based on the most up-to-date body of 
evidence available at the time (Coeliac Working Group of BSPGHAN 2005; NICE 
2009). These documents inform clinicians of the presenting intestinal and extra-
intestinal symptoms in children where a serological test should be offered or 
considered (Table 2a). Furthermore, active screening of children at increased risk for 
CD i.e. due to family history of the condition in a first-degree relative or previous 
diagnosis of an associated autoimmune disease is strongly advised in both guidelines 
(Table 2b). Although recent epidemiological research suggests clinicians are 
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referring to these guidelines in the UK; since more children are captured through 
screening and present with fewer classical symptoms (Buchanan et al. 2009; Hurley 
et al. 2012; Ravikumara et al. 2006) (see Section 2.4), it is uncertain whether better 
awareness of the condition’s varied presentation is independently causing a rise in 
diagnosed cases, or whether a true rise in cases is emerging (see Section 2.2).   
Table 2a Presenting symptoms where serological testing for coeliac disease should 
be offered or considered in children (Coeliac Working Group of BSPGHAN 2005; 
NICE 2009) 
 
Symptoms where serological testing 
should be offered 
Symptoms where serological testing 
should be considered 
 Chronic or intermittent diarrhoea 
 Failure to thrive 
 Abdominal distension 
 Vomiting 
 Weight loss (sudden or unexplained) 
 Prolonged fatigue 
 Abdominal pain/ cramping 
 Iron deficiency anaemia, or other 
unspecified anaemia 
 Constipation 
 Faltering growth/ idiopathic short stature 
 Amenorrhoea 
 Mouth ulcers 
 Dental enamel defects 
 Low-trauma fracture 
 Microscopic colitis 
 Persistently raised liver enzymes 
 Reduced bone mineral density 
 Unexplained alopecia 
 
 
 
 
 
Table 2b Presenting conditions or family history where serological testing for 
coeliac disease should be offered or considered in asymptomatic children (Coeliac 
Working Group of BSPGHAN 2005; NICE 2009) 
Presenting conditions where serological 
testing should be offered 
Presenting conditions where serological 
testing should be considered 
 Autoimmune thyroid disease 
 Dermatitis herpetiformis 
 Irritable bowel syndrome 
 Type 1 diabetes 
 Children of first-degree relatives with 
coeliac disease 
 Addison’s disease 
 Autoimmune liver conditions 
 Autoimmune myocarditis 
 Depression or bipolar disorder 
 Down syndrome 
 Lymphoma 
 Epilepsy 
 Metabolic bone disease 
 Polyneuropathy 
 Sarcoidosis 
 Sjogren syndrome 
 Turner syndrome 
 Unexplained subfertility 
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1.1.5 Diagnosis 
Although various systemic symptoms of CD may present, a universal indication of 
the disease is specific intestinal inflammation and damage. Until early 2012 
clinicians were advised to follow diagnostic guidelines devised in 1990 by the 
European Society for Paediatric Gastroenterology, Hepatology and Nutrition 
(ESPGHAN) (Walker-Smith et al. 1990). The guideline states that: 1) characteristic 
features of villous atrophy should be observed on histological examination of a small 
intestinal biopsy specimen whilst on a gluten-containing diet, and 2) there should be 
resolution of all clinical findings once following a strict GFD. A second biopsy is 
necessary in patients who are asymptomatic to prove mucosal recovery. However, 
these criteria were revised in January 2012 due to vast improvements in CD-specific 
antibody tests over the last 20 years and greater understanding of the genes 
associated with CD (Husby et al. 2012). Children and adolescents with signs and 
symptoms of CD may now be diagnosed on the basis of having an Anti-tTG titre 
over 10 times the upper limit of normal, Anti-EMA positivity and HLA DQ2 or DQ8 
positivity (Husby et al. 2012). All other persons i.e. asymptomatic children and 
adolescents, those with a positive Anti-tTG <10 times the normal limit and those 
Anti-tTG positive/Anti-EMA negative must still undergo duodenal biopsy to confirm 
diagnosis. Mucosal abnormality should be based on a Marsh-Oberhuber Score of II 
or III (Oberhuber et al. 1999). Normal mucosal architecture with IELs comprising 
over 40% of surface enterocytes is classified as a Marsh Type I lesion. A Marsh 
Type II lesion presents with crypt hyperplasia (elongation of the intestinal glands) 
and increased mitotic activity in addition to lymphocytosis, whereas villous atrophy 
denotes a Marsh Type III lesion (Ensari 2010; Oberhuber et al. 1999). Husby and 
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colleagues (2012) advise that children with a Marsh Type I lesion on biopsy should 
have an extended evaluation of their HLA markers, serology and biopsy before a true 
diagnosis of CD is established. These new guidelines will require careful 
consideration by gastroenterologists to ensure robust diagnosis of CD, and it is 
uncertain as yet whether these recommendations are adhered to in practice. 
1.1.6 Treatment 
Strict, life-long adherence to a GFD is the only scientifically proven treatment for 
CD recovery (Armstrong et al. 2009). Although constant advances in the 
understanding of pathogenesis of CD have led to development of non-dietary 
therapies such as peptide based immuno-therapy, tTG inhibitors and HLA-DQ2 
antagonists, Phase 1 and 2 clinical trials are still underway (Brown et al. 2011; 
Schuppan et al. 2009), and thus these approaches are not available for general 
practice. The earliest projection is 2016 for peptide based immunotherapy. 
As previously discussed (see Section 1.1.1), gluten is found in wheat, barley and rye. 
Therefore, these cereal grains and any cross-bred varieties must be completely 
excluded from the diet of patients with CD. Many foods are naturally GF including 
rice, potatoes, fresh fruits and vegetables, beans and pulses, meats, cheeses and other 
dairy products, and thus are safe to consume on a GFD (Blow et al. 2004). However, 
gluten-containing proteins are present in a considerable number of products from the 
obvious breads, pastas, breakfast cereals, cakes and biscuits to, perhaps more 
unexpectedly, soups, sauces, stock cubes, processed meats and crisps (Blow et al. 
2004). Therefore, excellent patient knowledge of naturally occurring GF foods and 
being able to interpret food labels of manufactured products is vital to ensure safety 
and strict adherence. Considering the vastness of our food supply, people eating out 
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more and dependence on many pre-prepared products, this presents a significant 
challenge for those diagnosed with CD. 
In the UK, individuals with a clinically confirmed diagnosis of CD may obtain a 
number of staple GF items on prescription as a way of increasing dietary adherence, 
reducing additional costs associated with following a GFD, and to help patients 
achieve a nutritionally balanced diet (Blow et al. 2011). Members of the Primary 
Care Society for Gastroenterology, Coeliac UK, the British Dietetic Association 
(BDA) and BSPGHAN collaborated to formulate the current prescribing guidelines, 
which aim to assist health care professionals in allocating patients the appropriate 
amount of GF products on prescription (Blow et al. 2011). Guidelines were 
developed based on consumption data from the National Diet and Nutrition Survey 
(Gregory et al. 2000b; Henderson et al. 2003), the ‘Eatwell Plate’ model for balanced 
eating (Department of Health 2011) as well as Dietary Reference Values (DRVs) for 
energy and carbohydrates (CHO) (Department of Health 1991). It is taken into 
consideration that naturally GF staple foods rich in CHO such as rice and potatoes 
will contribute to energy intakes as well as specialist GF CHO products (Blow et al. 
2011).  
As such, utilising the above sources of information it was established that GF 
substitutes should provide approximately 15% of total energy (Blow et al. 2011). 
Clinicians should refer to the prescribing guide to work out how much food; 
calculated in units, an individual may be allocated per month (Blow et al. 2011). The 
number of units will depend on the patient’s age and sex. Additionally, extra units 
may be allocated if the patient has a high physical activity level (PAL), they are 
breastfeeding or in the third trimester of pregnancy (Blow et al. 2011) due to greater 
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energy expenditure and or requirements. This is to address potential inequalities 
regarding food access, associated with increased cost of GF products. 
1.1.6.1 Food labelling and legislation 
Current legislation in Europe states that manufacturers must list on the food label all 
allergens present in packaged food, and that a product may only be labelled ‘GF’ if 
the gluten content does not exceed 20mg/kg (Codex Alimentarius Commission 2008; 
European Commission 2009). Furthermore, if a product contains 21-100mg of 
gluten/kg it may be labelled ‘very low gluten’ (Codex Alimentarius Commission 
2008). Very low gluten foods are unlikely to cause an inflammatory response in 
small quantities (Akobeng and Thomas 2008). Nonetheless, it is advised that 
individuals with CD seek advice from a dietitian regarding the inclusion of such 
foods in a GFD (Coeliac UK 2012). Such labelling may be confusing for patients and 
this is an area that may require more clinical support. 
Products that are naturally GF are not required by law to be labelled ‘gluten-free’. 
Manufacturers may use the term ‘no gluten-containing ingredients’ on the label, 
although this does not guarantee that these products have not been cross-
contaminated with gluten from other sources during processing (Coeliac UK 2012). 
Therefore, caution must be taken when selecting any pre-packaged food for 
consumption. BSPGHAN recommend that newly diagnosed patients with CD should 
initially exclude oats from the diet due to small numbers experiencing toxicity 
(Coeliac Working Group of BSPGHAN 2005). However, once a full recovery has 
been achieved reintroduction of pure oats (labelled ‘gluten-free’), with careful 
monitoring, should be considered (Coeliac Working Group of BSPGHAN 2005) in 
order to increase choice within the diet. Thus, there is a need for continual attention 
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to food choice, food labels and food preparation which may have a negative impact 
on health related quality of life. 
In summation, CD is an autoimmune condition of the small intestine triggered 
predominantly by gluten-containing peptides and, in rare instances, similar peptides 
present in oats. Although the candidate genes HLA-DQ2 and HLA-DQ8 are strongly 
associated with the presence of CD, further genetic susceptibility studies are required 
to identify more specific target genes. Due to the heterogeneous nature of CD 
presentation in children, making a diagnosis may prove challenging for clinicians, 
and the condition remains largely under-diagnosed. As such, epidemiological data is 
required to assess trends in newly diagnosed childhood cases including motives for 
diagnosis. This information could help to determine whether more cases are being 
diagnosed as a result of lower thresholds to test in practice or whether a true rise in 
cases is evident. In addition, once diagnosed following a GFD may prove 
challenging for a variety of reasons such as deciphering food labels or knowing 
where to eat out/purchase food safely. It is important to understand what factors 
specifically affect both adherence to the GFD in young people and the impact of 
following a GFD on quality of life parameters. Such knowledge could help to inform 
the management in clinical practice and the support delivered by third sector bodies. 
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Chapter 2: Literature review part 1 - The epidemiology and 
management of paediatric coeliac disease 
Coeliac disease epidemiological data collection methods have included retrospective 
case-note review, prospective surveillance and, more recently, population screening 
using the highly specific and sensitive haemological assays Anti-tTG and Anti-EMA 
(Rubio-Tapia et al. 2009). Such studies have not only increased our understanding of 
the varied geographical incidence and prevalence of CD across the globe (Dube et al. 
2005), but have exposed details of the diseases multi-factorial aetiology (Alessio 
2005), its association with particular genes (Dolinsek et al. 2004), environmental risk 
factors (Olsson et al. 2008b) and co-morbidities (Gillett et al. 2000; Nisihara et al. 
2005; Poulain et al. 2007), the delays in clinical diagnosis (Rampertab et al. 2006) as 
well as changes in disease presentation (Tack et al. 2010). This increasing knowledge 
aims to constantly enhance clinician understanding of CD and serves to improve 
diagnosis and treatment. Advances in case ascertainment are especially pertinent in 
the case of CD due to the ‘iceberg model’ of under-diagnosis previously described 
(see Section 1.1.4). Additionally, growing knowledge of the apparent risk factors 
associated with CD could play an important role in the primary prevention of this 
widespread condition.  
2.1 Estimated prevalence of paediatric coeliac disease 
Fletcher and Fletcher (2005) state that calculating the prevalence of a clinical 
condition answers the question “what proportion/percentage of a defined population 
has the condition at a given point in time?” A cross-sectional study approach is used 
to measure prevalence. This is achieved by either identifying all individuals with a 
diagnosis in practice at a specified time point, or, more accurately; especially in the 
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case of a symptomatic and asymptomatic heterogeneous condition; such as CD, by 
screening a defined population using both sensitive and specific diagnostic tools 
(Yarnell 2007). Prevalence studies help to inform practitioners of the risk of a 
condition in particular populations e.g. in children and adults, males and females, in 
different countries or in varying disease groups, and serve as an important guide for 
planning health care services in terms of prioritisation of funds, educational 
resources, screening programmes and prevention research (Fletcher and Fletcher 
2005). 
A review of childhood CD screening studies was undertaken through a number of 
online search engines (PubMed, The Knowledge Network, CINAHL, EBSCO Host) 
from January 1990 to the end of 2011. Only articles published in English were 
reviewed and the twenty-four studies identified are summarised in Table 3. The 
studies are limited to those performed in general child populations; screening studies 
performed specifically in ‘at risk’ groups are not included (see Table 2b, Section 
1.1.4) because these do not reflect the population prevalence as a whole. 
The reported prevalence of paediatric CD in unselected populations ranges widely 
from 1:18 in Saharawi children (Catassi et al. 1999) to 1:496 in Russia Karelia 
(Kondrashova et al. 2008). Just one study reports the prevalence of childhood CD in 
the UK (Bingley et al. 2004). Sensitive and specific Anti-tTG and Anti-EMA tests 
were utilised to screen 5470 school children (all aged 7.5 years) in Greater London, 
revealing a prevalence of 1% (both Anti-tTG and Anti-EMA positive) (Bingley et al. 
2004). The prevalence may be overestimated since a biopsy was not performed to 
confirm diagnosis in any of the children. However, the high sensitivity and 
specificity of Anti-tTG and Anti-EMA make them extremely accurate screening 
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tools (Rostom et al. 2005). Another limitation of the UK study is that the ethnic 
distribution of the population is not mentioned. In light of the fact that CD is a 
genetic condition, it is difficult to draw firm conclusions from prevalence data where 
the ethnic background of the screened population has not been described. HLA-DQ2 
and HLA-DQ8 are considered to be primarily European Caucasian genetic traits 
(Brar et al. 2006) although reasonably high frequencies of the genes coding for DQ2 
have also been detected in the populations of Northern and Western Africa, the 
Middle East and central Asia (Gujral et al. 2012). Although approximately 60% of 
the population in London are White Caucasian, around 30% are of Asian or African 
origin (Office for National Statistics 2012). As such, the prevalence data collected by 
Bingley et al. may not be reflective of other, less ethnically diverse regions within 
the UK. 
All other European screening studies have implemented biopsy to confirm CD 
diagnosis. Estimated prevalence ranges from 1:34 in Swedish 12-year-olds (selected 
at random from schools in five regions, ranging from Northern to Southern Sweden) 
(Mylus et al. 2009) to 1:290 (0.34%) in Estonian children aged 9 and 15 years; 
randomly selected from 25 schools across the country (Ress et al. 2007). The 
difference in prevalence between these countries could, in part, be due to 
unfavourable infant feeding practices in Sweden in the early to mid 1990s when the 
screened children were born (Ivarsson et al. 2000; Mylus et al. 2009). Children born 
between 1993 and 1994 in Estonia were observed to consume approximately half the 
amount of wheat at 12 months of age compared to children born in Sweden over a 
similar time period (Mitt and Uibo 1998). Additionally, the majority of Estonian 
children were introduced to gluten-containing cereals gradually between the ages of 
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four and eight months whilst still breastfeeding (Mitt and Uibo 1998); which is 
hypothesised to be protective in relation to CD development (Akobeng et al. 2006). 
At the same time in Sweden it was observed that less than 50% of children were 
breastfed at time of gluten introduction (Ivarsson et al. 2000). A certain degree of 
variation in the prevalence observed between these two countries may also be 
attributed to differences in the sample size, since researchers in Sweden screened 
around six times more children compared to Estonia (Table 3). Furthermore, it 
should be mentioned that the Estonian prevalence of 0.34% was associated with a 
wide 95% confidence interval (CI) (0.09-0.88%) (Ress et al. 2007) reflecting 
inaccuracy in the reported figure.  
From the current review, it is apparent that large disparity in the prevalence of 
childhood CD has even been reported in studies carried out within the same country. 
The lowest prevalence reported in Spain was 1:73 in children aged 10-12 years 
(Marine et al. 2011), whereas Cilleruelo et al. (2002) report a paediatric prevalence 
of 1:220 (1-14 years). However, the two studies were conducted in different 
geographical regions; Northeast (Marine et al. 2011) and central Spain (Cilleruelo 
Pascual et al. 2002) where there may be differences in gluten/wheat consumption, 
infant feeding or even infant infection rates which have all been proposed to 
influence CD development (Di Sabatino and Corazza 2009). The age range of 
participants is dissimilar between studies and ethnicity is not reported in either paper 
limiting their comparability. Furthermore, prevalence data was collected between the 
years 1999 and 2000 in study by Cilleruelo et al. and between 2004 and 2007 in 
Marine and colleagues research. Two adult screening studies have observed a rise in 
CD prevalence over time (Lohi et al. 2007; Rubio-Tapia et al. 2009). This could 
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partially explain the higher prevalence reported in the more recent Spanish screening 
study.   
Three studies carried out between 1992 and 2007 in Italy similarly vary in relation to 
estimated prevalence (Bonamico et al. 2001; Catassi et al. 1995; Tommasini et al. 
2004). Again, a lower prevalence (1:230) was observed in the earliest study (Catassi 
et al. 1995). Data was collected between 1992 and 1993 (Catassi et al. 1995) 
compared to 2007 in the most recent study (Bonamico et al. 2001). Therefore, the 
variation may be due to a true rise in numbers, especially considering both screening 
studies were carried out in similar geographical areas (central Italy). However, there 
is inconsistency between methodologies in relation to the age of participants (Table 
3). Moreover, Catassi et al. (1995) used anti-gliadin antibodies (AGA) as the first-
line test for CD which has a low sensitivity and specificity for CD compared to Anti-
tTG and Anti-EMA tests used by Bonamico et al. (2011) (Husby et al. 2012) which 
implies prevalence may be under-reported in the earlier research. 
Only one study has assessed the paediatric (6-18 years) prevalence of CD in the 
United States (Fasano et al. 2003). Prevalence was low in comparison to other 
Western countries (1:310). The study population included schoolchildren from four 
West Virginia counties identified through random sampling and was predominantly 
Caucasian (94%), although a minority of other ethnicities were included (3% 
African-American, 1.5% Hispanic and 1% Asian). The low prevalence compared to 
other predominantly Caucasian populations is likely due to the fact that all ‘at-risk’ 
groups such as those with a family history of CD or with TIDM were excluded from 
the analysis and studied separately.  
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Prevalence of childhood CD in North India has been investigated in two studies to 
date over similar time periods (between 2003 and 2004). Bhattacharya et al. (2009) 
observed a prevalence of 1:100 in children aged 0.5-12 years at hospital in Punjab, 
although findings are biased due to the very small sample size of the study and 
absence of random sampling. Four hundred consecutive patients attending the 
general paediatric department for venesection were tested for CD, of which 16% had 
iron-deficiency anaemia (IDA). It is well known that IDA is associated with an 
increased risk for CD in both symptomatic and asymptomatic populations (Dube et 
al. 2005); therefore the prevalence in the study by Bhattacharya et al. (2009) may 
have been overestimated. A much lower prevalence of 1:310 was reported in children 
(3-17 years) in New Delhi (Sood et al. 2006). Children were identified through 
random sampling in 73 schools in the region. However, this may be an underestimate 
of the true prevalence since IgA deficiency is associated with increased risk for CD 
and children with IgA deficiency were not considered in the study (only IgA-Anti-
tTG was tested for). Additionally, four children who were serology positive did not 
have a biopsy performed; these children were excluded from prevalence data. If these 
cases were included the prevalence would have been 1:242.      
The prevalence of 5.6% observed in Saharwi children (0-18 years) residing in 
Algerian refugee camps is unique (Catassi et al. 1999). A much lower paediatric (5-
17 years) prevalence of 1:127 was reported in neighbouring Libya (Alarida et al. 
2011). Although biopsies were not performed in the Saharawi children to confirm 
diagnosis and a small sample was selected, only 1.7% of the children tested in Libya 
had autoantibodies for tTG, suggesting the disparity in cases is still large between the 
two countries. Reasons for such large variation between the Saharawi children and 
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children in other countries is unknown, although infection rates in the refugee camps 
are likely to be high and several studies have implicated adenovirus infection, 
Hepatitis C virus, Rotavirus infection and Enterovirus infection in the development 
of CD (Plot and Amital 2009). However, results of a childhood prevalence study 
conducted in adjacent and genetically related populations; Russian Karelia (RK) and 
Finland contradict this theory, since a much higher prevalence (1:107) was observed 
in children (7.0-18.0 years) living in Northern Finland compared to children (6.2-
18.3 years) living in RK (1:496) (Kondrashova et al. 2008) despite a lower economic 
status, inferior hygienic environment and lower breastfeeding rate in RK. The 
unusual estimated prevalence figures in both Saharawi children and children from 
RK require further investigation to identify additional environmental factors that may 
be important in the primary prevention of CD such as type and quality of gluten 
intake, weaning practices or intestinal bacteria colonisation.  
Keeping in mind the limitations of the studies reviewed and variation between 
studies with regards to age range, sampling techniques, serological screening tools 
and sample size, the majority of papers that have screened over 1000 children report 
an estimated prevalence of around 1:100 (Alarida et al. 2011; Bingley et al. 2004; 
Bonamico et al. 2001; Ertekin et al. 2005; Kondrashova et al. 2008; Maki et al. 2003; 
Marine et al. 2011; Meloni et al. 1999; Rutz et al. 2002; Tommasini et al. 2004) 
Although differences in data collection methods are evident, there are likely to be 
both genetic and environmental explanations for the large variation in prevalence 
reported between, and even within countries. Overall, the prevalence of paediatric 
CD in general European populations seems to be high, emphasising that clinicians in 
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primary care should have a low level of suspicion to test for the condition and clearly 
defined support and management guidelines ought to be in place for those diagnosed.
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Table 3 Summary of coeliac disease prevalence studies in general child populations (1995-2011) 
Author (date) Country Numbers 
screened 
Age 
range 
(years) 
Screening 
tools 
Biopsy 
confirmed 
diagnosis? 
Prevalence Limitations 
(Bingley et al. 
2004) 
UK 5470 7.5 tTG, EMA No 1:100 IgA deficiency not considered. Prevalence data based 
on positive serology only. 
(Cilleruelo 
Pascual et al. 
2002) 
Spain 3378 10-12 EMA Yes 1:220 Only one serological test was used to capture CD. 
(Castano et al. 
2004) 
Spain 613 <3 tTG, EMA, 
AGA 
Yes 1:119 Children tested at 1-1.5 yrs and again at 2.5 yrs. Only 
484 participants returned for the second screen. Small 
sample size.  
(Marine et al. 
2011) 
Spain 2010 1-14 tTG, EMA Yes 1:73 IgA deficiency not considered. One child with positive 
serology did not have a biopsy performed (excluded 
from prevalence data). 
(Antunes 2002) Portugal 536 14 tTG, EMA Yes 1:134 Small sample size. Wide 95% CI for prevalence. 
(Catassi et al. 
1995) 
Italy 5280 11-15 AGA, EMA Yes 1:230 One child with positive serology did not have a biopsy 
performed (included in prevalence data). 
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Author (date) Country Numbers 
screened 
Age 
range 
(years) 
Screening 
tools 
Biopsy 
confirmed 
diagnosis? 
Prevalence Limitations 
(Tommasini et al. 
2004) 
Italy 3188 6-12 tTG, EMA Yes 1:91 IgA deficiency not considered. Children with known 
CD excluded from the study. One child with tTG 
positivity and HLA DQ2/DQ8 positivity did not have 
biopsy (excluded from prevalence data). Three 
children with positive EMA, tTG and HLA were 
included in incidence data without biopsy. 
(Bonamico et al. 
2001) 
Italy 4048 5.3-9.8 Salivary tTG, 
tTG and EMA  
Yes 1:84 IgA deficiency not considered. Five children with 
saliva tTG positivity did not undergo biopsy (excluded 
from prevalence data). 
(Meloni et al. 
1999) 
Sardinia 1607 6-14 AGA 
EMA 
Yes 1:95 Five children with positive serology did not have a 
biopsy performed (excluded from incidence data). 
Wide 95% CI for prevalence. 
(Rutz et al. 2002) Switzerland 1450 12-18 tTG, EMA Yes 1:132 IgA deficiency not considered. Two students with 
positive serology did not have a biopsy performed 
(authors included these two children and one with a 
negative biopsy in the prevalence data). 
(Mylus et al. 
2009) 
Sweden 7207 12 tTG, EMA Yes 1:34 Only 94% with positive serology had biopsy 
performed (these 12 patients excluded from 
prevalence data). 
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Author (date) Country Numbers 
screened 
Age 
range 
(years) 
Screening 
tools 
Biopsy 
confirmed 
diagnosis? 
Prevalence Limitations 
(Maki et al. 2003) Finland 3654 7-16 tTG 
EMA 
Yes 1:99 Parents of ten children with positive serology did not 
consent to biopsy (excluded from prevalence data).  
(Kondrashova et 
al. 2008) 
Russian 
Karelia 
(RK) and 
Finland (F) 
1988 (RK) 
3654 (F) 
6.2-18.3 
(RK), 7.0-
18.0 (F) 
tTG, EMA, 
AGA 
Yes 1:496 (RK), 
1:107 (F) 
Participants with EMA positivity and HLA-DQ2 or 
DQ8 haplotypes were also classed as having CD. 
(Ress et al. 2007) Estonia 1160 9 or 15 tTG Yes 1:290 IgA deficiency not considered. One child with positive 
serology did not have biopsy performed (excluded 
from prevalence data). Wide 95% CI for prevalence. 
(Korponay-Szabo 
et al. 1999) 
Hungary 427 3-6 EMA Yes 1:104 Small sample size. Older 1970s ESPGHAN criteria 
used to define CD. Wide 95% CI. 
(Ertekin et al. 
2005) 
Turkey 1263 6-17 tTG Yes 1:158 Three children with positive serology did not have a 
biopsy (excluded from prevalence data). 
(Dalgic et al. 
2011) 
Turkey 20190 6-17 tTG, EMA Yes 1:212 Intestinal biopsy only performed in 215/489 students 
with positive serology (all 215 excluded from 
prevalence data). 
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Author (date) Country Numbers 
screened 
Age 
range 
(years) 
Screening 
tools 
Biopsy 
confirmed 
diagnosis? 
Prevalence Limitations 
(Hariz et al. 2007) Tunisia 6286 NS tTG 
EMA 
Yes 1:224 Only 28 of 40 with positive serology had biopsy 
performed. Prevalence would be 1:157 if these 12 
included. Age range not stated. 
(Abu-Zekry et al. 
2008) 
Egypt 1500 0.5-18 tTG, EMA Yes 1:187 Wide 95% CI for prevalence. 
(Alarida et al. 
2011) 
Libya 2920 5-17 tTG, EMA Yes 1:127 IgA deficiency not considered. Three children with 
positive serology did not have a biopsy (included in 
the prevalence data). 
(Catassi et al. 
1999) 
North 
Africa 
(Saharawi 
refugees) 
989 0-18 tTG, 
EMA 
No 1:18 IgA deficiency not considered. Prevalence data based 
on positive serology only. 
(Sood et al. 2006) India 4347 3-17 tTG Yes 1:310 IgA deficiency not considered. Four children with 
positive serology did not have a biopsy (excluded 
from prevalence data). 
(Bhattacharya et 
al. 2009) 
India 400 0.5-12 tTG Yes 1:100 IgA deficiency not considered. Random sampling not 
performed. Small sample size. 
(Fasano et al. 
2003) 
USA 1281 6-18 AGA, EMA, 
tTG 
Yes 1:320 Two children with positive serology did not have a 
biopsy (included in the prevalence data). 
tTG: anti-tissue transglutaminase; EMA: anti-endomysial; AGA: anti-gliadin antibody; IgA: immunoglobulin A; CD: coeliac disease; CI: confidence interval; HLA: 
human leukocyte antigen; NS: not stated. 
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2.2 The changing incidence of paediatric coeliac disease 
As opposed to the prevalence of a condition, the incidence represents the number of 
new cases diagnosed over a specific time period in practice (Yarnell 2007). Incidence 
is most commonly presented as a rate per 100,000 of the population at risk, however 
the denominator may also be live births or the sum of person-years studied. Although 
prevalence studies indicate how widespread a condition is in a particular country, 
region or population, incidence studies can uncover trends in disease risk over 
relatively short periods of time which help to assist in our understanding of a 
condition’s pathogenesis (Fletcher and Fletcher 2005). Alternatively, a rising or 
subsiding incidence rate may reflect a change in knowledge or practice i.e. the 
threshold to test has been affected or the diagnostic accuracy of an investigative test 
has altered (Fletcher and Fletcher 2005). 
Articles on the incidence of paediatric CD started to appear in the 1970’s (Mylotte et 
al. 1973), and incidence data has been recorded from as early as 1940 (Logan et al. 
1986). A summary of all childhood (0-18 years) incidence studies published from 
January 1970 to December 2012 is shown in Table 4. Studies were identified on the 
PubMed database using the following search terms “celiac disease”[MeSH] AND 
“incidence”[MeSH] as well as “celiac disease”[MeSH] AND “epidemiology”. 
Reference lists of all suitable articles were searched successively. Again, articles 
were limited to those published in English. The following sections provide a critical 
review of these studies; highlighting how the incidence has changed over time and 
the rationales attributed to these trends. 
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2.2.1 Scottish studies 
Logan et al. (1986) authored the only identified Scottish study on the incidence of 
childhood CD conducted in the Lothian region of Scotland. Although all ages were 
included in the study, crude incidence was reported separately for children (0-14 
years) and adults. Retrospective data collection identified four children diagnosed in 
the quinquennia 1940-1944 (population ~750,000 adults and children). This rose to 
79 children in 1970-1974, although fell slightly in the period 1975-1979 to 57 cases. 
Authors hypothesised that the steady rise in incidence over the first 35 years of data 
accrual was largely due to a lower threshold to test and implementation of jejunal 
biopsy for diagnosis in the 1960’s. However, a number of methodological limitations 
must be noted; the crude figures do not take into account that the total population in 
the Lothian region grew by 7% between 1950 and 1979, nor were data adjusted for 
age or sex. Thus, the rise in the age/sex standardised incidence of paediatric CD over 
this time may not have been quite as high as the crude figures suggest. 
The decline in the last five years of study was unexpected, especially since 
awareness and knowledge of CD was improving and diagnostic techniques were 
quickly advancing. However, a similar pattern in childhood incidence had been 
observed elsewhere in the UK over a similar time period. In 1980 and 1981 several 
letters of communication were published in the Lancet journal from paediatric 
centres in Leeds, Somerset and Glasgow highlighting the common observation that 
CD seemed to be disappearing (Challacombe et al. 1997; Dossetor et al. 1981; 
Littlewood et al. 1980). In Leeds and Somerset a dramatic fall in incidence was seen 
in cases after 1973 up until 1979, whereas in Glasgow 10.77 cases/100,000 live 
births were detected in 1972 in children less than five years compared to zero cases 
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diagnosed in 1978. Interestingly, the fall coincided with new advice on infant feeding 
from the Department of Health and Social Security advocating later introduction of 
cereals (>4 months) and encouraging breastfeeding for at least six months 
(Department of Health and Social Security 1974). Therefore, there were potentially 
two significant changes in infant feeding practices prior to the decline in CD 
incidence. 
Challacombe and colleagues (1997) specifically investigated this decline in 
Yorkshire by comparing the infant feeding practices of children with CD (0-13 
years) to age-sex matched controls who both attended a single-centre from 1971 to 
1992. Incidence decreased from 0.68 cases/1000 live births in the period 1971-1980 
to 0.09 cases/1000 live births in 1981-1992. This case reduction corresponded with 
significantly later gluten introduction from 3.0 (95% CI 2.3-5.0) months to 5.5 (95% 
CI 5.0-7.3) months (p=0.01) in cases and from 3.0 (95% CI 2.0-3.0) months to 5.5 
(95% CI 4.5-6.0) months (p<0.0001) in controls. Sixty-one per cent of coeliac cases 
were initially weaned onto wheat-based foods in the later period, compared to 5% of 
controls (57.5% controls were initially fed milled rice), whereas between 1971 and 
1980 the majority of both groups were initially weaned onto wheat-based foods. 
Although this paper demonstrated preliminary support for later gluten introduction 
and initial weaning of infants onto GF foods, participation was low (n=36) and the 
number of controls was not stated, generating bias. Additionally, the proportion of 
cases and controls weaned onto gluten-containing foods whilst still breastfeeding 
was not ascertained, thus limiting the findings observed. However, infant feeding 
practices in relation to CD risk would later go on to be the focus of many 
epidemiological and case-control studies as discussed in Section 2.2.2, after an 
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apparent epidemic of paediatric CD was observed in Sweden in the mid 1980s to mid 
1990s.  
Since Logan’s early research, a full report on Scottish paediatric CD incidence has 
not been published. However, retrospective incidence figures have been assessed at 
two of three regional tertiary centres, responsible for paediatric gastroenterology, 
hepatology and nutrition (PGHAN) services in Scotland (of which findings have 
been presented at various conferences). Data has been collected on the incidence of 
paediatric CD (<16 years) for the whole of Southeast (SE) Scotland from 1990 to 
2006, inclusive (Basude et al. 2009; Gillett et al. 2009a). From the information 
gathered it is reported that the average incidence rate of CD increased significantly 
(p<0.05) between 1990-1994 and 2005-2006, from 1.81 to 6.09 cases per 100,000 
children. Buchanan et al. (2009) observed a similar rise in numbers in the West of 
Scotland, from a median (IQR) of four (1-6) cases per year in the epoch 1995-2001, 
to 11 (5-21) cases per year in 2002-2008 (p=0.02), suggesting a rise in incidence is 
occurring. 
These changes were mainly attributed to increased screening of at-risk populations, 
heightened awareness of CD among general practitioners and paediatricians, and 
advances in serological tests for CD detection (EMA and tTG tests were introduced 
in the 1990s) (Basude et al. 2009; Gillett et al. 2009a). However, neither study 
controls for any change in population number or structure over the years of data 
collection, and this may have an effect on true incidence rates between epochs. 
Furthermore, the incidence of cases diagnosed over time because of a lower 
threshold to test or on the basis of the classical presentation was not assessed. Only 
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by accounting for these factors can it be established whether a true rise in paediatric 
CD incidence is emerging in Scotland or not.  
2.2.2 National studies 
Only three countries to date have previously measured and have on going 
surveillance of paediatric CD incidence at a national level, namely The Netherlands, 
Sweden and Denmark. Prospective data on the incidence of paediatric CD (<14 
years) in the Netherlands has been collected since 1993 through the Dutch Paediatric 
Surveillance Unit (DPSU), although data analysis has not been completed since 2001 
(George et al. 1997a; Steens et al. 2005). Prior to establishment of its prospective 
surveillance register, incidence data in The Netherlands was gathered retrospectively 
between 1975 and 1990. The incidence of paediatric CD rose significantly between 
the periods 1975-1990 and 1993-1994 from 0.2 cases/1000 live births to 0.5 
cases/1000 live births (p<0.001) (George et al. 1997a). By 2001 the incidence rate 
had reached 1.1 cases/1000 live births (significance between previous years not 
stated) (Steens et al. 2005). Authors speculated that the rise in incidence could either 
reflect an apparent or true increase in numbers. The hypothesis behind an apparent 
rise was a positive correlation between the yearly incidence rate and the number of 
biopsies taken in the small intestine; increasing the likelihood of detecting CD. This 
was due to the vast replacement of Crosby capsule biopsy with small intestinal 
endoscopy. The use of serological screening tools also increased significantly over 
the era (98% of diagnosed children had an AGA test in 1993-1994 compared to 44% 
in the earlier epoch). This will have allowed less typical presentations of CD to be 
detected and thus general awareness of CD should have improved. However, a 
greater percentage of the small bowel biopsies taken in 1993-1994 showed evidence 
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of CD (295/1702) compared to those taken in 1985-1990 (238/2310) which may 
signify a true rise in CD incidence, but may also be due to more appropriate 
endoscopies (Saverymuttu et al. 1991). Authors did not observe a difference in 
breastfeeding or timing of gluten introduction between the general Dutch population 
and coeliac cases at any time point, although infant feeding data collected 
retrospectively may be inaccurate. One of the major limitations in the Dutch research 
is that data was collected retrospectively prior to 1992, covering six Dutch provinces 
(67.6% of the total population), whereas national prospective surveillance (100% 
coverage) was undertaken from 1992, thus differences in incidence between the two 
time periods may, in part, reflect inaccuracies in the initial data collection method. 
Researchers in Denmark aimed to identify all new cases of paediatric CD (0-15 
years) between 1996 and 2010 through the Danish National Patient Registry 
(DNPR), the National Registry of Pathology as well as retrospective hospital chart 
review (Dydensborg et al. 2012). Similar to epidemiological research in The 
Netherlands and more recent Scottish studies, Denmark experienced an increase in 
paediatric CD incidence from 0.8 per 100,000/yr (95% CI 0.3-1.4) in 1996, to 1.4 per 
100,000/yr (95% CI 0.7-2.1) in 1999 and 6.9 per 100,000/yr (95% CI 5.4-8.4) in 
2009 (significance not stated); children were excluded if their biopsy was not 
reflective of Marsh Grade II or III criteria (Oberhuber et al. 1999). Dydensborg and 
Colleagues (2012) do not address reasons for the over eightfold rise in incidence 
although it could be owed to changes in environmental factors such as infant 
weaning practices as observed in Sweden and The Netherlands (Olsson et al. 2008b; 
Steens et al. 2005), or due to significant changes in diagnostic practices and clinician 
awareness as previously described, or a combination of both. Trend analysis on the 
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incidence of cases diagnosed through screening or with atypical symptoms was not 
performed; therefore it is difficult to conclude whether the rise can be attributed to 
changes in environmental factors or whether improved case ascertainment initiated 
the rise. 
Researchers in Sweden have carried out some of the most extensive explorations of 
paediatric CD incidence to date. Initially, a retrospective database was established 
(1973-1990) which covered 15% of Sweden’s population (Ivarsson et al. 2000). 
From 1973 to the early 1980’s the incidence of CD in children less than two years of 
age appeared relatively stable at around 50-100 cases per 100,000 person-years each 
year. Subsequently, in the mid 1980’s, an epidemic pattern in this age group started 
to emerge and the incidence rate rose to over 300 cases per 100,000 person years 
(Ivarsson et al. 2000). These striking figures, urged the Swedish Paediatric 
Association to initiate a prospective epidemiological surveillance system in order to 
investigate the possible origins of this trend. From 1991 to 1997 the register covered 
40% of the population (<15 years) (Ivarsson et al. 2003) and nationwide coverage 
was achieved from 1998 onwards (Olsson et al. 2008b). The epidemic in children 
younger than two years continued over ten years until 1995 (Ivarsson et al. 2000). 
Since all the under 2-year-olds diagnosed experienced classical symptoms of CD 
improved case ascertainment was not deemed a sufficient explanation for the trend 
and an environmental trigger was proposed to play a role. Additionally, policy 
screening of ‘at-risk’ groups had not been implemented at this time. Like the UK, 
infant-feeding recommendations were thought to be responsible for the changing 
incidence. New guidelines were devised and communicated in 1996 prior to the 
epidemic that advocated postponing gluten-containing foods from four to six months 
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of age (Olsson et al. 2008b). This led to a smaller proportion of children being 
breastfed at the time of gluten introduction (68% mothers breastfeeding at 4 months 
compared to 48% at 6 months) (Olsson et al. 2008b) which may reduce future oral 
tolerance to gluten through immune mediating factors in breast milk or by altering 
gut micro-flora (Ivarsson et al. 2013). There was also a twofold increase in the 
consumption of gluten from milk cereal drinks (a liquid infant food common to 
Sweden where the major ingredients constitute wheat flour, water or any other liquid 
such as milk; often with added vitamins and minerals) in young children (<2 years) 
(Ivarsson et al. 2000). In light of these findings Sweden changed its infant feeding 
guidelines in 1995 to introduce gluten-containing foods gradually at 4 to 6 months 
whilst still being breastfed and the gluten content of milk-cereal drinks was to be 
reduced (Olsson et al. 2008b). A reduction in incidence in young children (<2 years) 
diagnosed with CD from ~250 cases/100,000 person-years in 1994 to ~50 
cases/100,000 person-years in 1997 coincided with the new recommendations 
(Olsson et al. 2008). This could be attributed to a rise in the proportion of infants in 
Sweden being breastfed at 6 months of age (from 54% to 76%) (Hernell et al. 2001), 
or the assumption, due to the publication of new guidelines, that a greater proportion 
of children were being breastfed at time of gluten introduction and were exposure to 
a lower amount of gluten during weaning; firm conclusions cannot be drawn at the 
moment.  
Although the epidemic was thought to have abated in 1997, the Swedish prospective 
incidence register continued (now covering 100% of the population) to include 
figures up until 2003 (Olsson et al. 2008). Over this period the incidence rate of CD 
in children less than two years of age doubled and the incidence rate in the whole 
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childhood population (<15 years of age) rose from 16 cases/100,000 person-years in 
1997 to 44 cases/100,000 person-years in 2003 (2.8-fold increase). In contrast to 
cohorts born before the epidemic; where cumulative incidence generally ceased after 
two years of age, cohorts born afterwards displayed a gradual rise in disease 
occurrence with increasing age. This rise in an older age group suggests that infant 
feeding may in fact just delay CD onset due to milder symptoms, although, apart 
from a rise in the proportion of infants being breastfed at six months of age the infant 
feeding practices in Swedish children after 1997 were not reviewed in the study. 
Additionally, the later trend may reflect a lower threshold to test/increased active 
screening in the older age group, although the symptom presentation of cases or 
motivation for diagnosis was not addressed, and thus firm conclusions cannot be 
made. 
Subsequent to the Swedish “epidemic” various case-control studies were conducted 
with the aim of exploring infant feeding in relation to paediatric CD in greater depth. 
A systematic review and meta-analysis of all previous research was published in 
2006 (Akobeng et al. 2006). The review looks firstly at the effect of duration of 
breastfeeding on CD risk, however due to wide methodological variations between 
the separate studies it was not possible to pool the data. Out of the six studies 
included only one did not find a difference in the length of time cases and controls 
were breastfed. Three papers observed that cases were breastfed significantly longer, 
one study found that children breastfed for <90 days were five times more likely to 
develop CD (OR 4.97, 95% CI 3.5 to 6.9) and another found that breastfeeding for 
<30 days was associated with a fourfold increased risk of CD (OR 4.05; 95% CI 2.2 
to 7.27) suggesting longer breastfeeding may protect against CD. The mechanism 
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behind this possible relationship is unclear. However, it is hypothesised that immune 
mediating factors in breast milk such as IgA antibodies, lactoferrin and lysozyme 
may protect against gastrointestinal (GI) infections that could play a role in the 
increased gut permeability in CD (Szajewska et al. 2012). Additionally, a small 
amount of gluten is present in breast milk, which could induce infant tolerance to 
gluten (Szajewska et al. 2012), thus greater exposure may reduce CD risk.  
Four studies in the review by Akobeng and colleagues (2006) were homogenous 
enough to carry out a meta-analysis examining whether or not children (<15 years) 
who were breastfed at the time of gluten introduction were at increased risk of CD. 
The pooled odds established that CD risk was significantly reduced in individuals 
who were breastfed at the time of gluten introduction (OR 0.48; 95% CI 0.40 to 
0.59). It cannot be ascertained from this article whether breastfeeding provides 
permanent protection or merely delays CD onset; this can only be established 
through a longitudinal prospective cohort study. Furthermore, the controls used in all 
but one study were not tested for CD; therefore it is possible, due to silent forms of 
the condition, that some controls were misclassified. 
Only one study to date has examined infant feeding practices prospectively from 
birth. Norris et al. (2005) followed 1560 children at increased risk for CD (HLA 
genotypes associated with CD or having a first-degree relative with TIDM) from 
1994 to 2004 in Colorado, observing whether timing of gluten introduction, 
breastfeeding duration or whether a child was breastfed when first exposed to gluten 
was associated with CD autoimmunity (the DAISY study). Multivariate analysis 
found that children exposed to gluten in the first three months of life (n=64) had a 
fivefold increased risk of developing CD autoimmunity compared to those exposed 
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at four to six months (n=548) (HR 5.17, 95% CI 1.44 to 18.57). In addition, a small 
increased risk was observed in children who did not consume gluten until the seventh 
month (n=895); however confidence intervals pass through 1.0 (HR 1.87; 95% CI 
0.97 to 3.60), therefore the real risk may not be significantly increased. Breastfeeding 
duration and whether a child was exposed to gluten whilst still being breastfed was 
not associated with CD risk. It therefore appears that timing of gluten introduction 
may be more important in relation to CD risk than breastfeeding. However, the 
results of this study are only applicable to children at increased risk for CD and 
infant feeding practices in this American population are likely to differ from the 
European populations previously studied (Akobeng et al. 2006). Moreover, the mean 
age (SD) of children at the end of the study was 4.8 (2.9) years, thus it is not known 
whether earlier gluten exposure merely leads to earlier appearance of CD or is 
associated with increased risk at an older age. Further longitudinal studies are 
warranted to examine CD development in relation to the quantity of gluten 
consumed, although the research to date supports current infant-feeding 
recommendations to avoid early (<4 months) or late (>7 months) gluten exposure 
and to introduce gluten gradually whilst breastfeeding (Agostoni and Shamir 2008). 
2.2.3 Worldwide incidence 
Excluding the three national cohort studies described previously and Scottish 
research, seven European cohort studies have assessed trends in childhood CD 
incidence from the 1980’s onwards (Garampazzi et al. 2007; Hawkes et al. 2000; 
Hurley et al. 2012; Lopez-Rodriguez et al. 2003; Lurz et al. 2009; Ravikumara et al. 
2006; Roma et al. 2009). All three studies undertaken in the UK were conducted in 
South Wales. Retrospective data collection was carried out in a Welsh tertiary care 
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centre between 1981 and 2005 (Hawkes et al. 2000; Hurley et al. 2012) covering a 
population area of 427,400 inhabitants (all adults and children residing in Cardiff or 
the Vale of Glamorgan). Just forty-two children (<16 years) were captured over the 
24-year period. There was not a significant change in incidence between 1981 and 
1995 (p>0.05), however the incidence rate more than tripled from a mean of 
2.1/100,000/year in the epoch 1981-1985 to 6.9/100,000/year in the epoch 2001-
2005; unfortunately statistical significance was not calculated between the first and 
last quinquennia of study which may be due to the low numbers captured. 
A prospective, single centre study recorded the number of new childhood cases (≤16 
years) diagnosed between 1983 and 2004 in South and East Wales (population of 
200,000 ≤16-year-olds) (Ravikumara et al. 2006). A rise in incidence was observed 
over time from a mean of 12.5/100,000/year to 25/100,000/year between the periods 
1990-1998 and 1999-2004. Again, significance was not stated, although this may be 
due to low numbers and absence of age-sex standardised rates. Both Welsh studies 
implicate better screening tools and active testing of ‘at-risk’ groups (e.g. children 
with TIDM or family history of CD in a first-degree relative) for the rise in incidence 
seen; however Hurley et al. (2012) observed a disproportionate increase in the annual 
number of patients tested for CD compared to the proportion of new CD cases 
diagnosed (6% of 309 tTG tests conducted in 1996 compared to 1% of 4616 tTG 
tests conducted in 2005). Therefore, it was suggested that additional factors might 
also be responsible for the rise, other than a better detection rate, for example 
changes in infant feeding practices or infection rates. 
Although research from both Switzerland and Greece focus on the number of 
paediatric patients (<16 years) diagnosed over time in regional and local clinics, 
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these studies present crude figures only; numbers are not presented as a proportion of 
the general population (Lurz et al. 2009; Roma et al. 2009). In the absence of wider 
population statistics it is difficult to draw conclusions from the raw data. A fairly 
short period was captured in Central Switzerland (from 2001 to 2006), nonetheless 
crude numbers doubled from 11 to 22 cases over the six years (Lurz et al. 2009). A 
much longer time frame was captured in Greece (from 1978 to 2007) (Roma et al. 
2009) and the mean (SD) number of patients diagnosed rose from 7.0 (4.0) in the 
period 1978-1987 to 14.1 (8.6) in 1998-2007 (P<0.05). However, the fact that a 
different set of criteria was used to define CD before 1990 (Interlaken criteria 1979) 
and after 1990 (ESPGHAN criteria 1990) limits the significance observed (Table 4). 
Nonetheless, there seems to be a rise in numbers, likely attributable to better 
awareness of CD and its associated conditions between the two time periods and 
improved serological screening tools. However, a true increase in the incidence of 
paediatric CD cannot be excluded.  
Epidemiological research carried out in a Spanish tertiary care centre seems to be the 
most methodologically robust in Europe to date (Lopez-Rodriguez et al. 2003). 
Paediatric (0-14 years) CD incidence rates were estimated based on direct age-sex 
standardisation between 1981 and 1999. Regression analysis revealed a significant 
rise in adjusted rates from 6.9/100,000/year (95%CI 5.3-8.8) in 1981-1990 to 
16.0/100,000/year (95%CI 13.0-19.6) in 1991-1999 (p<0.0001). Although data 
collection methods were particularly comprehensive, one shortcoming of the study 
was the small population area covered by the regional centre in Southeast Spain 
(65,137 <15-year-olds). The authors expressed that the age of gluten introduction, 
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better awareness of CD, and improved serological markers could all be implicated in 
the rising incidence, although these factors were not considered in the study design. 
Three studies have assessed trends in childhood CD incidence in North America 
(McGowan et al. 2009; Murray et al. 2003; Telega et al. 2008). Murray et al. (2003) 
collected data over fifty-two years (between 1950 and 2001) in Olmsted County, 
Minnesota. Incidence rates calculated were age-sex standardised and Poisson 
regression analysis was used to assess trends in rates over time; the standard and 
correct analysis for non-negative integer counts (Chatterjee and Hadi 2006). A 
significant linear trend in incidence was observed in children aged 4-18 years, rising 
from 0.0/100,000 person-years in 1950-1959 to 7.2/100,000 person-years in 2000-
2001, although a rising trend was not seen in children less than four years of age. The 
results of analysis, however, are likely under-powered since just 12 children (0-18 
years) were captured over the study period. 
Both Telega et al. (2008) and McGowan et al. (2009) describe paediatric CD (<18 
years) figures over much shorter time frames in North America, although compared 
to research in Olmsted County considerably more children were diagnosed in both 
single-centres. Telega and collegues (2008) witnessed an increase in new diagnoses 
from just one case in 1986 to 93 cases in 2003 (p<0.001). However, adjusted 
incidence rates were not calculated, limiting any significance observed. A rise in 
incidence was reported in Southern Alberta over similar years from 2.0/100,000/year 
in the epoch 1990-1996 to 7.3/100,000/year in the epoch 2000-2006 (p<0.05) 
(McGowan et al. 2009). Again, rates were not age-sex standardised to the general 
population, and it is unclear from the paper how trends in incidence were evaluated. 
Nevertheless, an important attribute of this study is that the incidence of classical CD 
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was ascertained. Since the incidence of classical cases (characterised by diarrhoea 
and failure to thrive or weight loss of >10% body weight) did not change 
significantly between the two periods it suggests that improved diagnostic techniques 
and better awareness of the condition in practice was the major cause behind the rise 
in CD. 
Only one other longitudinal study has explored paediatric CD incidence rates from 
the 1980’s onwards. Cook et al. (2004) retrospectively collected data on new 
childhood cases (0-12 years) diagnosed across multiple sites in the Canterbury region 
of New Zealand between 1970 and 1999. Although incidence rates were relatively 
stable between 1970 and 1995 (between zero and three cases per year), the number of 
subjects diagnosed increased in the late 1990s to between five and ten cases per year. 
Similar to the preponderance of CD incidence research, it was not clear whether the 
rise was ascribed to true environmental changes or a better detection rate. However, 
the highly sensitive and specific antibody screening tests, tTG and EMA, were 
available for primary diagnostic use from the early 1990s, which may have increased 
the detection rate. Additionally, the incidence of T1DM over the same time period in 
Canterbury rose 3.4-fold (Willis et al. 2002). This, inadvertently, may have led to a 
true rise in CD since TIDM is associated with increased CD risk, or could reflect that 
a similar environmental factor has influenced the rising incidence of both 
autoimmune conditions. 
2.3 Geographical variation in incidence 
Although the prevalence of paediatric CD has been shown to vary between and 
within countries, as discussed in Section 2.1, few studies have assessed geographical 
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distinctions in childhood CD incidence within a country. Regional disparity in CD 
incidence rates could reflect differences in genetics (depending on population 
ancestry), gene-environment interactions or simply differing clinical practice and 
thresholds to test. Paucity of epidemiological research observing geographical 
patterns in CD incidence is unsurprising due to low initiation of national surveillance 
studies. It is likely that smaller studies will have insufficient numbers to perform 
such analyses.   
Both Swedish and Dutch national cohort studies report provincial variation in 
childhood incidence rates (George et al. 1997a; Olsson et al. 2009b). In Sweden, the 
relative risk (RR) of paediatric CD (<15yrs) between 1998 and 2003 was higher in 
the West and in Småland and Islands (RR 1.37 [95% CI 1.14-1.64] and RR 1.38 
[1.13-1.68], respectively) compared to North Middle Sweden and Stockholm (RR 
0.74 [0.59-0.92], RR 0.71 [0.58-0.86], respectively) (Olsson et al. 2009). This 
difference could not be explained by differences in gender, age or calendar year. The 
authors proposed that it did not reflect variation in case ascertainment or reporting to 
the register since data from a corresponding screening study also reported north to 
south discrepancy in the prevalence of CD (Myleus et al. 2009). The geographical 
disparity is likely to be attributed to genetic distinctions in regional populations 
(since approximately one fifth of the Swedish population have foreign origins 
(Statistics Sweden 2012)) as well as environmental factors including dietary patterns.  
The incidence rate of paediatric (0-14 years) CD within the majority of Dutch 
provinces was found to be similar throughout the period 1993-1994; between 
0.30/1000 and 0.50/1000 live births (George et al. 1997a). The rate was slightly 
higher in Utrecht (0.70/1000 live births) and was lowest in Zeeland (0.22/1000 live 
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births). It was suggested that clinical suspicion for CD was higher at the centre in 
Utrecht, as a site associated with particularly extensive CD research, and that a lower 
number of cases were detected in Zeeland due to its small size, absence of a 
university hospital and long distance from the nearest referral centre. Authors, 
however, did not observe whether more or less serological tests per head of 
population were performed in these particular regions compared to other areas, or 
whether a greater incidence of classical, non-classical or actively screened cases 
were detected in Utrecht. This type of analysis would help to establish whether a true 
difference in incidence exists or whether variation between regions is accounted for 
through inconsistencies in primary and secondary care practice.    
Although no countrywide surveillance studies have been conducted in the UK, 
separate regional-centre Scottish studies suggest that national differences in 
childhood CD incidence may be evident. One hundred and twelve new cases of CD 
(<16yrs) were diagnosed in a Tertiary Care Centre (TCC) in the West of Scotland 
between 1995 and 2008 (Basude et al. 2009; Gillett et al. 2009a), whereas 141 
children (<16yrs) were diagnosed in a TCC covering the East of Scotland from 1990 
to 2004 (Buchanan et al. 2009). Although an extra year was observed in the East, and 
slightly different time periods were studied, the TCC in the West covers an area 
approximately double the population density (General Register Office for Scotland 
2011); implying regional variation in incidence.    
Fowell and colleagues (2006) reported preliminary evidence of CD clustering in 
particular areas of Dorset over the years 1998-2002. The incidence of CD in the 
Wimborne area of east Dorset accounted for around half of the rise in incidence in 
the region between the periods 1993-1997 and 1998-2003.  It was discussed that a 
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number of environmental triggers could have participated in the clustering, although 
the study did not account for potential confounders including differences in gender 
proportions, serological testing or case ascertainment based on active screening or 
non-classical presentation. Furthermore, the cohort included both children and adults, 
and thus is not truly applicable to paediatric CD. 
In contrast to Sweden, where, due to an increase in immigration post World War II, 
only 84% of the population are national descendants (Statistics Sweden 2012), just 
one per cent of the population in Scotland has foreign origins (General Register 
Office for Scotland 2012). While genetic variation was reasonably hypothesised to 
play a role in Sweden’s geographical variance, this would unlikely be the case in 
Scotland due to the country’s stable hereditary. Further research is needed in 
Scotland to determine incidence at a national level, but also to see whether regional 
variation in paediatric CD incidence is truly evident and, if so, whether this is a real 
difference or attributed to inequalities in practice.  
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Table 4 Review of paediatric coeliac disease incidence studies, sorted by continent and country of origin (January 1970-December 2012) 
 
Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
EUROPE 
Dossetor 
(1981) 
UK 
Western Scotland 
1962-1966 
1972-1980 
0-4 TC, RCR Grade 3 or 4 
histological 
change (Rubin 
and Dobbins 
1965) 
Cases/104 live 
births: 
6.0 (1963) 
10.7 (1972) 
0.0 (1978) 
Fairly constant incidence between 1962 and1966 (between 4.91 and 
5.96/10,000 live births). 5-fold decrease in hospital admissions of 
infantile gastroenteritis between 1971 and 1978. 15% rise in BF 
locally between 1972 and 1978. 11% of cases in 1962-1966 were 
BF compared to 0% in 1972-‘80. 
Logan 
(1986) 
UK 
Lothian region of 
Scotland 
1940-1979 0-14 SC, RCR + 
HAD + S 
NS (Pre 1960) 
Post 1960 = 
Authors 
definition† 
Crude numbers 
only: 
4 (1940-’44) 
7 (1945-’49) 
12 (1950-’54) 
14 (1955-’59) 
35 (1960-’64) 
76 (1965-’69) 
79 (1970-’74) 
57 (1975-’79) 
 
75% cases <2yrs at diagnosis. The decline in numbers after 1974 
was evident in all ages. 
 
Gillett 
(2006) 
conference 
abstract 
UK 
Southeast 
Scotland 
1990-2005 0-15 TC, RCR ESPGHAN 1990 Cases/105 
1.81 (1990-’94) 
4.3 (1995-’99) 
6.3 (2000-’04) 
Incidence of classical cases stable (~2 per year). Rise in median age 
at diagnosis over time.  
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Basude 
(2009) 
conference 
abstract 
UK 
Southeast 
Scotland 
1990-2006 0-15 TC, RCR ESPGHAN 1990 Cases/105 
1.8 (1990-’94) 
4.3 (1995-’99) 
6.3 (2000-’04) 
7.6 (2005-’06) 
Incidence of classical cases stable (~2 per year). Rise in median age 
at diagnosis over time. 
Buchanan, 
(2009) 
conference 
abstract 
UK 
Western Scotland 
1995-2008 0-15 TC, RCR ESPGHAN 1990 Median crude 
numbers only: 
4 (1995-2001) 
11 (2002-2008) 
Rise in median age at diagnosis over time. All 24 cases diagnosed 
with TIDM captured between 2002 and 2008. Proportion of 
children with diarrhoea and poor weight gain reduced. Rise in 
asymptomatic patients. 
Langman 
(1985) 
UK 
Avon, 
Birmingham, 
Bristol, 
Derbyshire, 
Nottinghamshire 
Merseyside and 
West Midlands, 
England 
1967-1981 0-9 O (records of 
the Coeliac 
Society 
membership 
were 
examined) 
NS Crude numbers 
only: 
38 (1968-’69) 
42 (1970-’71) 
78 (1972-’73) 
89 (1974-’75) 
99 (1976-’77) 
62 (1978-’79) 
45 (1980-’81) 
The proportion of early childhood diagnoses fell over time. 
Kelly 
(1989) 
UK 
London, England 
1960-1985 0-2  SC, RCR ESPGHAN 1970 Crude numbers 
only: 
1 (1960) 
2 (1966) 
4 (1971) 
12 (1973) 
4 (1976) 
2 (1982) 
0 (1985) 
 
Most children presented classically. No difference in presentation 
with time. Rise in mean age at diagnosis. Rise in median age at 
gluten introduction. Age at gluten introduction correlated with age 
at presentation. 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Challacomb
e (1997) 
UK 
West Somerset, 
England 
1971-1992 0-13 SC, RCR + S ESPGHAN 1970 Cases/1000 live 
births: 
0.68 (1971’-80’) 
0.09 (1981’-92’) 
Rise in age at diagnosis. Later introduction of gluten into the diet 
associated with declining incidence and later presenting age. Gluten 
introduced later to breastfed than bottle fed coeliac patients. 
Breastfed children diagnosed later. CD cases and controls weaned 
onto only gluten-containing foods in 1971-‘80. In 1981-‘92 all 
cases weaned onto gluten-containing baby foods, 57.5% of controls 
weaned onto baby rice. 
Fowell 
(2006) 
UK 
East Dorset, 
England 
1993-2002 0-14 SC, APS NS Cases/105 
2.5  
Space-time clustering was evident in the Wimborne Minster area 
during 1998-2002. Accounted for ~half the rise in incidence for 
whole study zone. 
Hawkes 
(2000) 
UK 
South Glamorgan, 
Wales 
1981-1995 0-15 TC, RCR ESPGHAN 1990 Cases/105 
2.1 (1981-’85) 
2.5 (1986-’90) 
2.2 (1991-’95) 
14 M, 13 F. Rise in age at diagnosis (ns). Diarrhoea and vomiting 
commonest symptoms between 1981 and 1990. Replaced by 
differing patterns of abdominal symptoms in 1991-1995. All 
younger children (<4 yrs) had abdominal symptoms. 71% older 
children (>4 yrs) had abdominal symptoms and 29% had anaemia, 
joint pain, vitamin deficiency or fatigue. 
Ravikumara 
(2006) 
UK 
South Glamorgan, 
Wales 
1983-2004 0-16 SC, APS + 
RCR 
ESPGHAN 1990 Cases/105 
12.5 (1990-‘98) 
25 (1999-2004) 
Rise in age at diagnosis. Younger children presented with more GI 
symptoms. Rise in proportion of cases without GI symptoms. Cases 
diagnosed through targeted screening increased. 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Hurley 
(2012) 
UK 
South Glamorgan, 
Wales 
1981-2005 0-15 TC, RCR ESPGHAN 1990 Cases/105 
2.1 (1981-‘85) 
6.89 (2001-’05) 
62% F. Mean age at diagnosis 7.2 yrs. Diarrhoea, weight loss, 
bloating, FTT, vomiting and anaemia most common symptoms. 
9.5% asymptomatic. No difference in mode of presentation between 
two periods. Annual number of patients tested increased 
disproportionately to the proportion of new CD cases diagnosed. 
Mylotte 
(1973) 
Ireland 
Western 
1960-1972 0-11 SC, RCR Grade II or III 
changes on biopsy 
(McNicholl and 
Egan 1968) 
Cases/live births: 
1/597 (Co. 
Galway) 
1/736 (Co. Mayo 
and Co. 
Roscommon) 
Incidence high compared to estimated incidence in England, 
Scotland or Wales at the time.  
 
Stevens 
(1987) 
Ireland 
County Galway 
1960-1981 0-11 TC, O (biopsy 
specimens) 
Grade II or III 
changes on biopsy 
(McNicholl and 
Egan 1968) 
Cases/1000 live 
births: 
1.7 (1960-’70) 
1.9 (1971-’76) 
0.7 (1976-’81) 
Just incidence reported. 
Van Stirum 
(1982) 
Switzerland 
Northeast 
1960-1978  TC, RCR STVA or TVA, 
with remission on 
GFD. 
Cases/live births: 
1/1165 
(1966-’75) 
No linear trend in incidence between 1966-’75. Higher incidence in 
Ireland, Sweden and Austria. Lower incidence in France and 
Australia. 
Lurz (2009) Switzerland 
Berne and 
Lucerne 
2001-2006 0-15 TC, RCR NASPGHAN 
2005 (Marsh 
grade II or III) 
Crude numbers 
only: 
11 (2001) 
22 (2006) 
50.1% F. Similar proportion <2yrs of age each year. No change in 
age. Abdominal pain and diarrhoea most frequent symptoms. 61% 
of cases iron deficient. 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Roma 
(2009) 
Greece 
Athens 
1978-2007 0-15 SC, RCR ESPGHAN 1990 
(post 1989) and 
Interlaken Criteria 
1979 (Pre 1990) 
Crude numbers 
only: 
7.0 (1978-’87) 
7.1 (1988-’97) 
14.1 (1998-’07) 
66% F. Rise in age at diagnosis. Less cases breastfed after 1998 and 
dietary gluten was added to the diet at an older age. Trend towards 
longer delay in diagnosis in more recent years. Atypical forms 
increased and classical forms decreased. Asymptomatic forms only 
discovered after 1998.  
Savilahti 
(2010) 
Finland 
Helsinki 
2000-2005 0-16 TC, HAD + 
RCR 
PVA, STVA or 
TVA or raised 
tTG/EMA and 
IEL count. 
Cases/105 
12.3 
67.5% F. Mean age 7.2yrs. 54.3% GI symptoms. Chronic diarrhoea 
most prevalent in <3yr olds, abdominal pain in >3yr olds. 18.8% 
actively screened. 23.5% low Hb. 42.5% iron deficiency. 
Lopez-
Rodriguez 
(2003) 
Spain 
Southwest 
1981-1999 0-14 TC, RCR ESPGHAN 1990 Cases/105 
6.9 (1981-’90) 
16.0 (1991-’99) 
M:F ratio 1:1.34. Highest incidence in <5 yr olds in both periods. 
Increase in age at diagnosis. Decrease in proportion with typical 
symptoms. Decrease in <2yr olds with typical symptoms. Rise in 
age at gluten introduction. No difference in duration of BF between 
two periods. Positive correlation between age at diagnosis and age 
at gluten intro in both groups. 54.6% sidropenic anaemia, 21.5% 
folate deficiency.  
Greco 
(1989) 
Italy 
Campania 
1973-1986 0-17 SC, RCR + S ESPGHAN 1970 Cases/1000 live 
births: 
0.1 (1973) 
0.2 (1975) 
0.4 (1977) 
0.7 (1979) 
0.8 (1981) 
0.9 (1982-’86) 
59.4% F. No difference in incidence between working class and 
educated class. Home location not associated with CD. Proportion 
of patients living in urban, suburban or rural areas did not change 
with time. Mdn age at diagnosis 15.3 yrs. 2.3% diagnosed >10 yrs 
of age. No change in age at diagnosis. Most children experienced 
symptoms in first year of life, even when diagnosed later. 
Diarrhoea, anorexia and vomiting most common symptoms. No 
variation in pattern of symptoms over time. 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Greco 
(1989) 
Italy 
Campania 
1973-1986 0-17 SC, RCR + S ESPGHAN 1970 Cases/1000 live 
births: 
0.1 (1973) 
0.2 (1975) 
0.4 (1977) 
0.7 (1979) 
0.8 (1981) 
0.9 (1982-’86) 
59.4% F. No difference in incidence between working class and 
educated class. Home location not associated with CD. Proportion 
of patients living in urban, suburban or rural areas did not change 
with time. Mdn age at diagnosis 15.3 yrs. 2.3% diagnosed >10 yrs 
of age. No change in age at diagnosis. Most children experienced 
symptoms in first year of life, even when diagnosed later. 
Diarrhoea, anorexia and vomiting most common symptoms. No 
variation in pattern of symptoms over time. 
Bottaro 
(1993) 
Italy 
Sicily 
1984-1989 0-14 TC, RCR ESPGHAN 1970  Crude numbers 
only: 
117 (1984-’86) 
208 (1987-’89) 
M:F ratio 1:2. Greater proportion of cases with weight loss in later 
period. No difference in minor symptoms such as pallor, short 
stature over time. No difference in proportion breastfed between 
groups. No difference between cases and controls in relation to 
gluten introduction before 4 months. 
Magazzu 
(1994) 
Italy 
Sicily 
1975-1989 0-15 MS, RCR + 
HAD 
ESPGHAN 1990 Cases/1000 live 
births: 
0.42 (1975) 
0.39 (1976) 
0.63 (1977) 
0.73 (1978) 
0.77 (1979) 
Cases/1000 child 
years: 
2.5 (1980) 
2.9 (1984) 
3.25 (1989) 
Unusual symptoms were rare. Decrease in proportion of cases with 
diarrhoea. Rise in age at diagnosis (ns). 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Garampazi 
(2007) 
Italy 
Torino, Novara 
1987-2006 0-15 SC, APS ESPGHAN 1990 
and NASPGHAN 
2005 
Crude numbers 
only: 
66 (1987-’91) 
113 (1992-’95) 
43 (1996-2000) 
85 (2001-2006) 
 
Proportion of cases with typical symptoms decreased. Age at 
diagnosis increased. Rise in proportion of asymptomatic cases. 
Children with typical symptoms were younger. 
Welie 
(1993) 
Denmark 
Copenhagen 
County 
1960-1988 NS CW, HAD + O 
(contact with 
Celiac-Patient 
Society) 
Not specific Cases/1000 live 
births: 
0.08 (1960-’69) 
0.12 (1970-’79) 
0.07 (1980-’88) 
 
There was no difference in incidence between Copenhagen County 
and the rest of Denmark. Lowest incidence yet described (1/7 of 
that diagnosed in Sweden). 
 
Dydensborg 
(2012) 
Denmark 
 (countrywide) 
1996-2010 0-15 CW, HAD + 
RCR 
Marsh grade II or 
III 
Cases/105 
0.8 (1996) 
1.4 (1999) 
6.9 (2009) 
M:F ratio 1:1.7. 15% had an associated condition. Proportion of 
children with associated disorders did not change over time. Rise in 
mean age at diagnosis. Increasing incidence overtime for all ages, 
although this was highest in older children. Children with 
associated conditions were older. 
George 
(1997) 
The Netherlands 
 (countrywide) 
1975-1994 0-14 CW, APS + 
RCR 
STVA or TVA Cases/1000 live 
births: 
 
0.2 (1975-’90)  
0.5 (1993-’94) 
Incidence in each Dutch province was fairly similar (between 0.30 
and 0.50), although it was highest in Utrecht (0.70) and lowest in 
Zeeland (0.22). Decease in proportion of children with abdominal 
distension and growth failure. 7% of children in 1993-94 had 
atypical symptoms. No difference in age at diagnosis between 
periods. No differences in infant feeding between cases and 
controls. 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Steens 
(2005) 
The Netherlands 
 (countrywide) 
1974-2000 0-14 CW, APS + 
RCR 
STVA or TVA Cases/1000 live 
births: 
0.5 (1993) 
0.6 (1994) 
0.6 (1995) 
0.9 (1996) 
1.0 (1997) 
0.9 (1998) 
1.1 (1999) 
0.9 (2000) 
1.1 (2001) 
M:F ratio 1:1.6. From 1996 CD increased more in children >2yrs 
than <2yrs (ns). During 1993-2000 there was a sig. increase in 
diagnosis by partial villous atrophy and decrease in subtotal villous 
atrophy. Rise in age at diagnosis. Children >2yrs more associated 
disorders. Rise in the number of children with FH of CD. 
 
 
 
 
 
 
Stenhamma
r (1987) 
Sweden 
Southeast 
1970-1982 0-15 TC, O (biopsy 
specimens) 
ESPGHAN 1970 Cases/1000 live 
births: 
1.27 (1970-’76) 
1.43 (1977-’82) 
 
68% F.  
Ascher 
(1993) 
Sweden and 
Finland 
Tampere and 
Gothenburg 
1985-1989 0-17 MS, RCR ESPGHAN 1970 
and ESPGHAN 
1990 
Crude numbers 
only: 
61 (Tampere) 
86 (Gothenburg) 
Older age at diagnosis in Finland. Finnish patients and patients with 
a late diagnosis had sig. less severe symptoms. Controlling for 
differences in age and sex, abdominal distension, constipation and 
abnormal weight gain were more frequent in Swedish children 
(P<0.05). 12% Finnish and 2% Swedish=TIDM. Finnish children 
BF slightly longer. Gluten introduced slightly later in Swedish 
children. 
Ivarrson 
(2003) 
Sweden 
(countrywide) 
1973-1997 0-14 MS, HAD + 
RCR + APS 
ESPGHAN 1990 Cases/105 
9.7 (1973-’84) 
34.5 (1985-’95) 
21.1 (1996-’97) 
Incidence twice as high is girls RR1.9 in <2 yr olds.  
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Olsson 
(2008) 
Sweden 
(countrywide) 
1973-2003 0-14 CW, RCR + 
APS 
ESPGHAN 1990 Cases/105 
10 (1974-‘84) 
45 (1994) 
16 (1997) 
44 (2003) 
 
Rise in age at diagnosis. 
 
Olsson 
(2009) 
Sweden 
(countrywide) 
1998-2003 0-14 CW, RCR + 
APS 
ESPGHAN 1990 Cases/105 
40 (West Sweden) 
39 (Smaland and 
the islands) 
21 (North Middle 
Sweden) 
22 (Stockholm) 
 
RR for CD was significantly higher in West Sweden (RR 1.37) and 
Smaland and the islands (RR 1.38) compared to North Middle 
Sweden (RR 0.74) and Stockholm (RR 0.71) controlling for gender, 
age at diagnosis and year of diagnosis. 
NORTH AMERICA  
 
58 F, 24 M. All white European decent. All symptomatic. Murray 
(2003) 
USA 
Olmsted County, 
Minnesota 
1950-2001 0-3 
4-18 
MS, HAD + 
RCR + O 
(membership 
rolls of the 
local celiac 
support group) 
ESPGHAN 1990 Cases/105 person 
years: 
0-3 years 
1.7 (1950-’59) 
0.0 (1960-’69) 
1.6 (1970-’79) 
1.5 (1980-’89) 
2.8 (1990-’99) 
0.0 (2000-’01) 
4-18 years 
0.0 (1950-’59) 
0.5 (1960-’69) 
0.4 (1970-’79) 
0.0 (1980-’89) 
0.4 (1990-’99) 
7.2 (2000-’01) 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Telega 
(2008) 
USA 
Wisconsin 
1986-2003 1-17 SC, RCR NASPGHAN 
2005 
Crude numbers 
only: 
1 (1986) 
93 (2003) 
Rise in age at diagnosis. GI symptoms predominated in children <3 
years old, the majority of >3-year-olds had extra-intestinal 
symptoms. Decease in number of patients only presenting with GI 
symptoms. 69.7% diagnosed on the basis of an associated 
condition. With increasing histological injury there was increased 
frequency of GI symptoms. 
McGowan 
(2009) 
USA 
Southern Alberta 
1990-2006 0-17 SC, RCR NASPGHAN 
2005 
Cases/105 
2.0 (1990-’96) 
7.3 (2000-’06) 
61% F.  Increase in age at diagnosis. Proportion of cases with 
classical CD decreased. Atypical and extra intestinal presentation 
remained unchanged. Silent presentation increased. 
ASIA  
55% F. Mean age 9.6 years. 51% actively screened. 49% classical 
symptoms of malabsorption. Diarrhoea, anorexia, abdominal 
distension, poor weight gain and abdominal pain commonest 
symptoms. 35% weight <3rd centile and 38% height <3rd centile. 
66% anaemic, 35% low albumen, 17% raised ALT and AST. 
Saadah 
(2011) 
Saudi Arabia 
Jeddah 
2002-2007 0-18 SC, RCR Not specific Crude numbers 
only: 
80 
Balamekin 
(2010) 
Turkey 
Ankara 
2000-2008 0-15 TC, RCR ESPGHAN 1990 Crude numbers 
only: 
220 
60.9% F. Mean age 7.2 years. 58.6% GI symptoms, 34.6% non-GI 
symptoms, 6.8% asymptomatic. Patients with GI symptoms were 
younger. 52.3% weight <3rd centile, 38.2% height <3rd centile. 
48.2% anaemia. 
Rawashdeh 
(1996) 
Jordan 
Northern 
1991-1994 0-16 TC, APS ESPGHAN 1990 Cases/1000 live 
births: 
0.4 
12 M, 22 F. Mean age at diagnosis 8.4 yrs. Median delay in 
diagnosis from onset of symptoms was 4 yrs. Median delay in 
children who first experienced symptoms after the age of 5 was 6.5 
yrs. 
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Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
Dahan 
(1984) 
Israel 
Rehovot-Ashdod 
1968-1981 NS TC, RCR PVA, STVA or 
TVA 
Cases/1000 live 
births: 
0.5 (1968) 
1.5 (1974) 
0.6 (1978) 
 
52% F. 70% diagnosed <2 yrs of age. Highest incidence in children 
born to women of Asian and Middle Eastern origin and lowest in 
children born to women from Israel. 
 
Singh Puri 
(2004) 
India 
New Delhi 
1998-2002 0-15 TC, RCR ESPGHAN 1990 Crude numbers 
only: 
12 
7 M, 5 F. Age range 4-15 yrs. 7 cases non-diarrhoeal (atypical). 
Children presenting with atypical symptoms were older. 
 
Bhattachary
a (2012) 
India 
New Delhi 
 
2009-2011 NS TC, RCR ESPGHAN 1990 Crude numbers 
only: 
381 
M:F ratio 1.4:1. Mean age 6.2yrs. Children with non-diarrhoeal CD 
presented at a later age compared to classical cases. Abdominal 
pain, abdominal distension, constipation, vomiting, FTT and 
anaemia commonest symptoms. 16.7% asymptomatic. 50% iron 
deficiency, 38.6% B12 deficiency, 18.1% folate deficiency. 
AFRICA 
Al-Tawaty 
(1998) 
 
Libya 
Benghazi 
 
1976-1993 
 
0-18 
 
TC, RCR + 
APS 
 
ESPGHAN 1990 
(patients 
diagnosed 1976-
1990 on clinical 
grounds were 
challenged and 
biopsied to 
confirm 
diagnosis) 
 
Crude numbers 
only: 
40 (1976-’90) 
37 (1991-’93) 
 
 
M:F ratio 1:1.3. Mean age at presentation 5.9yrs. Three children 
had giardiasis, one had growth hormone deficiency. Weight loss, 
anaemia, diarrhoea and abdominal distension most frequent 
symptoms. Finger clubbing in three patients, six coeliac crisis 
(circulatory collapse, oedema, weight loss, abdominal distension 
and electrolyte disturbance). One child had rectal prolapse. 
 
  
  
56 
Author 
(year) 
Country & 
Jurisdiction or 
region 
Years of 
data 
collection 
Age 
range* 
(years) 
Method of 
case 
ascertainment 
Definition of CD Incidence rate Main observations 
 
AUSTRALIA 
 
      
 
M:F ratio 1:2. Median age 5.5 yrs. 9% <2yrs. 93% symptomatic. 
Diarrhoea, irritability, weight loss commonest symptoms in <5yr 
olds. Abdominal pain, diarrhoea, tiredness, abdominal distension 
most common symptoms in <5yr olds. Four children TIDM screen, 
1 screened due to recurrent infection. 18% FH (not screened). 5% 
weight and height more than 2SD below the mean. 25% 
Hb<118g/L. 86% iron deficiency. 
Stone 
(2005) 
Australia 
Sydney 
1997-2002 0-14 TC, RCR ESPGHAN 1990 Crude numbers 
only: 
119 
Ussher 
(1994) 
New Zealand 
Wellington 
1985-1992 0-12 SC, RCR STVA or TVA  Cases/105 
0.19 
 
Cook 
(2004) 
New Zealand 
Canterbury 
1970-1999 0-11 MS, RCR Marsh grade III 
(Oberhuber et al. 
1999) 
Cases/1000 live 
births: 
0 (1970-‘72) 
1.40 (1997-‘99) 
M:F ratio 1:2.1. 
 
 
 
 
Westerbeek 
(2005) 
New Zealand 
Auckland 
1999-2002 0-16 TC, RCR PVA to TVA, 
crypt hyperplasia, 
raised IEL count, 
and increased 
infiltration of 
lymphocytes and 
plasma cells in the 
lamina propria. 
Crude numbers 
only: 
48 
58% F. 81% symptomatic. 62% >5yrs of age. Asymptomatics were 
identified mainly on the basis of screening. Mean age 6.9yrs. FTT, 
diarrhoea, abdominal pain and poor appetite were commonest 
symptoms. Older cases had more abdominal pain and younger cases 
more FTT. 33% FH. 
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Method of case ascertainment: SC, single centre; TC, tertiary care centre; MS, multi-centre; CW, countrywide; APS, active prospective surveillance; RCR, retrospective chart review; S, 
retrospective survey; HAD, health administrative data or large area epidemiological database; O, other.  
Definitions of CD: ESPGHAN 1990 (Walker-Smith et al. 1990); ESPGHAN 1970 (Meeuwisse 1970); NASPGHAN 2005 (Hill 2005); Interlaken criteria (McNeish et al. 1979); Marsh 
Grade II or III (Oberhuber et al. 1999); STVA, sub-total villous atrophy; PVA, partial villous atrophy; IEL, intraepithelial lymphocytes; TVA, total villous atrophy; †Either 1) STVA, 
disorganised enterocyte lining, loss of brush border, raised IEL count, infiltration of propria lamina with plasma cells and lymphocytes, and prominence of crypts with hyperplasia and 
hyperchromasia or 2) Changes in villous architecture, crypts, lamina propria, enterocyte lining and IEL count. 
Incidence rate: NR, specific numbers not reported, just overall trends in disease occurrence i.e. an increase or decrease in incidence. 
Other abbreviations: CD, coeliac disease; M, male; F, female; GFD, gluten-free diet; BF, breastfeeding; TIDM, type 1 diabetes mellitus; tTG, ant-tissue transglutaminase; EMA, 
endomysial antibodies; FTT, failure to thrive; FH, family history; Hb, haemoglobin; GI, gastro-intestinal; ALT, alanine aminotransferase; AST, aspartate aminotransferase; RR, relative 
risk; Mdn, median; ns, not significant; NS, not stated. 
*Age range reported is inclusive. 
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2.4 The changing presentation of paediatric coeliac disease 
In Section 2.2, the changing incidence of childhood CD was discussed in detail. 
Prospective and retrospective longitudinal research has observed that the incidence 
of CD has risen dramatically over the last 20-30 years. Improved clinical awareness 
of the heterogeneity of CD may have influenced incidence rates, as greater numbers 
are diagnosed on account of a lower threshold to test. Coinciding with a rise in 
incidence, a number of papers further report changes in the presentation of childhood 
CD. In the UK, Buchanan et al. (2009) witnessed a rise in the number of CD cases 
with associated TIDM between 1995 and 2008 in a Scottish tertiary centre. Although 
in this study it was not clarified whether these patients were diagnosed through active 
screening or were detected on the basis of a symptomatic presentation. The 
proportion of children diagnosed with CD, who present with diarrhoea and poor 
weight gain decreased whilst there was a rise in the number of 
asymptomatic/actively-screened cases. Additionally, the median (IQR) age of cases 
at diagnosis rose from 2.42 (1.62-4.60) years in 1995-2001 to 7.25 (3.58-10.56) in 
2002-2008 (p<0.0001). The findings suggest that increased active screening of 
children ‘at-risk’ for CD and a lower threshold to test for CD in older age groups will 
likely have played a role in the rising incidence, although the influence of improved 
clinician awareness is not controlled for in the study. 
Researchers in Wales have also described alterations in the presentation and 
diagnosis of CD. Ravikumara and colleagues (2006) observed that a greater 
percentage of children diagnosed with CD in the epoch 1990-1998 exhibited GI 
symptoms compared to those identified between 1999 and 2004. There was a rise in 
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the number of cases detected on the basis of active screening and median age at 
diagnosis increased from four years in 1983-1989 to eight years in 1999-2004. In 
contrast, in a separate Welsh study carried out over a similar time period, mode of 
presentation was found to be similar in both early and later cohorts (Hurley et al. 
2012). However, this could be a result of the small sample size (n=69), and thus the 
study being under-powered to detect any significant differences. 
Several European and North American studies further report a rising trend towards 
older age at diagnosis and a reduction in the proportion of cases (in more recent 
years) with classical forms of childhood CD as well as GI symptoms in general 
(Garampazzi et al. 2007; Lopez-Rodriguez et al. 2003; Magazzu et al. 1994; 
McGowan et al. 2009; Roma et al. 2009; Steens et al. 2005; Telega et al. 2008). The 
percentage of children presenting with non-classical CD at a single-centre in Greece 
rose from 1.4% to 36.2% (p<0.001) between the periods 1978-1987 and 1998-2007 
(Roma et al. 2009). Clinicians at a hospital in Italy also observed a significant 
increase in asymptomatic patients diagnosed with CD between the cohorts 1987-
1995 and 1996-2006 (Garampazzi et al. 2007), although statistical tests used for 
analysis were not stated in the paper, limiting the results observed. National data 
collected in The Netherlands shows a rising trend in the proportion of cases with 
family history of CD from 4% in 1993 to 19% in 2000 (Steens et al. 2005), although 
authors do not mention how many of these cases were diagnosed due to active 
screening. 
Results of the above studies do suggest advances in clinician awareness of atypical 
presentations and related conditions that will likely have played a significant role in 
the rising incidence observed. However, the observation that a lower proportion of 
  
60 
cases in more recent years have classical or predominantly GI symptoms does not 
necessarily mean that fewer children are presenting in this manner or that these 
children were not detected through screening. It is also important to mention that 
until recently there was lack of consensus regarding the definition of classical CD 
(Ludvigsson et al. 2012). There are likely to be inconsistencies in presentation data 
prior to the publication of ‘Oslo’ definitions in 2012 which, after an extensive review 
of the literature by an expert panel, defined paediatric classical CD as having specific 
signs/symptoms of malabsorption where either diarrhoea, steatorrhea, weight loss, 
growth failure, muscle wasting or abdominal distension must be present (Ludvigsson 
et al. 2012). Only by determining trends in motivations for testing overtime can it be 
confirmed whether a rise in incidence is due to a lower threshold to test or whether 
other exogenous factors may be implicated.  
2.5 The dietetic management of coeliac disease in childhood 
Once diagnosed the life-long treatment for CD is strict adherence to a GFD as 
discussed in Section 1.1.6. Unlike NICE clinical guidelines for the recognition and 
assessment of CD, there are no definitive UK guidelines in place for the dietetic 
management or follow-up of paediatric CD in practice. However, documents 
published by BSPGHAN and the British Society of Gastroenterology (BSG) provide 
advice on how best to treat and monitor CD in childhood (BSPGHAN 2005; BSG 
2002) (Table 5). Specialist input from a registered dietitian is clearly inferred in both 
documents, supporting the views of the National Institutes of Health (NIH) 
consensus panel on CD (NIH 2005). The panel stress that consultation with a 
specialist dietetic professional is essential both at time of diagnosis and throughout 
follow-up to deliver advice, education and support to patients and that they should be 
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the principal source of nutritional information (NIH 2005). Additionally, UK 
gastroenterologists have stated that a coeliac disease specialist dietitian should be 
employed in every hospital throughout the UK to provide dietary advice, empathy 
and empowerment to patients (Sanders et al. 2005). A dietitian should have in-depth 
knowledge or skills in the following areas:  
1) the role of food and nutrients in the treatment and prevention of disease and 
how specific conditions can influence nutritional intake and nutritional status; 
2) the nutritional composition of foods and how different foods/meals are 
prepared;  
3) the impact of socioeconomic, psychological and educational issues on food 
choice and nutritional intake;  
4) communicating scientific information in lay terms, empowering individuals 
to gain knowledge, improve decision-making skills and change behaviours 
(Case 2005).  
Dietitians have argued that a delay in referral after diagnosis of CD increases the 
probability that the patient, or family of the patient (child) will seek inaccurate 
information from sources such as the internet, health food stores, friends and 
alternative health practitioners, which may result in misunderstandings, frustration 
and poor knowledge in relation to CD and the GFD (Dennis and Case 2004). 
However, limited research on the dietetic management of CD patients has been 
conducted, and thus it is not known how differences in practice affect physical, 
psychological and emotional health.  
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Table 5: Summary of BSPGHAN and BSG guidelines on the management of 
paediatric coeliac disease 
Importance of 
management: 
 Resolve symptoms and nutritional deficiency 
 Reverse bone-demineralisation if pre-pubescent (reducing future 
osteoporosis risk) 
 Reduce the risk of delay in puberty, menstrual problems, subfertility and 
spontaneous abortion 
 Prevent onset of other autoimmune conditions 
 Possibly improve diabetic control 
 Decrease rate of some intestinal cancers to normal population levels 
Important issues 
to be addressed: 
 The definition of gluten free foods 
 The role of oats in the diet 
 Wheat starch and malt extract in the GFD 
 Support group contact; specifically Coeliac UK 
 Prescription products 
 The need for life-long treatment 
 Possible supplementation until deficiencies resolve 
 Importance of calcium 
 How to overcome situations and stages in life when adherence may seem 
difficult. 
Monitoring 
progress should 
involve: 
 A clinical assessment of symptoms, growth, physical examination and 
adherence to the GFD. This should take place 6-12 months after GFD 
initiation by an experienced paediatric dietitian. In addition to carefully 
questioning patients to identify adherence levels an anti- tTG test will be 
required to expose any relapse. 
 Subsequent annual clinical assessment (as above) should take place. 
 Urgent clinical review if symptoms reoccur. 
 Review at times of stress (physical or emotional) 
Adapted from BSPGHAN guideline for the diagnosis and management of coeliac disease in children (2005) and 
BSG guidelines for the management of patients with coeliac disease (2002) 
Abbreviations: BSPGHAN, British Society for Paediatric Gastroenterology, Hepatology and Nutrition; BSG, 
British Society of Gastroenterology; GFD, gluten-free diet. 
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A survey undertaken by Coeliac UK uncovered large variation in the level and type 
of dietetic provision available to patients as reported by chief dietitians or dietetic 
managers in the UK (Nelson, Mendoza, and McGough 2007). It was identified that 
in 101 centres over 50% of paediatric departments allocated no specific time to 
patients with CD, only a sixth of children were seen in a specialist coeliac clinic and 
just 59% of centres had policy in place for management of CD. This is worrying, 
since operating specialised coeliac clinics and having defined local policy was 
positively associated with the number of hours devoted to patient care (Nelson, 
Mendoza and McGough 2007). Furthermore, research has demonstrated that tailored 
nutritional advice in intestinal diseases improves nutritional knowledge, nutritional 
intake and nutritional status in patients (Culkin, Gabe, and Madden 2009). Therefore, 
due to inconsistencies in the dietetic management of paediatric CD across the UK, 
children with CD living in certain geographical areas may not be getting the same 
education or support with regards to their condition, which may lead to increased risk 
of nutritional inadequacy and poor adherence to the GFD. 
Research is lacking regarding the details of CD management in the UK such as who 
provides the management e.g. a multi-disciplinary or dietetic-led team, the planned 
frequency of follow-up, the type of information and advice provided, methods 
employed to assess health status or the actions taken to improve health status. It is 
important to collect this information to see whether differences in management effect 
levels of adherence to the GFD, health related quality of life, nutritional status or 
other outcomes such as fertility status or management of associated conditions; 
TIDM for example. Additionally, it may help to identify key areas that are not 
addressed or insufficiencies in practice which could have an impact on adherence or 
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the current and future health of patients, thus helping to inform management policy 
which is due to be published in June 2015 (NICE 2012). 
2.6 Rationale for a national paediatric coeliac disease incidence register 
in Scotland 
NHS Scotland is divided into three tertiary regions (East, West and North) for 
paediatric gastroenterology, hepatology and nutrition (PGHAN) services. Key 
tertiary centres and outreach clinics within each region are responsible for the 
diagnosis and management of paediatric CD. Incidence of childhood CD within 
Scotland as an entirety has never been addressed and therefore it is not known if 
differences in CD diagnosis or practice exist between separate tertiary regions.  
Previous research from Sweden, The Netherlands and the UK report geographical 
variation in paediatric CD incidence, and unpublished data collected in tertiary 
centres in the East and West of Scotland suggests there may be differences in the 
incidence of paediatric CD between these two regions. However, disparity and 
limitations in methodologies could also explain the variation in the reported numbers 
diagnosed since different time periods were captured and incidence rates were not 
age or sex standardised. Thus, a study that implements the same data collection 
methods between regions and accurate measures of incidence is needed. 
Additionally, no previous report has related regional distinctions to variation in the 
incidence of cases diagnosed due to a lower threshold to test i.e. due to active 
screening or a non-classical presentation, or variation in the incidence of cases 
diagnosed because of having classical symptoms (which may signify a true 
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difference). If regional variation is detected, establishing trends in the reasons behind 
case ascertainment may provide better insight into why such disproportion exists.  
Establishing a prospective national incidence register in Scotland is timely. New 
guidelines on the recognition and assessment of CD
 
have been accessible to 
clinicians practicing in both primary and secondary care in Scotland since 2009. The 
unpublished Scottish studies noted above cover different time periods in which 
clinical knowledge of non-classical symptoms and associated conditions may have 
varied. Recognising inequalities in case ascertainment between centres and reasons 
underlying this through a prospective incidence register will provide an evidence 
base for future allocation of funding or practitioner education in primary or tertiary 
services in the UK. Additionally, due to limited data on dietetic follow-up in CD an 
obvious extension of the clinical data collected in new patients will be to gather 
information on their management once diagnosed. Over time, this will help to 
determine the most desirable modes of practice for optimal health in this population 
and establish whether any inequalities in management exist with the hope of 
informing future treatment policy guidelines. 
2.7 Rationale for a paediatric retrospective cohort study in Scotland 
A historical report on the incidence of childhood CD in SE Scotland has not been 
published since 1986 (Logan et al. 1986). Clinical data has been retrospectively 
collected in the region on affected children for audit between 1990 and 2005, but 
never comprehensively collated and published. Although the majority of studies that 
have observed trends in paediatric CD incidence over the last thirty years report a 
rise in new cases, an extensive review of the literature has uncovered various 
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methodological limitations and bias- including lack of age-sex standardised rates, 
inappropriate use of statistical tests to observe trends in incidence over time, low 
numbers and changes in the definition of CD between early and late cohorts. 
With a child population (<16 years) of ~225,000 (General Register Office for 
Scotland 2011) SE Scotland is sufficiently large enough to observe longitudinal 
trends in incidence further, thus allowing comparisons over time to be made. 
Pathologists in the region have used the same criteria to define CD since 1990 
(Walker-Smith et al. 1990). Furthermore, Scotland’s ethnic stability and low rate of 
immigration from countries outwith the UK (0.57%) (Registrar General for Scotland 
2001) makes epidemiological surveillance of a genetic condition particularly robust. 
A few studies have associated the rising incidence of paediatric CD with changes in 
environmental exposures such as infant feeding practices. Additionally, a lower 
threshold to test has continually been implicated as a key factor in the accrual. The 
rationale behind this being that more cases in recent years present at an older age 
with non-classical or no apparent symptoms, and fewer children present with 
classical GI indicators. No report, however, has specifically calculated the age-sex 
standardised incidence of cases diagnosed over time because of a lower threshold to 
test or on the basis of a well defined classical presentation. Analyses performed on 
such robust data will help to expose whether a rise in incidence can entirely be 
attributed to a heightened clinical awareness of CD, i.e. due to improved knowledge 
of CD’s varied presentation and active screening of children with associated 
conditions, or whether a true rise is evident. 
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2.8 Research aims 
Study 1: The incidence of childhood coeliac disease in Scotland – the Scottish 
Paediatric Surveillance Unit (SPSU) coeliac project 
The principle aims of this study are to:  
1. Determine the current diagnosed incidence (all new cases) of childhood CD 
in Scotland. 
2. Identify case presentation and reasons for diagnosis. 
3. Identify any differences in case ascertainment and practice between regional 
networks. 
4. Collect information on the nutritional status and dietetic management of 
newly diagnosed paediatric coeliac patients. 
The SPSU study and corresponding dietetic management audit proposed to answer 
the following specific research questions: 
1. What is the age-sex standardised incidence of paediatric CD in Scotland 
between 01/09/2009 and 31/08/2011? 
2. What is the age-sex standardised incidence of paediatric CD in each regional 
Scottish NHS network: East, West and North between 01/09/2009 and 
31/08/2011? 
3. What are the demographic and disease characteristics of the newly diagnosed 
cases and how are they diagnosed? 
4. What is the age-sex standardised incidence of cases diagnosed primarily due 
to: 1) a classical presentation; 2) a non-classical presentation; 3) targeted 
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screening of an at-risk condition or family history of CD in a first-degree 
relative? 
5. How many serological tests for paediatric CD (Anti-tTG and EMA) were 
performed in each regional Scottish network between 01/09/2009 and 
31/08/2011? 
6. Are there any differences between regional networks with regards to 
incidence, reasons for diagnosis, demographics characteristics, diagnostic 
techniques and serological test requests? 
7. What is the nutritional status of newly diagnosed patients, and what method 
of dietetic input do they receive? 
Study 2: Trends in paediatric coeliac disease in southeast Scotland from 1990-
2009 – a retrospective audit of cases 
The two primary aims of the retrospective audit are: 
1. To review all newly diagnosed cases of paediatric CD in SE Scotland 1990-
2009 to determine longitudinal trends in: 
 diagnosed incidence 
 demographic characteristics at time of diagnosis 
 initial reasons for clinical suspicion of CD i.e. classical presentation, non-
classical presentation or the presence of an associated condition e.g. 
TIDM or family history of CD in a first-degree relative 
2. To determine the most common serological abnormalities at diagnosis for 
patients diagnosed 2005-2009. 
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The twenty-year retrospective audit of case notes proposed to answer the following 
specific research questions: 
1. What is the mean age-sex standardised incidence of paediatric CD (<16 
years) in the following five-year epochs in SE Scotland: 1990-1994 (Epoch 
1), 1995-1999 (Epoch 2), 2000-2004 (Epoch 3) and 2005-2009 (Epoch 4)? 
2. What are the demographic and disease characteristics of the newly diagnosed 
coeliac patients in each five-year epoch including the number of under 2-
year-olds diagnosed? 
3. What is the mean age-sex standardised incidence of cases diagnosed 
primarily due to: 1) a classical presentation; 2) a non-classical presentation; 
3) targeted screening of an at-risk condition or family history in a first-degree 
relative in each five-year epoch? 
4. Are there any significant trends over time with regards to age-sex 
standardised incidence, initial reasons for clinical suspicion of CD or 
demographics characteristics? 
5. For the five-year period from 2005-2009, what are the most common blood 
abnormalities of the paediatric coeliac patients (<16 years) in SE Scotland? 
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Chapter 3: Literature review part 2 – Adolescent adherence to the 
gluten-free diet; nutritional adequacy, factors associated with 
adherence and health-related quality of life 
3.1 The gluten-free diet: importance for health 
Untreated CD has been observed to increase the risk of future complications 
including osteoporosis, fertility difficulties and even certain cancers (Haines et al. 
2008). It is well established that following a strict GFD leads to resolution of 
symptomatic complaints and improves nutritional status (Steele and CRF 2011). 
However, perhaps more importantly, adherence to the diet may reduce the risk of the 
complications aforementioned (Cranney et al. 2005). The following sections discuss 
in greater detail the existing evidence that supports adherence to the GFD in relation 
to nutritional status, bone health, reproductive health and risk of malignancy, but will 
also consider HRQoL, as for many, dietary choices become limited and following the 
GFD may lead to stigmatisation or negative emotions (Cinquetti et al. 1999; Ohlund 
et al. 2010; Olsson et al. 2009a). 
3.1.1 Nutritional status 
Small intestinal enteropathy of the villi in CD can severely affect absorption of 
essential nutrients (Jones and Sleet 2009). Iron, calcium and folate deficiencies are 
common at diagnosis due to their absorption being affected in the proximal small 
bowel, although increased progression of the disease without detection may lead to 
malabsorption of fat, carbohydrate and the fat soluble vitamins; A, D, E and K 
(Cranney et al. 2005; Fasano and Catassi 2001; Haapalahti et al. 2005). However, the 
removal of gluten from the diet allows restructure of the duodenal and jejunal villi, 
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improved absorption of nutrients and symptomatic remission in the vast majority of 
patients (Niewinski 2008).  
A follow-up study of 25 Indian children (mean [SD] age 8.3 [3.4] years) with CD 
identified that the proportion of children with height standard deviation scores 
(HSDS) <-2 (representing short stature) decreased from 76% (19/25) at diagnosis to 
12% (3/25) after a mean of 3.7 years on a GFD (Yachha et al. 2007). Additionally, 
the number of undernourished children (percentage of median weight for height less 
than 90%) decreased from fifteen (60%) to four (16%) over the study period. 
Although small bowel histology did not normalise in all patients there was a marked 
improvement in villous architecture overall suggesting the GFD plays an important 
role in bowel recovery and favourable catch-up growth. Ciacci and colleagues (2005) 
compared anthropometric measurements and clinical data between adults (mean [SD] 
age 23.7 [4.3] years) diagnosed with CD in Italy as children who had always 
maintained a GFD (n110) and adults (mean [SD] age 23.1 [1.2] years) diagnosed as 
children who, after a variable time period (at least one year), were re-exposed to 
gluten and were currently following a normal diet (n=85) (reasons for re-exposure 
are not stated). Body mass index (BMI), serum ferritin and haemoglobin (Hb) 
(measures of iron status) and total serum protein were all significantly lower 
(p<0.01) in the re-exposed group (Ciacci et al. 2002). However, authors do not state 
whether more cases in the re-exposed population had definitively low markers of 
nutritional status, limiting the findings of this study.  
A small Italian study (n=20) assessed measures of body-composition in children 
diagnosed with CD (mean age [SD] 10.12 [3.07] years) at diagnosis and again after 
one year following a strict GFD (Barera et al. 2000). Outcomes were compared to 
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age-sex matched healthy controls. Weight, lean mass of limbs, fat mass and 
percentage fat mass were all significantly lower (p<0.05) in the CD group at 
diagnosis compared to controls, whereas after one year measures of body 
composition were similar in both groups. A similar case-control study was conducted 
in another Italian centre and showed comparable results (Rea et al. 1996). Twenty-
three children diagnosed with CD (mean [SEM] age 4.7 [0.76] years) had 
significantly (p<0.01) lower measurements of height, arm muscle area, triceps 
skinfold (TSF), subscapular skinfold (SSSF) and fat area index (FAI) compared to 
age-sex matched control subjects at diagnosis. After 12 months on a GFD all 
measurements significantly increased (p<0.01) and TSF, SSSF and FAI 
measurements were similar to controls. It should be noted that mean height z-scores 
were still significantly lower compared to controls at follow-up (p<0.05). However, 
the number of children with height z-scores below the normal range decreased from 
six to one (Rea et al. 1996). Although the aforementioned studies report favourable 
anthropometric outcomes related to following a GFD, they are both under-powered 
to detect truly significant differences. Additionally, serological markers (Anti-tTG 
and Anti-EMA) were used to assess adherence to the GFD in both studies and 
validation research has shown that these tools are poorly associated with GFD 
adherence (Leffler et al. 2007). 
A systematic review of the evidence base for the long-term management of CD 
shows that a GFD in adult CD patients can prevent nutritional deficiencies, 
especially iron deficiency anaemia (Haines et al. 2008). A study carried out in 
Finland, identified 12 of 26 adolescents and young adults (median age [range] 17 
[16-25] years) with CD to have nutritional abnormalities at diagnosis (nine had low a 
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serum folate, eight low ferritin, three low vitamin B12 and nine low receptor-ferritin 
index) (Haapalahti et al. 2005). The majority of participants’ iron indices improved 
on a GFD, however significance is not stated in the paper and it is not known 
whether serum levels returned to normal ranges, limiting the interpretation of 
findings. Additionally, Rea and colleagues (1996) observed that Hb and serum iron 
concentrations were below normal ranges in approximately 50% of 23 children with 
CD at diagnosis. After 12 months on a GFD just one patient had low Hb levels 
(p<0.001) and three had low serum iron (p<0.01). Although the results reported 
above highlight that a GFD is likely to be beneficial in terms of reducing iron 
deficiency neither study mentions whether nutritional supplements were taken after 
diagnosis, thus limiting interpretation as to whether improved status is solely through 
compliance to a GFD or additional supplementation. Larger longitudinal studies are 
necessary to investigate the role of GFD adherence on nutritional status parameters 
over longer periods of follow-up, controlling for nutritional supplementation. 
3.1.2 Bone health 
Impairment of bone health has been associated with CD since the 1950’s (Mora 
2008). Low bone mineral content (BMC), depleted bone formation markers and 
increased bone resorption markers have all been observed in children and adolescents 
with CD (Barera et al. 2004; Corazza et al. 1995). A North American study 
determined that at time of diagnosis children with CD (mean [SD] age 10.6 [3.4] 
years) were around five times more likely to have low whole body BMC (z-score <-
2) for age (OR 4.88, 95% CI 1.17-20.32) and height (OR 4.92, 95% CI 1.15-21.11) 
compared to age-sex matched controls (Jatla et al. 2009). However, the odds ratios 
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calculated in the study were associated with wide confidence intervals, which may be 
attributed to the study being under-powered.    
The pathogenic process attributed to poor bone health in CD patients is controversial. 
Numerous factors have been implicated including low calcium and vitamin D 
absorption (due to villous damage) leading to increased secretion of parathyroid 
hormone (PTH), which augments bone resorption (Bianchi and Bardella 2008). 
Additionally, factors relating to chronic inflammation such as deficiency of growth 
factors, raised inflammatory cytokines and other auto-immune alterations involved in 
bone remodelling, resorption and bone loss have been proposed to play a role 
(Bardella et al. 2005; Capriles et al. 2009).  
The majority of studies that have assessed the effect of a GFD on bone health have 
found that initiation of a GFD improves biochemical parameters of bone turnover 
(calcium, osteocalin, c-propeptide of type I procollagen, osteoprotegerin, vitamin D 
metabolites and PTH) leading to a rapid improvement of BMC and bone mineral 
density (BMD) (Barera et al. 2004; Corazza et al. 1995; Elbaky et al. 2009; Kalayci 
et al. 2001; Margoni et al. 2012; Mora et al. 2001; Sdepanian et al. 2003; Valerio et 
al. 2008). There is evidence to suggest that complete recovery of bone mineralisation 
occurs after just one year on a GFD in children and adolescents with CD (Barera et 
al. 2004; Mora et al. 2001). In contrast, Kalayci et al. (2001) observed that 
osteopenia was still evident in over 30% of Turkish children (age range 3.5-17 years) 
after one year of compliance to a GFD. However, since diagnosis these levels were 
reduced by half, which highlighted the diet’s importance in relation to bone health. 
Similarly, a study conducted in Greece found that adolescents with CD (mean [SD] 
age 18.3 [2.2] years) had significantly lower BMD z-scores than expected (<-2.0), 
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even after one and two years of following a GFD, as measured using endomysial 
antibodies (p<0.05 and p<0.001, respectively (Margoni et al. 2012). This may be due 
to a prolonged period of poor calcium/vitamin D absorption prior to diagnosis. 
Nonetheless, children following a GFD for at least one year had higher mean (SD) 
BMD z-scores compared with baseline (-1.45 [0.28] and -0.61 [0.25], respectively, 
p<0.01). 
Mora and colleagues (1999) carried out a study in Italy to examine the long-term 
effects on bone health associated with following a strict GFD in 30 patients 
diagnosed as children or adolescents (mean [SD] age at diagnosis 11.4 [5.0] years). 
Spinal BMD measurements in the CD group were not significantly different 
compared to healthy age-sex matched controls after following the GFD for ≥5 years. 
This may denote the importance of dietary treatment on bone mineralisation and 
turnover, however it is not known whether the CD group were taking calcium 
supplements or whether their BMD was significantly different to controls at 
diagnosis. Nonetheless, a study conducted in France identified severe osteopenia in 
four of eleven adults (age range 19-52 years) diagnosed with CD as children but who 
consumed a normal gluten-containing diet throughout adolescence (Cellier et al. 
2000). It is well known that achieving peak bone mass in early adulthood reduces the 
risk of osteoporosis in later life (Eisman et al. 1993). Thus, strict GFD adherence 
along with engaging with other dietary and lifestyle practices related to bone health 
throughout childhood and adolescence could help to prevent future fractures 
associated with osteoporosis, and thus early CD diagnosis is important to ensure 
education and positive dietary and lifestyle interventions for bone health. 
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3.1.3 Reproductive health 
Untreated CD has been associated with reproductive difficulties for approximately 
30 years (Ferguson et al. 1982). One of the largest studies examining this relationship 
in detail was conducted in Italy. Martinelli et al. (2000) tested 845 pregnant women 
(median age 28 years) for CD. Twelve women were biopsy positive and three of the 
12 cases had previously been diagnosed with CD as children but had not complied 
with a GFD for over 10 years. Compared to 210 healthy controls, the CD group were 
significantly older at menarche (p<0.05), were more likely to have a history of prior 
miscarriage (p<0.05) and had an increased risk of breech delivery (OR 22.5, 95% CI 
3.0-170) (Martinelli et al. 2000). Despite these differences, confounding factors such 
as cigarette smoking, pre-pregnancy BMI or the mother’s energy intake were not 
controlled for, increasing bias; thus limiting firm conclusions to be drawn. 
Additional studies have shown that women being treated for infertility have an 
increased risk of CD. One hundred and fifty infertile women (median [range] age 31 
[22-42] years) were tested for CD at a hospital in Finland (Collin et al. 1996). Four 
(2.7%) of the women with unexplained fertility were biopsy positive for CD, 
compared to none of the women in a control group (p=0.02). Although the results 
suggest untreated CD increases the risk of infertility, the serological tests used for 
primary detection of CD in the study (anti-reticulin antibody and AGA tests) are no 
longer considered reliable in practice due to their poor sensitivity for CD (NICE 
2009). Furthermore, authors do not elaborate on any characteristics of the control 
population and, again, confounding factors in relation to infertility risk are not 
controlled for, for example smoking, underweight or overweight, thus firm 
conclusions cannot be drawn. Two studies conducted in Italy and Finland failed to 
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detect a significant increased risk of CD in infertile women (Kolho et al. 1999; 
Tiboni et al. 2006). However, findings may be limited since the number of women 
screened in each study was small.  
The results of the above research suggest that a positive effect of a strict GFD in 
relation to reproductive health should not be ruled out. However, longitudinal studies 
examining infertility, pregnancy outcomes and early reproductive problems such as 
delayed onset of menarche in adherent and non-adherent patients with CD are 
necessary to determine more robust associations. 
3.1.4 Malignancy 
Many research papers have examined the association between CD and cancer risk. A 
recent meta-analysis of 17 peer-reviewed articles to determine the risk of all-cause 
mortality, any malignancy and lymphoid malignancy showed an increased risk of 
non-Hodgkin lymphoma (NHL) (OR 2.61, 95% CI 2.04-3.33) and T-cell non-
Hodgkin lymphoma (OR 15.84, 95% CI 7.85-31.94) in CD patients (Tio et al. 2012). 
However, studies investigating the risk of malignancy in CD in relation to GFD 
adherence are scarce.  
Early UK research by Holmes et al. (1989) observed a significant increased risk of 
developing mouth, pharynx and oesophageal cancer (RR 22.7, p< 0.01) and NHL 
(RR 77.8, p<0.001) in 210 patients who were non-adherent to the GFD. No excess 
risk (RR 1.5, p>0.05) was associated with patients strictly adherent to the GFD 
(Holmes et al. 1989). More recently, a significant increased risk of NHL (OR 6.0, 
95% CI 2.4-12.4) was observed in 781 patients with CD diagnosed as children and 
adults (median [range] age at follow-up 53 [9-89] years) (Viljamaa et al. 2006). All 
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patients who developed cancer were diagnosed as adults and all had either been 
recently diagnosed with CD or were non-compliant to the GFD. Furthermore, Silano 
and colleagues (2008) detected a small increased risk of all-cause malignancy 
(standardised incidence rate [95% CI] 1.3 [1.0-1.7], p<0.0001) in untreated coeliac 
patients (mean age [SD] 36.2 [13.8] years), although the risk was not compared with 
treated patients, limiting the findings observed (Silano et al. 2008). It is important to 
note that the methods used to assess adherence were not described in any of the 
above studies, Holmes and colleagues (1989) do not report the age of the study 
population, and the risk of future malignancy in children and teenagers who do not 
comply with the diet is unknown, signifying the need for further research. However, 
these investigations provide preliminary support for the protective role of the GFD in 
relation to malignancy, justifying the importance of education and the need for strict 
adherence once diagnosed. 
In summary, following a strict GFD may help to improve nutritional status 
parameters such as muscle mass, fat mass, height, weight, haematinics and bone 
mineral density, and could further play a role in reducing the risk of long-term 
complications such as infertility, adverse pregnancy outcomes, osteoporosis, NHL, 
mouth, pharynx and oesophageal cancers. Thus, adherence to the diet is considered 
to be of utmost importance in the treatment of CD, and determining factors that aid 
adherence but also factors that may be barriers are important to inform future 
management and support. 
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3.2 Adolescent health 
The World Health Organisation (WHO) defines ‘adolescents’ as “young people 
between the ages of 10 and 19 years” and ‘health’ as “a state of complete physical, 
mental and social well-being and not merely the absence of disease or infirmity” 
(World Health Organisation 2003; World Health Organisation 2012). Adolescence is 
a time of complex and unique physical, cognitive, social and emotional development 
(Viner et al. 2012). In terms of physical change the adolescent will experience 
pubertal development (Christie and Viner 2005). Cognitive maturity advances from 
childhood and teenagers acquire more abstract thought patterns, deepened moral 
thinking and a sense of interest in moral reasoning (Viner et al. 2012). Additionally, 
social and emotional development throughout adolescence involves struggling with a 
sense of identity, feelings of awkwardness, anxiety about normality, being popular, 
peer group pressure, a desire for independence and privacy, mood swings, testing 
rules and limits and the realisation that parents are not perfect (McDonagh and 
Kaufman 2009; Viner et al. 2012). This developmental instability is likely to play a 
considerable role in relation to heightened risk taking behaviours associated with 
adolescence ranging from poor dietary choices, smoking, alcohol consumption and 
drug experimentation to non-adherence to medical regimes which may impinge on 
current and future health (Umeh 2009), this includes dietary adherence.  
Due to the distinctive changes associated with adolescence, when conducting any 
study on health status or health-related behaviour adolescent populations should be 
separated from younger children and adults. Inclusion of older or younger age groups 
will confound study results, making them difficult to interpret in relation to teenage 
populations. As outlined, adolescence is a critical stage in terms of independence, 
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teenagers are likely to have a greater responsibility over their GFD compared to 
children and may encounter more social and emotional obstacles related to 
compliance. Furthermore, due to physical changes a teenager’s dietary requirements 
differ to that of adults and younger children (Department of Health 1991). As such, 
adolescent specific studies with regards to GFD adherence, dietary intake and 
HRQoL are required to inform healthcare providers and policy makers about the type 
of management and support that would best support the needs of this vulnerable sub-
group of the population at a critical stage of life. 
3.3 Nutritional adequacy of the gluten-free diet  
Adhering to a GFD necessitates the complete exclusion of many cereals common 
within the UK diet, particularly wheat (Dickey 2009). Wheat flours and wheat-based 
products are, in large, good sources of energy, non-starch polysaccharide (NSP), 
calcium, magnesium, thiamin, niacin, riboflavin, iron, vitamin B6 and folate (Holland 
et al. 1988). In the UK it is mandatory to fortify wheat flours (excluding wholemeal 
flour) with iron, thiamin and nicotinic acid or nicotinamide due to the loss of these 
micronutrients in the milling process and with calcium to ensure optimum bone 
health within the population (Ministry of Agriculture, Fisheries and Food 1998). 
However, this is not the case for GF flours or those prepared with Codex wheat 
starch, where gluten has been removed to an acceptable level (Codex Alimentarius 
Commission 2008). Therefore, the need to follow a GFD may result in reduced 
intakes of certain nutrients, and thus ensuring appropriate food choice, nutrient dense 
foods and monitoring of nutritional intake and status is paramount. 
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In the UK, wheat is the main grain used to make cereals and cereal products. As 
such, these are the main contributors to energy (34%), CHO (44%), NSP (41%), iron 
(M:57%, F:53%), magnesium (M:32%, F:20%), thiamin (M:43%, F:38%), riboflavin 
(M:34%, F:31%), niacin (M:38%, F:34%) and folate (M:44%, F:37%) intakes in the 
general teenage population (11-18 years) (Bates et al. 2012). Additionally, cereals 
and cereal products are the second highest contributors to calcium intake (27%) in 
the UK (Bates et al. 2012; Gregory et al. 2000a; Henderson et al. 2003). Thus, the 
absence of wheat, rye and barley based cereal products in the GFD and lack of 
legislation requiring fortification of GF flours has led to questions being raised 
regarding the diet’s nutritional adequacy. 
The nutritional content of GF foods compared to gluten-containing equivalents has 
not been examined in the UK. However, a study conducted in the United States 
compared the folate, iron and dietary fibre content of various staple GF products; 
including breads, pastas and breakfast cereals to their matching wheat-containing 
counterparts (Thompson 2000). Of 37 GF cereal products with available data on 
folate, 30 (81.1%) contained lower quantities compared to gluten-containing 
equivalents. Additionally, 64 of 83 (77.1%) GF cereal products contained less iron 
compared to matching wheat-based products and 26 of 85 (30.6%) products 
contained less dietary fibre (Thompson 2000). The absolute difference in the amount 
of micronutrients was not stated in the paper and significance was not reported, 
limiting the conclusions drawn, however the results provide preliminary evidence 
that inequalities in nutritional intake may exist between the general population and 
those following a GFD. 
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3.3.1 Dietary intakes of UK adolescents 
Dietary intakes of macro and micronutrients in the general teenage population in the 
UK are known to be of concern in relation to certain nutrients. This is shown in data 
gathered by the national diet and nutrition survey (NDNS) (Bates et al. 2012) and the 
survey of sugar intake among children in Scotland (Sheehy et al. 2008). Many 
teenagers (11-18 years) have low energy and NSP intakes, high intakes of non-milk 
extrinsic sugars (NMES) and high intakes of saturated fatty acids (SFAs) relative to 
recommendations. They consume intakes below recommended values for calcium, 
iron, riboflavin and folate (Bates et al. 2012; Sheehy et al. 2008). In terms of dietary 
patterns and food choices, teenagers (aged 11, 13 and 15 years) in the UK consume 
more carbonated soft drinks and confectionery than adolescents resident in 35 
separate European countries as well as Israel, Canada and the United States 
(Vereecken et al. 2005). Furthermore, intakes of fruit and vegetables are poor, with 
less than 20% of Scottish teenagers in the aforementioned study eating these on a 
daily basis. Poor intake of fruits and vegetables in UK adolescents is also reported in 
the most recent NDNS (Bates et al. 2012) with only 10% of 11- to 18-year-olds 
meeting the “five-a-day” guideline (Bates et al. 2012; Department of Health 2010). 
Such dietary patterns are unfavourable in terms of potential poor micronutrient 
intakes, but longer term they may lead to increased risk of dental, cardiovascular and 
bone health issues as well as anaemia, type 2 diabetes, particular cancers, heart 
disease and osteoporosis (Balarajan et al. 2011; Cashman 2007; Lock et al. 2005).  
Since the GFD may further restrict dietary intakes (see Section 3.3.2), it is important 
to assess whether adolescents following at GFD in the UK are not at greater risk of 
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nutritional inadequacy than the general UK teenage population. However, with the 
opportunity for dietetic input, this may not be the case, but is unknown. 
3.3.2 Gluten-free diet and energy and nutritional intake 
A review of research focusing on the nutritional adequacy of the GFD is shown in 
Table 6. An extensive literature search of online databases (PubMed, The Knowledge 
Network, CINAHL and EBSCO Host) was undertaken to identify relevant articles. 
Studies observing nutritional adequacy of the GFD in the UK have, to date, only 
focused on adult populations (Dickey et al. 2008; Kinsey et al. 2008; McFarlane et 
al. 1995; Robins et al. 2008b; Robins et al. 2008c; Wild et al. 2010), however there is 
learning to be to be taken from these. Additionally, only three studies outwith the UK 
have collected data on the energy and nutrient intakes of younger populations (4-18 
years) (Hopman et al. 2009; Mariani et al. 1998; Ohlund et al. 2010). 
With regards to adult studies, a number of conflicting results have been observed. 
Two UK papers report significantly higher energy intakes in CD cases compared to 
NDNS controls (Robins et al. 2008c; Wild et al. 2010). Nonetheless, the energy 
intakes of those following a GFD were not compared to population requirements and 
results are further limited in the study by Wild et al. (2010) since 23% and 13% of 
men and women, respectively, were found to overestimate their energy intake (based 
on physical activity level and basal metabolic rate). Moreover, the variation in 
energy intakes between cases and controls may be attributed to differences in the 
measure of dietary intake since a 7-day weighed diet diary was implemented in the 
NDNS, whereas a 5-day un-weighed food diary was used for data collection in the 
adults with CD. In their review, Trabulsi and Schoeller (2001) identify large 
variation in the percentage of participants under-reporting energy intakes between 
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studies using weighed and un-weighed food records. In contrast to the findings 
above, Kinsey, Burden and Bannerman (2008) found 40 out of 48 adults (83%) in the 
UK with CD to have energy intakes below the Estimated Average Requirement 
(EAR) and it was observed that males (n=22) following a GFD (19-64 years) had a 
lower mean (SD) energy intake compared to age-sex matched controls (1632 [418] 
kcals and 1754 [403] kcals, respectively, p<0.05), although no assessment of 
individuals’ energy expenditure were made. No exclusion criteria were mentioned in 
the paper, therefore it is not known whether certain participants had coexisting 
conditions that may have further affected dietary intakes such as secondary 
intolerances, irritable bowel syndrome (IBS) or autoimmune thyroid disease. The 
study is further limited by low numbers and is a potentially biased sample since a 
low response rate (46%) was observed. 
Various studies have reported carbohydrate (CHO) intakes in adults prescribed a 
GFD. Wild et al. (2010) found that CD cases had significantly higher intakes of CHO 
compared to healthy controls (p<0.05). It was identified that 54% (11.3g) and 37.5% 
(6.6g) of the additional CHO consumed by females and males, respectively, was 
derived from non-milk extrinsic sugar (NMES), and that NMES intakes were 
significantly higher in both male and female CD cases compared to NDNS controls 
(p<0.05). A greater mean (SD) CHO intake was similarly observed for adults with 
CD on a GFD (242±82g) compared to age-matched controls (210g [±70g], p<0.05) 
in Finland using four-day diet diaries for data collection. However, the CHO intake 
as a percentage of energy was not calculated and NMES intake was not recorded in 
the study (Kemppainen et al. 1995). Conversely, research conducted in Sweden 
(Grehn et al. 2001) found that adults with CD consumed less energy from CHO 
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compared to Nordic Nutritional Recommendations (NNR) (51% compared to the 
NNR of 55-60%). Nevertheless, the mean intake of CHO (g) in the Swedish CD 
group was similar to that of healthy controls and the CD cases actually consumed a 
significantly higher mean (SD) proportion of food energy from CHO (51±5.8%) 
compared to control subjects (48±7.2%, p<0.05). The CD group also consumed more 
CHO in the form of rice, cornflakes, root vegetables and sweets compared to the 
control participants who consumed more CHO from pasta and porridge. This 
suggests that a higher proportion of the CHO intake in the CD group may be coming 
from more refined sources of sugar, although this requires further investigation. It 
should be mentioned that in the study by Grehn et al. (2001) different methods of 
dietary assessment were used to collect food consumption data in CD cases (4-day 
un-weighed diary) and controls (7-day un-weighed diary) and this may have 
influenced the variation in estimated nutrient intakes. It is also worthy of note, that 
healthcare and prescribed GF products vary between countries and thus direct cross-
country comparisons must be performed with caution. 
The majority of research in adult populations provides evidence that a GFD is low in 
dietary fibre or NSP (Grehn et al. 2001; Kemppainen et al. 1995; Kinsey et al. 2008; 
Storsrud et al. 2003; Wild et al. 2010). Ninety-eight per cent (n=47) of CD 
participants (19-64 years) had NSP intakes below the Reference Nutrient Intake 
(RNI) in one UK study, although mean (SD) NSP intakes were not significantly 
different from NDNS data (12.0±5.0g vs. 12.6±5.0g for females and 16.0±5.0g vs. 
15.2±6.0g for males, respectively, ns) (Kinsey et al. 2008). Three additional studies 
observed mean NSP/dietary fibre intakes in adults with CD to be lower than the UK 
RNI of 18g/day and significantly lower than intakes in healthy control populations 
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(Grehn et al. 2001; Kemppainen et al. 1995; Wild et al. 2010). Conversely, research 
by Thompson et al. (2005) found mean (SD) intakes of dietary fibre to be higher in 
CD cases (24.3±5.3g for males and 20.2±6.9g for females) compared to mean (±SE) 
general population data from the American National Health and Nutrition 
Examination Survey (NHANES) (18.0±0.2g and 14.0±0.2g). Although these results 
seem to contradict outcomes reported elsewhere, significant comparisons were not 
stated and only 46% of the CD group actually met the American Dietary Reference 
Intake (DRI) for fibre (24g/day). Furthermore, the tool used to collect dietary intakes 
in the control group was not stated. 
Only two adult papers report differences between CD cases and controls in relation 
to fat and protein consumption. Wild and colleagues (2010) found that women (mean 
[SD] age 53 [13] years) following a GFD consumed more energy from protein 
(74.1g) and total fat (68.4g) compared to NDNS controls (63.1g and 58.6g, 
respectively, p<0.01). However, these variances were not observed when intakes in 
the same group of females were compared to data from the UK Women’s Cohort 
Study (UKWCS). This may be attributed to differences in the data collection 
methods implemented in the two control populations; a 7-day weighed food diary 
was used in the NDNS and a food frequency questionnaire as well as a 4-day semi-
weighed food diary was used in the UKWCS. Male patients following a GFD also 
consumed significantly more energy from total fat compared to age-sex matched data 
in the NDNS (94.7±36.0g and 77±42.4g, respectively, p<0.05) (Wild et al. 2010). 
Interestingly, similar research carried out in the UK identified that men prescribed a 
GFD (19-64 years) consumed significantly less protein and total fat compared to 
male NDNS data (Kinsey et al. 2008), whereas females of the same age in the study 
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had significantly higher intakes. Nonetheless, the single-centre design and low 
participation rate in each of the above studies limits the significance observed and 
may be a factor of under-reporting. Furthermore, neither study accounts for 
differences between populations with regard to the type of fat consumed; this 
requires further investigation. 
In relation to dietary recommendations, numerous studies have shown calcium 
intakes to be low in adults following a GFD (Kinsey et al. 2008; Robins et al. 
2008b). However, only one UK study found individuals with CD (19-64 years) to 
have significantly lower calcium intakes (from food sources only) compared to the 
general population (29% <LRNI compared to 3% <LRNI, respectively; p<0.05) 
(Kinsey et al. 2008). On the contrary, two papers report higher mean calcium intakes 
(excluding supplement sources) for adults on a GFD (Thompson et al. 2005; Wild et 
al. 2010). Only one study has observed women following a GFD to have lower iron 
intakes compared to healthy controls (Wild et al. 2010), although it is not clear from 
the paper whether intakes were significantly lower than the RNI for iron or whether a 
greater proportion of females following the diet had intakes below the LRNI in 
contrast to control subjects. It is worthy of note regarding all micronutrients that it is 
often the case that very few manufactured GF products are included in dietary 
analysis software packages (Wild et al. 2010). Therefore, the micronutrient profile of 
GF products added to these databases, and subsequently micronutrient dietary 
estimates, may be inaccurate or incomplete. 
In addition to the micronutrients described above, the GFD has also been reported to 
affect the intake of certain B-vitamins, particularly vitamin B12 and folate. Studies 
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from the UK and Sweden have observed adults to have significantly lower intakes of 
vitamin B12 and folate compared to control subjects (Grehn et al. 2001; Kinsey et al. 
2008). In the Swedish study the mean intake of folate in CD cases was below NNR 
recommendations, although mean intakes of vitamin B12 in cases and controls were 
above the NNR value (Grehn et al. 2001). Similarly, in the UK population, mean 
intakes of both B vitamins in the CD group (19-64 years) were comparable to 
individual RNI values and there was not a significant difference in the proportion of 
cases and controls with vitamin B12 and folate intakes below the LRNI (Kinsey et al. 
2008). A separate Swedish study also found vitamin B12 intakes to be significantly 
lower in participants with CD compared to healthy controls, yet, again mean intakes 
were above NNR values in both groups which may reflect the nutritional adequacy of 
B12 in the GFD since milk and milk products and meat and meat products are the 
main food sources of vitamin B12 (Hallert et al. 2002). However, neither Swedish 
study states whether nutritional supplements were accounted for in the analyses, 
which may have affected estimated intakes of these micronutrients. 
A recent systematic review of the literature concludes that, due to numerous 
methodological limitations in research to date, robust evidence does not exist to 
suggest the GFD leads to nutritional inequalities in adults resident within the UK 
(Robins et al. 2008a). Authors propose that future studies comparing the dietary 
intakes of those prescribed a GFD to NDNS data are warranted (Robins et al. 2008a). 
Differences in dietary assessment methods may have affected results and thus using 
the same methods is important for making comparisons. 
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Only two papers have included teenagers within their study populations when 
addressing nutritional adequacy of the GFD, one in Sweden and one in The 
Netherlands. Ohlund et al. (2010) compared the dietary intakes of 4- to 17-year-olds 
with CD in Sweden (n=25) to healthy controls (nutritional intakes of 4- to 17-year-
olds without CD collected in two separate Swedish studies). CD subjects consumed 
less fibre, iron and calcium and more NMES than the reference population. The CD 
group had a mean (SD) fibre intake slightly below the lower range NNR of 10-
25g/day (9.9±2.1g), whereas both control groups had mean fibre intakes within the 
NNR range (13g (Riksmaten 2006) and 23g (Larsson and Johansson 2002)). All 
groups had mean NMES intakes above the NNR (<10% of total energy). However, 
results of the study are limited since significance is not stated in the paper, results are 
also not specific to adolescents since younger children were included in the study and 
different measures of dietary intake were used for CD cases (5-day estimated diet 
diary) and controls (4-day estimated diet diary (Riksmaten 2006), diet history 
(Larsson and Johansson 2002)). In general, diet histories result in higher estimates of 
mean intakes of all nutrients compared to diet diaries (Gibson 2005), and thus the 
much higher fibre intake in the latter control group may be an overestimate. 
Although authors report that two of the teenagers with CD >13 years (n=4) had iron 
and calcium intakes below Average Requirements (AR) (calcium AR = 900g/day; 
iron AR = 11g/day for males and 15g/day for females) and none of the children met 
recommendations for vitamin D (7.3µg) or magnesium (280g), intakes were not 
compared to healthy controls; possibly due to low subject numbers.  
Adolescents in The Netherlands (13-16 years; n=37) similarly consumed less fibre 
and less iron compared to the general Dutch population (Hopman et al. 2006). 
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Additionally, participants aged 12-25 years (n=132) in the study who did not 
incorporate enriched GF products into their diet had lower intakes of all B-vitamins, 
calcium, fibre and iron. Despite these observations, analyses to determine significant 
differences were not performed and certain results are confounded by inclusion of 
young adults as well as teenagers. Additionally, authors do not take into account 
other dietary restrictions in the population that may affect dietary intakes such as 
TIDM, lactose intolerance or vegetarianism/veganism. 
To our knowledge, no study has examined the dietary patterns or nutritional intakes 
of teenagers following a GFD in the UK. Adolescence is a critical time nutritionally 
and many teenagers in the UK have poor intakes of energy as well as macro- and 
micronutrients (Bates et al. 2012). Furthermore, teenagers tend to have increased 
independence in relation to food acquisition and are more likely to make poor dietary 
choices compared to younger and older populations (Umeh 2009). The review of the 
literature has uncovered a number of conflicting findings with regards to energy, 
CHO, protein, fat, fibre (NSP), calcium, iron, magnesium and B-vitamin intakes in 
individuals with CD. This is likely to be reflective of considerable variability 
between studies in terms of age range, country of data collection, tools used for data 
collection and government nutrition recommendations used for comparison. 
Furthermore, a number of limitations are evident in research to date including 
absence of exclusion criteria, low response rates, low numbers, absence of statistical 
analyses to determine significant differences, lack of comparison with nutritional 
recommendations, different methods of data collection between cases and controls 
and not considering the possible intake of micronutrients from supplement sources. 
Thus, the review highlights the need for more robust data, particularly in 
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nutritionally vulnerable populations such as UK adolescents, to determine whether 
individuals with CD following the GFD experience inequalities compared to the 
general population in relation to nutrient intakes. The uses of such data are discussed 
in Section 3.7. 
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Table 6  Review of estimated energy and nutrient intakes and dietary patterns in diagnosed coeliac patients (1990-2010) 
 
Adult studies  
 
    
Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
 
Main observations Limitations 
Wild et al. 
(2010), UK 
SC, case-control 
 
CD group 93 (62 
F, 31 M)  
 
NDNS controls1 
451 (195 M, 256 
F) 
 
UKWCS controls2 
(708 F) 
 
Intakes  compared 
to DRV3 
recommendations 
 
CD group: 
mean age 54 
years (F: 53 ± 
13, M: 56 ± 
15) 
 
NDNS 
controls: age 
range 19-64 
 
UKWCS 
controls (not 
stated) 
CD group: 5-
day estimated 
diet diary 
 
NDNS controls: 
7-day weighed 
diet diary 
 
UKWCS 
controls: FFQ 
and 4-day semi 
weighed food 
diary 
CD cases compared to controls 
F CD group: Significantly higher energy, protein, fat and CHO 
and NMES intake. Significantly lower fibre intake. 
 
M CD group: Significantly higher energy, fat, CHO and NMES 
intake. Similar fibre intake. 
 
F CD group: Significantly higher calcium intake. Significantly 
lower manganese, iron, zinc, selenium and folate intake 
 
Greater % of F controls meeting RNI4 for magnesium and 
selenium compared to CD group (significance not stated) 
% of CD M meeting RNI for 
micronutrients not compared to standard 
population 
 
Four men and 15 women with CD had 
additional health conditions. Five cases 
following additional diets. These may 
have affected nutritional intake 
 
26% men and 23% women in the CD 
group under-reported and 23% men and 
13% women over-reported intakes 
 
Analysis not spit by those taking 
supplements and those not 
Dickey et al. 
(2008), 
Northern 
Ireland (UK) 
SC, case control 
 
CD group 100 (71 
F, 29 M)-35 
untreated, 24 non-
compliant, 41 
compliant 
 
Healthy controls 
200 (142 F; 58 M) 
 
CD group: 
mean (SD) 
age 55.0 ± 
11.7 
 
Healthy 
controls: 
mean (SD) 
age 54.7 ± 
12.4 
 
 
CD group: 4-
day estimated 
diet diary 
 
Healthy 
controls: 4-day 
diet estimated 
diary 
 
No difference in intake of vitamin B12, vitamin B6 or folate 
between controls and all CD groups 
 
Compared to controls all CD groups had significantly higher 
intakes of riboflavin 
Intakes in cases and controls were not 
compared to DRV recommendations 
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Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
Main observations Limitations 
Kinsey et al, 
(2008), UK 
SC, case-control. 
 
CD group 48 (35 
F, 13 M) 
 
NDNS controls 
19-65 years1 1724 
(833 F, 891 M) 
 
NDNS controls 
>65 years7 1523 
(833 F, 632 M) 
 
Intakes also 
compared to 
DRV3 
recommendations 
 
 
CD group: 
mean (SD) 
age 58.6 ± 17 
 
Mean age of 
NDNS 
controls not 
stated 
 
 
 
 
 
CD group: 3-
day estimated 
diet diary and 
questionnaire on 
gluten-free 
products. 
 
NDNS controls 
19-64 years: 7-
day weighed 
diet diary 
 
NDNS controls 
>65 years: 4-
day weighed 
diet diary 
Compared to DRV 
CD group: Significant proportion <RNI/EAR for energy (83%), 
vitamin D (100% >50 years), NSP (98%) and calcium 
(1500mg/d) (95%). Percentage of energy derived from protein 
was significantly higher than the DRV and percentage energy 
derived from fat was significantly lower that the DRV 
 
GFP provided 28% of total NSP 
GFP provided 22% energy (31% total CHO) 
 
Compared to NDNS 
F CD group 19-64 years: Significantly lower mean intake 
vitamin D. Significantly higher intake of protein. 
 
F CD group >65 years: Significantly lower fat, vitamin B12 
and vitamin D intake. 
 
M CD group 19-64 years: Significantly lower energy, protein, 
fat and folate intakes. 
 
CD group (M&F): Greater proportion <LRNI for calcium (36% 
compared to 5%) 
Single-centred 
 
Low numbers 
 
No inclusion/exclusion criteria stated 
 
Low response rate (potential bias) 
 
 
 
Robins, Wild 
and Howdle¹, 
(2008), UK 
(Abstract) 
SC, cross-
sectional 
 
CD group 46 (32 
F, 14 M) 
 
Intakes compared 
to RNI4 values 
 
Mean age 
(range) 54 
(21-79) 
5-day estimated 
diet diary 
 
3% of females and 7% of males met RNI for calcium (1500mg) 
 
14% of males and 28% females met RNI for magnesium 
 
No participants met RNI for selenium 
 
Intakes not compared to healthy controls 
 
No exclusion criteria stated 
 
Single centred 
Robins, Wild 
and Howdle², 
(2008), UK 
(Abstract) 
SC, case-control 
 
CD group 46 (32 
F, 14 M) 
 
NDNS controls1  
 
CD group: 
mean age 
(range) 54 
(21-79) 
 
NDNS 
controls: age 
range 19-64  
CD group: 5-
day estimated 
diet diary 
 
NDNS controls: 
7-day weighed 
diet diary 
 
F CD group: Significantly higher energy intake 
 
CD females consumed 244g of CHO/day whereas controls 
consumed 202g/day (significance not stated) 
 
Increased fibre accounted for just 1g of this, whereas NMES 
accounted for 23g; equivalent to 29% of the extra calories 
ingested.  
No exclusion criteria stated 
 
Single centred 
 
Included people up to 79 years of age but 
only compared to adult NDNS (19-64 
years) 
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Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
 
Main observations Limitations 
Thompson et al. 
(2005), USA 
MC, case-control 
 
CD group 47 (39 
F, 8 M) 
 
NHANES 
controls10 
(numbers not 
stated) 
 
Intakes also 
compared to 
American DRI 
values11 
 
CD group: 
mean (SD) 
age 51 ± 11  
 
NHANES 
controls: not 
stated 
 
 
 
 
CD group: 
3-day estimated 
diet diary 
 
NHANES 
controls: not 
stated 
 
Compared to DRI values 
46% of F met DRI for fibre 
44% of F met DRI for iron 
31% of F met DRI for calcium 
 
21% consumed 6 portions of grain foods/day 
 
Compared to NHANES data 
CD subjects had higher mean intakes of all nutrients apart from 
iron 
 
Significant comparisons not stated. 
 
NHANES values not stated  (unsure 
whether mean intakes were above or 
below DRI values) 
 
Calcium intakes may be low due to high 
proportion of lactose intolerance (19%). 
 
Analysis not spit by those taking 
supplements and those not. 
 
Storsrud et al. 
(2003), Sweden 
SC, case-control 
 
CD group 18 
(11F, 7 M) 
 
Baseline intakes 
compared to 
intakes after 
consuming 100g 
oats/day for 6 
months or 2 years. 
 
Intakes also 
compared intake 
to NNR values5 
Mean (SD) 
age 41 ± 14 
Base-line 4-day 
estimated diet 
diary 
 
Then 4-day 
estimated diet 
diary at fixed 
intervals for 
either 6 months 
(3 patients) or 2 
years (15 
patients) 
 
Mean oat intake was 93g/day 
 
Baseline GFD was balanced, except low mean fibre intake of 
15.1g and low iron of 11.1mg 
 
Energy and macronutrient intake did not change when oats 
were added 
 
Oats increased mean intake of iron, NSP, thiamin and zinc 
significantly 
 
Iron and NSP increased significantly to ranges within NNR 
 
Intake of cereal foods increased significantly 
 
Due to high phytate levels in the oats iron absorption remained 
the same before and after oats were included even though 
intakes increased 
 
 
 
CD group intakes not compared to 
healthy population 
 
Very small numbers 
 
Single-centred 
 
Did not take into account dietary 
restrictions that may affect dietary intake 
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Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
 
Main observations Limitations 
Hallert et al. 
(2002), Sweden 
MC, case-control 
 
CD group 30 (18 
F, 12 M) 
 
Healthy control 
504 (254 F, 250 
M) 
 
Intakes also 
compared intake 
to NNR values5 
 
CD group: 
mean (95% 
CI) 55 (53.2-
56.8)  
 
Healthy 
controls: 
range 43-64  
 
CD group: 4-
day estimated 
diet diary  
 
Healthy 
controls: not 
stated 
 
 
Folate intake significantly lower in CD cases  (intakes lower 
than NNR in cases and controls) 
 
Vitamin B12 intake significantly lower in CD cases (intakes in 
cases and controls higher than NNR) 
 
Vitamin B6 intakes similar in CD cases and controls 
Concomitant conditions in some patients 
that may affect intakes (not excluded) 
 
Analysis not spit by those taking 
supplements and those not 
 
Grehn et al. 
(2001), Sweden 
MS, case-control 
 
CD group 49 (32 
F, 17 M)  
 
Healthy controls 
498 (248 F, 250 
M) 
 
Intakes also 
compared intake 
to NNR values5 
CD group: 
range 45-64  
 
Healthy 
controls: 
range 45-64  
CD group: 4-
day estimated 
diet diary 
 
Healthy 
controls: 7-day 
estimated diet 
diary 
Compared to NNR values 
CD group: higher % energy from fat and lower % energy from 
CHO. Below the NNR for fibre, folate, vitamin E and selenium 
(also true of controls) 
 
100% CD group not meeting NNR for fibre and nearly 100% 
not meeting NNR for folate (figures not stated for controls) 
 
Compared to healthy controls 
CD group: fibre, folate, vitamin B12, niacin, calcium, 
phosphorous and zinc intakes were significantly lower 
 
F CD group: vitamin E, thiamin and selenium intakes were 
significantly higher 
 
CD group: more CHO from rice, corn-flakes, root vegetables, 
greens (women) and sweets. Controls: more CHO from pasta 
and porridge 
 
 
 
 
 
No exclusion criteria stated 
 
Did not take into account other dietary 
restrictions or conditions that affect 
health and dietary intake 
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Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
 
Main observations Limitations 
Mariami et al. 
(1998), Italy 
SC, case-control 
 
CD group 47 (37 
F, 10 M) 
 
Health controls 47 
(34 F, 13 M) 
 
Values also 
compared 
American RDA9 
recommendations 
 
Strictly adherent 
compared to non-
adherent 
 
CD group: 
mean (SD) 
15.2 ± 2.3  
 
Healthy 
controls: 
mean (SD) 
15.7 ± 2.3  
 
CD group: 
3-day estimated 
diet diary 
 
Healthy 
controls: 
3-day estimated 
diet diary 
 
Compared to healthy  controls 
CD group: lower % energy from CHO  
(both groups’ intakes below RDA of 50%) 
 
Compliant compared to non-compliant 
Both groups had mean intakes below the RDA for calcium and 
iron, although non-compliant significantly more so 
 
Both groups mean % energy from CHO was below the RDA, 
although compliant significantly more so 
 
Fibre intakes significantly lower in compliant participants, 
although RDA for fibre not stated 
No exclusion criteria stated 
 
Did not take into account other dietary 
restrictions or conditions that affect 
health and dietary intake 
McFarlane et 
al. (1995), UK 
Case-control  
 
CD group 54 (44 
F, 10 M) 
 
Healthy controls 
(age-sex matched) 
 
Intakes also 
compared RNI 
values4 
 
Mean (range) 
50.1 (27-69)  
 
CD group: 10-
day estimated 
diet diary 
 
Health controls: 
10-day 
estimated diet 
diary 
78% followed strict GF diet 
 
No correlation between adherence and any nutritional intakes 
% of CD group consuming below the RNI or EAR for specific 
nutrients = Energy - 48% 
Magnesium – 54% 
Iron – 33% 
Copper – 33% 
Retinol – 48% 
Vitamin D – 80% (only >65’s) 
Folic acid – 35% 
Nutrient intakes of healthy controls not 
stated 
 
Significant comparisons not stated 
 
No exclusion criteria stated 
 
Did not take into account other dietary 
restrictions or conditions that affect 
health and dietary intake 
 
Not sure where the population was 
recruited from 
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Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
 
Main observations Limitations 
Kemppainen et 
al. (1995), 
Finland 
SC, case control 
 
Untreated CD 
group 40 (35 F, 5 
M) 
 
CD group 
following GFD 52 
(29 F, 23 M) 
 
Healthy controls 
77 (37 F, 40 M) 
Untreated CD 
group mean 
(SD): F 44 ± 
13; M 47 ± 12  
 
CD group 
following 
GFD mean 
(SD): F 45 ± 
11; M 46 ± 12  
 
Healthy 
controls  mean 
(SD): F age 
53 ± 13; M 52 
± 10  
Untreated CD 
group: 4-day 
estimated diet 
diary 
 
CD group 
following GFD: 
4-day estimated 
diet diary 
 
Healthy 
controls: not 
stated 
Untreated compared to treated 
Fibre intake significantly lower in treated cases 
 
Cereal intake was significantly higher in untreated cases 
 
Energy and CHO intakes were significantly higher in untreated 
cases 
 
Cases compared to controls 
Untreated cases significantly higher intake of energy, CHO and 
fat 
 
Untreated cases sig lower intake of fibre 
 
Mean intakes in all groups were above RDA recommendations 
Healthy controls significantly older than 
cases and included a higher proportion of 
males 
 
Single centred 
Child and adolescent studies     
Ohlund et al, 
(2010), Sweden 
SC, case-control.  
 
CD group 25 (18 
F, 7 M) 
 
Healthy controls 
from a separate 
study 60 (30 F, 30 
M) 
 
Values also 
compared intake 
to Nordic 
Nutritional 
Recommendations 
(NNR)5  and 
Average 
Requirements 
(AR)6 
CD group: 
range 4-17  
 
Healthy 
controls: 
mean (SD) 
17.5 ± 1.0  
CD group: 5-
day estimated 
diet diary 
 
Healthy 
controls: 4-day 
estimated diet 
diary  
CD cases compared to NNR and AR 
13/25=Energy intake < NNR (12/13 <10 years) 
 
Mean NMES and  SFA  intakes > NNR 
All children=fibre and PUFA intakes < lower NNR value 
(Healthy controls = mean fibre intake within the NNR range) 
 
Magnesium and Vitamin D intakes < AR in 19/25 and 17/25 of 
children respectively  (no child >13 years met AR). 14 children 
< AR for selenium 
 
CD cases compared to controls 
Controls: Higher mean intakes of vitamin D, thiamin, niacin, 
riboflavin, magnesium and selenium. Lower intakes of iron and 
calcium 
 
Both CD group and healthy controls >NNR for NMES, 
however higher intake in CD group  
Low numbers 
 
Significant comparisons not stated 
 
CD group recruited in 2004 when oats 
were considered too harmful; now 
included which could increase fibre 
 
Unsure whether the nutrient intakes in 
the CD group were significantly 
different to healthy controls 
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Abbreviations: F: female; M: male; SC: single-centred; MC: multi-centred; CD: coeliac disease; FFQ: food frequency questionnaire; CHO: carbohydrate; NMES: non-milk extrinsic 
sugar; SFA: saturated fatty acids; PUFA: polyunsaturated fatty acids; tTG: tissue-transglutaminase antibody test; GFD: gluten-free diet 
1National Diet and Nutrition Survey: adults aged 19-64 years (Henderson et al. 2003) 
2The UK Women’s Cohort Study (Cade et al. 2004) 
3UK Dietary Reference Values for Food Energy and Nutrients (Department of Health 1991) 
4Reference Nutrient Intake: the RNI is two notional standard deviations above the mean. Intakes above this amount will be adequate for 97.5% of the population (Department of Health 
1991) 
5Nordic Nutritional Recommendations (Becker et al. 2008) 
6Nordic Estimated Average Requirement: intakes below this have increased risk of inadequate intake (Becker et al. 2008) 
7National Diet and Nutrition Survey people aged 65 years and older (Smithers et al. 1998) 
8 Dutch Recommended Daily Allowances (Health Council of the Netherlands 2000; Health Council of the Netherlands 2001)  
9 American Recommended Dietary Allowances (National Research Council 1989) 
10 National Health and Nutrition Examination Survey (Bialostosky et al. 2002) 
11 American Dietary Reference Intakes (Food and Nutrition Board 2001) 
 
Authors 
(year), country 
Study design/ 
sample size  
Age (years) Measure of 
dietary intake 
Main observations Limitations 
Hopman et al. 
(2006), The 
Netherlands 
MC, case-control 
 
CD group 132 (87 
F, 45 M) 
 
Healthy controls 
(numbers not 
stated) 
 
Values also 
compared to 
Dutch (DRDA)8 
and American 
(ARDA)9 
recommendations 
 
CD group: 
mean (SD) 
16.9 ± 4.3 
 
Healthy 
controls: not 
stated 
 
 
 
 
CD group: 3-
day estimated 
diet diary 
 
Healthy 
controls: not 
stated 
Compared to ARDA and DRDA 
CD group: Fibre and iron intakes significantly lower than the 
ARDA. % energy from SFA significantly higher than DRDA 
 
Cases <19 years did not meet ARDA for calcium (1300mg) 
Compared to healthy controls 
13-16 year olds and 22-25 year olds consumed significantly 
less protein and SFA (both groups intakes above ARDA) 
 
<19y olds consumed significantly less fibre (both groups 
intakes below ARDA) 
 
16-19y olds consumed significantly less iron (both groups 
intakes below the ARDA) 
 
22-25y olds = consumed significantly more calcium (both 
groups intakes above the ARDA) 
 
Those consuming enriched GF products to had higher intakes 
of B vitamins, calcium, fibre and iron intakes 
Significant comparisons sometimes not 
stated 
 
Did not take into account other dietary 
restrictions or conditions that affect 
health and dietary intake 
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3.4 Adolescent adherence 
Adherence has been defined as “the extent to which a person’s behaviour, in terms of 
taking medications, following diets, or executing lifestyle changes, coincides with 
medical or health advice” (Taddeo et al. 2008). Different interpretations of non-
adherence exist - one view is that non-adherence wastes valuable resources, causes 
considerable morbidity and mortality that is preventable and contributes to poorer 
quality of life (Lemanek et al. 2001; Oldridge 2001). Another interpretation is that it 
represents rational choice if the regime is emotionally or physically distressing or 
impacts of HRQoL (Dunbar-Jacob and Mortimer-Stephens 2001).  
Adolescence presents a unique clinical challenge in terms of disease management, 
and the prevalence of non-adherence to medical treatment during adolescence has 
been reported to be high (Taddeo et al. 2008). Biological, psychological and social 
transformations throughout adolescence are known to influence adherence 
behaviours (Christie and Viner 2005; Trew et al. 2006). Teenagers often have 
difficulties taking practitioner points of view, perceiving them as ‘additional parents’ 
and cognitive immaturity can harbour an adolescent’s ability to anticipate the 
consequences of his or her actions (McDonagh and Kaufman 2009). It has been 
recognised that an action may be repressed if it does not relate to normative peer 
group behaviour during adolescence (McDonagh and Kaufman 2009). Additionally, 
teenagers have a tendency to sacrifice long-term goals for the needs of the moment, 
such as fitting in with peers (Coleman et al. 2007). 
Furthermore, adherence to dietary advice, such as following the GFD in CD, is 
reported to be lower than that of other health behaviours including taking medication 
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or exercising in adults and children (DiMatteo 2004; Johnson et al. 1992). This may 
be attributed to the fact that eating plays an integral role in everyday life – it is 
considered to be the most social of human activities and is associated with various 
neural reward mechanisms (Gahagen 2012). Therefore, making significant changes 
to eating behaviour is likely to be extremely challenging for most individuals. 
Although natural teenage rebellion may lead to intentional non-adherence to the 
GFD, poor education and understanding of the dietary regime could lead to 
unintentional deviance. Therefore, it is imperative to recognise why certain 
adolescents are adherent or non-adherent to dietary advice, such as in the case of CD, 
so that management intervention strategies and support to improve adherence can be 
designed based on the particular facilitators but recognising potential barriers for the 
patient group.    
3.4.1 Measuring adherence to the gluten-free diet 
Debate over a universally appropriate, sensitive and specific tool to measure 
adherence to the GFD in coeliac populations is long withstanding. Duodenal 
endoscopy documenting the histological extent of mucosal damage is considered to 
be the ‘Gold Standard’ for evaluation of adherence to the GFD (Pietzak 2005). 
However, this method is extremely invasive, and thus more practical, timesaving, 
cost-effective and non-invasive measures have been considered and validity 
explored. 
Leffler and colleagues (2007) compared five separate measures of GFD adherence to 
expert nutritionist evaluation in adults (≥18yrs); Anti-tissue transglutaminase IgA 
(Anti-tTG-IgA), Anti-tTG-IgG, Anti-deaminated gliadin peptide IgA (Anti-DGP-
IgA), Anti-DGP-IgG and a self-report method using a 5-point Likert scale ranging 
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from ‘Highly compliant’ to ‘I am not following a GFD at this time’. No serological 
test distinguished reliably between ‘Excellent’, ‘Good’ and ‘Poor’ adherence (gluten 
consumed under three times per year; once per month and 1-2 times per week 
respectively), shown by poor performance of ROC (receiving operator characteristic) 
curve analysis (all AUC <0.7). Additionally, the use of serology for predicting poor 
adherence yielded a positive predictive value (PPV) of <32% for all tests. ROC curve 
results for all serological tests did improve slightly only when adults who had been 
following the GFD for ≥12 months were included (AUC values ranging from 0.72-
0.79 suggesting moderate reliability), although this was not the case for the self-
report method. It was concluded that current serological tests or self-report methods 
cannot replace trained nutritionist or dietetic evaluation in determining GFD 
adherence since these methods exhibit a limited ability to accurately determine minor 
dietary transgressions in relation to the GFD (Leffler et al. 2007), which can be 
identified by detailed diet history and questioning. However, it can be argued that 
there are limitations to such an evaluation method since it is very subjective, reliant 
on qualified health professionals and time consuming, and thus further development 
of such tools is warranted. 
Research from Italy compared non-adherence to a GFD in adults (n=390, ≥18 years) 
as determined by intestinal damage on biopsy to Anti-EMA serological results and 
subjective expert nutritionist evaluation (Ciacci et al. 2002). The same trained 
nutritionist carried out a diet history and dynamic clinical interview with each patient 
to quantify their gluten intake with ‘no gluten-containing foods per week’ defined as 
good adherence. The PPV of both Anti-EMA and the nutritionist evaluation in 
detecting intestinal damage were high at 96.8% and 92.8% respectively. However, 
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the negative predictive value (NPV) of EMA for detecting intestinal damage was just 
56.6%; denoting that 43.4% of those identified as being adherent to the GFD from 
the EMA sample were actually classified as non-adherent on biopsy. This may be 
attributed to the test’s inaccuracy in detecting individuals who infrequently 
transgress from the GFD. NPV for subjective nutritionist evaluation was 92.2%, 
signifying its superiority over the Anti-EMA tool in measuring adherence. 
Additional studies have suggested endomysial antibodies may be unreliable markers 
for dietary transgressions, compared with expert evaluation in both adults and 
adolescents with CD. Troncone and colleagues (1995) determined the gluten intake 
of 23 adolescents (median [range] age 14.5 [10-19] years) in a similar manner to 
research by Ciacci et al. Of six patients with slight dietary transgressions only one 
case was Anti-EMA positive (Troncone et al. 1995). Although small numbers may 
reduce the reliability of this Italian study, more recent research from Argentina found 
IgA EMA serology to have a low sensitivity (41.2%), PPV (66.7%) and NPV 
(66.1%) for detecting partial adherence (one lapse per week) to the GFD in adults 
(mean [range] age 38 [17-65] years) as compared to detailed dietetic assessment. 
Results of ROC curve analysis showed that the assay had a limited value for 
assessing patients’ level of adherence (AUC <0.72) (Sugai et al. 2010). Comparable 
research from France observed similar results in a cohort of 95 adults (Vahedi et al. 
2003), with the test having just 37% sensitivity to detect moderate transgressions 
(≤18g of gluten/two months) as assessed by expert nutritionist evaluation. As such, 
EMA seems to be a poor measure of GFD adherence, especially in patients who 
consume gluten in small amounts or at irregular intervals.  
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Due to the limitations associated with detailed nutritionist/dietetics evaluation and 
duodenal biopsy for assessment to GFD adherence discussed above, research has 
focused on devising a surrogate measure that is less invasive, less time-consuming, is 
more objective and is not reliant on qualified personnel. Two questionnaires have 
recently been developed based on clinical expertise that allows a more standardised 
assessment of adherence (Biagi et al. 2009; Leffler et al. 2009). The tool devised by 
Biagi et al. (2009) was developed for adults based on the clinical experience of 
doctors at a hospital in Italy. It consists of four questions that lead to a score being 
obtained between zero and four; zero indicative of ‘not following a GFD’ and four 
being ‘strictly adherent’. The questionnaire was validated against the patients’ 
subjective evaluation of adherence (self-report), serological tests, duodenal biopsy 
results and presence of complications whilst on the GFD. The tool correlated 
significantly with all these parameters (Fisher’s exact tests all p<0.01). Moreover, 
lower scores were associated with higher Marsh grading on biopsy (p<0.05) 
signifying the tool’s accuracy in relation to different levels of adherence. However, 
the study population was relatively small (n=168) and there was a substantial period 
of time between the patients’ serological and histological investigations and them 
completing the questionnaire (median [IQR] length of time 53 [29-72] months) 
during which time the patient may have become more/less compliant.  
The Celiac Dietary Adherence Test (CDAT) is a similar, simple, 7-item 
questionnaire developed by Leffler and colleagues (2009) in the United States from 
adult focus group interviews. Scores range from 7 to 35, with higher scores denoting 
worse GFD adherence. The tool was validated against standardised dietetic 
evaluation and IgA-tTG. Results correlated highly with both external measures 
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(p<0.01) and the CDAT performed better on the ROC analysis (AUC 0.82) 
compared to IgA-tTG (AUC 0.65). A test-retest evaluation furthermore confirmed its 
reproducibility (r=0.82, p<0.001).  
Although the Biagi and CDAT validation studies were conducted in adult 
populations residing in Italy and America, respectively, and may be subject to 
selection bias since they were validated in single-centres, their use seems to be 
superior to serological investigation or self-report methods, especially, in the case of 
the Biagi tool, due to its discriminative properties between varying levels of 
adherence. In comparison to more validated methods of assessing adherence such as 
duodenal biopsy and detailed nutritional/dietetic assessment the questionnaires are 
more viable for a number of reasons; they are less invasive, more cost-effective and 
do not required highly skilled personnel to administer. Furthermore, they are 
appropriate for use in English speaking populations, and worth further investigation 
in other populations.  
The majority of adolescent GFD adherence studies have implemented self-report 
methods in order to evaluate adherence (Kumar et al. 1988; Ljungman and Myrdal 
1993; Roma et al. 2010b; Wagner et al. 2008). The fact that self-reporting can either 
intentionally or unintentionally lead to the patient overestimating adherence is clearly 
exposed in research by Kumar et al. (1988) where 22 teenagers from the UK reported 
strict adherence, however further investigation revealed that 17 of these patients had 
small intestinal villous atrophy suggesting intentional or unintentional misreporting. 
Additionally, it is interesting that a self-report approach was used to assess adherence 
to the GFD in the teenage study with the highest reported rate of strict adherence 
(Wagner et al. 2008). Due to the poor reliability and validity of this type of 
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methodology it is likely that the strict adherence rate of 81% observed by Wagner 
and colleagues was an overestimate of the true concordance in this population.  
Research in an adolescent population undertaken by Fabiani and colleagues (1996) 
used serological markers; Anti-EMA and Anti-AGA as well as diet history to 
determine adherence rates to the GFD. The poor validity of these serological tools in 
detecting slight transgressions was observed in the study since 11 of 28 participants 
(11-14 years) diet histories suggested that they occasionally consumed gluten, 
although EMA and AGA markers were normal in nine out of 11 cases. Only one 
adolescent study carried out in Italy has utilised dietetic evaluation to assess 
adherence to the GFD (Mayer et al. 1991). The participants (mean [range] age 13.7 
[10.6-23] years) were classified into those on a normal gluten-containing diet (~15g 
gluten/day), those with occasional gluten intake (0.06-2g gluten/day) and those not 
consuming any gluten; although the exact methodology leading to these estimations 
is unclear from the paper. Furthermore, only teenagers that had been diagnosed in the 
first three years of life were included in the study, possibly due to the fact this 
research was conducted over 20 years ago when CD was thought to appear 
predominantly in children <2 years of age. Thus, the results may not be applicable to 
teenagers diagnosed at older ages or teenagers with less typical symptoms. 
Moreover, the availability, palatability, choice and labelling of GF foods has 
improved vastly since the study was conducted, more rigorous standards for GF 
foods are required during manufacture and due to better recognition of CD over the 
last 20 years the management of CD is likely to have improved significantly. Such 
factors are likely to have an effect on adherence levels.  
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Although intestinal biopsy is considered to be the ‘Gold Standard’ means of 
measuring adherence to the GFD, no adolescent study has utilised this method to 
determine GFD adherence, possibly due to its invasive nature. Only one study has 
employed expert nutritionist evaluation to measure adherence to the GFD, this 
assessment of adherence has been validated against biopsy and is considered to be a 
good surrogate measure. However, this research was carried out in Italy over twenty 
years ago, and is unlikely to reflect the practices of teenagers today due to vast 
improvements in the diagnosis and management of CD and advances in GF product 
production and information. All additional adolescent studies, including those 
conducted in the UK, have utilised inadequate measures of GFD adherence such as 
Anti-EMA serological tests or self-report methods. Therefore, more up-to-date 
research, using validated and viable instruments to establish adherence to the GFD in 
UK teenagers is needed. 
3.4.2 Adherence to the gluten-free diet; differences with age 
Invariably, studies that have assessed adherence to the GFD in CD have studied adult 
populations. The most up-to-date systematic review of this data revealed that non-
adherence is uncommon in European and American adults; <5% (range 0-32%) in 
most studies (Hall et al. 2009). Two current papers on adherence in childhood have 
observed variation in adherence between older and younger children and present 
quite different findings to adults (Chauhan et al. 2010; Roma et al. 2010). Roma and 
colleagues (2010) examined adherence levels in 73 children (median [IQR] age 9.3 
[5-14.5] years) followed in a single-centre in Greece. Sixty per cent of children 
(n=40) aged between five and thirteen years were classified as strictly adherent, 
whilst only 50% of adolescents (n=20, 13-18 years) were fully adherent to the GFD. 
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Mean (SD) length of follow-up after diagnosis was higher in the teenage group (7.7 
[4.6] years) compared to the younger children (4.4 [3.6] years). Therefore, although 
the teenage group had been diagnosed longer and should have greater knowledge of 
the GFD, many were non-adherent. However, authors do not assess any additional 
factors between the two groups that may explain differences in adherence. Transition 
to adolescence was stated by four of the participants as the main reason for non-
adherence, and this may be attributed to greater independence or reduced parental 
control, although the determinants for non-adherence between the younger children 
and teenagers are not compared in the study. Additionally, it should be mentioned 
that the single-centre design (population bias) and self-report method used to 
measure adherence limit the results of this study.  
Chauhan et al. (2010) identified even greater differences in an Indian hospital with 
>80% strict adherence in young children (n=70, 2-9 years) compared to just 44% in 
10- to 17-year-olds. Although increased peer group pressure; perhaps at parties or 
during school lunch-breaks and low income were among various reasons attributed to 
greater non-adherence in adolescents (Chauhan et al. 2010), factors associated with 
adherence in this age group or reasons for disparity were not specifically identified. 
Again, the study population may be biased, since participants were recruited from 
just one hospital. Furthermore, the number of adolescents that participated is not 
stated, limiting the results observed. 
Adherence to the GFD was examined in adolescents and young adults (12-30 years) 
diagnosed as children or teenagers in research from Italy (Errichiello et al. 2010). 
One hundred and fifty patients (73.5%) were identified as being adherent to the GFD 
utilising a 24-hour dietary recall method and diet history to quantify gluten 
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consumption over the last 30 days. This percentage is considerably lower than that 
observed in most adult populations (Hall et al. 2009) possibly due to the inclusion of 
adolescents. However, teenagers in the study are not examined as a group 
independently. As discussed in Section 3.2, when conducting any self-management 
study teenagers should always be studied separately due to the complex 
developmental and social changes associated with this formative stage of life. 
Additionally, the adolescents and young adults in the study by Errichiello et al. 
(2010) may have experienced different types of dietetic and clinical management i.e. 
in paediatric or adult services and the teenage participants are likely to share a certain 
amount of disease responsibility with a parent in contrast to the adults. 
In research restricted to adolescents only, strict adherence has been found to range 
from 22.7% to 81.0% (Anson et al. 1990; Chauhan et al. 2010; Fabiani et al. 1996; 
Fabiani et al. 2000; Kumar et al. 1988; Ljungman and Myrdal 1993; Mariani et al. 
1998; Mayer et al. 1991; Roma et al. 2010; Wagner et al. 2008). This wide variation 
in adherence is unsurprising due to substantial disparity in the number of participants 
included in each study; just 22 subjects participated in one Italian investigation 
(Fabiani et al. 2000) whereas Wagner and colleagues (2008) collected data on 283 
Austrian teenagers. Furthermore, different methods were employed to determine 
dietary adherence; many of which are unreliable in nature (as previously discussed in 
Section 3.4.1) and the studies were conducted in various countries where approaches 
to healthcare, disease management and disease education are unlikely to be 
comparable. 
Only one study has observed adherence to the GFD in UK adolescents, and this is 
now more than 25 years old. Kumar et al. (1988) assessed adherence in 102 patients 
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(12-20 years) using a self-report method. Fifty-seven teenagers (55.9%) reported 
strict adherence, 36 (35.3%) considered themselves semi-strict (consuming several 
products containing gluten per week) and nine (8.8%) were classified as non-
adherent. Since the publication of Kumar’s findings the awareness of CD in both 
medical and food manufacturing communities has grown dramatically (Cureton and 
Fasano 2009). From the late 1990s population screening studies started to report a 
much higher prevalence of CD than originally was thought (~1% of Western 
populations) which propelled European and US government agencies to enforce GF 
food labelling. The estimated market value of GF products in the UK was £74 
million in 2007, rising from an estimated £42 million in 2004 (Cureton and Fasano 
2009; Sloan 2012) and is projected to reach approximately £200 million in 2014 
(Brockman 2012). Due to an increased understanding and recognition of CD over the 
last twenty years there have been substantial developments in the management of 
CD, dietetic support, food choice, availability and aesthetics of GF foods as well as 
an increase in external support groups and forums (Cureton and Fasano 2009). 
However, with this comes potential complexity such as interpreting labelling on pre-
prepared foods, contradictory information on different websites and forums 
regarding the GFD and determining whether advertised GF options in restaurants and 
cafes are safe for consumption. Therefore, adherence to the GFD and factors 
associated with adherence in UK teenagers needs to be further explored. This 
information could be used to develop tailored advice and support for those non-
adherent teenagers potentially at risk of a number of health conditions previously 
discussed (see Section 3.1).  
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3.5 The burden of following a gluten-free diet and patient experiences 
In terms of the burdens associated with following a GFD, the majority of research 
focuses on the limited availability of GF foods and the financial burden of 
purchasing GF items. Lee and colleagues (2007) explored the economic burden of a 
GFD in five regions of the United States by comparing the cost and availability of 
foods in standard and GF ‘market baskets’ between various food outlets. Authors 
observed large variation in both the cost and availability of GF foods between 
different shopping venues, with regular supermarkets supplying a mean of just 36% 
of the products in the GF basket compared to health food stores that carried an 
average of 94% of the GF counterparts. Although health food stores stocked the 
greatest variety of GF foods, they were considerably more expensive at a mean (SD) 
of $0.42 ($0.17) per ounce (46p per 50g), compared to $0.32 ($0.15) per ounce (34p 
per 50g) in regular grocery stores (Lee et al. 2007). Overall, GF products cost on 
average 240% more than their wheat-based versions (p<0.05). Similar findings were 
reported in a Canadian price comparison study (Stevens and Rashid 2008); on 
average (mean [SD]) GF products were 242±212% more expensive compared to 
gluten-containing equivalents, although just two regular supermarkets were included 
in the analysis, which has likely resulted in bias. Additionally, the Canadian study 
does not take into account that patients are eligible to claim the incremental cost of 
GF foods as a medical expense (The Canadian Celiac Association 2012) and thus the 
financial impact on patients is unlikely to be as significant as in America where a 
subsidy or prescription is not provided.  
Only one published study has assessed the availability and cost of GF foods in the 
UK (Singh and Whelan 2011). The researchers identified ten wheat-based products 
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(including bread, pasta and biscuits) and ten everyday products (including soy sauce, 
fish fingers and frozen sausages) and carried out analyses across 30 food stores in 
London (regular supermarkets, quality supermarkets, budget supermarkets, health 
food stores and corner shops) to determine the availability of GF versions of these 
items and the price difference between regular and GF foods. It was found that, as an 
average per store, just 8.2 (41%) of the 20 products had a GF equivalent available. 
Unlike findings from the United States, where health food stores provided the most 
GF options, regular supermarkets in London supplied, on average, 18 (90%) of the 
20 products in a GF version, whereas health food shops supplied an average of 9.8 
(49%) items. Interestingly, budget supermarkets and corner shops carried no GF 
versions of the wheat-based products. Comparable to observations by Lee et al. 
(2007) all GF equivalents of wheat-based foods were 76-518% more expensive (all 
p<0.001), and compared to regular supermarkets the cost of some GF foods in health 
food stores and quality supermarkets were significantly higher such as pasta, stock 
cubes, cream crackers and barbeque sauce (all p<0.05). 
The above results imply that following a GFD in the UK may prove challenging for 
those on a low income or living in areas without access to large supermarkets, such 
as rural locations. However, a limitation of the study by Singh and Whelan is that it 
does not take into consideration that over 90% of diagnosed patients obtain various 
staple GF products on prescription in the UK (Hogan 2010). Prescribable GF 
products aim to provide 15% of a person’s total energy intake with increased 
allowances for high physical activity levels, third trimester of pregnancy and 
breastfeeding (Blow et al. 2004). A recent study (Abernethy and Bannerman 2011) 
compared a week’s gluten-containing ‘market basket’ to a ‘GF alternative basket’ 
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across four localities in Scotland, accounting for high and low socioeconomic status 
(SES) as well as urban and rural areas. Additionally, the estimated cost of a week’s 
prescribed food items was subtracted from the GF basket. The cost of a GF basket 
(mean £49.71) was significantly more expensive than the standard basket (mean 
difference £7.50, p=0.03). Authors also observed that there was less choice and 
availability of GF products, especially in rural localities. This pilot study provides 
preliminary evidence that the cost of a GFD in Scotland may be a burden to those 
with a diagnosis of CD, despite obtaining prescription products. Furthermore, people 
living in rural areas may have to travel further to obtain a better variety of GF food 
items. Both these factors could potentially impinge on adherence to the GFD. 
Although a GFD may be expensive and the availability of GF food items poor, it is 
important to know whether individuals diagnosed with CD actually experience issues 
surrounding the cost, access and availability of GF foods. If patients make use of the 
current prescribing system or are financially stable, cost may not be such a burden. 
Additionally, it may be that only individuals with CD living in remote/rural areas 
experience issues with regards to accessibility and availability of GF foods. 
Moreover, children and adolescents that do not purchase food themselves may be 
unaware of issues surrounding the cost, access and availability of products; although 
they may still wish for a greater variety of GF foods. It is also important to determine 
whether any other factors related to following the diet or being diagnosed with CD 
have a negative impact on patients. Anything that potentially instigates an 
undesirable experience could affect a person’s ability to comply with the strict 
dietary regime and thus insight may help inform management of patients with CD.   
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 A few studies have assessed the burdens experienced by patients following a GFD. 
Whitaker and colleagues (2009) collected data through mail-out questionnaires on 
patient perceptions of the burden of CD and its treatment in the UK. One hundred 
and forty-seven adults (median [IQR] age 54 [44-62] years) participated and a 
number of concerns were raised. Sixty-eight per cent of the patients stated that the 
GFD reduced their enjoyment of food, 54% participated in enjoyable activities less 
often; particularly going out for a meal, whilst 46% reported that food cost them 
more. Despite this, just 21% of these adults said cost was a problem, which may 
reflect the older age of the sample and that over 90% of adults obtain a proportion of 
staple GF products on prescription in the UK (Hogan 2010). Significantly more cases 
who experienced non-classical symptoms or who were asymptomatic before 
diagnosis in the study by Whitaker et al. regretted being diagnosed compared to 
those with classical symptoms (p<0.01), this may lead to poor adherence in such 
individuals. Although the questionnaire implemented in the study was developed 
based on the clinical expertise of gastroenterologists and dietitians and was piloted in 
a small sample of CD patients prior to the main protocol (n=10), participants did not 
have the opportunity to comment on any further issues that they felt were particularly 
burdensome and thus key patient issues may have been missed. 
Researchers in Canada conducted a similar study involving a large number of adult 
CD patients across the country (n=3408) (Zarkadas et al. 2006). In terms of the 
burdens experienced, 60% of participants revealed they had difficulty finding GF 
foods, 48% avoided restaurants and 25% avoided travelling. Information from family 
doctors was rated poor in quality, although information was usually sought from 
other sources such as dietitians or the Canadian Celiac Association. Respondents 
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stated that earlier diagnosis, improved food labelling, more choices on restaurant 
menus and better dietary counselling would improve their lives. Sverker et al. (2005) 
explored the feelings and experiences of CD patients (aged 20-40 years) in 
significant depth in Sweden using a popular interview method known as Critical 
Incident Technique to capture specific dilemmas encountered by patients. Food 
situations at work, food purchases, travel and meals with other people were the major 
areas in which patients experienced dilemmas. In these situations emotions such as 
isolation, fear and ‘being a bother’ were felt and the persons with CD constantly felt 
they had restricted food choice, had to put in double the work and believed 
themselves to continually be ‘on call’ as they always thought about the diet (Sverker 
et al. 2005). In turn, these dilemmas may impinge on the patients’ adherence to the 
GFD and their HRQoL. 
While the aforementioned studies highlight some of the burdens experienced by 
adults following a GFD, as discussed in Section 3.2 adolescence is a time of 
physical, cognitive and social change and teenagers may encounter different issues in 
relation to treatment regimes compared to adults and younger children. Interestingly, 
it was observed in the research by Sverker et al. (2005) that individuals diagnosed in 
childhood often described their most severe dilemmas originating from the period of 
adolescence. These included experiences of dining with people outside the home and 
poor school awareness of foods that were GF leading to accidental gluten exposure 
and illness. Despite this, there is limited research concerning adolescent opinion or 
experience associated with following a GFD, in particular with the UK. 
Qualitative analysis implementing focus group discussions in Swedish adolescents 
(15-18 years) identified that this particular age group face various degrees of 
  
115 
stigmatisation because of the need to follow the GFD in everyday life (Olsson et al. 
2009a). It was ascertained that the foods teenagers consumed made them feel visible 
in public, putting them at risk of social devaluation and they prefer to eat at home 
where the GFD is accepted. The teenagers felt guilty about not accepting food 
offered by others and commented that peers thought they were “making it up” or 
were “self important” because the condition was not visible. Many of the adolescents 
lacked knowledge or had misconceptions about CD and the GFD, but felt stigma was 
reduced by having a good understanding of the diet as well as practical or social 
support. Exclusion of younger teenagers in the study by Olsson et al. (2009a) may be 
a limitation since older adolescents have a tendency to think more abstractly, 
whereas younger teenagers are inclined to believe everything they experience or 
witness as fact (Taddeo et al. 2008). This implies younger adolescents may not value 
the importance of following the GFD in the long-term and will possibly encounter 
different forms of stigmatisation. Additionally, younger teenagers are likely to be 
less independent and therefore the implications of following the diet during early 
adolescence may not be so overwhelming. 
Although the studies discussed above describe specific concerns or issues 
surrounding the GFD in adults and adolescents, they do not specifically address 
factors associated with adherence or non-adherence to the GFD. Knowledge of these 
associations in relation to adolescence is of particular importance since strict 
adherence to the GFD in this age group has repeatedly been shown to be poor.  The 
following section reviews the literature in relation to factors associated with 
adherence to a GFD in teenagers with CD. 
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3.5.1 Factors associated with adherence to the gluten-free diet in adolescence 
There is a paucity of research relating to factors associated with adherence to the 
GFD during adolescence. A UK cross-sectional study was the first to report motives 
behind non-adherence in this age group (Kumar et al. 1988). Teenagers and young 
adults (n=102; 12-20 years) were recruited from two London children’s hospitals. 
Non-compliant participants (36/102) in the study informed researchers that the diet 
proved difficult for practical and social reasons, although these rationales were not 
elaborated upon. Additionally, non-adherent teenagers reported purchasing gluten-
containing foods specifically at school ‘break-times’ such as hamburgers, rolls, 
biscuits and cakes which may have been due to poor availability of GF food items at 
school or the teenagers not wanting to appear different from their peers in social 
contexts. Despite these observations, no quantitative or qualitative analyses were 
performed between adherent and non-adherent teenagers, adherence levels were not 
correlated with any demographic variables and a subjective and unreliable self-report 
method was used to measure adherence.  
Two Italian studies have assessed adherence to the GFD in teenagers originally 
detected on the basis of active screening (Fabiani et al. 1996; Fabiani et al. 2000). 
Fabiani and colleagues (1996) initially assessed adherence levels in 28 screen-
detected adolescents (aged 11-14 years). Authors reported that dietary transgressions 
were more likely to occur at weekend events such as parties with friends, although 
additional reasons for adherence or non-adherence were not reported. Moreover, this 
study is significantly under-powered, the questionnaires used for data collection were 
not validated and older teenagers were not recruited. Therefore, the results are only 
applicable to younger adolescents. The same research group later compared 
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adherence levels in teenagers with screen-detected CD (Group A; n=22) to 
adolescents with typical symptoms prior to diagnosis (Group B; n=22) (Fabiani et al. 
2000). A higher proportion of teenagers in ‘Group A’ reported dietary transgressions 
(17/22) compared to ‘Group B’ (7/22), although significance was not stated. 
However, the results are confounded by the fact that ‘Group A’ were significantly 
older at diagnosis (mean (SD) age 13.0 (1.0) years vs. 4.3 (3.7) years, respectively, 
p<0.01). Thus, poor adherence in ‘Group A’ may be attributed to less experience of 
following the GFD from an early age. Making such substantial changes to dietary 
routine during adolescence is likely to be associated with more anguish, emotion and 
feelings of being different or isolated, resulting in transgression from the diet. 
Additional demographic variables have also been shown to correlate with GFD 
adherence in teenagers. Superior adherence in younger adolescents has been 
observed in two studies (Greco et al. 1997; Ljungman and Myrdal 1993). Findings by 
Hopman et al. (2006) may help to explain these differences given that younger 
teenagers living in The Netherlands reported more frequent medical visits, and they 
were more likely to seek support from parents when unsure of the gluten content in 
different foods. On the contrary, older adolescents stated that they were more 
inclined to chance eating food items they were unsure of and see if they experienced 
symptoms afterwards (Hopman et al. 2006). A longitudinal study may help to truly 
determine whether adolescents become less compliant over-time and why. 
Ljungman and Myrdal (1993) found teenage girls to adhere better to the GFD than 
boys in a Swedish single-centre study. Ninety-one per cent (raw numbers not stated) 
of the girls in the study reported strict adherence to the diet when at school, 
compared to 75% of boys. Furthermore, 82% of girls were strictly compliant to their 
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diet when out with friends in comparison to 58% of boys. This may reflect greater 
peer support experienced by adolescent girls compared to boys (Colarossi 2001) or 
gender differences in personality traits; one meta-analysis found girls to experience 
higher traits of anxiety compared to boys (Feingold 1994), as such girls may 
encounter greater worry regarding the consequences of non-adherence. However, 
separate adolescent, adult and child studies have not observed such differences 
between adherent and non-adherent participants in relation to gender (Anson et al. 
1990; Errichiello et al. 2010; Hall et al. 2009; Leffler et al. 2008; Roma et al. 2010). 
Compliant adolescents in the Swedish study were additionally observed to have a 
better knowledge of CD and GFD compared to non-adherent teenagers (Ljungman 
and Myrdal 1993). Nonetheless, findings may be unreliable since authors do not state 
how adherence is measured in the paper, the knowledge questionnaire was not 
validated and statistical analyses are not performed/presented. 
Only more recently have studies addressed more in-depth sociological, behavioural 
and psychological factors associated with adherence to the GFD. Researchers in 
Sweden conducted focus group interviews with forty-seven 15- to 18-year-olds with 
CD (Olsson et al. 2008a). The interview questions were developed to attain 
information on the teenager’s beliefs, perceptions and experiences in relation to CD 
and a GFD as well as social life, managing situations and obstacles. Participants were 
categorised into ‘compliers’ (strictly following a GFD), ‘occasional non-compliers’ 
(mostly adhering to a GFD and only intentionally eating gluten in problematic 
situations) and ‘non-compliers’ (predominantly eating an ordinary gluten-containing 
diet), with data transcribed to identify recurring themes in each group. Absence of 
immediate symptoms after gluten ingestion, lack of knowledge surrounding long-
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term health outcomes, poor palatability of GF foods and lack of acceptance that the 
diet was important enough to integrate into everyday life were the agreed feelings of 
non-adherers. Very much the opposite was reflected in conversation by strict 
compliers. Additionally, firm GFD adherence was related to better emotional support 
from family and friends and organisation skills such as pre-preparing food for 
travelling or attending sports camps. Although this study is the first to examine 
factors associated with adherence in detail, it is not without limitations. Adherence is 
measured very subjectively through interviews, and thus certain teenagers may have 
been misclassified. Additionally, researchers do not assess any demographic 
variables in relation to adherence, and, for example, it may be that adherent teenagers 
in the study were significantly younger, and thus received greater parental input in 
terms of pre-prepared food for events, or non-adherent adolescents had been 
diagnosed with CD for a shorter length of time which compromised their knowledge 
of CD and the GFD. 
In summary, research to date has observed that demographic factors such as age and 
gender may be associated with adherence to the GFD in adolescents. Additionally, 
adherence in this age group may be related to the patients’ symptoms of CD, 
knowledge of the condition and the GFD, acceptance of the sensory characteristics of 
GF foods, emotional support from significant others, organisational skills and 
attending events/parties. However, limitations in adolescent research methodologies 
exist, particularly in relation to measuring adherence to the GFD. Research 
addressing factors associated with adherence to the GFD in younger children and 
teenagers (5-14.5 years) has identified that adherence may be associated with the 
presence of additional medical conditions such as TIDM or lactose intolerance, the 
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child’s level of education and difficulties interpreting food labels (Hommel et al. 
2008; Roma et al. 2010). Whereas ethnicity, feelings of anger towards being 
diagnosed, embarrassment, poor confidence in the advised treatment and 
affordability of GF foods have all been associated with GFD adherence in adults with 
CD (Hall et al. 2009). As such, factors such as demographic and disease 
characteristics, knowledge of CD and the GFD (including labelling of GF products), 
perceived support from significant others, sensory experiences of GF foods and the 
emotional and physical impact of following the GFD/being diagnosed with CD 
require further exploration in relation to adherence in adolescents with CD. 
Additionally, although inadequacies in the access and availability of GF foods have 
been reported, it is not known whether the ability of obtain GF foods (prescribed and 
un-prescribed) is associated with adherence or non-adherence to the GFD during 
adolescence. Such information could help health professionals and support networks 
such as Coeliac UK to develop tailored advice and support for adolescents at risk of 
poor adherence. In turn, this may facilitate a decline in the incidence of short- and 
long-term health implications associated with not following the GFD. 
3.6 The gluten-free diet and health-related quality of life 
Food serves numerous functions, besides providing the body with adequate nutrition. 
As humans we innately and adaptively associate particular foods with remembered 
and anticipated pleasure, food often plays a central role in social contexts and is a 
tool for sharing and communication (Rozin and Gohar 2011; Woodruff and Hanning 
2011). It helps to form individual, group, religious, ethnic and national identity but 
may also be associated with self-conflict and guilt in terms of eating for pleasure or 
eating for health. Furthermore, food choice is determined by an array of factors 
  
121 
including palatability, price, anticipated health consequences and convenience (ease 
of procurement, preparation and ingestion) (Ares 2011). As such, the need to follow 
a GFD for life has the potential to affect a person’s social and psychological well-
being, as well as their physical health. In recent years, there has been a push from 
government for the collection and reporting of Patient-Reported Outcome Measures 
(PROMs) i.e. information on how patients feel about their own health, and the 
biological, social and psychological impact of the treatment or care they receive 
(Department of Health 2009). Thus, many generic and disease-specific health-related 
quality of life (HRQoL) tools have been developed to collect such information. 
It is important to differentiate HRQoL from more general definitions of well-being. 
Gerson and Firth (2012) refer to HRQoL as “one’s sense of well-being and 
functional outcome within various domains of life, assuming that a disease/injury 
and its treatment have impacted aspects of psychological, social, physical, 
educational and/or vocational functioning”. The multi-dimensional construct of 
HRQoL is largely based on the WHO definition of health described earlier in Section 
3.2, and a measure of HRQoL should incorporate the following four “core” domains: 
1) disease state and physical symptoms; 2) functional status; 3) psychological 
functioning and 4) social functioning (Spieth and Harris 1996). Additionally, 
academic/educational achievement, neuropsychological functioning and overall 
satisfaction with life are believed to be important determinants of HRQoL, and are 
considered important domains to assess in adolescents (Matza et al. 2004; Spieth and 
Harris 1996). 
HRQoL assessment has many uses including the potential to evaluate the quality of 
medical and clinical care and support being received and evaluating the impact of a 
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particular treatment such as the GFD in CD patients. This knowledge can facilitate 
improvements in clinical decision-making and help to inform health policy (Gerson 
and Firth 2012; Spieth and Harris 1995). It was previously thought that children and 
teenagers could not reliably express their opinions, attitudes and feelings regarding 
their own HRQoL (Herjanic et al. 1975). However, subsequent research has shown 
that children and adolescents can effectively report on their health status and 
functioning as long as the HRQoL assessment tool is specific to the child’s age and 
cognitive level (Ravens-Sieberer et al. 2001). Therefore, it is important when 
designing an HRQoL instrument that it corresponds to the views, experiences, 
contexts and activities that are directly relevant to the age group in question (Ravens-
Sieberer et al. 2001).  
As previously stated, HRQoL instruments can be generic or disease specific, and it is 
important to clarify the differences of each tool. The advantage of utilising a generic 
scale is its applicability to all persons, irrespective of their condition or number of 
conditions (Chen et al. 2005). As such, these tools help researchers and clinicians to 
compare HRQoL outcomes between different disease states and between people with 
a single condition or number of conditions and the general healthy population. 
However, disease-specific instruments have been developed to address burdens that 
are perhaps more unique to a distinct condition, and are therefore regarded as more 
sensitive and specific for evaluating HRQoL between patients with the same disease 
or condition (Chen et al. 2005; Loonen et al. 2002). Combined use of both a generic 
and disease specific tool may address the deficits of the other. 
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3.6.1 Adolescent adherence to the gluten-free diet and health-related quality of life 
Complete avoidance of gluten can be extremely difficult as previously highlighted. 
Children and adolescents prescribed a GFD may experience feelings of guilt, 
uneasiness and envy around those with dietary independence (Cinquetti et al. 1999; 
Ohlund et al. 2010). Additionally, it is reported that teenagers suffer various degrees 
of stigmatisation as a result of this dietary regime (Olsson et al. 2009a). Evaluation 
of the condition’s emotional impact in adults has uncovered that sentiments of fear, 
anger, anxiety and sadness are associated with being diagnosed (Ciacci et al. 2002). 
Regardless of this, adhering to the GFD has been shown to have a positive impact on 
both short and long-term health outcomes in patients with CD (see Section 3.1). The 
majority of research in adult populations with CD supports the beneficial association 
between strict adherence and health-related quality of life (HRQoL), with partially 
adherent or non-adherent patients scoring significantly worse in generic HRQoL 
instruments compared to adherent patients and the general population (Casellas et al. 
2008; Fera et al. 2003; Johnston et al. 2004; Usai et al. 2002). Little research, 
however, has examined the association between HRQoL and adherence to the GFD 
in adolescence, thus a major gap in the literature exists. 
Wagner et al. (2008) used two validated generic tools, namely the Inventory of Life 
Quality in Children and Adolescents and the Berner Subjective Well-being Inventory 
to examine HRQoL in Austrian teenagers with CD (10-20 years; n=283) who 
consumed gluten frequently, infrequently or who were adherent to the GFD and 
compared them to healthy age-matched controls (n=83). Teenagers who had frequent 
intakes of gluten experienced more family and leisure time related problems than 
healthy controls, whereas adherent patients achieved similar scores to controls in 
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relation to family problems, physical health and in their global (overall) HRQoL 
rating. Interestingly, it was reported that strict compliers had significantly less leisure 
time problems in comparison to healthy controls (p<0.05). Impairment of HRQoL 
was more prominent in all dimensions (school, family, social contact with peers, 
interests and activities, physical health and mental health) in those with frequent 
transgressions compared to teenagers with infrequent transgressions (Wagner et al. 
2008). Similar findings have additionally been observed in patients with T1DM; 
where adolescents who are concordant with their insulin injecting regimes have a 
better HRQoL than non-concordant patients (Wagner et al. 2005). These types of 
studies only establish ‘association’ between adherence and HRQoL, therefore it is 
not known whether HRQoL affects adherence or vice versa. However, a longitudinal 
study examining HRQoL in children (n9, 2-4 years) diagnosed with CD through 
mass screening in The Netherlands found HRQoL (as scored by the parents of the 
children) improved significantly (p<0.05) after one year following a strict GFD 
(intestinal biopsy used to measure strict adherence) (van Koppen et al. 2009). 
Although the study was under-powered to detect true differences, the findings 
suggest that adhering to the GFD directly influences HRQoL. 
Constraints of the study by Wagner and colleagues (2008) include the use of a self-
report method to assess adherence and possible population bias, since participants 
were all members of the Austrian Celiac Society. Being a member of a CD support 
group has been associated with better adherence to the GFD in adult patients with 
CD (Hall et al. 2009). Furthermore, disease-specific HRQoL was not assessed. Thus, 
there is a need for additional HRQoL research in adolescents with CD utilising both 
generic and CD-specific tools and validated measures of adherence. 
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3.6.2 Measuring generic health-related quality of life in UK adolescents 
Although a variety of validated and reliable generic instruments have been developed 
globally to assess health-related quality of life (HRQoL), not all tools are adolescent 
or UK specific. As discussed in Section 3.6, it is imperative when measuring HRQoL 
that the instrument corresponds to the views, experiences, contexts and activities that 
are directly relevant to the group in question (including age and disease). In 2008, 
Solans et al. published a systematic review of all generic and disease specific 
HRQoL questionnaires developed for use in children and adolescents between 
January 1980 and December 2006. The review was restricted to English, Spanish and 
French documents and instruments intended specifically for children and adolescents 
up to the age of 19 years. Solans and colleagues (2008) identified 30 generic HRQoL 
questionnaires from three previous reviews, original database searches and hand-
searching reference lists of eligible articles. Of these, 23 were developed for use in 
children/teenagers residing in countries outwith the UK, leaving seven that were 
applicable for use in the UK. However, only two of the seven instruments were 
intended for use with an 11-18-year-old audience; namely the Perceived Illness 
Experience Scale (PIE) (Eiser et al. 1999) and the KIDSCREEN-52 questionnaire 
(Ravens-Sieberer et al. 2008). 
The systematic review assessed each tool’s reliability and validity. For the reliability 
of the instrument to be classified as ‘accepted’, measures of internal consistency or 
test-retest had to be ≥0.70 in 70% or more of the HRQoL dimensions. ‘Accepted 
validity’ was interpreted depending on the type of validity that was measured: 
structural, construct or criterion (Solans et al. 2008). Although dimensions of the PIE 
instrument were found to have good correlation with other validated measures 
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(convergent validity), internal reliabilities were <0.70 for five of the eight subscales, 
indicating lack of homogeneity in these specific domains (Eiser et al. 1999). This 
was in contrast to the KIDSCREEN-52 that was identified as having accepted 
reliability and validity as assessed by measures of internal inconsistency and 
construct validity, respectively (Solans et al. 2008).  
An additional literature search of instruments developed between 2007 and 2010 was 
conducted and a further three generic HRQoL tools for use in children and 
adolescents were identified; namely the EQ-5D-Y (Burstrom et al. 2011), the Quality 
of Life in School (QoLS) questionnaire (Weintraub and Bar-Haim 2009) and the age 
adapted World Health Organisation Quality of Life Questionnaire (WHO QOL-
BREF) (Agnihotri et al. 2010). Although development of each instrument included 
measures of reliability and validity, the EQ-5D-Y was only validated in Sweden, 
Italy, Spain, Germany, and South Africa, the QoLS in Israel and the WHO QOL-
BREF in Northern India. Therefore, the KIDSCREEN-52 questionnaire seems to be 
the most valid and age/country appropriate for adolescents resident in the UK. 
The psychometric properties of the KIDSCREEN-52 were tested in 13 different 
countries (Ravens-Sieberer et al. 2008). In the UK 1,877 children and adolescents (8-
18yrs) participated in research to assess the validity and reliability of the 
questionnaire (Ravens-Sieberer et al. 2008). The sample was representative of the 
UK population with regards to the number of children/teenagers receiving private 
and public education, those living in rural vs. urban areas and in terms of age and 
gender.  The KIDSCREEN-52 showed good internal consistency with Cronbach 
alpha scores ranging from 0.77 to 0.89 for each dimension. Intraclass correlation 
coefficients (ICC) ranged from 0.56 to 0.77, with just three of the ten subscales in the 
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questionnaire scoring only slightly below the a priori specified threshold of 0.60; 
‘Moods and Emotions’, ‘Autonomy’ and ‘Social Acceptance’. As for validity, both 
construct and convergent validity were assessed. Measures of convergent validity 
examine how well two concepts that hypothetically should be related, are in fact 
related (Mitchell and Jolley 2010).  
Convergent validity was determined by correlating dimensions of the KIDSCREEN-
52 instrument with scores of other validated questionnaires measuring similar 
constructs such as the Pediatric Quality of Life Inventory (PedQL 4.0) (Ravens-
Sieberer et al. 2008). The PedQL Physical Functioning scale correlated highest with 
the KIDSCREEN-52 Physical Well-Being dimension (r=0.44), the PedQL Emotional 
Functioning Scale correlated highest with Moods and Emotions (r=0.53), the PedQL 
School Functioning Scale correlated highest with the School Environment dimension 
in the KIDSCREEN-52 (r=0.45) and the PedQL Social Functioning Scale correlated 
highest with the Social Acceptance (Bullying) domain (r=0.50), all as expected. 
However, these only account for ~19%-25% of the variance. Thus, when comparing 
domain scores of the KIDSCREEN-52 with scores of similar domains measured 
using separate HRQoL instruments significant differences should be interpreted with 
caution. 
Construct validity was evaluated based on previously developed hypotheses. These 
were centred on existing literature, the author’s experience, and the results of pilot 
testing (Ravens-Sieberer et al. 2008). As hypothesised, children with special 
healthcare needs reported lower physical, psychological and emotional well-being 
compared to healthy children; differences between groups were significant (p<0.01) 
with small to moderate effect sizes (d=0.17-0.72). The more frequently children 
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suffered from psychosomatic complaints, for example dizziness, headaches or 
fatigue, the lower their HRQoL scores (p<0.01), especially for the moods and 
emotions domain (d=0.72), although sizable effect sizes (d=0.32-0.72) were 
observed for all dimensions. Similar significant differences in HRQoL domains were 
observed between healthy children and those with mental health and behaviour 
problems (d=0.17-0.42). Therefore, the KIDSCREEN-52 seems to discriminate well 
between children and adolescents in good health and those with poorer physical and 
mental health, and thus will help to identify whether adherent on non-adherent 
teenagers with CD require additional educational, clinical, social or psychological 
support. 
3.6.3 Measuring disease specific health-related quality of life in adolescents with coeliac 
disease 
A detailed database search of the literature revealed three instruments that have been 
specifically developed to assess disease-specific HRQoL in individuals diagnosed 
with coeliac disease; namely the TACQOL-COE (Kolsteren et al. 2001), the 
CDDUX (van Doorn et al. 2008) and the CD-QOL (Dorn et al. 2010). Although the 
CD-QOL is the most up-to-date measure and displays both high internal consistency, 
reliability and convergent as well as discriminative validity (Kolsteren et al. 2001), it 
was designed for and validated in adults >18 years, making it of limited relevance to 
adolescents. Issues concerning adolescents such as following the diet at school or 
during extra-curricular activities such as sports clubs were not addressed. 
Furthermore, the use of language is likely to be too complex for younger teenagers. 
Both the TACQOL-COE and the CDDUX were developed for use in children and 
adolescents living in The Netherlands, however the CDDUX was validated in 
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teenagers up to the age of 18 years, whereas validation of the instrument designed by 
Kolsteren and colleagues only included adolescents up to the age of 16 years. The 
TACQOL-COE does not provide information regarding the child’s viewpoint; the 
questions were merely based on the child/teenagers symptomatic experience and 
only test-retest psychometric analysis was assessed. Questions related to following 
the GFD within different social contexts, such as at home, at school and when 
socialising with peers are not included in the TACQOL-COE. Additionally, concerns 
regarding living with CD in general such as future health or feeling different are not 
examined. Thus, it is felt that the TACQOL-COE requires further development and 
validation before it should be used to measure CD-specific HRQoL in children and 
adolescents. As it stands, important factors that may affect HRQoL in this age group 
are not included in this questionnaire. 
The CDDUX was developed using a bottom-up approach, whereby focus groups of 
8- to 18-year-olds were undertaken to enable interactive discussions where 
individuals could express their perceptions of living with CD (van Doorn et al. 
2008). Successive to this, expert trainers selected relevant information about living 
with CD using a card sorting system with the following themes “Home”, “School”, 
“Peers”, “Going out/Parties”, “Holidays”, “Feeling different”, “Future”, “Sports”, 
“General statements”, “Advantages”, “Disadvantages” and “One wish to be happier”. 
A number of questionnaire items were established using these data. Cognitive 
debriefing was carried out in 28 families to assess the comprehensibility, age 
appropriateness and relevance of the questions. The pilot edition of the questionnaire 
consisted of 24 items using 5-point, Likert type scales to assess individual agreement 
to statements. 
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The CDDUX was piloted in members of the Dutch Celiac Patients Society. In total, 
1512 children and adolescents (8-18yrs) were invited to participate; a 70% response 
rate was achieved. Test-retest and internal consistency statistical tests were 
performed to assess the instruments reliability. Only items with acceptable reliability 
test scores were included in a final version of the CDDUX. This revised tool 
comprises 12 items and three domains: ‘Diet’, ‘Communication’ and ‘Having CD’. 
The ‘Diet’ scale gives an impression of how the child feels in relation to adherence, 
dietary restrictions and life-long dietary treatment. The ‘Communication’ scale tells 
the researcher how the child feels when discussing CD and explaining the condition 
to others, whereas the ‘Having CD’ domain gives information on how the participant 
feels when offered gluten-containing food or when she or she thinks about gluten 
foods. This 12-item questionnaire showed good reliability with Cronbach alphas 
ranging between 0.77 and 0.87 for each domain. Construct validity was accepted on 
the finding that the a priori hypotheses that teenagers with CD with a poorer health 
status would score significantly worse in each domain was true (p<0.05 for each 
domain). However, it should be mentioned that since the CDDUX was developed in 
The Netherlands, it may not be specific to the thoughts and feelings of UK 
adolescents, and thus disease-specific HRQoL measures for CD require development 
in the UK populations.  
3.7 Summary and rationale for a cross-sectional adolescent study  
Strict life long adherence to a GFD currently is the only effective treatment for CD 
improvement. This will not only alleviate intestinal injury; relieving multiple 
symptoms and normalise nutrient absorption, it may further act to prevent serious 
future complications associated with untreated CD including osteoporosis, 
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malignancy, fertility difficulties and exacerbation of associated medical conditions 
(Haines et al. 2008). However, it has been suggested that complete removal of 
gluten-containing foods in the diet may put individuals at risk of nutritional 
inadequacy. This is especially pertinent in UK teenagers, as many have poor dietary 
intakes already (Bates et al. 2012). There are inconsistencies between adult studies in 
relation to the nutritional adequacy of the GFD. Only two papers include teenage 
participants with CD in their study populations. Both provide preliminary evidence 
that intakes of certain macronutrients and micronutrients may be poor. However, the 
findings reported are not adolescent specific and these studies were conducted in 
Northern Europe where dietary intakes differ from UK populations (Samuelson 
2000). Thus, original UK research is necessary to identify any nutritional 
inadequacies in adolescents following a GFD. If particular disparities in energy or 
nutrient intakes are recognised between adolescents following a GFD and the general 
population this will help to guide the dietetic management of CD in teenage patients. 
Additionally, findings may help to inform government bodies in relation, for 
example, to the fortification policy of GF flours. 
There is evidence to suggest GFD adherence is poor in a significant proportion of 
adolescents with CD. Although a few studies have identified burdens related to the 
GFD and assessed factors associated with adherence and non-adherence in this age 
group, limitations in current adolescent methodologies are evident. Most of the 
studies utilise unreliable measures to determine adherence to the GFD, many of the 
methods used to assess factors associated with adherence have not been validated or 
piloted and younger or older teenagers have often been omitted from analyses. 
Furthermore, the majority of research has been carried out in Sweden and Italy and 
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experiences of the GFD in the UK are likely to differ from other countries due to 
variation in the clinical and dietary management of CD, dietary patterns, food cost, 
access and availability and general attitudes towards medical regimes. Therefore, a 
novel study within a UK adolescent population is required. Research is important so 
that tailored advice and support can be developed for those teenagers at-risk of the 
conditions associated with non-adherence. 
As well as affecting physical symptoms, non-adherence to the GFD in adults with 
CD has also been associated with inferior HRQoL. However, there is a lack of 
research investigating HRQoL in relation to adherence levels in teenagers, in 
particular in the UK. Although findings in one teenage study support the outcomes 
observed in adults (Wagner et al. 2008), it should be noted that authors use a very 
subjective method to determine adherence, the study was not conducted in the UK 
and CD specific HRQoL was not established. On the basis of these limitations, 
differences in HRQoL between adherent teenagers, non-adherent teenagers and 
healthy controls in the UK need to be ascertained. If any inequalities in HRQoL 
dimensions are evident between groups it will provide an evidence base for future 
educational, social and psychological support services in this population.  
3.8 Research aims 
Study 3: Adolescent adherence to the gluten-free diet; nutritional adequacy, factors 
associated with adherence and health-related quality of life 
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The primary aims of this study are threefold.  
 To determine whether any specific factors are associated with adherence to a 
GFD in Scottish adolescents (11-18 years) with a medical diagnosis of 
coeliac disease (CD).  
 To identify whether health-related quality of life (HRQoL) differs amongst 
teenagers adherent to the GFD, non-adherent teenagers and a healthy control 
population.  
 To establish whether estimated energy and nutrient intakes vary significantly 
between teenagers with CD and a healthy control group. 
The study anticipated answering the following research questions subsequent to data 
collection in a Scottish adolescent population: 
1. Do estimated energy and nutrient intakes differ between adolescents with CD 
and a healthy control group? 
2. Are any demographic or disease characteristics, additional medical conditions 
or specific disease related experiences associated with adherence to the GFD 
in adolescents? 
3. Is knowledge of CD and the GFD associated with adherence to the GFD? 
4. Do adolescents who are non-adherent to the GFD have a poorer HRQoL in 
comparison to those who strictly adhere to the diet, and a healthy control 
population? 
It was hypothesised from existing literature that non-adherent teenagers would have 
poorer health-related quality of life indices compared to adherent teenagers.  
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Chapter 4: Methodologies 
4.1 Study 1: The incidence and management of childhood coeliac disease 
in Scotland- the Scottish Paediatric Surveillance Unit (SPSU) coeliac 
project 
4.1.1 Study design 
A national prospective cohort study design was employed. Data collection took place 
between 01/09/2009 and 01/10/2011. 
4.1.2 Defining coeliac disease 
Coeliac disease was defined according to 1990 ESPGHAN criteria (Walker-Smith, 
Guandalini, and Schmitz 1990) i.e. characteristic histological features of villous 
atrophy on histological examination of a small intestinal biopsy specimen whilst on 
gluten-containing diet, and resolution of clinical findings on gluten-free diet. 
ESPGHAN criteria were revised in 2012 (Husby et al. 2012). These new criteria 
further allow clinicians to diagnose CD on the basis of an Anti-tTG result >10 times 
the normal upper value, in addition to having a positive EMA result and HLA DQ2 
or DQ8 positivity.  However, the 1990 guidelines were used given the time frame of 
data capture. 
Cases were categorised into three groups according to primary reason for diagnosis; 
(1) actively screened (diagnosed due to an ‘at risk’ condition or family history of CD 
in a first-degree relative); (2) ‘classical’ (presenting with ≥ 2 GI symptoms or 1 GI 
symptom and additional common signs/symptoms of CD, for example fatigue or iron 
deficiency anaemia); and (3) ‘non-classical’ (presenting with either one isolated GI 
symptom or just extra-intestinal indicators). 
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4.1.3 Population 
4.1.3.1 Inclusion criteria 
 All children (<16 years) newly diagnosed with CD between 01/09/2009 and 
31/08/2011. 
 Resident in Scotland.1 
 Biopsy confirmed diagnosis of CD; in line with 1990 ESPGHAN guidelines 
(see Section 4.1.4). 
4.1.3.2 Exclusion criteria 
 Children newly diagnosed with CD resident outwith Scotland. 
 Diagnosed before 01/09/2009 or after 31/08/2011. 
 ≥16 years at diagnosis. 
 Children without a biopsy confirmed diagnosis of CD in line with 1990 
ESPGHAN criteria. 
4.1.4 Identifying new cases of paediatric coeliac disease 
Data collection was achieved through an e-reporting system set up by the Scottish 
Paediatric Surveillance Unit (SPSU), and replicates similar methods used by the 
Dutch Paediatric Surveillance Unit (DPSU) which have been successful in capturing 
incidence of CD in The Netherlands (Steens et al. 2005). Scottish paediatric 
gastroenterology, hepatology and nutrition (PGHAN) services are divided between 
three regional networks (East, West and North) and are each managed through an 
allocated regional tertiary care centre (TCC) (figure 1).  All children (<16 years) with 
suspected CD should be referred to one of the four TCCs for duodenal biopsy to 
                                                     
1
 A Microsoft Access database of all Scottish postcodes is available from The Scottish Government 
website. (General Register Office for Scotland 2012) Each patient’s first part of postcode was checked 
against the database to ensure they were resident within Scotland at time of diagnosis.  
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confirm diagnosis. Through face-to-face meetings and email contact, key Scottish 
Paediatric Society (SPS) members were recruited within each PGHN TCC and all 
surrounding regional outreach centres to assist in the reporting of data. These 
strategic contacts were added to a SPSU emailing database (Scottish Paediatric 
Society 2012). 
From 01/08/2009 onwards an automated monthly email was sent to all SPS members 
within the SPSU database that asked whether they had diagnosed any children 
<16yrs with CD in the preceding month. Contacts were asked to reply even if they 
had diagnosed zero cases. If after two weeks a reply was not received, a reminder 
email was sent to prompt a response. A positive response from SPS members 
generated an email to the Principal Investigator (PI) (Dr Peter Gillett) and a 
questionnaire was automatically forwarded to the clinician to complete on each new 
patient (see Section 4.1.6).  
To ensure an optimal response, contacts were given a month to familiarise 
themselves with the protocol before the actual start of data collection on 01/09/2009. 
Furthermore, results were cross-checked with SPS members after data collection to 
make certain all new coeliac cases had been forwarded to the PI. 
4.1.5 Collecting dietetic data 
It was not possible to accumulate dietetic data for the whole of Scotland within the 
time frame and scope of this PhD. However, through strategic dietetic contacts in 
both NHS Lothian and NHS Fife, data was collected on patients (<16 years) 
diagnosed with CD between 01/09/2010 and 31/08/2011. This would enable 
alignment of both medical and dietetic data over one year in these areas. Dietitians 
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practicing in the Scottish Borders were also contacted in the hope that data collection 
could be extended to the whole of Southeast Scotland, however recruitment in this 
area was not possible. 
 
 
Figure 1 Tertiary centres for paediatric gastroenterology, hepatology and nutrition in 
Scotland 
The Royal Aberdeen Children’s Hospital and Ninewells Hospital in Dundee provide services in the 
North; The Royal Hospital for Sick Children (RHSC), Edinburgh provides services in the Southeast; 
and RHSC, Glasgow provides services in the West. The numbers within each area represent the total 
paediatric population under 16 years within the region (2009 mid-year estimates) (General Register 
Office for Scotland 2011). 
 
Similar to identification of key clinicians to collect information for the SPSU study, 
key dietitians involved in the care of newly diagnosed paediatric coeliac patients 
were identified via contact through emails and subsequent meetings, where the 
importance of the study’s outcomes were highlighted. Although the majority of 
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children with CD living within NHS Lothian and NHS Fife health boards are seen by 
paediatric dietitians at RHSC, Edinburgh, Victoria Hospital, Fife or St John’s 
Hospital, Livingston, some older children may be reviewed in adult services, and a 
selected few may be seen by community dietitians. Thus, all dietitians based in 
Lothian and Fife at the time of data collection, whose patient groups included those 
with CD, were made aware of the audit and agreed to be included in an email contact 
list.  
As in the SPSU national study, dietitians were asked to complete a pro-forma (see 
Section 4.1.6) post each new patient consultation over the year. Monthly emails were 
sent to each dietetic contact asking them to report the number of new patients they 
had seen in the preceding month and prompted them to submit completed 
questionnaires either by post or email. Again, reminder emails were forwarded if a 
reply was not received after two weeks of sending the initial email in order to 
maximise response rates. 
4.1.6 Questionnaire development 
A medical pro-forma, using a range of closed and open-ended questions was 
developed in consultation with members of the SPS in order to gather routine clinical 
data on children newly diagnosed with CD (Appendix 4.1). No patient identifiable 
data was collected. It included questions referring to the patients: 
 Demographic characteristics (including first part of postcode to map 
geographical distribution). Full postcode and date of birth were not collected 
to ensure anonymity. 
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 Presenting symptoms, additional medical conditions, family history of CD 
and whether the child had been actively screened for CD (due to presentation 
of an associated condition or family history of CD in a first-degree relative). 
 Investigations at presentation (including Anti-tTG, Anti-EMA, vitamin tests, 
full blood count, liver function tests, thyroid function tests and 
immunoglobulins).  
 Endoscopic confirmation and advice and information given at presentation.  
 
Clinical and academic dietitians and nutritionists from Lothian and Fife developed a 
questionnaire to collect information on the nutritional status and dietetic management 
of patients with newly diagnosed CD (<16 years) based on standard methods of 
assessment (Appendix 4.2). The two-page pro-forma comprised closed and open-
ended questions focusing on the patients: 
 Method of dietetic input (for example: whether seen by a general paediatric 
dietitian or paediatric GI specialist and the timing of appointment) 
 Anthropometry (weight, height and BMI).  
 Assessment of additional dietary requirements (for example: stage of life, 
activity level, other intolerances/allergies) 
 Dietary intake (highlighting any areas for concern, for example calcium, iron 
or NSP intake). 
 Education and resources provided. 
 Arrangement of GF product prescriptions. 
  Planned frequency of follow-up.  
  
140 
The questionnaire was piloted for ease, clarity and comprehensiveness at RHSC, 
Edinburgh and the Western General Hospital, Edinburgh. Dietitians indicated that it 
only took a few minutes to extract the relevant information from dietetic record cards 
and complete the necessary information. Furthermore, dietitians at both hospitals 
were satisfied with the questionnaires level of content and the wording of questions.  
The first part of patients’ postcodes, date of endoscopy and Anti-tTG test result on 
presentation would be used to link individual patient data in the medical and dietary 
databases. 
4.1.7 Laboratory data 
In Scotland, diagnostic tests for paediatric CD; Anti-tTG and Anti-EMA are 
performed in various regional laboratories across the country. In the East of 
Scotland, all childhood (<16 years) serology samples are dispatched to the GI 
Laboratory at the Western General Hospital, Edinburgh. Samples from children 
living in the West of Scotland are sent to Paediatric Biochemistry at Gartnavel 
General Hospital, Glasgow. Three test sites are responsible for CD serological 
investigations in the North; the Department of Immunology at Ninewells Hospital, 
Dundee, the department of Pathology at Aberdeen Royal Infirmary and the 
Microbiology Department at Raigmore Hospital, Inverness. All regional laboratories 
were contacted primarily by email and then by phone if a response were not gained 
initially. Members of staff were asked to provide information on the total number of 
paediatric (<16 years) coeliac screens requested in the 12 months from 01/09/2009 
and 31/08/2010. They were also asked to confirm, if possible, how many tests were 
requested by primary care clinicians and how many by secondary care clinicians, in 
order to ascertain whether there are differences in thresholds to test between regions.  
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4.1.8 Statistical analyses 
4.1.8.1 Age-sex standardised incidence rates 
The majority of paediatric CD incidence studies have calculated incidence using the 
simple equation below: 
Total number of new cases per year × 100,000 
         Childhood population for that year 
(McGowan, Castiglione, and Butzner 2009; Olsson, Hernell et al. 2008; Ravikumara, Tuthill, and 
Jenkins 2006; Savilahti et al. 2010) 
However, to enable the valid comparison of groups; for example across different 
geographical regions, it was important that confounding factors between groups were 
controlled (Miller et al. 2005). In relation to the Scottish population under 16 years, 
the East, West and North differed slightly with regards to age. For example, 33.3% 
of children in 2009 were aged 6-10 years in the East, compared to 29.6% in the West 
and 29.7% in the North (General Register Office for Scotland 2011). Although 
gender differences were minor across regions (the proportion of males being 49.0%, 
48.9% and 48.5% in the East, West and North, respectively (General Register Office 
for Scotland 2011), sex is a strong determinant of CD, being approximately twice as 
common in females (Ivarsson et al. 2003). Therefore, it was imperative to adjust for 
this and age as potential confounders. 
Two major approaches are used to standardise rates; the direct method and the 
indirect method (Miller et al. 2005). The indirect method is generally used when the 
observed population is small, or the outcome is very rare (Miller et al. 2005). The 
direct method seemed the more appropriate technique in the case of this study, since 
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the incidence of a reasonably widespread condition was being calculated on a 
national scale. In direct standardisation, one estimates the rate that would have been 
observed if the study population had the same age and sex structure as a chosen 
reference population. Conventionally, the reference population should either be the 
World Health Organisation’s ‘World Standard Population’, or a census population 
count from the country the research is being conducted in (Bray 2002), for example 
Scotland’s Census data. 
To enable standardisation, the age-sex-specific incidence rates within the study group 
were calculated using the equation above using known population figures from 2001 
Census data (General Register Office for Scotland 2011). Then these rates are 
multiplied by the number of people in that age and sex group in the reference 
population. These expected counts are summed and divided by the total population 
size of the reference population to yield the direct standardised rate. In the current 
study, yearly incidence rates were standardised to the 2001 Scottish Census 
population using the direct method in the epitools package in ‘R’ version 2.9.2 
(Aragon 2009; Registrar General for Scotland 2001). 95% confidence intervals (95% 
CIs) were determined using a method based on gamma distribution (Fay and Feuer 
1997). Children were split into three age groups; pre-school (0-5yrs), primary school 
(6-10yrs) and secondary school (11-15yrs) to enable standardisation. Rates are 
presented per 100,000 of the childhood population at-risk (<16 years).  
4.1.8.2 Statistical analyses 
To identify any differences in nominal (categorical) variables between groups, Chi-
Square tests were performed. Kruskal-Wallis tests were used to identify any 
differences in non-normally distributed continuous variables between tertiary 
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networks. All tests were performed in SPSS v.17.0 (SPSS 2010). Odds ratios and 
95% CIs were calculated where appropriate. A significance of p<0.05 was used for 
all statistical analyses. 
4.1.9 Ethical considerations 
NHS SE Scotland Research Ethics Committee approved the medical and dietetic data 
gathering methods as service evaluation audits since no patient-identifiable data was 
being collected (Appendices 4.3 and 4.4). Data collection pro-formas were 
completed by clinicians and anonymised data sheets forwarded to the researcher, as 
not part of any patients’ clinical team. All data was stored in line with NHS 
guidance, in a locked cabinet on Queen Margaret University premises. All electronic 
data was stored on a password-protected university computer. All electronic data was 
password encrypted with access limited to the PI and research team. 
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4.2 Study 2: Trends in paediatric coeliac disease in Southeast Scotland 
from 1990-2009: a retrospective audit of cases 
4.2.1 Study design 
This study was a twenty-year retrospective clinical audit of case-notes, pathology 
database, endoscopy records and electronic patient records between the years 1990 
and 2009. 
4.2.2 Defining coeliac disease 
Coeliac disease was defined according to 1990 ESPGHAN criteria (see Section 
4.1.4). Similar to the prospective study, cases were primarily split into three groups 
according to their initial reason for clinical suspicion; (1) actively screened 
(diagnosed due to an ‘at risk’ condition or family history of CD in a first degree 
relative); (2) ‘classical’ (presenting with ≥ 2 GI symptoms or 1 GI symptom and 
additional common signs/symptoms of CD, for example fatigue of iron deficiency 
anaemia); and (3) ‘non-classical’ (presenting with either one isolated GI symptom or 
just extra-intestinal indicators). However, in February 2012, soon after the 
retrospective data had been collected and analysed, a review undertaken by 16 
physicians from seven countries, in which coeliac disease and related terms were 
accurately defined; referred to as ‘Oslo’ definitions (Ludvigsson et al. 2012) were 
published. 
Ludvigsson and colleagues (2012) defined paediatric classical CD as having signs 
and symptoms specifically of malabsorption, which in children is often characterised 
by failure to thrive, diarrhoea, muscle wasting, poor appetite and/or abdominal 
distension. Therefore, to bring the research up to date with current terminology, the 
original ‘classical group’ was reclassified into those exhibiting an ‘Oslo classical’ 
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presentation. Children presenting with ≥2 GI symptoms including abdominal pain, 
constipation, bloating and flatulence but no malabsorption were not included in the 
Oslo classical group. 
4.2.3 Population 
4.2.3.1 Inclusion criteria 
 All children (<16 years) newly diagnosed with CD between 01/01/1990 and 
31/12/2009. 
 Resident within the core Southeast Scotland NHS health board areas; 
Lothian, Fife and Scottish Borders.
2
 
 Biopsy confirmed diagnosis of CD in line with 1990 ESPGHAN guidelines 
(see Section 4.1.4). 
4.2.3.2 Exclusion criteria 
 Children newly diagnosed with CD resident outwith the three core SE 
Scotland health board areas. 
 Diagnosed before 01/01/1990 or after 31/12/2009. 
 ≥16 years at diagnosis. 
 Children without a biopsy confirmed diagnosis of CD in line with 1990 
ESPGHAN criteria. 
  
                                                     
2
 Since age-sex standardised incidence rates of paediatric CD were calculated for the retrospective 
study using population statistics from the three core SE Scotland NHS health board areas; Lothian, 
Fife and Scottish Borders (General Register Office for Scotland 2011), it was important that only 
newly diagnosed children resident within these health boards at time of diagnosis were included in the 
data. Each patient’s postcode was entered into The Scottish Government’s ‘Full Scotland Postcode 
Lookup’ database (The Scottish Goverment 2012) to ensure eligibility.     
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4.2.4 Identifying new cases of paediatric CD in SE Scotland 
Although the Royal Hospital for Sick Children (RHSC), Edinburgh is the tertiary 
care centre (TCC) for PGHN services in SE Scotland; and is the hospital children 
should be referred to for biopsy, paediatric patients may initially be referred by a 
General Practitioner to Victoria Hospital, Kirkcaldy (VHK), St John’s Hospital 
(SJH), Livingston or Borders General Hospital (BGH), Melrose regarding suspicion 
of CD.  Blood may be drawn at any of the above hospitals to test for CD auto-
antibodies, nutrient levels, liver function, thyroid function, immunoglobulins, full 
blood count (FBC) and haematinics. However, a few children may have an 
emergency biopsy depending on severity of symptoms. These patients are likely to 
have blood work taken post diagnosis. 
Staff at RHSC, Edinburgh, formerly collected data on all new childhood cases (<16 
years) of CD diagnosed in SE Scotland between 01/01/1990 and 31/12/2005 using a 
standard pro-forma for data collection. Data on patients diagnosed from 2000-2004 
had been collected by a medical student as part of a Special Study Module (Claire 
Bradshaw 2005) and each patient was documented in a Microsoft Access database. 
Another paediatric trainee had entered data from children diagnosed in 2005 into a 
Microsoft Excel spread sheet, although this spread sheet was largely incomplete. For 
the current study, a research student (Lois White) and a paediatric ST5 doctor (Dr 
Victoria Merrick) practicing at RHSC Edinburgh collected information on new cases 
diagnosed between 01/01/2006 and 31/12/2009 in SE Scotland. Data from 2005 was 
also rechecked and updated and all cases were entered into a new Microsoft Access 
database (Microsoft Corporation 2010) that was then merged with the original (1990-
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2004) catalogue. Prior to the most recent data collection, the case population was 
identified from the following sources: 
1. Hospital records: all patients with ICD10 coding of coeliac disease (1990-
1999): Enabled identification of all children treated in SE Scotland paediatric 
clinics with a clinical label of coeliac disease between the dates. 
2. Regional paediatric gastroenterologist endoscopy books (1990-2005): These 
helped to identify which cases underwent duodenal/jejunal biopsy to test for CD 
between the dates. 
3. Paediatric pathology records; all duodenal biopsies (1990-mid 2003): The 
records include all duodenal/jejunal biopsy pathology reports. Each patient’s 
report was examined to ensure it met 1990 ESPGHAN criteria. 
4. Regional serology database at the Western General Hospital (1990-1999): 
All paediatric CD serology for SE Scotland is sent to the Western General 
Hospital for analysis. By identifying who tested positively in the time period 
data-collectors were able to cross-check RHSC records to see if any positive 
cases were not diagnosed at the hospital or were overlooked in hospital records. 
By tracking individuals possibly diagnosed in District General Hospitals it was 
hoped a more complete picture of incidence would be seen. Researchers in the 
Netherlands discovered another twenty CD cases by cross-checking numbers 
with the Dutch Network and National Database of Pathology (George et al. 
1997). 
New patients, diagnosed between 01/01/2006 and 31/12/2009, were primarily 
identified from hospital lists of all children attending regional coeliac clinics at 
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RHSC, VHK, SJH or BGH between the dates. Furthermore, every child was cross-
checked with the paediatric gastroenterology endoscopy record book, held at RHSC, 
to ensure their biopsy confirming CD was performed between the two dates. Data for 
cases from 2005-2009 was retrieved from electronic copies of GI clinic letters, 
TRAK (the RHSC electronic patient record) and iLAB (the RHSC electronic results 
system). Where results of blood tests were incomplete in iLAB, regional hospitals 
were contacted to see if missing values could be tracked on local systems. 
Although the General Register Office for Scotland (GROS) includes just three core 
NHS health boards in its population statistics of SE Scotland (Lothian, Fife and 
Scottish Borders), the real life referral base is rather more complex.  For many years 
patients were referred to RHSC, Edinburgh for biopsy from 'core SE Scotland' areas, 
although a select few were additionally referred from Perth area of Tayside, East 
Lanarkshire, Forth Valley, and Dumfries. At present, clinicians at RHSC diagnose 
patients from 'core' postcode areas but acknowledge that some North Fife are referred 
to Ninewells Hospital, Dundee, and still a few from Lanarkshire, Perthshire and 
Forth Valley are biopsied in Edinburgh. It may be assumed that these equalise out, 
however it was decided that children from only ‘core SE Scotland’ health boards 
would be used in the incident data in order to link with robust population data from 
GROS. Each patient’s postcode was entered into The Scottish Government’s ‘Full 
Scotland Postcode Lookup’ database (The Scottish Goverment 2012) to ensure 
eligibility. 
4.2.5 Data collection 
The following information was collected on each new patient diagnosed with CD 
between 01/01/1990 and 31/12/2009: 
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 Demographic details at time of diagnosis including age and gender. Data was 
further collected on each patient’s age at first positive CD antibody test and 
the date they were first seen in clinic regarding suspicion of CD. 
 Results of serological tests (tissue transglutaminase, endomysial antibodies 
and/or anti-gliadin antibodies) and pathological statements from duodenal 
biopsy.  
 Postcode at time of diagnosis. Using readily available government data the 
deprivation level of each postcode was identified; known as the Standard 
Index of Multiple Deprivation (SIMD), a decile range where 1 represents 
most deprived and 10 least deprived (General Register Office for Scotland 
2012). Additionally, each postcode’s Urban-Rural classification index was 
determined (ranging from 1; ‘large urban area’ to 6; ‘remote rural area’) 
(General Register Office for Scotland 2012). 
 Symptomatology pre-diagnosis. As discussed in section 4.2.4 cases were 
initially split into three groups according to their primary reason for 
diagnosis; (1) actively screened (diagnosed due to an ‘at risk’ condition or 
family history of CD in a first-degree relative); (2) ‘classical’ (presenting 
with ≥ 2 GI symptoms or 1 GI symptom and additional common 
signs/symptoms of CD; for example fatigue of iron deficiency anaemia); and 
(3) ‘non-classical’ (presenting with either one isolated GI symptom or just 
extra-intestinal indicators). Classical cases were further re-classified into 
those diagnosed due to ‘Oslo classical’ symptoms.  
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Additionally, for children diagnosed between 01/01/2005 and 31/12/2009 results of 
the following blood tests from around the time of diagnosis were collected (within 
three months pre- or post-diagnosis): 
 Haemoglobin (Hb), Mean Cell Volume (MCV), vitamin B12, ferritin, folate, 
Alanine Transaminase (ALT), Gamma-Glutamyl Transpeptidase (GGT), 
bilirubin, albumin, Alkaline Phosphatase (ALP), Thyroid-Stimulating 
Hormone (TSH), Free Thyroxine (Free T4), and immunoglobulins A, G and 
M.  
The Microsoft Access 2010 pro-forma used for data collection can be observed in 
figure 2. 
4.2.6 Statistical analyses 
4.2.8.1 Age-sex standardised incidence rates 
Similar to the prospective study, incidence rates were age-sex standardised to enable 
the valid comparison of groups. Whereas differences between regions were observed 
in the prospective research, one of the main objectives of the current study was to 
compare incidence rates between different time periods. In SE Scotland the number 
of children under 16 years old decreased from a mean of 230,587 per year in 1990-
1994 (Epoch 1) to 224,750 per year in 2005-2009 (Epoch 4) (General Register Office 
for Scotland 2011). Standardising incidence rates in each epoch to the 2001 Scottish 
Census population aimed to control for such changes in population structure. Age-
sex standardised incidence rates per year were calculated in exactly the same way as 
described in Section 4.1.8.1, using the direct method in epitools package in ‘R’ 
version 2.9.2 (Aragon 2009) and 95% CIs determined using a method based on 
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gamma distribution (Fay and Feuer 1997). Mean rates for each five-year Epoch are 
presented per 100,000 of the childhood population at risk (<16 years). 
4.2.8.2 Poisson regression 
In the current study, one of the main aims was to observe the relationship between 
time (in the form of five-year epochs) (independent variable X) and CD incidence 
(dependent variable Y). Unlike simple regression, where a relationship between a 
scalar dependant variable and independent variable is modelled, a different type of 
regression model is generally used when the outcome variable is numeric, but in the 
form of counts (such as the number of new cases of a disease occurring in a 
population over a certain period of time) (Chatterjee and Hadi 2006). Poisson 
regression is used to model the (natural) log of the expected count, since the Poisson 
distribution only includes variables with non-negative integer values (≥0) (Chatterjee 
and Hadi 2006). Like all other regression coefficients, a Poisson regression 
coefficient represents the change in response corresponding to a one-unit difference 
in the corresponding predictor. Since rate data was observed, counts had to be 
modelled per 100,000 of the population at risk (<16 years), rather than modelling just 
counts per se. This is allowed for in the Poisson regression model by handling such 
data as an ‘offset’, whereby the population size is included in the right hand side of 
the equation. All Poisson regression analyses were performed using the epitools 
package in ‘R’ version 2.9.2 (Aragon 2009) to observe trends in the total incidence 
of paediatric CD over time (four 5-year epochs) and trends in the incidence of those 
diagnosed on the basis of 1) classical symptoms (and Oslo classical symptoms); 2) 
non-classical symptoms and 3) active screening over time. 
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4.2.8.3 Additional analyses 
A Kruskal-Wallis test was performed to observe any variation in age between epochs 
and differing presentations of CD. The non-parametric test was further employed to 
see whether differences in median SIMD classifications and urban-rural indexes 
between epochs existed. Chi-Square analyses were used to determine whether the 
proportion of children under two years old varied significantly between epochs, as 
well as the proportion of males and females. Additionally, the percentage of males 
and females diagnosed between 2005-2009 with blood test results (Hb, MCV, 
vitamin B12, ferritin, folate, ALT, GGT, bilirubin, albumin, ALP, TSH, Free T4 and 
immunoglobulins A, G and M) either above or below the normal range were 
compared using the Chi-Square test. For all analyses a 5% significant level was used. 
These statistical analyses were performed using SPSS for Windows vs. 18 (SPSS 
2010). 
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Figure 2 Retrospective study standard pro-forma for data collection 
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4.3 Study 3: Adolescent adherence to the gluten-free diet; nutritional 
adequacy, factors associated with adherence and health-related quality of 
life 
4.3.1 Study design  
A multi-centre, cross-sectional study design was conducted to describe and identify 
factors associated with adherence to the GFD in Scottish adolescents. A case-control 
approach was employed to assess HRQoL as well as estimated nutrient intakes in CD 
adolescents and healthy controls. Data was collected between October 2011 and May 
2012. 
4.3.2 Inclusion and exclusion criteria 
4.3.2.1 Inclusion criteria for coeliac participants: 
    Boys and/or girls with biopsy positive coeliac disease according to 1990 
ESPGHAN criteria.(Walker-Smith, Guandalini and Schmitz 1990) 
    Aged between 11 and 18 years. 
    Diagnosed for a minimum of 12 months.3 
    Must be able to understand spoken English.4 
4.3.2.2 Exclusion criteria for coeliac participants: 
 Any know psychological or learning disability that may affect an individual’s 
ability to understand and complete questionnaires themselves. 
 Non-English speaking. 
                                                     
3
 It can take up to 12 months for the gut mucosa to heal after following a stringent gluten-free diet 
(Niewinski 2008). Therefore, the tool used to assess adherence in the current study was validated in a 
population who had been following a GFD for >12 months (Biagi et al. 2009) including adolescents in 
the current study with a more recent diagnosis could have reduced the validity of results.  
4
 Some of the main outcome measures for all participants were validated in English and translations 
would affect the validity of these outcome measures. For this reason non-English speakers were 
selected as part of the exclusion criteria. 
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4.3.2.3 Inclusion criteria for HRQoL control group 
    Published 'normative data' collected by the KIDSCREEN Group on 
adolescent HRQoL. This data is considered representative of the general 
healthy teenage population (The KIDSCREEN Group Europe 2006). 
4.3.2.4 Inclusion criteria for estimated energy and nutrient intakes control group 
 Published data on dietary intakes of 11- to 18-year-olds who participated in 
years 1 (2008/9) and 2 (2009/10) of the National Diet and Nutrition Survey 
(NDNS) rolling programme (Bates et al. 2011). This sample is considered 
representative of the UK population.  
4.3.3 Ethical considerations 
NHS Ethics was sought in May 2011 and approved on 18 August 2011 by Southeast 
Scotland Research Ethics Committee (Appendix 4.5). In line with NHS Ethics 
guidance, no one outside the participants’ clinical care team was allowed access to 
their clinical data. Any data collected that could reveal identity was kept confidential. 
Names were replaced with a participant number, and it is not possible for the 
participant to be identified in any reporting of the data gathered. Personal addresses 
and telephone numbers were only used to arrange study dates with participants that 
fully consented to taking part in the research. All files containing patient data were 
encrypted and needed a password to decrypt. All personal data including consent 
forms were stored in a locked cabinet on Queen Margaret University premises. All 
electronic data was stored on a password-protected laptop and transferred to a 
password-protected university computer. All electronic data was password encrypted 
with access limited to the PI and research team. 
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4.3.4 Recruitment 
Participants with CD were recruited from three NHS centres in Scotland; the Royal 
Hospital for Sick Children (RHSC), Edinburgh, Victoria Hospital, Kirkcaldy and 
Ninewells Hospital in Dundee. The RHSC, Edinburgh and Ninewells Hospital, 
Dundee are two of three tertiary centres in Scotland responsible for the diagnosis and 
treatment of paediatric CD, whereas Victoria Hospital holds an independent clinic 
for those children originally diagnosed at RHSC, Edinburgh but who reside in the 
Fife health board, thus covering a significant proportion of the Scottish adolescent 
CD population. The third tertiary care centre, RHSC, Glasgow was contacted as a 
potential site for recruitment, however a local study was currently being undertaken 
and consultants did not want to fatigue/over study patients. 
 
The consultant paediatric gastroenterologist or paediatrician at each NHS site 
identified eligible participants from outpatient databases. Letters of invitation which 
included information sheets and consent forms with stamped, addressed envelopes 
for return were sent to the parents of the adolescent if aged 11-15 years, and directly 
to the patient if they were aged 16-18 years. Although the teenagers were encouraged 
to read through the information pack with a parent, a signature of consent was only 
required from the patient themselves. Signed consent forms were returned by post to 
the PI. Eligible participants who did not respond after three weeks of initial contact 
were sent a reminder recruitment letter to try and maximise the response rate. 
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4.3.5 Protocol 
Once the PI had received informed consent, mutually convenient times and dates for 
the study to take place were arranged with the participant (if ≥16 years) and the 
parents/guardians of participants (if 11-15years). Participants attended two sessions 
within seven days of one another where they completed all research tools (see 
Section 4.3.6). Outpatient consulting rooms were booked at each participant’s 
primary hospital for consultations and data collection. Full details of the final 
protocol are described in Section 4.4.5. 
4.3.6 Methodological tools 
This section will discuss the rational behind each methodological tool selection and 
development of data collection methods employed to answer stated research 
objectives. All revised instruments and those not specifically validated in adolescent 
populations were piloted to assess their face and content validity before conduct of 
the focal study. Results and objectives of the pilot research, and subsequent 
amendments to the following methodological tools and protocol are detailed in 
Section 4.4. 
4.3.6.1 Measuring adherence to the gluten-free diet 
Two questionnaires were originally selected to measure adherence to the GFD in the 
adolescent study; the Biagi adherence questionnaire and the Celiac Dietary 
Adherence Test (CDAT) (Biagi et al. 2009; Leffler et al. 2009). Both tools have been 
validated against accurate measures of adherence: intestinal biopsy and expert 
nutritionist/dietetic evaluation (previously discussed in Section 3.4.1) (Leffler et al. 
2007; Pietzak et al. 2009). As well as being validated, both instruments are non-
invasive, quick and cheap to administer and are not reliant on qualified personnel.  
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The tool devised by Biagi et al. (2009) was developed for adults constructed on the 
clinical experience of doctors at a hospital in Italy. It consists of four questions that 
lead to a score being obtained between zero and four (0-IV). Scores represent the 
following; 0- non-adherent, I- following the GFD with major errors, II- following the 
GFD with a few errors, III- following the GFD with minor errors, IV- strictly 
adherent to the GFD. The measure also allows patients to be dichotomised into those 
adherent to the GFD (score between III and IV) and those non-adherent (score 
between 0 and II).  
The CDAT is a similar, simple, 7-item questionnaire developed in the United States 
from adult focus group interviews (Leffler et al. 2009). Scores range from 7 to 35, 
with higher scores indicating poorer GFD adherence. Individuals scoring ≥13 are 
classified as non-adherent. Both the Biagi and CDAT tools have been developed for 
use in English-speaking populations and take approximately two minutes each to 
complete. Permission from contact authors was granted to use both the Biagi 
Adherence Questionnaire and the CDAT tool in the current study (Appendices 4.6 
and 4.7, respectively). Both questionnaires were piloted in a small adolescent 
population prior to the study’s commencement to ensure their face and content 
validity in this age group as they were both initially developed for use in adults. Pilot 
research was able to dictate which method was most appropriate for use in the 
primary study (see Section 4.4). 
The most significant limitation of research observing adherence levels is that non-
adherent populations are less likely to participate.(Hall, Rubin, and Charnock 2009; 
Leffler et al. 2008) It is hoped, however, that by recruiting volunteers through 
hospital databases rather than through support groups (where a higher percentage of 
  
159 
members are likely to be compliant (Hommel et al. 2008)) a more true to life 
representation of coeliac patients will be captured. 
4.3.6.2 Identifying factors associated with adherence to the GFD in adolescents with 
CD 
In order to ascertain what specific factors were associated with adherence or non-
adherence to the GFD in a Scottish adolescent population, a questionnaire was 
developed by a team of nutritionists, dietitians and a paediatric gastroenterologist, all 
with either a specialist interest in CD or expertise in the area clinically. 
The final questionnaire, the revised Global Coeliac Assessment Scale (r-GCAS), was 
based on a tool originally designed by an expert panel of gastroenterologists, 
psychologists, nutritionists and adults diagnosed with CD in the United States 
(Leffler et al. 2008). Although a few studies, published prior to the development of 
the r-GCAS, similarly used questionnaires to collect information on factors relating 
to adherence, these were either designed to assess very few factors (Fabiani et al. 
1996; Jadre+íin et al. 2008; Ljungman and Myrdal 1993) or details of how the tool 
was developed were not stated (Butterworth et al. 2004). Items in Leffler and 
colleagues questionnaire were piloted in two successive focus groups of 8-12 adults 
with biopsy confirmed CD to assess for clarity and comprehensiveness before 
incorporation into the final questionnaire; the Global Coeliac Assessment Scale 
(GCAS).  
The original GCAS comprised 147 questions relevant to life with CD (Leffler et al. 
2008). Questions were posed regarding the patients demographic background and 
diagnosis of CD, symptoms experienced, psychosocial burdens e.g. concerns about 
future problems and social difficulties such as travelling, parties and dining outside 
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of the home, social and health support, general health, self-efficacy (belief in ability 
to avoid gluten-containing products), intentional and unintentional intake, reasons for 
avoidance or consumption of gluten (e.g. stress, guilt, importance for heath) and 
feelings regarding diagnosis and following the stringent diet. A knowledge quiz was 
further incorporated to evaluate whether an individuals understanding of the diet and 
CD affected their adherence. 
Rationale behind revision of the GCAS was twofold; it was necessary to make the 
tool applicable to a teenage cohort since complex developmental changes, unstable 
health beliefs and the sharing of disease management responsibility with parents 
throughout adolescence suggests that the thoughts and experiences of a teenager 
following the GFD are likely to differ from that of an adult population (McDonagh 
and Kaufman 2009). Moreover, the GCAS was originally devised in the United 
States where, in comparison to the UK, different approaches to healthcare, disease 
management and education are evident (Starfield et al. 2005). Permission was 
granted by key authors to modify the methodological tool for use in the current 
audience (Appendix 4.8). 
A study conducted in Sweden (previously discussed in Section 3.5.1) used in-depth 
interviews to evaluate issues of importance for GFD adherence or non-adherence in 
adolescents with CD (Olsson et al. 2008a). Outcomes of these discussions that were 
not already included in the GCAS were incorporated into the r-GCAS in order to 
assess specific issues or factors pertinent to teenagers, for example feeling 
embarrassed when following the GFD outside of the home and having immediate 
symptoms after diagnosis. Table 7 outlines the outcomes of the research by Olsson et 
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al. and specifies all outcomes that were formulated into specific questions posed in 
the r-GCAS.  
Table 7 Factors associated with teenage adherence to the gluten-free diet, and thus 
their incorporation in the Revised Global Coeliac Assessment Scale 
Factors affecting adolescent 
adherence to the gluten-free 
diet in Sweden* 
 
Already included in the GCAS 
Doubts about the diets 
importance 
No. A question in the original tool covers this factor asking participants to 
state how much they agree (on a Likert scale) with the following statement: 
“Avoiding gluten-containing foods is important because it’s important for my 
health” 
Feeling frustrated/angry about 
the GFD and being diagnosed 
with CD 
No. Questions concerning this were already included 
Appropriate knowledge about 
following the GFD and its 
importance 
No. The GCAS poses questions about the diets importance for health and the 
quiz assesses individual knowledge 
Practical and emotional support 
of others 
No. Questions in relation to support from friends, family and health 
professionals were already included in the GCAS 
Factors affecting adolescent 
adherence to the gluten-free 
diet in Sweden*  
 
Formulated into r-GCAS questions 
Immediate symptoms after 
gluten ingestion 
Questions were added regarding symptoms at diagnosis, symptoms still 
experienced, and whether these happen immediately after ingestion. 
Embarrassment outside the 
home 
A new question was included asking teenagers to state how much they agree 
or disagree with the following statement on a Likert scale: “Having a 
diagnosis of coeliac disease often makes me feel embarrassed when outside of 
my home”  
Incorrect beliefs about the GFD 
i.e. thinking that the condition 
would disappear after time 
A question was included in the section ‘Reasons for avoidance of gluten’ 
asking patients if they thought their CD would disappear if they continued to 
follow the GFD 
Ability to find acceptable 
solutions in different situations 
outside the home 
Although peoples ability to follow the GFD in a number of situations such as 
at parties, weddings and restaurants are included in the original tool, extra 
questions in relation to takeaway restaurants and school/university/workplace 
were incorporated  
Ability to abstain even if a GF 
alternative was not available 
A question regarding this was included in the section ‘Social and situational 
behaviours and issues’ 
Taste of GF foods and other 
sensory qualities 
Just questions regarding the quality of GF products/foodstuffs were posed in 
the original tool, however this was categorised into taste, texture, appearance 
and overall quality in the revised version for a more detailed approach 
Availability of GF foods Although questions concerning the availability of GF foods whilst shopping 
were encompassed in the GCAS, questions relating to the availability of these 
specialised foodstuffs at school, university or at work were further 
incorporated  
GFD, Gluten-free diet; r-GCAS, Revised Global Coeliac Assessment Scale; CD, Coeliac disease 
*Olsson et al. (2008) 
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In addition to these amendments, as a group it was felt that the hospital site at which 
the teenagers were treated and their level of coeliac clinic attendance may affect their 
adherence, and thus questions relating to both these aspects were included in the r-
GCAS. It was agreed that questions specific to experiences at school should be 
included in addition to whether the teenager was following another diet for religious 
or moral reasons. Furthermore, questions on who buys the majority of foodstuffs that 
are consumed by the adolescent were added, as anecdotal evidence from the clinical 
dietitian and gastroenterologist suggested that teenagers who bought their own food 
regularly were less likely to be compliant than those whose parents or school caterers 
were the main procurers. 
In order to make the questionnaire applicable to a UK audience, general changes 
were made to particular questions such as those on the education level of patients and 
ethnicity. The six ethnic categories stated in the original document were adapted to 
include the six most common ethnic groups in Scotland as published in the 2001 
Census (Registrar General for Scotland 2001). The GCAS was further appended to 
encompass factors that were found to influence adult adherence to the GFD in a 
study carried out within the UK by Butterworth et al. (2004). Authors identified that 
issues surrounding UK prescriptions of GF products, Coeliac UK membership and 
understanding of GF product labelling were associated with adherence to the GFD. 
Pilot research further highlights a number of barriers in obtaining GF products on 
prescription in the UK and inequality in experiences of the prescription system 
(Bruce 2010). Additionally, 30% of all adults (n=130) who participated in the survey 
indicated that they found food labelling difficult to understand. As such, issues 
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associated with UK prescriptions, support groups and product labelling were 
included in the questionnaire to ensure country specificity.  
The r-GCAS; prior to piloting, was a 103-item questionnaire combining both closed 
and open-ended questions in addition to 5-point Likert scale responses. The 
questionnaire took approximately 20 minutes to complete and was split into the 
following domains: 
 Background information (e.g. demographics, disease presentation, 
presence of other conditions/following another specialised diet, clinic 
attendance) 
 Social and situational behaviours and issues (e.g. ability to follow the diet 
in different settings or avoidance of such situations, availability of GF foods 
and cost of GF foods) 
 Prescription products (e.g. feelings regarding the availability, variety and 
collection of GF prescription products) 
 Sensory qualities of GF products (e.g. feelings regarding the taste, texture, 
appearance and overall quality of GF products) 
 Social and clinical support (e.g. the amount of support from family, friends 
and different health professionals) 
 Educational support (who or what has been helpful with regard to learning 
about CD and the GFD e.g. health professionals, support groups, 
family/friends with CD, the media or the internet) 
 Reasons for avoidance of gluten (e.g. stress, guilt, importance for health, 
incorrect beliefs) 
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 Intentional and unintentional gluten consumption 
 Food purchases (e.g. who buys breakfast, lunch, dinner and snack products) 
 Impact on physical and mental health 
 Knowledge of coeliac disease and the gluten-free diet 
Spaces were provided at the end of each section for participants to comment, if so 
desired, about any other factors that they felt were of importance for adherence or 
non-adherence. Issues arising from these open-ended questions in the pilot study 
were subsequently included in the final version of the r-GCAS (see Section 4.4.5). 
The finalised r-GCAS, post-piloting may be observed in Appendix 4.9. 
4.3.6.3 Assessing generic health-related quality of life 
Although a variety of validated and reliable generic instruments have been developed 
globally to assess health-related quality of life (HRQoL) (previously discussed in 
Section 3.6.2), it was important to select an adolescent specific tool and to ensure the 
validity of the instrument in the UK. From the review of current tools (see Section 
3.6.2) it was established that the KIDSCREEN-52 questionnaire was the most 
appropriate instrument for use in the current study, due to it being culturally and age 
specific, as well as having strong psychometric properties. Additionally, the 
KIDSCREEN Group have available normative data on the HRQoL of healthy 
teenagers (12-18 years) in the UK as assessed by the KIDSCREEN-52 measure (The 
KIDSCREEN Group Europe 2010). This was used as reference data/a control in the 
current study.   
The KIDSCREEN-52 development consisted of several phases (The KIDSCREEN 
Group Europe 2006). Initial item development was constructed by firstly performing 
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a literature review of all papers that had previously developed HRQoL instruments. 
Secondly, a Delphi study was conducted, whereby the conceptualisation and 
operationalisation of HRQoL was identified through multiple interviews in an invited 
expert panel and the number and type of dimensions/items to include were agreed 
upon. Thirdly, six focus group discussions in 13 countries (including the UK) were 
arranged to include the opinion of children, adolescents and their parents about what 
they felt constituted HRQoL. Two thousand five hundred and five statements were 
formulated through focus groups and these underwent a reduction process by 
removal of redundant or inappropriate items using guidelines from the EUROHIS: 
Developing common instruments for health surveys report (World Health 
Organisation 2003). Remaining questions were then rated by each centre (country) 
for applicability, clarity and importance and subsequently translated into the 
language of the target population using a forward-backward-forward technique. 
After initial piloting to further reduce the original 127-items included in the 
instrument, the KIDSCREEN-52, which can be used in healthy as well as chronically 
ill children, consisted of 10-dimensions (Table 8) and 52-items, taking approximately 
10-15 minutes to complete. In this finalised version, 5-point, Likert type scales are 
used to assess either the frequency (never-seldom-sometimes-often-always) of 
certain behaviours/feelings or intensity of attitude (not at all-slightly-moderately-
very-extremely). Rasch scores are computed for each dimension (the sum of scores 
from each item in the domain) and transformed into T–values with a mean of 50 and 
a standard deviation of 10 enabling the questionnaire to be analysed using parametric 
statistics. Higher scores obtained for each item or dimension indicates better HRQoL. 
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A score is defined as ‘low’ if it minus half a standard deviation below the normal 
threshold mean of the general population (The KIDSCREEN Group 2010). 
The KIDSCREEN group holds the copyright to the KIDSCREEN-52 tool, however a 
collaboration form has been signed for the free use of this questionnaire and 
permission has been granted (see Appendix 4.10).  
Table 8 HRQoL dimensions of the KIDSCREEN-52 instrument 
Dimensions of the KIDSCREEN-
52 instrument 
Description 
Physical Well-Being Physical activity, energy and fitness 
Psychological Well-Being Positive emotions and satisfaction with life 
Moods and Emotions Experience of depressive moods, emotions and stressful 
feelings 
Self Perception Perception of bodily appearance positively or negatively. 
Satisfaction with looks, clothes and personal accessories 
Autonomy Respondents opportunity to shape their social and leisure 
time 
Relations with Parents and Home 
Life 
Relationship with parents and atmosphere at home 
Social Support and Peers Relationship with other children/teenagers 
School Environment Perceptions of cognitive capacity, learning and 
concentration and feelings about school 
Social Acceptance (Bullying) Aspect of feeling rejected by peers 
Financial Resources Perceptions of financial resources 
*The KIDSCREEN Group (2010) 
4.3.6.4 Assessing disease-specific health-related quality of life 
From a literature review of disease-specific HRQoL instruments (see Section 3.6.3) it 
was established that the CDDUX questionnaire; developed in The Netherlands was 
the most applicable for use in this Scottish cross-sectional study since it was 
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validated in teenagers up to the age of 18 years, it was developed using adolescent 
focus groups and displays good reliability and construct validity (van Doorn et al. 
2008) 
This tool consists of 12 items and three domains: ‘Diet’, ‘Communication’ and 
‘Having CD’ (van Doorn et al. 2008). The ‘Diet’ scale (six items) gives an 
impression of how the child feels in relation to adherence, dietary restrictions and 
life-long dietary treatment. The ‘Communication’ scale (three items) tells the 
researcher how the child feels when discussing CD and explaining the condition to 
others, whereas the “Having CD” domain (three items) gives information on how the 
participant feels when offered gluten-containing food or when she or she thinks 
about gluten foods. Five-point Likert scales are used to score the instrument. Scores 
are calculated for the three domains separately and an overall score can be calculated 
as an average of all dimensions.  
Permission was granted by authors to use the CDDUX instrument in the current 
research (Appendix 4.11). However, the decision to include the disease specific tool 
was decided upon subsequent to the pilot study, therefore the face and content 
validity of the CDDUX in adolescents resident within the UK was not assessed 
before use.   
4.3.6.5 Estimated energy and nutrient intakes 
The current research aims to compare the energy and nutrient intakes of coeliac 
participants to a healthy reference population i.e. data collected from 11- to 18-year-
olds in the NDNS rolling programme (Department of Health 2011). Results of this 
countrywide survey were elected as the preferred control group for the cross-
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sectional research since the NDNS is the largest study on dietary patterns, food 
consumption, estimated energy and nutrient intakes and nutritional status in the UK. 
It has been designed to be representative of the population as a whole. Although a 
series of methodological instruments exist which allow measurement of dietary 
intake at an individual, national and household level; thus permitting assessment of 
nutrient intakes (Gibson 2005), it was felt necessary to utilise methods used in the 
NDNS to allow for a standardised measure across all groups and accurate 
comparisons to be made.  
Although previous NDNS surveys assessed diet using weighed food records of 
several days duration for young people (Gregory et al. 2000), the decision was made 
by the NDNS programme to change the method since weighed techniques result in 
considerable participant burden. A comparison study of two instruments including 
four repeat 24-hour recalls and a four-day estimated diet diary was carried out in 
order to identify a reliable, less burdensome tool for data collection (Lennox et al. 
2011). Authors identified that response rates were very similar for the two 
approaches and there were no major differences in the scientific literature between 
the un-weighed diet diary and the multiple 24-hour recall method. However, the diet 
diary was decided upon to be the tool of use since it was, on balance, considered to 
be a more flexible and adaptable method to cover the extensive age range covered in 
the NDNS survey. Crawford et al. (1994) investigated the validity of a similar three-
day estimated diet diary in addition to a 24-hour recall method and five-day food 
frequency questionnaire by comparing results of each to observer weighed 
recordings over the same days. Mean differences between observed and reported 
intakes were best for the estimated food diary when energy, carbohydrate, protein, 
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total fat, saturated fat and cholesterol were assessed (all p>0.05) confirming the 
construct validity of this methodological tool (Crawford et al. 1994). Permission was 
granted by the Food Standards Agency (FSA) allowing us to employ the diary that 
was used in the 2008/2009 data collection, and to amend example products to include 
only those that are GF (Appendix 4.12). 
Participants were asked to keep a record of everything they consumed (including 
supplements and fluids) over four consecutive days, including both weekend days. 
Instructions on how to complete the diary were explained both in writing and by the 
PI, taking participants through the instruction page, how to describe food, drink and 
portion sizes, and looking over an example day. Portion sizes were recorded in 
household measures such as tablespoons or cupfuls. For packaged food the weight on 
the packet was requested as well as how much was consumed. Brand names were 
recorded whenever possible and packet information/wrappers of any unusual or GF 
foods were required to be saved. A separate page was included in the diary for any 
homemade dishes, allowing participants to state individual ingredients, quantities for 
the whole dish and cooking methods employed. After each day, participants recorded 
whether their intake was typical for that day, and if not they were asked to state the 
explanations for this. To increase diet diary adherence participants were contacted by 
telephone after their second day of completion to encourage continuation and to 
assist with any difficulties they may have encountered. The slightly revised NDNS 
diet diary may be observed in Appendix 4.13. 
It is important to note that diet diaries are prone to social desirability bias through 
patient under-reporting or under-eating (Briefel et al. 1997). However, they are a 
widely accepted tool for estimating dietary intake and used in national studies, as 
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discussed. Young participants in the current cross-sectional research were verbally 
encouraged to complete the diary as honestly as possible, not to alter their current 
dietary routine and it was stressed that what they consumed was not being judged. 
Diet diaries were checked for completeness with the participant at the end of the 
study and portion sizes were converted into weights. 
Dietary intakes were analysed using the programme ‘WinDiets (2005)’ to estimate 
energy, macronutrient and micronutrient intakes. Manufacturers of GF products were 
contacted or supermarkets were visited to obtain ingredient lists and/or nutritional 
content of any GF or other foods mentioned in the diary where labels were not 
available; these items were subsequently added to the database. Where reliable 
information was not available for nutrients, values for such foods were obtained by 
extrapolating from data for similar foods (Appendix 4.14). 
4.3.7 Sample size 
The maximum number of adolescents meeting the inclusion and exclusion criteria for 
the study within the research sites was 143. It was estimated that the adherent/non-
adherent spilt would be approximately 50/50 in this population group. This was 
based on pilot data collected and previous similar research conducted in this age 
group (Roma et al. 2010). Using data from an internal pilot (n=5 in each group, of 
two groups) to arrive at an estimate of the variation for these two groups across the 
KIDSCREEN-52 HRQoL outcome domains, resulted in an estimated effect size of 
0.8, a range of difference in means from approximately 3 to 9 and the associated 95% 
confidence interval range +/-2 to +/-6 respectively for 26 persons per group. These 
figures were based on an independent t-test, p<0.05 significance level and 80% 
power (Appendix 4.15). 
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4.3.8 Statistical analyses 
Prior to data analysis, Shapiro-Wilk tests for normality were performed on all 
continuous variables in order to determine the use of parametric or non-parametric 
tests for statistical exploration. Male and female estimated intakes of macronutrients 
and micronutrients from food sources only and from food and supplement sources 
combined were compared to NDNS data using a one-sample Wilcoxon signed rank 
test. A one-sample t-test was employed to observe any differences in percentage 
intake of energy from macronutrients between cases and controls against DRVs and 
the same test was used to observe any differences in percentage contribution of 
different food types to average daily energy intake between cases and NDNS 
controls. Lastly, the proportion of patients and controls with average daily intakes of 
micronutrients below the Lower Reference Nutrient Intake (LRNI) was compared 
utilising Chi square and Fisher’s exact tests. The LRNI is two notional standard 
deviations below the mean and represents the lowest intakes that will meet the needs 
of very few individuals (2.5% of the population group) (Department of Health 1991), 
suggesting intakes less than this carry a high risk of inadequate dietary intake. 
To evaluate which disease related experiences, associated medical conditions, 
demographic and disease characteristics and knowledge levels were associated with 
adherence levels, Spearman rank correlation coefficients were applied for ordinal 
variables (Likert scales) and cross-tabulations and Fisher’s exact tests were 
employed for nominal variables. One-sample Wilcoxon signed rank tests were used 
to see whether any differences in HRQoL scores in each of the ten KIDSCREEN-52 
domains existed between adherent coeliac participants and controls as well as non-
adherent participants and controls. Additionally, the Mann-Whitney U test was 
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performed to observe differences specifically between adherent and non-adherent 
coeliac participants with regard to KIDSCREEN-52 dimensions. The KIDSCREEN 
group define a ‘normal score’ on any particular domain as the mean of the general 
UK population plus or minus half a standard deviation. Values below this range are 
considered ‘low’. Therefore, the proportion of adherent and non-adherent adolescents 
with low scores was compared using the Chi-square test.  
To assess any variation between the scores of adherent and non-adherent teenagers 
on the three subscales of the CDDUX disease specific HRQoL questionnaire, Mann-
Whitney U tests were employed. All analyses were performed using SPSS 18.0 
(SPSS Inc. 2010). A significance of p<0.05 was used for all statistical analyses. 
Bonferroni corrections for multiple testing were not applied to the data as such 
corrections will inflate the type II error rate, so that differences that may be important 
are incorrectly considered not significant (Perneger 1998).  
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4.4 Pilot Study of all methods to be used in Study 3 
4.4.1 Rationale 
Rationale for the conduct of a pilot study was to assess the face and content validity 
of all revised methodological tools as described in Section 4.3.6 and to determine the 
sample size required for the primary study. Face validity ensures that posed questions 
have a logical link with an objective (Kumar 2011); therefore researchers and 
participants should agree that the questions presented in each tool are appropriate for 
answering their specified intentions. In contrast, content validity is necessary to make 
sure that items in each tool encompass the full scope of issues or attitudes being 
measured (Kumar 2011). In relation to the Revised Global Coeliac Assessment Scale 
(r-GCAS), it was important to obtain feedback from a representative teenage 
population on any factors not covered in the questionnaire that were considered 
detrimental or advantageous to GFD adherence in order to assess this form of 
validity. 
In addition to the assessment of revised tools, the pilot study was imperative to 
establish how appropriate the two short validated questionnaires were for use in 
adolescents. Both measures were developed to evaluate adherence to the GFD in 
adults (Biagi et al. 2009; Leffler et al. 2009) and a teenager’s ability to understand 
and interpret questions may differ from that of an adult population. Furthermore, the 
pilot study was necessary to ascertain the readability of revised questionnaires and 
those designed for adults, as well as ensuring participants were not fatigued by the 
overall protocol procedure.  
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Although meta-analyses comparing face to face, telephone and mail surveys indicate 
that questionnaires completed in the presence of an investigator; such as in the 
current study, result in higher respondent rates, lower item non-response and more 
detailed responses to open-ended questions (Leeuw 1992), a study of 1,050 
American school children found that straight-line responding (i.e. patterned 
answering) at the end of questionnaires occurred significantly more in longer 
versions (2hrs) compared to when the same questionnaire was split into five shorter 
surveys (Herzog and Bachman 1981). Longer questionnaires have also been 
associated with lower response rates and higher rates of “don’t know” answering 
(Galesic and Bosnjak 2009; Krosnick et al. 2002). Expected questionnaire 
completion time for the present study was 1 hour, it was therefore felt necessary to 
split the study into two sessions where approximately 30 minutes of questionnaires 
would be administered in each meeting with the aim to increase response rate and 
reduce uniform answering. However, teenagers were additionally asked to comment 
on whether they felt focused and interested throughout completion and, if not, how 
they would restructure the sessions to reduce questionnaire fatigue.  
4.4.2 Aims and objectives 
Aims: 
1) To ensure the face and content validity of all revised questionnaires and a diet 
diary to be employed in the study ‘Adherence to the Gluten-Free Diet in a 
Scottish Adolescent Population’. 
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2) To make sure two questionnaires; previously validated for use in adult coeliac 
patients out with the UK, are appropriate for use in adolescent coeliacs within 
the UK. 
3) To ensure the overall protocol for the cross-sectional study works effectively.   
4) To provide data for power analysis for the main study. 
Specific Objectives: 
 To ensure a UK modified questionnaire; entitled the Revised Global Coeliac 
Assessment Scale (r-GCAS), previously validated in the United States 
(Leffler et al. 2008) is read, understood and answered appropriately by 
adolescent coeliac subjects in the UK.  
 To determine whether the questions in the r-GCAS sufficiently cover all 
disease related experiences that may be associated with adherence or non-
adherence to the GFD. 
 To ensure a UK modified GFD quiz, previously validated in the United 
States to assess coeliac patients’ knowledge of the GFD (Leffler et al. 2008), 
is read, understood and answered appropriately by adolescent coeliac 
subjects in the UK. 
 To make sure two validated questionnaires used to assess GFD adherence in 
adult coeliacs from Italy (Biagi et al. 2009) and the United States (Leffler et 
al. 2009) are read, understood and appropriately completed by adolescent 
coeliacs in the UK. 
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 To ensure the instructions on a four-day diet diary are correctly read and 
understood and that the diary is appropriately completed by adolescent 
coeliac subjects in the UK in order to be able to estimate energy and nutrient 
intakes.  
 To administer all tools that will be used in the main study to ascertain how 
participants felt about the length of time each session took to complete and 
whether participants remained focused and interested. 
4.4.3 Methodology 
4.4.3.1 Methodological tools 
All methodological tools; excluding the CDDUX disease specific health related 
quality of life (HRQoL) questionnaire
5
 described in Chapter 4 were administered in 
the pilot study. Additionally, the PI asked subjects a series of structured questions 
regarding any issues affecting adherence not covered in the r-GCAS, their 
understanding of this tool and their ability to focus throughout its completion. 
Questions were furthermore posed regarding the teenagers comprehension of both 
the CDAT and Biagi adherence questionnaire, whether participants encountered any 
specific difficulties during completion of the 4-day diet diary and whether all 
instructions for completion of the diary; written and verbal, were understood. Lastly, 
participants were asked if they felt focused and interested throughout each data 
collection session and to make suggestions for improvement of future studies.   
  
                                                     
5
 Use of the CDDUX disease specific HRQoL questionnaire in the study ‘Adherence to the GFD in a 
Scottish Adolescent Population’ was decided upon by researchers after conduct of the pilot study. 
This tool has previously been validated in young persons aged 8-18 years and takes just 5 minutes to 
complete (Van Doorn et al. 2008). The omission of this questionnaire from the pilot study was not, 
therefore, deemed to be of great significance. 
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4.4.3.2 Inclusion criteria 
The following requisites were required of participants:  
1) Boys and/or girls who were medically diagnosed subscribers to Coeliac UK 
2) Aged between 11 and 18 years of age 
3) Resident in Norfolk or London 
4) Diagnosed with CD for a minimum of 12 months 
5) Able to understand spoken English 
4.4.3.3 Exclusion criteria 
Individuals were excluded from the study if they presented with the following: 
1) A known psychological or learning disability that affected capacity to 
understand and complete questions 
2) Inability to understand spoken English 
4.4.3.4 Population and recruitment 
Participants were recruited through the charity Coeliac UK with permission from the 
charity’s Chief Executive. Recruitment was sought in this manner due to the disease 
specificity of participants required. Coeliac UK is the leading charity in the UK for 
individuals with CD and has over 50,000 members; adult and children, medically 
diagnosed with the condition (Coeliac UK 2011). The pilot research took place in 
England to ensure all Scottish adolescents remained eligible for the primary study. 
The healthcare of CD patients in England is largely the same as in Scotland; 
therefore participants from England were considered to be highly representative of 
those in Scotland. 
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Using their membership database, Coeliac UK posted pre-stamped recruitment letters 
to all eligible members of the charity with a known diagnosis of coeliac disease (CD) 
in the Norfolk county region. This region was chosen as a geographically practical 
place to get to. The letters included information sheets explaining the study 
procedure and requirements. Despite repeated contact with Norfolk members, only 
six of the thirty-three mailed recipients agreed to participation, it was decided, 
therefore, to extend participation to London members of the charity. In collaboration 
with the London Coeliac UK Facebook group, a link was set up with details of the 
study. Interested members were able to contact the PI (Principal Investigator) or an 
independent contact to discuss participation further and agree to participation by 
email or telephone. The link was posted every two days until the agreed pilot sample 
size was met. 
4.4.3.5 Ethical considerations 
Ethical approval to conduct the pilot study was granted by Queen Margaret 
University Research Ethics Committee reviewers on 6 October 2010 (Appendix 
4.16).  
An important ethical issue to consider when carrying out any form of research is that 
the participants personal information and data collected throughout the study must 
remain confidential to the research team. Following recruitment all participants were 
coded for anonymity in order to meet these confidentiality requirements. All personal 
data, including contact details, were stored in a locked cabinet on Queen Margaret 
University (QMU) premises for which only the PI had access. All electronic data was 
stored on a password-protected laptop and transferred to a password-protected 
university computer for analyses. Furthermore, all electronic data was password 
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encrypted with access limited to the PI. Twelve months after the study completion all 
personal data will be destroyed.  
Another ethical consideration reflected upon was the possibility of young 
participants confiding in the researcher about any previously undisclosed issues of 
risk to themselves or others. Participants <16 years and their parents were made 
aware that if such disclosure arose the PI had a responsibility to contact their school 
or college about the risk and to forward concerns to Care Connect who pass queries 
about child safety on to appropriate teams within Children’s Services. This was 
explained in both information sheets and consent forms. 
4.4.3.6 Procedure 
The pilot study was undertaken in February 2011. On agreement of participation by 
Norfolk members of Coeliac UK mutually convenient times and dates were arranged 
for the PI to carry out the study at either the teenagers attending school or college or 
at Hellesdon High School in Norwich; an independent location in the region. 
Permission was granted by the head teacher at Hellesdon High School to use the 
school facilities as an independent setting for this research. Arrangements were made 
with participating members of London Coeliac UK to conduct the study at their 
home addresses due to data collection throughout school holidays. Accompaniment 
of a parent or guardian was permitted throughout the study sessions; however the 
parent/guardian was made fully aware through information sheets and verbal 
communication that assisting with any of the questionnaires administered would 
invalidate results. 
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After discussion with Norfolk County Council Children’s Services, it was decided 
that on the grounds of the study being so small and the subject material not being of 
relevance to the majority of schools in Norfolk, allowing the PI access to each school 
for research purposes would be at the discretion of each Head Teacher. Head 
Teachers required documentation of identification in addition to proof of Enhanced 
Disclosure before access was granted.    
During the first meeting, participants were required to give written informed consent 
before commencement of the study procedure. In the case of participants aged <16 
years, written informed consent from a parent or guardian was also mandatory as per 
Department of Health (DoH) guidance (Department of Health 2001). Three of the 
questionnaires were administered in the first meeting and the diet diary was 
explained. Participants were then required to return for a second meeting within 
seven days. They returned their completed diaries and the last two questionnaires 
were administered. Structured questions were asked at specific intervals throughout 
the two sessions, Table 9 outlines full details of the pilot study procedure and 
timescale. 
4.4.4 Results of pilot investigation 
A total of ten adolescents participated in the pilot research and met all inclusion 
criteria; six were recruited through mailing of information sheets to Norfolk 
members of Coeliac UK and four participants replied to advertisements posted on the 
London Coeliac UK Facebook page. One of the teenagers who agreed to participate 
was excluded from the study due to a learning disability affecting their capacity to 
complete questionnaires and understand verbal instruction. The participants’ ages 
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ranged from 11-17 years. Mean (SD) age of participants was 13.7 (2.2) years. Six of 
the ten adolescents were female. 
 
Table 9 Procedure and timescale for the pilot study 
Procedure (February 2011) Timescale 
The PI verbally discussed with each participant the questionnaires that were 
to be completed, in which order they should be completed and how 
instructions on each questionnaire should be read through thoroughly. 
 
 
5 minutes 
The participant was asked to complete both questionnaires designed to 
measure adherence levels:  
1) CDAT 
2) Gluten-free diet score (Biagi)  
 
 
 
Approx. 2 minutes 
Approx. 2 minutes 
The participant completed the r-GCAS followed by a short interview 
regarding both adherence measure questionnaires and the r-GCAS. 
 
15-20 minutes 
The PI discussed with the participant how to effectively complete the diet 
diary. They were given a diary to complete at home.  
 
5 minutes 
The participant completed the diary at home over 4 days, including both 
weekend days. To increase diet diary adherence participants were be 
contacted by telephone after the second day of completion to encourage 
continuation and to assist with any difficulties they may have encountered. 
 
Approximately 1hr in 
total 
Participants returned for a second meeting where they handed in their 
completed diet diary. The PI checked this for completeness and went over 
anything that was not addressed clearly. 
 
5 minutes 
The participant completed the KIDSCREEN-52 questionnaire 15-20 minutes 
The GFD knowledge quiz was completed by the participant 5 minutes 
The PI finally interviewed participants about the overall protocol and about 
research tools administered in the second meeting. Appendix (N
o
) outlines the 
key points that were covered during the interviews in the first and second 
meeting. 
 
10 minutes 
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4.4.4.1 Revised Global Coeliac Assessment Scale: participant comments 
All participants agreed that the majority of written instructions and questions in the r-
GCAS were easy to read and understand, although the terms ‘flatulence’ and 
‘gastroenterologist’ had to be explained in two circumstances and a few teenagers 
were unsure of their exact date of diagnosis or the symptoms they experienced prior 
to commencing a GFD. None of the adolescents felt any of the questions posed in 
each section of the questionnaire were irrelevant to stated objectives; however 
teenagers expressed, through open-ended questions and interviews, a number of 
additional issues that they felt affected their ability to comply to the GFD and 
situations they found burdensome. 
Two of the participants suggested that the r-GCAS should include more questions 
relating to maintaining a GFD whilst on holiday, including the ability to follow a 
strict GFD whilst travelling to the destination. One teenager commented that her 
“...experiences of holidaying within the UK and abroad have been very different”. 
She explained the difficulties of trying to decipher food labels abroad and concluded 
“...sometimes [she] felt ill afterwards [holidays abroad]”.  
Although participants found adhering to the GFD problematic abroad; primarily due 
to product labelling, others expressed concerns of poor GF labelling within the UK 
and lack of awareness of what ‘GF’ actually signified by smaller establishments 
including cafes, coffee shops, local stores and takeaways. A 16-year-old male 
participant stated that “...in general, labels [of GF products] in supermarkets are 
really good, but sometimes you’ll order something labelled as GF from a cafe or 
restaurant and realise half way through that it’s got barley in it, or oats!” Another 
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girl mentioned; “We [her family] don’t buy food from the takeaway any more. Me 
and my sister don’t trust it [the takeaway’s GF claims].” 
Statements in the interviews revealed consensus by a number of participants that 
each school’s level of awareness of the pupils condition played an important factor in 
whether they complied to the diet or not. A comment by one teenage girl; identified 
in both adherence questionnaires as being non-compliant with her GFD, was; “My 
school don’t know I’m [a] coeliac so when I forget my packed lunch I just eat what 
everyone else does”. In contrast, one strictly adherent participant expressed that all 
the staff in her school canteen knew who she was and prepared her a separate 
“special” lunch everyday. A further statement by one 16-year-old male, relating to 
school meals was; “It’s easier to follow the [GF] diet at lunchtime, but at break-time 
there are so many cakes and biscuits, you just can’t say no”, indicating that school 
snack products are likely to play a role in adolescent non-adherence. 
Many of the participants answered ‘non-applicable’ in the r-GCAS questionnaire to 
statements regarding the amount of help they receive from different healthcare 
professionals. In the open-ended section of the survey; allowing participants to 
comment further on their answers given, it was established that these teenagers had 
either never seen this health professional regarding their CD diagnosis or saw them 
maybe once very soon after diagnosis. This information could not be determined 
from any previous questions in the survey.  
Lastly, a few of the teenagers remarked during completion of the r-GCAS that 
question G19 (‘I always use the Coeliac UK food and drinks directory to check 
whether a product is gluten-free?’) was slightly confusing as their parents were likely 
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to purchase the majority of food-stuffs and may use the directory more stringently. 
Feelings were that this question should be split between practices of the teenager and 
carer.  
4.4.4.2 GFD Knowledge Quiz: participant comments 
In relation to Q5 in the GFD Knowledge Quiz (‘Is vinegar gluten-free?’) two 
participants enquired as to whether this supposed malt vinegar or wine vinegar and 
were unsure how to answer without confirmation. Certain teenagers expressed that 
they were not aware of ever having consumed a numbers of grains in Q6 and it was 
felt unfair under these circumstances that they should be expected to know whether 
the grain was GF or not if this was not part of their normal diet. Furthermore, two of 
the younger adolescents, aged 11 and 12 years, did not know what alcopops were 
(Q8). These participants were unable to make an informed answer as to whether 
these drinks were GF or not and felt the question should be replaced with one 
understood by all. 
4.4.4.3 Four-day diet diary: participant comments 
Four of the ten participants conveyed feelings of embarrassment during completion 
of the diet diary at school; this was predominantly attributed to its A4 size being 
deemed too “bulky” to carry around and a 15-year-old criticised the booklet saying; 
“Everyone was looking at me [other school children] because it was really eye-
catching...it was getting squashed in my bag”. One teenager made a comment that in 
the ‘General Questions’ section of the diary there was a question concerning whether 
subjects mainly consumed either white, brown or wholemeal bread and they were 
unsure whether this meant gluten-containing or GF breads. Another observation 
made by participants was that the 5-8 pm time slot in the diary was missing. 
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4.4.4.4 Measuring adherence 
All instructions and questions in both the CDAT and Biagi adherence measures were 
read with ease and understood by all adolescents. However, it was identified that one 
male participant who was categorised as being ‘non-adherent’ from the Biagi 
questionnaire; and who admitted consuming gluten voluntarily in the r-GCAS, was 
typecast as having ‘fair adherence’ in the CDAT tool. All the remaining participants 
who were classified as principally ‘adherent’ or ‘non-adherent’ in the Biagi 
questionnaire were found to be similarly categorised in the CDAT. 
4.4.4.5 Overall methodological design 
All participants were content with the number of questionnaires administered in each 
data collection session and questionnaire fatigue was not said to be experienced at 
any point. Furthermore, all verbal and written instructions were understood and no 
additional comments or recommendations for methodological design changes were 
expressed by participating adolescents. 
4.4.5 Discussion and methodological amendments 
4.4.5.1 Amendments to the r-GCAS 
Although each of the ten participants conveyed in structured interview responses that 
they felt all questions posed in the r-GCAS were pertinent, four of the teenagers 
answered ‘non applicable’ to questions concerning information and support received 
from a dietitian or gastroenterologist (G39 and G41) and the helpfulness of these two 
healthcare professionals in individual learning of CD and the GFD (G42 and G43). 
Patients commented that they had not seen these healthcare professionals regularly 
enough to respond which seems unsurprising considering the results of a survey 
undertaken by Coeliac UK; whereby 50% of paediatric departments in the UK were 
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found to allocate no specific time to CD patients (Nelson et al. 2007). Similar 
inequalities in practice have been observed in separate areas of gastroenterology 
including inflammatory bowel disease (Butcher 2007). Butterworth and colleagues 
(2004) identified that regular dietetic follow-up and thorough explanation of the GFD 
by a physician were both associated with better adherence to the GFD in a UK adult 
population (>16 years), therefore additional questions regarding how often 
participants see individual healthcare professionals (HCPs) in relation to their CD 
were included in the r-GCAS to observe whether lack of contact with specific HCPs 
has a negative effect on adherence in an adolescent population. 
General amendments were made to the r-GCAS to simplify terms including 
‘flatulence’ and ‘gastroenterologist’. Other validated questionnaires used regularly to 
collect information on functional GI disorders in children and adolescents, such as 
the Rome II and Rome III surveys, have used the term ‘gas’ instead of ‘flatulence’ 
for better understanding in this age group (Caplan et al. 2005). A definition of 
‘gastroenterologist’ was also provided in the revised questionnaire for those unsure 
of the terminology. Furthermore, to avoid poor accuracy of symptom reporting and 
date of diagnosis throughout the study, participants in the Scottish study were made 
aware through information sheets and telephone contact before the meetings that 
these details were required. 
Based on the pilot study findings more questions were included in the r-GCAS 
relating to maintaining a GFD whilst on holiday in the UK and abroad, as well as 
travelling to the destination. A question on difficulties experienced with food 
labelling abroad was also incorporated. Although no study to date has related holiday 
experiences to adherence or non-adherence, poorer adherence in adolescents (12-17 
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years) has been associated with various social situations (Hommel et al. 2008). A 
further study from the USA, observing factors affecting adherence to the GFD in 
adults (22-91 years) identified that ‘ability to follow a GFD when travelling’ was 
significantly correlated (p<0.01) with better GFD adherence levels (Leffler et al. 
2008). As such, inclusion of these questions was deemed important to identify 
whether such situations should be given more importance in follow-up appointments 
with healthcare professionals or more coherent information and advice on following 
the GFD whilst on holiday and travelling developed. 
Further comments made by participants related to poor labelling of foodstuffs and 
menu items in smaller establishments including cafes, coffee shops and restaurants 
and lack of GFD awareness in these venues by staff. Research on GFD adherence in 
children has repeatedly shown that a large proportion of families who have a child 
with CD avoid restaurants (Rashid et al. 2005; Roma et al. 2010); however motives 
behind this have not been established. Furthermore, 46.6% of children (n=73; median 
[IQR] age 9.4 [5-14.5] years) from a single-centre study in Greece experienced 
difficulties reading labels and all but one of these patients were non-compliant to the 
GFD (Roma et al. 2010). To date, it has not been established whether poor awareness 
by staff or poor GF labelling of menus/products in these social establishments is 
associated with adherence levels in a specifically adolescence coeliac population, or 
whether those that are strongly adherent avoid these eateries in order to maintain a 
strict GFD. Therefore, additional questions relating to these experiences were 
included in the r-GCAS. 
Similar to findings of the current pilot study, dissatisfaction of GF snack foods in 
schools has been observed in coeliac teenagers within the UK. Kumar and colleagues 
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(1988) identified that adolescents resident in London who were not following a 
stringent GFD tended to go out with friends at break-time and consume “hamburgers, 
rolls, biscuits and cakes”, although GF products were readily available on school 
premises. One limitation of this study is that it was performed over twenty years ago 
and it is likely that the availability and quality of GF snack foods in schools is very 
different at present due to advances in GF product development and publication of 
more recent policy documents on food in schools such as Hungry for Success in 
Scotland and Nutritional Standards and Requirements for School Food in England 
(Education England 2007; The Scottish Government 2002). However, a more recent 
analysis of online talk between coeliac disease patients in The Netherlands revealed 
that individuals with CD were still considering quitting their dietary practices due to 
the temptation of gluten-containing snack foods such as pizza (Veen et al. 2010). 
Consequently, new questions concerning adolescent ability to follow a strict GFD 
when purchasing snacks or meals from school, university or work were incorporated 
in the r-GCAS. 
Teenage interviews carried out in Sweden (Olsson et al. 2008a) highlighted 
difficulties with keeping a GFD arising from lack of disease-related knowledge by 
school canteen staff. Present observations suggest that in addition to lack of GFD 
knowledge by caterers, schools’ full awareness of individual pupils’ dietary needs 
may further influence adherence, as students attending schools that were unaware of 
the medical condition did not question food purchases, whereas those that were 
conscious provided specially prepared meals specifically for that child. A final 
amendment to the r-GCAS was made to incorporate a question intended to determine 
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whether adolescents who had not passed on details of their dietary requirements to 
their school/university or workplace had poorer adherence to the GFD. 
4.4.5.2 Amendments to the Knowledge Quiz 
Although the 2010 Coeliac UK Food and Drink Directory (Coeliac UK 2010) states 
that all vinegars are safe to include in a GFD, certain participants felt they would 
have answered question Q5 in the quiz (‘is vinegar gluten-free?’) differently had it 
referred to ‘wine vinegar’ or ‘malt vinegar’ and stated they were unable to respond 
without knowledge of this. To avoid confusion, ‘malt vinegar’ replaced the term 
‘vinegar’ in the revised quiz. Comments were further made concerning Q6, as a 
number of teenagers felt it was unreasonable to ask a question about whether a grain, 
plant or flour was GF if they had never consumed it. In acknowledgment of this an 
additional response column was included in Q6 allowing adolescents to answer ‘I do 
not eat this grain’. The last amendment made to the Knowledge Quiz was the 
substitution of ‘Alcopops’ in Q8 to ‘vodka’. Vodka was identified to be the most 
popular alcoholic beverage consumed by Scottish adolescents (n=1240; mean age 
14.5 years) in a cross-sectional survey (Forsyth and Barnard 2000). Moreover, results 
from the 2007 ESPAD report on substance use among students in 35 countries 
confirmed the popularity of white spirits in the UK; 48% of school children aged 14-
18 years had consumed these drinks in the 30 days prior to completing the 
questionnaire, lesser consumed beverages were Alcopops, cider and wine (Hibell et 
al. 2009). 
4.4.5.3 Amendments to the Four-day Diet Diary 
Due to embarrassment felt by some of the participants in relation to the A4 diary 
being cumbersome and eye-catching, a decision was made to reduce the size to A5 
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dimensions. The PI believed this would be more discreet to carry over the four-day 
period. The 5-8 pm time slot was included and the document was inspected to ensure 
all example products and questions referred to GF foodstuffs. This would avoid the 
confusion experienced in the pilot study, where certain teenagers did not answer 
questions because a gluten-containing product was cited. 
4.4.5.4 Amendments to measuring Adherence 
Although both adherence measures were read and understood by all participants, it 
was decided that the Biagi questionnaire would solely be used to measure each 
participant’s level of adherence to the GFD. The CDAT tool was considered to be 
less accurate as one teenage boy who admitted to consuming gluten voluntarily in the 
r-GCAS and in the Biagi questionnaire was classified as having ‘fair adherence’ 
from questions posed in the CDAT. Furthermore, the Biagi tool has been validated 
against the ‘gold standard’ measure of adherence (intestinal damage); unlike the 
CDAT, which was validated against standardised dietetic evaluation as well as 
serological tests (Biagi et al. 2009; Leffler et al. 2009). 
4.4.5.5 Overall protocol amendments 
No further recommendations to change the overall protocol design were suggested by 
participants in the pilot study. All verbal and written instructions were understood 
and none of the teenagers experienced fatigue during questionnaire completion. 
Therefore, the overall protocol design for the Scottish study remained largely the 
same as that proposed in Table 9. The only amendment was exclusion of the CDAT 
questionnaire; the CDDUX disease specific HRQoL tool was administered in place 
of this during session one. A summary of methodological tool amendments as result 
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of the pilot study may be observed in figure 3 and the final protocol for the main 
study in Table 10.  
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Figure 3 Methodological developments of tools to be used in Study 3
Pilot Study Outcomes Original Methodological 
Design and Tool 
Development 
 R-GCAS questionnaire 
development (adapted for 
adolescents and UK 
audience) 
 CDAT adherence 
questionnaire (validated in 
adults) 
 Biagi adherence 
questionnaire (validated in 
adults) 
 KIDSCREEN-52 HRQoL 
tool (previous validation in 
UK teens) 
 4-Day Diet Diary (adapted 
for use in coeliac subjects) 
 GFD Knowledge Quiz 
(adapted for use in a 
coeliac audience) 
 Study split into two 30 min 
sessions within 7 days of 
one another 
• Additional factors affected teenage ability to comply to 
the GFD 
•  Poor understanding of terms flatulence and 
gastroenterologist 
•  Poor knowledge regarding diagnosis date and symptoms 
experienced 
•  Certain questions felt more applicable to their parents 
i.e. food purchases 
•  Statements from participants regarding very little or no 
contact with a number of healthcare professionals 
• Read with ease and understood by all participants 
•  CDAT incorrectly categorised one teenager as having 
‘fair adherence’ after admitting eating gluten voluntarily  
• Diary too ‘bulky’- some participants felt embarrassment 
at school 
•  Not all examples were gluten-free 
•  5-8pm time slot missing  
•   Poor understanding of what Alcopops were by younger 
adolescents 
•  Confusion regarding whether ‘vinegar’ supposed ‘malt’ 
or ‘wine’ vinegar. 
•  Certain grains in the quiz were never consumed by 
participants  
• All participants were content. No fatigue. 
 
 
 
 
 
• Include more questions concerning: holidays; 
labelling of foodstuffs and staff awareness of 
the GFD in various establishments; awareness 
of  pupils CD by schools and school 
purchases at lunch and break time 
•   Simplify more complex terms 
•   Inform participants before data collection of 
any necessary information required 
• Split questions on food purchase behaviours 
between the parent and child 
• Add questions re. Patient time spent with 
individual healthcare professionals   
 • The Biagi questionnaire alone will be used to 
measure each teenagers adherence level 
 • Make diary A5 size 
•  Include 5-8pm time slot 
•  Ensure all examples and questions relate to 
GF products 
 • Change ‘Vinegar’ to ‘Malt Vinegar’ 
•  Include a ‘I do not eat this grain’ answer 
choice in Question 6 
•  Amend the ‘Alcopop’ question to ‘vodka’; 
another popularly consumed alcoholic drink 
by teenagers   
 
Methodological Amendments 
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Table 10 Final protocol for the Scottish cross-sectional adolescent study 
 
Protocol Timescale 
1 Hospital consultants send out study invitation letters to eligible adolescent 
patients under their care and their parents (if <16 yrs). These include 
information sheets and consent forms. 
  
 
2 Patients and their parents (if <16 yrs) return signed consent forms to the PI and 
mutually convenient times and dates to meet at their hospital of recruitment are 
arranged. 
  
 
SESSION 1 
3 The PI verbally discusses with each participant the questionnaires that are to be 
completed, in which order they will be completed and how instructions on each 
questionnaire should be read through thoroughly. 
 
5 minutes 
4 Participant completes the r-GCAS; a questionnaire to assess factors associated 
with adherence to the gluten-free diet (GFD). 
 
15-20 
minutes 
5 The PI administers the Biagi adherence questionnaire. This it to determine 
whether the participant is adherent to the GFD or non-adherent. 
 
2 minutes 
6 The PI discusses with the participant how to effectively complete the diet diary. 
They are given a diary to complete at home. 
5 minutes 
BETWEEN SESSIONS 
7 The participant completes the diary at home over 4 days, including both 
weekend days. To increase diet diary adherence participants are contacted by 
telephone after the second day of completion to encourage continuation and to 
assist with any difficulties encountered. 
 
Approx. 1 
hour in total. 
SESSION 2 
8 Participants return for a second meeting where they hand in their completed diet 
diary. The PI checks this for completeness and goes over anything that is not 
addressed clearly. 
 
Approx. 10 
minutes 
9 The participant completes the KIDSCREEN-52 questionnaire to assess health-
related quality of life. 
 
15-20 
minutes 
10 The GFD knowledge quiz is completed by the participant. 5 minutes 
11 The participant completes the CDDUX coeliac specific HRQoL questionnaire to 
assess quality of life in relation to coeliac disease. 
 
5 minutes 
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Chapter 5: Results 
5.1 Study 1: The incidence and management of childhood coeliac disease 
in Scotland- the Scottish Paediatric Surveillance Unit (SPSU) coeliac 
project  
5.1.1 Crude numbers diagnosed 
The SPSU had an 85% response rate over the year (personal communication, 
Professor Neil McIntosh, SPSU administrator). A total of 129 questionnaires were 
received between the two dates (Table 11), although fifteen duplicate cases were 
excluded through identification of sex, age, first part of postcode data and biopsy 
date, and nineteen children were omitted because their diagnosis was before 
01/09/2009. Additionally, four cases were excluded as confirmatory biopsies were 
not performed (1 East; 2 West; 1 North). This left a total of 91 new cases reported 
between 01/09/2009 and 31/08/2010 in Scotland (Table 11). 
Table 11 Crude number of CD cases (<16yrs) diagnosed in Scotland between 
01/09/2009 and 31/08/2010 by tertiary GI network 
Region Persons at risk* Forms Received Numbers excluded Crude 
numbers 
East 225,275 45 8 37 
West 461,814 60 23 37 
North 225,057 24 7 17 
*Number of persons at risk (i.e., less than 16 years old) identified from 2009 mid-year population 
estimates 
5.1.2 Regional age-sex adjusted incidence rates 
The national age-sex standardised incidence rate per 100,000 child population at risk 
was 10.0/100,000/yr (95% CI 8.1-12.3). The adjusted incidence rate was 
approximately twice as high in the East over the year (16.3/100,000/yr, 95% CI 11.5-
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22.6) compared to the West (8.1/100,000/yr, 95% CI 5.7-11.1) and North 
(7.7/100,000/yr, 95% CI 4.5-12.4) (figure 4).  
Figure 4 Annual age-sex adjusted incidence and 95% CIs of paediatric CD (<16 
years) in each Scottish tertiary GI network between 01/09/2009 and 31/08/2010 
5.1.3 Presentation and primary reasons for diagnosis 
The most frequent symptoms reported were abdominal pain (50/91; 54.9%), failure 
to thrive (29/91; 31.9%), fatigue (29/91; 31.9%), diarrhoea (27/91; 29.7%) and 
bloating (19/91; 20.9%). Additional presenting symptoms may be observed in Table 
12. The most common additional medical conditions were type 1 diabetes mellitus 
(T1DM) (14/91; 15.4%), asthma (8/91; 8.8%), eczema (4/91; 4.4%), and lactose 
intolerance (3/91; 3.3%). A further nineteen medical conditions had been previously 
diagnosed in the patient group (see Appendix 6.1 for details). Twenty-two children 
(24.2%) were diagnosed through active screening (East 10: West 9: North 3), of 
which fourteen had associated T1DM, one Down syndrome and seven had family 
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history of CD in a first-degree relative. Fifty-five per cent (12/22) of the patients 
diagnosed through active screening were asymptomatic. The age-sex adjusted 
incidence rate of actively-screened cases was 2.5/100,000/yr (95% CI 1.5-3.7). 
Nineteen cases (20.9%) were diagnosed due to having non-classical presentations of 
CD (East 6: West 8: North 5). The standardised incidence rate of ‘non-classical’ 
cases (excluding actively-screened cases) was 2.2/100,000/yr (95% CI 1.3-3.4). The 
remaining fifty children (54.9%) were diagnosed based on the presentation of 
classical symptoms (East 21: West 20: North 9). The age-sex adjusted incidence of 
‘classical’ CD was 5.4/100,000/yr (95% CI 4.0-7.2). The standardised incidence of 
‘classical’ cases and those diagnosed through active screening in the East was more 
than double that observed in the West and North over the year (Table 13).  
Table 12 Presenting symptoms of children newly diagnosed with CD between 
01/09/2009 and 31/08/2010 in Scotland (n=91) 
Symptom Number of children % of children (n91) 
Abdominal pain 50 54.9 
FTT 29 31.9 
Fatigue 29 31.9 
Diarrhoea 27 29.7 
Bloating 19 20.9 
Constipation 16 17.6 
Mouth ulcers 10 11.0 
Vomiting 10 11.0 
IDA 7 7.7 
Rectal bleeding 7 7.7 
Flatulence 4 4.4 
Pallor 4 4.4 
Delayed menarche 2 2.2 
Nausea 2 2.2 
Vitamin D deficiency* 1 1.1 
FTT= Failure to thrive; IDA = Iron deficiency anaemia 
*It is not certain how many children were tested for vitamin D deficiency 
Body mass index (BMI) was determined in seventy-four out of the 91 children (26 
East: 32 West: 16 North) using recently published SACN and RCPCH population 
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surveillance definitions for underweight, overweight and obesity (SACN and 
RCPCH 2012). Four children (5.4%) were at risk of obesity (>=95
th
 centile), 13.5% 
(n=10) were at risk of overweight (85
th
-94
th
 centile) and seven children (9.5%) had a 
low BMI (<=2
nd
 centile). There was not a significant difference between tertiary GI 
networks with regard to the proportion of cases classified as underweight, 
overweight or obese (see Appendix 6.2). 
Table 13 Annual age-sex adjusted incidence rates (per 100,000) of newly diagnosed 
CD in children aged <16 years in each Scottish tertiary GI network (East, West and 
North) by primary reason for diagnosis 
 
 
Primary 
reason 
for 
diagnosis 
 
 Scotland 
(total) 
 East  West  North 
 
 
n 
Annual 
incidence 
(95% CI) 
 
 
 
n 
Annual 
incidence 
(95% CI) 
 
 
n 
Annual 
incidence 
(95% CI) 
 
 
n 
Annual 
incidence 
(95% CI) 
Actively-
screened* 
22 2.5 (1.5-3.7) 10 4.6 (2.2-8.5) 9 2.0 (0.9-3.8) 3 1.3 (0.3-4.0) 
 
Non-
classical† 
 
19 
 
2.2 (1.3-3.4) 
 
6 
 
2.8 (1.0-6.0) 
 
8 
 
1.8 (0.8-3.5) 
 
5 
 
2.4 (0.8-5.5) 
 
Classical† 
 
50 
 
5.4 (4.0-7.2) 
 
21 
 
9.0 (5.5-13.9) 
 
20 
 
4.3 (2.6-6.7) 
 
9 
 
4.0 (1.8-7.7) 
*Actively-screened children were diagnosed due to the presence of an associated condition or family 
history (FH) of CD in a first-degree relative, although nine children exhibited additional symptoms. 
†Excluding children with symptoms whose primary reason for diagnosis was active screening of an 
‘at risk’ condition or FH in a first-degree relative. 
5.1.4 Demographic characteristics 
The overall male to female ratio was 1:1.8 (n=33 and n=58, respectively). Median 
(IQR) age at diagnosis was 90 (50-129) months and seven of the 91 children (7.7%) 
were under two years of age. There was no significant difference between the tertiary 
GI networks with regard to proportion of under 2-year-olds diagnosed, median age at 
diagnosis or gender ratio. Excluding actively-screened cases, a significantly greater 
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proportion of older children (≥6yrs) presented non-classically in contrast to children 
aged <6yrs (χ2=5.366; p=0.021) (Table 14). A similar proportion of older and 
younger children were diagnosed through active screening (Table 14). Figure 5 
illustrates the frequency of cases diagnosed in each postcode area. More cases were 
diagnosed in population dense postcode areas including Edinburgh (EH) and 
Glasgow (G); however no cases were reported from Dumfries and Galloway (DG), 
Ayrshire (KA) or the far North-East (KW). 
Table 14 Differences in the primary reason for CD diagnosis between younger 
(<6yrs) and older (≥6yrs) children 
Primary reason 
for diagnosis 
Patients 
<6yrs 
Patients 
≥6yrs 
OR (95% CI) p-value 
Actively-
screened* 
5/35 17/56 0.38 (0.11-1.28) 0.081 
Non-classical† 4/30 15/39 4.06 (1.05-17.0) 0.021* 
Classical† 26/30 24/39 0.25 (0.06-0.95) 0.021* 
*Calculated as a proportion of total cases (n91). †Calculated as a proportion of cases whose primary 
reason for diagnosis was based on symptoms; either classical or non-classical (n=69) 
 *P<0.05, values determined from χ2 analyses. 
 
5.1.5 Serological testing and biopsy practices 
Two children did not have a CD serological test prior to diagnosis (1 East, 1 North). 
In both cases absence of testing was due to severe symptoms warranting urgent 
endoscopy. Excluding these cases, all children either had Anti-tTG or Anti-EMA 
serology pre-biopsy. Two of the children (2.2%) had their endoscopy performed by 
an adult gastroenterologist, and a paediatric gastroenterologist (n=85; 93.4%) or a 
paediatric surgeon (n=4; 4.4%) scoped all the other children. Significantly more CD 
diagnostic serological tests (Anti-tTG and Anti-EMA tests) were performed per head 
of population in the East compared to the West (χ2=417.68; p<0.0001) and North (
χ2=378.79; p<0.0001) over the year, and in contrast to the North significantly more 
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were performed per head of population in the West (χ2=9.38; p=0.002) (Table 15). 
Although the proportion of coeliac serological investigations requested from primary 
and secondary care clinicians in the North could not be confirmed, significantly more 
tests were requested by GPs in the East (728/2972) compared to the West (293/3712) 
(OR 3.79 [95% CI 3.26-4.39], χ2=351.51; p<0.0001). 
 
 
Figure 5 Frequency of paediatric coeliac disease cases (<16yrs), diagnosed in each 
Scottish postcode area between 01/09/2009 and 31/08/2010 
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Table 15 Differences in the proportion of CD serological tests (Anti-tTG/Anti-EMA) 
performed in each tertiary GI network (East, West and North) per head of population 
(<16yrs) 
Tertiary 
GI 
network 
Proportion of CD tests performed 
per head of population (<16yrs) 
 
OR (95% CI) P-value 
East (E) 2972/225,273 E vs. W = 1.65 (1.57-1.73) <0.0001 
West (W) 3712/461,814 W vs. N = 1.10 (1.03-1.16) 0.002 
North (N) 1653/225,057 E vs. N = 1.81 (1.70-1.92) <0.0001 
Values determined from χ2 analyses. 
 
5.1.6 The dietetic management of paediatric coeliac disease 
Thirty-seven pro-formas on the dietetic management of paediatric CD patients 
diagnosed between 01/09/2010 and 31/08/2011 were received. Twenty-five of the 
newly diagnosed cases were seen at a regional multi-disciplinary team clinic and 12 
new cases were seen at a district general dietetic-led clinic. No forms were excluded 
from data analyses. Since SPSU data was not collected over the second year of study, 
the dietetic data could not be linked with associated clinical information as proposed. 
Therefore, it is not known how many of the patients who saw a dietitian for the first 
time after endoscopy had already started or been advised to start a GFD.  
5.1.6.1 Demographic characteristics 
The overall male to female ratio was 1:1.8 (n=21 and n=12, respectively); the gender 
of four cases was not reported (3 regional clinic, 1 district general clinic). There was 
not a significant difference in the male to female ratio of children treated in the 
regional clinic or the general district clinic (1:1.6 and 1:2.3, respectively; Fisher’s 
Exact Test p=0.71). Median (IQR) age of patients (n=37) was 72 (60-145) months. 
The median (IQR) age of cases was not significantly different between children 
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treated in the regional clinic and those treated in a district general clinic (72 [54-126] 
and 75 [60-149] months, respectively; p=0.59).  
5.1.6.2 Timing of dietary advice and type of dietetic input 
Twenty-two cases (59.5%) were seen first by a dietitian on the day of their UGIE (all 
these cases were seen in the regional clinic). Fifteen children (40.5%) had their first 
appointment with a dietitian after endoscopy (3 regional clinic, 12 district general 
clinic). Significantly more patients treated at the regional clinic were seen at time of 
endoscopy compared to children treated at the district general clinic (Fisher’s Exact 
Test p<0.0001). With regards to cases seen after endoscopy (n=15), the median 
(IQR) time to follow-up was 37 (20-68) days. In total, twenty-six children (70.3%) 
(24 regional clinic; 2 district general clinic) were seen by a paediatric GI specialist 
dietitian and eleven (29.7%) (1 regional clinic; 10 district general clinic) were seen 
by a general paediatric dietitian. A significantly greater proportion of patients were 
seen by a paediatric GI specialist dietitian at the regional clinic compared to patients 
treated at the district general clinic (Fisher’s Exact Test p<0.0001). 
5.1.6.3 Areas of concern noted 
Dietitians reported twelve nutritional areas of concern at the first appointment (Table 
16). The most frequent concerns noted were low calcium intakes (n=10 patients), 
iron deficiency anaemia (IDA) (n=5 patients), poor appetite/low energy (n=4 
patients), fussy eating (n=3 patients) and weight loss/poor weight gain (n=3 patients). 
Both patients with IDA treated at the regional clinic were prescribed iron 
supplements. Of the three children with IDA seen at the district general clinic, one 
was advised how to improve iron intake by a specialist paediatric dietitian. However, 
an action plan to improve iron status was not reported for the two children seen by a 
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general paediatric dietitian at the district general clinic. With regards to low calcium 
intakes, three of four patients treated at the regional clinic were prescribed calcium 
supplements and dietary advice on calcium was provided, whereas one child was 
solely advised to improve calcium intake through dietary changes. Five of six 
patients seen at the district general clinic were recommended to increase calcium 
intake through dietary changes, including discussing products high in calcium, use of 
supplements was not reported. 
Although four patients treated at a district general clinic were observed to have poor 
appetite/low energy, a plan of action was only stated for one patient, which was to 
eat smaller, more frequent, energy dense meals and snacks. A comprehensive action 
plan was not described for the two children seen at a regional clinic who were found 
to be fussy eaters. Conversely, a general paediatric dietitian at the district general 
clinic took a detailed diet history to see whether a fussy eater was particularly 
sensitive to codex wheat starch and identified codex-free products for the patient. 
5.1.6.4 Education provided 
In all initial CD appointments at the regional clinic, dietitians provided education on 
the diet disease link, the GFD in general, prescribable products, food labels, cross-
contamination, the controversy surrounding the use of oats in the diet and the 
importance of calcium. Education on food labels and oats was provided in 
significantly less initial appointments at the general district clinic (Fisher’s Exact 
Test p<0.05 and p<0.01, respectively; Table 17). Education on following the GFD at 
children’s parties was provided in just over half of the patients initial appointments 
(14 of 24) at the regional clinic and five of nine (56%) initial appointments at the 
district general clinic (ns; Table 17). Additionally, education on following the GFD 
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Table 16 Nutritional areas of concern observed in newly diagnosed paediatric CD patients followed in the regional and general district 
clinics and the action taken  
Regional Clinic District General Clinic 
Nutritional 
area of 
concern 
Number 
of cases:  
Type of 
dietetic 
input 
Action taken Number 
of cases 
Type of 
dietetic 
input 
Action taken 
IDA 2 PGIS Arranged GP prescription: iron supplementation 3 
 
1 
PD 
 
PGIS 
2 = No action stated. 
 
Advice on dietary sources of iron. 
Low calcium 
intake 
4 PGIS 3 = Arranged GP prescription: calcium supplementation. 
1 = Advice on dietary sources of calcium. 
5 
 
 
1 
PD 
 
 
PGIS 
2 = Increase milk consumption. 
2 = Advice on dietary sources of calcium. 
1 = No action stated. 
Advice on dietary sources of calcium. 
Fussy eater 2 PGIS 1 = Education. 
1 = No action stated. 
1 PD Diet history to see if very sensitive to codex. wheat starch. Identified 
codex-free GF products. 
Weight loss/ 
poor weight 
gain 
3 PGIS 2 = Advised to commence GFD. 
1 = Advised to commence GFD and increase protein 
intake. Discussed possibility of future nutritional 
supplementation.  
0 - -  
Egg allergy 1 PGIS Provided with a list of egg-free and GF products. 1 PD No action stated. 
Poor dietary 
pattern 
0 - - 2 PD 1 = No action stated. 
1 = Advised to eat regular meals. Encouraged to eat breakfast. Advice 
on lunch at school and arranged to speak with school caterer. Advised to 
eat a varied diet; reasons for this and how best to achieve with dietary 
restrictions. 
Poor growth 0 - - 1 
 
1 
PD 
 
PGIS 
Lots of food to grow. Increase milk intake to 1 pint per day. 
 
No action stated. 
Allergic type 
episodes 
0 - - 1 PD Advised to keep a record of all allergic episodes and to find different GF 
products as may be sensitive to codex wheat starch. 
Poor diabetic 
control 
0 - - 1 PD No action stated. 
Nut allergy 0 - - 2 PD No action stated. 
Poor appetite & 
low energy 
0 - - 4 PD 3 = No action stated. 
1 = Smaller frequent meals. Eat energy dense foods and snacks. 
Poor fruit & 
vegetable 
intake 
0 - - 1 PD Advice on how to increase. 
CD, coeliac disease; IDA, iron deficiency anaemia; PGIS, paediatric gastro-intestinal specialist dietitian; PD, general paediatric dietitian; GFD, gluten-free diet; GF, gluten-free
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on holiday was provided in six of 24 (25%) initial appointments at the regional clinic 
and four of 11 (36%) appointments at the district general clinic (ns; Table 17). 
Table 17 Comparison of the education provided by dietitians during the first 
appointment with newly diagnosed coeliac disease patients at regional and district 
general clinics 
Education provided Number of patients (%) P-value* 
 Regional clinic 
(n25) 
District general 
clinic (n12) 
 
Diet disease link 25 (100) 11 (92) 0.31 
Advised about the GFD 25 (100) 12 (100) 1.00 
Prescribable products 25 (100) 12 (100) 1.00 
Food labels 25 (100) 9 (75) 0.02 
School/nursery meals 23 (92) 9 (90) [2 N/A] 1.00 
Cross contamination 25 (100) 11 (92) 0.31 
Eating out 20 (80) 8 (88) [1 N/A] 1.00 
Children’s parties 14 (58) [1 N/A] 5 (50) [2 N/A] 1.00 
Holidays 6 (25) [1 N/A] 4 (33) 0.69 
Oats 25 (100) 7 (64) [1 N/A] 0.006 
Calcium 25 (100) 11 (100) [1 N/A] 1.00 
Wheat starch 18 (72) 8 (67) 1.00 
Codex standards 22 (88) 4 (33) 0.003 
Family screening 9 (90) [15 N/S] 2 (18) [1 N/A] 0.005 
MDT, multi-disciplinary team; DL, dietetic-led 
Numbers and abbreviations in square brackets: N/A, education on this particular topic was not 
applicable to this number of patients; N/S, it was not stated whether this topic of education was 
covered in the appointment or not for this many patients 
*Values determined from 2 and Fisher’s Exact Test analyses 
 
Education on codex standards and the importance of family screening was provided 
in significantly less initial appointments at the district general clinic compared to the 
regional clinic (p<0.01; Table 17). However, in 15 initial appointments at the 
regional clinic it was not stated whether the topic of family screening was covered. In 
one appointment at the regional clinic a paediatric GI specialist dietitian also 
informed parents of the most beneficial weaning practices for the newly diagnosed 
child’s 6-month-old sibling. Additionally, the families of two new cases treated at the 
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district general clinic were educated about malt extract in the first appointment and in 
another two sessions play dough and home baking were covered. 
5.1.6.5 Prescriptions 
Twenty-two out of 25 (88%) patients seen at the regional clinic clearly had a 
prescription for GF products provided at the first appointment. For the remaining 
three CD cases it was not stated whether a prescription for GF products was 
arranged. Eleven of the twelve (92%) new cases seen at the district general clinic had 
a prescription organised during their first appointment. One child did not have a 
prescription organised because it was stated there were ‘no prescription items that he 
liked’. 
5.1.6.6 Resources provided 
Comparisons of resources provided during the first appointment with newly 
diagnosed CD patients at the regional and a district general clinic are shown in Table 
18. For two new patients seen in the regional clinic no details were provided to 
questions relating to resources. Excluding these children, all newly diagnosed cases 
(or their parents) were advised to join Coeliac UK in their first appointment and, 
apart from one child seen in the regional clinic and one child seen in the district 
general clinic, all families were advised to purchase the Coeliac UK food and drink 
directory (96% and 92% of families, respectively). Twenty of 23 (87%) children 
treated at the regional clinic were provided with information on their local branch of 
Coeliac UK, compared to two of seven (29%) children treated at the district general 
clinic (p<0.01; Table 18). All children seen in the regional clinic were provided with 
sample cards for GF trial packs and with a calcium counter at their initial 
appointment, in contrast to no calcium counters being provided at first appointments 
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in the district general clinic (p<0.0001, Table 18). Two of 23 (9%) children seen in 
the regional clinic were given product samples of GF breads compared to seven of 
eight (88%) new patients treated in the district general clinic (p<0.0001, Table 18). 
Additionally, one child seen in the regional clinic was given a sample pack of 
different flours, pasta and biscuits and one child treated in the district general clinic 
was offered samples of pasta, pizza bases, crackers and biscuits. 
Table 18 Comparison of the resources provided by dietitians during the first 
appointment with newly diagnosed coeliac disease patients at regional and district 
general clinics 
Resources provided Number of patients (%) P-value* 
 Regional clinic 
(n25) 
District General clinic 
(n12) 
 
Advised to join Coeliac 
UK 
23 (100) [2 NS] 12 (100) 1.00 
Food and drink monthly 
updates 
22 (96) [2 NS] 11 (92) 1.00 
Local branch info 20 (87) [2 NS] 2 (29) [3 N/A, 2 NS] 0.007 
Sample cards for GF 
trial packs 
23 (100) [2 NS] 9 (90) [2 NS] 0.30 
Calcium counter 23 (100) [2 NS] 0 (0) [1 NS] <0.0001 
Product samples of GF 
bread 
2 (9) [2 NS] 7 (88) [4 NS] <0.0001 
GF, gluten-free 
Numbers and abbreviations in square brackets: N/A, the resource was not applicable to this number of 
patients; NS, it was not stated whether the resource was provided or not at the appointment to this 
number of patients 
*Values determined from 2 and Fisher’s Exact Test analyses 
5.1.6.7 Planned frequency of follow-up 
It was arranged that 23 of the 25 (92%) new cases seen in the regional clinic would 
be seen again in three months time and two cases after one month. It was planned 
that 10 of the 12 (83%) newly diagnosed children treated at the district general clinic 
would be seen again after six weeks and thereafter at an interval of three months, six 
months and then every year. However, it was arranged that one new patient would be 
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seen again after one year with telephone contact as required and a dietitian would see 
one patient at six-month intervals. 
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5.2 Study 2: Trends in paediatric coeliac disease in Southeast Scotland 
from 1990-2009: a retrospective audit of cases 
5.2.1 Crude numbers diagnosed 
In total, 290 children were diagnosed and treated for CD between 1990 and 2009 in 
SE Scotland. Twenty-four children were excluded from the final incidence data for 
the following reasons: 18 of the children’s pathology reports were not in keeping 
with the 1990 ESPGHAN diagnostic criteria; one patient did not have a biopsy 
performed but was put on a GFD due to strong family history in first-degree 
relatives, one patient had an unsuccessful Crosby capsule biopsy and was not 
followed up to ascertain positivity, and four children were resident outwith ‘core’ SE 
Scotland health board areas. Following exclusion of the above children, 266 biopsy 
positive children were captured over the study period. Table 19 outlines the crude 
number of patients diagnosed in each Epoch by sex. 
 
Table 19 Crude number of paediatric CD cases diagnosed in each epoch by sex 
  Crude number of cases 
Year Persons at risk* Male Female Total 
1990-1994 (Epoch 1) 230,587 9 11 20 
1995-1999 (Epoch 2) 235,119 17 29 46 
2000-2004 (Epoch 3) 230,116 25 43 68 
2005-2009 (Epoch 4) 224,750 52 80 132 
*Mean number of persons at risk (<16 years) for each year of the epoch (calculated from Scottish 
Government mid-year estimates). 
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5.2.2 Trends in age-sex standardised incidence over time 
The mean age-sex standardised incidence rates of paediatric CD were 
1.60/100,000/yr (95% CI 0.97-2.49), 3.81/100,000/yr (95% CI 2.79-5.10), 
5.89/100,000/yr (95% CI 4.58-7.47) and 11.81/100,000/yr (95% CI 9.88-14.01) in 
Epochs 1, 2, 3 and 4, respectively. The adjusted mean incidence rate was 
significantly higher in Epoch 4 compared to all other Epochs, and although rates 
were similar for Epochs 2 and 3, there was a significant rise from Epoch 1 to Epoch 
2 and between Epochs 1 and 3 (figure 6). 
 
  
Figure 6 Mean paediatric CD incidence between 1990 and 2009 (5 year epochs) in 
SE Scotland. *P<0.05; **P<0.01; ns=not significant.  
** 
** 
** 
** 
* 
ns 
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5.2.3 Trends in presentations of paediatric CD (reasons for diagnosis) over time 
5.2.3.1 Actively-screened cases 
Just one child diagnosed in Epoch 1 was actively screened for CD (due to family 
history (FH) in a first-degree relative). A further three children were diagnosed 
through targeted screening in Epoch 2 (2 FH, 1 T1DM), rising to 16 in Epoch 3 (3 
FH, 12 T1DM, 1 Down syndrome) and 29 children in Epoch 4 (11 FH, 16 T1DM, 2 
Down syndrome). Since so few children were diagnosed through screening in Epoch 
1, incidence rates were compared between the first and last ten years of data 
collection, rather than between each Epoch. There was a significant 11-fold rise in 
the incidence of cases diagnosed through active screening from the 1990-1999 cohort 
(0.17/100,000/yr; 95% CI 0.05-0.45) to the 2000-2009 cohort (2.04/100,000/yr; 95% 
CI 0.49-2.72) (figure 7). 
 
Figure 7 Percentage rise in age-sex standardised incidence rates of cases diagnosed 
through active screening and due to non-classical presentations over time. *P<0.05, 
†P<0.001. P-values determined from Poisson regression analysis. 
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5.2.3.2 Non-classical cases 
Over the 20 years studied, thirty-eight children were diagnosed on the basis of a non-
classical presentation; two children in Epoch 2 (one presented with extra-intestinal 
symptoms (EIS) and one presented mono-symptomatically (MS)), eight children in 
Epoch 3 (4 EIS, 4 MS), rising to 28 cases in Epoch 4 (13 EIS, 15 MS). Again, 
regression analysis was performed between the first and last ten years of data 
collection. Following age-sex standardisation, the incidence rates of non-classical 
cases rose significantly from 0.09/100,000/yr (95% CI 0.01-0.32) in the cohort 1990-
1999, to 1.41/100,000/yr (95% CI 0.97-2.00) in the cohort 2000-2009 (figure 7). 
5.2.3.3 Classical cases 
Nineteen of the twenty children captured in Epoch 1 were diagnosed due to 
exhibiting a classical presentation. Forty-one classical cases were diagnosed in 
Epoch 2, forty-four in Epoch 3, and seventy-four in Epoch 4. Adjusted mean 
incidence rates were 1.51/100,000/yr (95% CI 0.91-2.38), 3.38/100,000/yr (95% CI 
2.43-4.60), 3.98/100,000/yr (95% CI 2.91-5.31) and 6.77/100,000/yr (95% CI 5.33-
8.48) in Epochs 1, 2, 3 and 4, respectively. Although there was not a significant 
change in incidence between Epochs 1 and 2, Epochs 2 and 3 or between Epochs 3 
and 4 (Table 20), there was a significant rising trend in classical incidence from 
Epoch 1 to Epoch 3 (P<0.05) and a significant fourfold rise in incidence was 
observed from Epoch 1 to Epoch 4 (figure 8). Following exclusion of children 
presenting without an ‘Oslo Classical’ presentation of CD, there was a still a 
significant threefold rise in the incidence of Oslo classical cases between Epoch 1 
(1.51/100,000/yr; 95% CI 0.97-2.38) and Epoch 4 (5.22/100,000/yr; 95% CI 3.98-
6.75) (figure 8). 
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Table 20 Trends in the incidence of cases diagnosed on the basis of a classical 
presentation over time 
Trend analysis RR SEM t-value p-value  
Epoch 1-Epoch 2 2.11 0.333 2.251 0.055 
Epoch 1-Epoch 3 2.42 0.311 2.847 0.022 
Epoch 1-Epoch 4 4.10 0.379 3.723 0.006 
Epoch 2-Epoch 3 1.14 0.239 0.576 0.581 
Epoch 2-Epoch 4 1.94 0.283 2.349 0.047 
Epoch 3-Epoch 4 1.69 0.264 1.993 0.081 
SEM=standard error of the mean; RR=point estimate of incidence rate ratio; p-values determined from 
Poisson regression analysis; numbers in italics represent significant rises in incidence (p<0.05). 
 
 
Figure 8 Percentage rise in age-sex standardised incidence rates of cases diagnosed 
due to classical presentations and Oslo classical presentations of CD over time. 
*p<0.01. p-values determined from Poisson regression analysis. 
5.2.4 Patient demographics 
Patient demographics may be observed in Table 21. SIMD and urban-rural 
classification data were obtainable for 246 (92%) patients. Median SIMD decile 
scores and 6-fold urban-rural classification indices of the coeliac patients were 
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comparable to the general SE Scotland population and similar across each Epoch. 
The overall male to female ratio was 1:1.6 and gender ratios were similar across all 
four time periods. Median age at diagnosis rose significantly between Epoch 1 and 
Epoch 4 (figure 9). A significantly greater proportion of children were less than two 
years of age at diagnosis in Epoch 1 in comparison to Epoch 3 and Epoch 4 (p<0.001 
and p<0.0001, respectively); additionally a significantly greater proportion of 
children diagnosed in Epoch 2 were aged under two years in comparison to Epoch 3 
(p<0.001) and Epoch 4 (p<0.0001).  
Table 21 Demographic characteristics of patients diagnosed between 1990 and 2009 
in SE Scotland 
Demographic 
characteristic 
Total General 
SES pop. 
(<16yrs) 
Epoch 1 Epoch 2 Epoch 3 Epoch 4 
Age n=266 - n=20 n=46 n=68 n=132 
Median age 
(months) 
(IQR) 
77 (37-
126) 
- 29 (16-24) 46 (19-
121) 
75 (38-
136) 
90 (54-
130) 
<2yrs (%) 
 
42 (16) - 9 (45) 17 (37) 9 (13) 7 (5) 
Sex n=266 - n=20 n=46 n=68 n=132 
Males (%) 103 (61) - 9 (45) 17 (37) 25 (37) 52 (39) 
Females (%) 
 
163 (39) - 11 (55) 29 (63) 43 (63) 80 (61) 
Geographical area n=246 n=35,737 n=16 n=43 n=60 n=127 
SIMD decile 
(IQR) 
7 (4-9) 6 (4-9) 8.5 (4-10) 6 (3-8) 7 (4-9) 7 (4-9) 
6-fold Urban-
Rural    index 
classification 
code (IQR) 
 
2 (1-3) 2 (1-3) 1 (1-2) 2 (1-3)  2 (1-3) 2 (1-3) 
SIMD=Standard index of multiple deprivation; SES=Southeast Scotland; IQR=interquartile range. 
Numbers (n) in bold are the number of children with data available at diagnosis. 
Children presenting classically were significantly younger at diagnosis (median age 
61 months; IQR 26-113) compared with the non-classical and actively screened 
groups combined (median age 109 months; IQR 67-141) (p<0.0001). Furthermore, 
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classical cases were significantly younger in Epoch 1 (median age 26 months; IQR 
16-53) compared with Epoch 4 (median age 81 months; IQR 48.3-120.8) (p<0.0001). 
 
 
Figure 9 Change in age at diagnosis over time (5 year epochs). Box and whisker plot 
showing median, IQR and range. *Kruskal-Wallis test is significant at p<0.0001 
across all epochs. 
 
5.2.5 Haematology 
Haemoglobin (Hb) results were unavailable for 12% of the 132 children diagnosed 
between 2005 and 2009. MCV was unavailable for 13% of children and ferritin, 
folate, vitamin B12 and albumin results were unavailable for 27%, 52%, 50% and 
20% of patients, respectively. The test not routinely being performed at diagnosis 
was the primary reason for missing results, although 15 vitamin B12 samples and 13 
folate blood samples were described as being ‘insufficient’ to carry out the test. 
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Mean values for the remaining children are summarised in Table 22 as well as the 
proportion of children with blood results below the normal reference ranges. 
Mean (SD) Hb concentration was 12.2 ± 1.6g/ml and mean (SD) MCV was 79 ± 
6.3fl. Twenty-eight per cent (32/116) of children had Hb concentrations below WHO 
limits defining anaemia; <11g/ml for children aged 6-59 months, <11.5g/ml for 
children 5-11 years of age, <12.0g/ml for 12- to 14-year-olds and females aged 15 or 
older and <13.0g/ml for males aged 15 years or older. Twenty-three per cent 
(27/115) had an MCV result below 77fl, indicative of microcytic anaemia, suggestive 
of iron deficiency. Mean (SD) ferritin concentration at CD diagnosis was 
19.8±16.0µg/L and 53.1% (51/96) had results below the lower level of normality; 
<20µg/L for boys and <15µg/L for girls. Mean Hb, MCV and ferritin concentrations 
were not significantly different for girls compared to boys, nor were the proportions 
of girls and boys with results below normal ranges (Table 22).  
Mean (SD) folate concentrations were similar for boys and girls, at 11.1±5.6µg/L 
and 11.6±6.1 µg/L, respectively and there was not a significant difference in the 
proportion of boys and girls who had concentrations below 5µg/L (2=0.794, 
p>0.05; Table 22). Just one of the 66 (1.5%) children with available vitamin B12 
results had levels below the lower level of normality (200ng/L) and there was not a 
significant difference between boys and girls with regard to mean vitamin B12 
concentrations, at 579.2ng/L and 636.7ng/L respectively (p>0.05; Table 22). 
Fourteen of 105 children had low albumin levels (13.3%). The proportion of girls 
and boys with low albumin levels was not significantly different (2=0.510, p>0.05; 
Table 20). 
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Table 22 Mean (SD) haemoglobin, MCV, ferritin, folate, vitamin B12 and albumin 
results of patients diagnosed between 2005 and 2009 (n=132) by sex, and proportion 
with results below lower levels of normality for each test 
 
 
Hb (g/ml) MCV 
(fl) 
Ferritin 
(µg/L) 
Folate 
(µg/L) 
B12 (ng/L) Albumin 
(g/L) 
All children n=116 n=115 n=96 n=63 n=66 n=105 
Mean (SD) 
 
12.2±1.6 79.0±6.3 19.8±16.0 11.4±5.9 613.1±235.2 43.3±4.6 
Proportion < lower 
level of normality 
32/116 27/115 51/96 7/63 1/66 14/105 
Boys n=44 n=43 n=40 n=24 n=27 n=44 
Mean (±SD) 12.4±1.3 79.3±4.7 20.3±13.6 11.1± 5.6 579.2 ±199.9 43.2±4.2 
       
Girls n=72 n=72 n=56 n=39 n=39 n=61 
Mean (±SD) 12.1±1.8.1 78.8±7.1 19.5±17.7 11.6±6.1 636.7±256.7 43.4±4.8 
p-value* 0.238 0.643 0.825 0.716 0.332 0.774 
Boys        
Proportion < lower 
level of normality 
 
9/44 
 
8/43 
 
24/40 
 
4/24 
 
0/27 
 
7/44  
Girls       
Proportion < lower 
level of normality 
 
23/72 
 
19/72 
 
27/56 
 
3/39 
 
1/39 
 
7/61 
p-value** 0.179 0.341 0.302 0.412 1.00 0.510 
*p-values determined from independent t-tests; **p-values determined from 2 analysis or Fisher’s 
Exact Test 
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5.3 Study 3: Adolescent adherence to the gluten-free diet; nutritional 
adequacy, factors associated with adherence and health-related quality of 
life 
5.3.1 Demographic characteristics of the overall sample 
A total of 39 out of 143 adolescents were recruited within Lothian, Fife and Tayside 
(27.3% recruitment rate). The demographic characteristics of the CD adolescent 
sample are shown in Table 23. Data on length of time diagnosed and age at 
participation data were both negatively skewed (Shapiro-Wilk test). Therefore, these 
continuous variables are presented using medians and interquartile range (IQR). 
There was no significant difference in median (IQR) age at time of participation 
between boys and girls (13.7 [12.7-17.5] years and 13.6 [12.0-15.0] years, 
respectively; p>0.05) nor length of time diagnosed (6.0 [2.0-8.1] years and 5.3 [3.5-
10.2] years, respectively; p>0.05).  
Table 23 Demographic characteristics of the CD adolescent sample (n=39) 
Demographic characteristics  
Median age (IQR) yrs 13.6 (12.0-15.0) 
Median length of diagnosis (IQR) yrs 5.8 (3.0-10.0) 
Girls (%) 32 (82.1) 
Oslo Classical CD (%) 28 (71.8) 
Race 
           White (%) 
           Other (%) 
 
38 (97.4) 
1 (2.6) 
CD=Coeliac disease, IQR=interquartile range. 
 
5.3.2 Estimated energy and nutrient intakes  
Of the 39 teenagers recruited, 35 returned completed four-day food diaries (90% 
response rate). One teenager did not return for the second session of data collection 
and three teenagers failed to return the completed diary despite reminders to do so. 
All returned diaries were included in the final analysis. More girls (n=29, 82.9%) 
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than boys (n=6, 17.1%) participated, reflecting the gender distribution of the overall 
sample. Median (IQR) age of respondents was 13.7 (12.3-15.1) years; there was no 
significant difference in median (IQR) age between boys (13.3 [12.4-17.7] years) and 
girls (13.8 [12.2-15.1] years) (p>0.05). Eight (22.9%) participants reported taking 
nutritional supplements (7 girls, 1 boy) (figure 10). Four participants were lactose 
intolerant (3 girls, 1 boy). These particular participants did not report taking any 
prescribed or over the counter nutritional supplements. Analyses were performed 
with and without additional nutrients from supplements. 
 
Figure 10 Use of nutritional supplements (n=8).   
Estimated nutrient intakes (girls) were not normally distributed for iron and niacin, 
whereas adolescent boy data was not normally distributed for vitamin B12 (Shapiro-
Wilk test). Non-parametric tests were therefore employed for all micronutrient 
analyses to ensure standardisation across groups. Additionally, non-parametric tests 
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were utilised when analysing male and female data separately, due to the low number 
of boy participants. 
5.3.2.1 Estimated energy and macronutrient intakes compared to DRVs, SACN 
EARs for energy and NDNS data (2008/09-2009/10) (Bates et al. 2012; Department 
of Health 1991; SACN 2011) 
Estimated energy and macronutrient intakes of the CD group were analysed split by 
gender. In the adolescent CD group, median (IQR) daily energy intake was 2322 
(2022-2910) kcal (9.71 MJ) for boys and 1889 (1603-2304) kcal (7.90 MJ) for girls 
(Table 24). The majority of boys and girls had energy intakes below revised SACN 
EAR values (SACN 2011) (5/6 [83%] and 19/29 [66%], respectively). Estimated 
energy intake in both boys and girls with CD was significantly higher compared to 
NDNS data (p<0.05 and p<0.01; respectively) (Table 24). 
Table 24 Median (IQR) estimated intakes of macronutrients (food sources only) in 
adolescents (11-18 years) with coeliac disease compared to NDNS controls (11-18 
years)
a 
Daily intakes Girls Boys 
 CD (n29) NDNS 
(n215) 
CD (n6) NDNS 
(n238) 
Energy (kcal) 1889 (1603-2324)* 1617 2322 (2022-2910)* 1916 
Protein (g) 75.2 (63.7-86.8)* 57.2 91.7 (77.0-124)* 71.2 
Total fat (g) 75.8 (60.7-94.8)* 63.8 89.4 (71.4-112) 73.9 
SFA (g) 28.9 (23.9-38.5)* 22.0 35.1 (22.2-41.3) 26.9 
CHO (g) 243 (200-305)* 220 322 (258-374) 263 
NMES (g) 93.7 (64.7-137)* 61.2 81.5 (65.5-159) 79.1 
NSP (g) 13.3 (11.2-17.5)* 10.5 15.1 (13.3-27.6)* 12.2 
NDNS = national diet and nutrition survey, CD = coeliac disease, SFA = saturated fatty acids, CHO = 
carbohydrates, NMES = non-milk extrinsic sugars, NSP = non-starch polysaccharide 
*P<0.05; Wilcoxon signed rank test. Dietary intakes significantly different compared to NDNS data.  
a
Bates et al. (2012) 
 
Median (IQR) daily protein intake was 91.7 (77.0-124) g for boys and 75.2 (63.7-
86.8) g for girls with CD, which were significantly higher than intakes reported in 
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the NDNS (Table 24). Median protein intake (IQR) was 214% (182%-229%) of the 
RNI in adolescent boys with CD, and 180% (153-197%) of the RNI in girls with CD. 
Participants consumed a significantly greater proportion of daily food energy from 
protein compared to controls (p<0.0001) (Table 25), and this was significantly higher 
than the DRV for percentage of daily energy from protein (p<0.01) (Table 25). 
Mean (SD) estimated energy from fat was 35.0±5.7%, which was not significantly 
different from teenage NDNS data and the DRV for percentage energy from total fat 
(both p>0.05, Table 25). Mean (SD) saturated fatty acid (SFA) intake was 14.0±3.2% 
of total energy intake in teenagers with CD. This was significantly greater than 
NDNS controls (p<0.05, Table 25) and the DRV for SFA (≤10%) (p<0.0001, Table 
25). In comparison to NDNS data, both total fat and SFA intakes were greater in 
adolescent girls with CD (p<0.01, Table 24), whereas a significant difference in total 
fat and SFA consumption was not observed between boys with CD and boys in the 
NDNS (p>0.05, Table 24). 
Table 25 Mean (SD) percentage intake of energy from carbohydrate, total fat, 
protein, saturated fatty acids and non-milk extrinsic sugars in patients with CD 
compared to NDNS controls (11-18 years)
a 
and DRVs
b 
 DRV CD group (n=35) NDNS (n=453) 
% energy from CHO 50 52.0 ± 7.2 51.0 ± 5.4 
% energy from protein 15 17.2 ± 3.7* 14.7 ± 2.8 
% energy from total fat 35 35.0 ± 5.7 34.3 ± 4.8 
% energy from SFA 10 14.0 ± 3.2* 12.6 ± 2.5 
% energy from NMES 10 19.3 ± 6.4* 15.7 ± 6.4 
CD = coeliac disease, NDNS = national diet and nutrition survey, DRV = dietary reference value, 
SFA = saturated fatty acids, NMES = non-milk extrinsic sugars 
*P<0.05, One sample t-test. Values significantly different compared with NDNS data and DRVs. 
a
Bates et al. (2012) 
b
DoH (1991) 
 
Fifty-two per cent of total daily food energy came from CHO in the CD diets (boys 
and girls), which was not significantly different from the DRV for CHO or control 
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group data (p>0.05, Table 25). Conversely, mean (SD) intake of non-milk extrinsic 
sugar (NMES) as a percentage of energy was significantly higher in the CD group 
compared to the general teenage population and the DRV (p<0.01 and p<0.0001, 
respectively, Table 25). Girls with CD had higher intakes of CHO and NMES 
compared with NDNS data (243g vs. 220g and 93.7g vs. 61.2g, p<0.05 and p<0.01, 
respectively, Table 24). Both boys and girls with CD had a greater average intake of 
NSP in comparison to controls (p<0.05 and p<0.0001, respectively, Table 24), 
however, these were significantly below the RNI of 18g in both boys and girls with 
CD (p<0.05, Table 24).  
5.3.2.2 Contribution of foods to energy and NSP intake and comparison to NDNS 
data (2008/09-2009/10) (Bates et al. 2012) 
Compared to NDNS data, adolescents with CD consumed a greater percentage of 
daily food energy from milk and milk products (17% vs. 9%), fruit (4% vs. 2%) and 
sugar, preserves and confectionery (9% vs. 6%) (p<0.0001, p<0.01 and p<0.01, 
respectively; figure 11). Whereas cereal and cereal products, meat and meat products 
and fish and fish dishes provided adolescents with CD significantly less energy on a 
daily basis than they did the general teenage population (p<0.0001, p<0.01 and 
p<0.0001, respectively; figure 11). 
On further investigation, it was found that teenagers with CD attained more food 
energy specifically from semi-skimmed milk compared to the NDNS population (7% 
and 2%, respectively; p<0.01), as well as cheese (5% and 2%, respectively; 
p<0.0001). The contribution of energy from high fibre breakfast cereals and 
puddings was lower in the coeliac group, compared to the general population (0% vs. 
2% and 0% vs. 1%, respectively) (both p<0.0001). However, teenagers with CD 
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consumed more energy from wholemeal bread compared to NDNS teenagers (3% vs. 
1%, respectively) (p<0.05). 
Compared to NDNS data, the adolescent CD group consumed a significantly lower 
percentage of their mean daily NSP intake from meat and meat products (2% and 
11%, respectively), fish and fish dishes (0% and 1%, respectively) and nuts and 
seeds (0% and 1%, respectively) (all p<0.0001; figure 12). Fruit contributed to a 
significantly greater percentage of mean NSP intake in teenagers with CD compared 
to NDNS controls (11% and 7%, respectively, p<0.05, figure 12). 
 
 
Figure 11 Percentage contribution of food types to mean daily total energy for teenagers with 
coeliac disease (11-18yrs) compared to NDNS data (Bates et al. 2012). *p<0.05, One sample t-test. 
Values significantly different compared to NDNS data  
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Figure 12 Percentage contribution of food types to mean daily non-starch polysaccharide intake for 
teenagers with coeliac disease (11-18yrs) compared to NDNS data (Bates et al. 2012). *p<0.05, One 
sample t-test. Values significantly different compared to NDNS data 
 
5.3.2.3 Estimated micronutrient intakes compared to DRVs and NDNS data 
(2008/09-2009-10) (Bates et al. 2012) 
Taking into consideration micronutrient intakes from food sources only, both 
adolescent boys and girls with CD had median calcium intakes above the RNI 
(Tables 26a and 26b). However, only the girls’ median calcium intakes were 
significantly higher than the RNI value (p<0.05, Tables 26a). Four (14%) teenage 
girls with CD had calcium intakes below the LRNI, although this was not 
significantly different compared to NDNS data (Table 26a). Girls with CD had a 
significantly higher median (IQR) calcium intake compared to girls in the NDNS 
(p<0.0001, Table 26a). Considering calcium intakes from food and supplement 
sources (n=5 took supplements) two girls with CD (7%) had intakes <LRNI, similar 
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to controls (Table 26a). Although adolescent boys with CD had a median daily 
calcium intake from food sources only similar to the general population (Table 26b), 
their calcium intake from food and supplement sources (n=1 took supplements) was 
significantly higher compared to NDNS controls (p<0.05, Table 26b).  
Median iron intakes in girls with CD, both from food sources only, and from food 
and supplement sources combined (n=1 took supplements) were significantly lower 
than RNI values (both p<0.05, Table 26a) but significantly higher compared to 
NDNS data (p<0.05 and p<0.01, respectively, Table 26a). Whereas median iron 
intakes in boys were significantly higher than RNI values when taking into 
consideration intakes from food sources only and food and supplement sources (n=0 
took supplements) (both p<0.05, Table 26b). None of the boys with CD had iron 
intakes below the LRNI (Table 26b). Ten (34%) of the girls with CD had iron intakes 
from food sources only below the LRNI. This reduced to nine (31%) when iron 
intakes from food and supplement sources were considered. Although a greater 
percentage of adolescent girls with CD had iron intakes (from food and supplement 
sources) below the LRNI compared to NDNS controls (20%) this did not reach 
statistical significance (p=0.17, Table 26a). 
Estimated average daily folate, thiamin, niacin, riboflavin and vitamin B12 intakes 
from food sources in girls and boys with CD were all higher than individual RNIs 
(Table 26a and 26b). Apart from folate, all differences reached statistical significance 
in girls (all p<0.05, Table 26a). Both adolescent boys and girls with CD had higher 
median daily intakes of folate, riboflavin, niacin and vitamin B12 from food sources 
only and food and supplement sources combined than NDNS control subjects 
(p<0.05, Table 26a and 26b). There were no significant differences between 
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adolescents with CD and NDNS controls in relation to the proportion with intakes 
below the LRNI for folate, thiamin, riboflavin, niacin and vitamin B12 (Table 26a 
and 26b). 
There was no significant difference in median daily vitamin D intake from food 
sources or from food and supplement sources (n=1 took supplements) between boys 
with CD and NDNS controls (Table 26b). Although median vitamin D intakes from 
food sources only were not significantly different between girls with CD and NDNS 
controls, adolescent girls with CD had a greater median intake of vitamin D from 
food and supplement sources (n=6 took supplements) combined compared to the 
general NDNS population (p=0.01, Table 26a). 
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Table 26a Girls median (IQR) estimated daily intakes of micronutrients compared to 
Reference Nutrient Intake (RNI)
a
 and NDNS data
b
 in girls with CD and percentage 
of with intakes below the Lower Reference Nutrient Intake (LRNI)
a
 compared to 
NDNS data
b 
 
FOOD SOURCES ONLY  
 
 
 
RNI 
 
CD Group (n29) 
 
NDNS data (215)c   
 
 
Age group 
 
 
 
LRNI 
 
 
Median (IQR) intakes 
 
N (%) 
<LRNI 
 
Median 
intakes 
 
N (%) 
<LRNI 
 
Calcium (mg) 
 
11-18 yrs 
 
450 
 
800 
 
1057 (695-1409)*† 
 
4 (14) 
 
653 
 
32 (15) 
Iron (mg) 11-18 yrs 8.0 14.8 9.3 (7.3-11.5)*†  10 (34) 8.2 95 (44) 
Folate (µg) 11-18 yrs 100 200 201 (164-289)† 2 (7) 181 13 (6) 
Thiamin (mg) 11-14 yrs 
15-18 yrs 
0.4  
0.5  
0.7  
0.8  
1.5 (1.0-1.7)* 
1.1 (0.8-1.3)* 
1.3 (1.0-1.6) [11-18yrs] 
 
 
0 (0) 
 
 
1.20 
 
 
0 (0) 
Riboflavin 
(mg) 
11-18 yrs 0.8 1.1 2.0 (1.1-2.8)* 2 (7) 1.18 37 (17) 
Niacin (mg) 11-14 yrs 
15-18 yrs 
8.0  
9.0  
 
12 
14 
31.8 (24.5-42.3)* 
32.5 (23.7-37.2)* 
31.8 (24.5-40.0) [11-18yrs]† 
 
 
0 (0) 
 
 
27.8 
0 (0) 
Vitamin B12 
(µg) 
11-14 yrs 
15-18 yrs 
0.8  
1.0 
1.2 
1.5  
4.3 (3.1-6.0)* 
5.5 (3.3-6.6)* 
4.3 (3.3-6.2) [11-18yrs]† 
 
 
1 (3) 
 
 
3.1 
 
 
2 (1) 
Vitamin D 
(µg) 
 - - 1.9 (0.9-3.1)  1.6  
FOOD AND SUPPLEMENT SOURCES     
 
Calcium (mg) 
 
11-18 yrs 
 
450 
 
800 
 
1115 (719-1409)*† 
 
2 (7) 
 
653 
 
14 (7) 
Iron (mg) 11-18 yrs 8.0 14.8 9.6 (7.6-12.0)*† 9 (31) 8.2 43 (20) 
Folate (µg) 11-18 yrs 100 200 201 (164-293)† 2 (7) 182 5 (2) 
Thiamin (mg) 11-14 yrs 
15-18 yrs 
0.4 
0.5 
0.7 
0.8 
1.5 (1.0-1.7)* 
1.1 (0.8-1.6)* 
1.3 (1.0-1.7) [11-18yrs] 
 
 
0 (0) 
 
 
1.21 
0 (0) 
Riboflavin 
(mg) 
11-18 yrs 0.8 1.1 2.0 (1.1-2.8)*† 2 (7) 1.18 9 (4) 
Niacin (mg) 11-14 yrs 
15-18 yrs 
8.0 
9.0 
12  
14 
31.8 (24.5-42.3)* 
35.9 (24.1-43.7)* 
33.0 (24.5-42.3)* [11-18yrs] 
 
 
0 (0) 
 
 
27.9 
 
 
0 (0) 
Vitamin B12 
(µg) 
11-14 yrs 
15-18 yrs 
0.8 
1.0 
1.2 
1.5  
4.3 (3.3-6.0)* 
5.5 (3.3-6.6)* 
4.3 (3.3-6.2) [11-18yrs]† 
 
 
1 (3) 
 
 
3.1 
 
 
1 (<1) 
Vitamin D 
(µg) 
 - - 2.3 (1.2-4.3)† - 1.7 - 
NDNS, National Diet and Nutrition Survey; CD, coeliac disease; IQR, interquartile range 
*p<0.05, dietary intakes significantly different to RNI values; †p<0.05, dietary intakes significantly different 
compared to NDNS data (one-sample Wilcoxon test) 
-Vitamin D does not have an established LRNI 
a
DoH (1991); 
b
Bates et al. (2012); 
c
NDNS interquartile range data is unavailable 
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Table 26b Boys median (IQR) estimated daily intakes of micronutrients compared to 
Reference Nutrient Intake (RNI)
a
 and NDNS data
b
 in boys with CD and percentage 
of boys with intakes below the Lower Reference Nutrient Intake (LRNI)
a
 compared 
to NDNS data
b 
 
FOOD SOURCES ONLY   
CD Group (n6) 
 NDNS data 
(n238)c 
   
  
Age group 
 
LRNI 
 
RNI 
 
Median (IQR) intakes 
N (%) 
<LRNI 
Median 
intakes 
N (%) 
<LRNI 
 
Calcium (mg) 
 
11-18 yrs 
 
480 
 
1000 
 
1477 (705-1678) 
 
0 (0) 
 
800 
 
19 (8) 
Iron (mg) 11-18 yrs 6.1 11.3 15.5 (12.2-22.1)*† 0 (0) 10.5 12 (5) 
Folate (µg) 11-18 yrs 100 200 332 (269-419)*† 0 (0) 216 5 (2) 
Thiamin (mg) 11-14 yrs 
15-18 yrs 
0.5  
0.6 
0.9  
1.1 
1.9 (1.3-2.2) 
2.9 (2.0-2.9)  
2.0 (1.6-2.6) [11-18yrs] 
 
 
0 (0) 
 
 
1.53 
 
 
0 (0) 
Riboflavin 
(mg) 
11-14 yrs 
15-18 yrs 
0.8 
0.8 
1.2 
1.3 
2.7 (2.0-3.5) 
3.0 (2.2-3.0) 
2.7 (2.1-3.7) [11-18yrs]† 
 
 
0 (0) 
 
 
1.42 
 
 
19 (8)  
Niacin (mg) 11-14 yrs 
15-18 yrs 
8.0 
9.0 
15 
18 
41.7 (33.9-44.2) 
66.1 (59.7-66.1) 
43.6 (38.6-62.9) [11-18yrs]† 
 
 
0 (0) 
 
 
35.4 
 
 
0 (0) 
Vitamin B12 
(µg) 
11-14 yrs 
15-18 yrs 
0.8 
1.0 
1.2 
1.5  
6.0 (5.9-9.7) 
7.6 (5.9-7.6) 
6.0 (5.9-9.7) [11-18yrs]† 
 
 
0 (0) 
 
 
4.0 
 
 
5 (2) 
Vitamin D 
(µg) 
 - - 2.5 (1.2-3.8) - 2.1 - 
FOOD AND SUPPLEMENT SOURCES     
 
Calcium (mg) 
 
11-18 yrs 
 
480 
 
1000 
 
1477 (930-1678)† 
 
0 (0) 
 
804 
 
8 (3) 
Iron (mg) 11-18 yrs 6.1 11.3 15.5 (12.2-22.1)†* 0 (0) 10.5 5 (2) 
Folate (µg) 11-18 yrs 100 200 332 (269-419)†* 0 (0) 217 2 (1) 
Thiamin (mg) 11-14 yrs 
15-18 yrs 
0.5  
0.6 
0.9  
1.1 
1.9 (1.3-2.2) 
2.9 (2.0-2.9) 
2.0 (1.6-2.6) 
 
 
0 (0) 
 
 
1.55 
 
 
0 (0) 
Riboflavin (mg) 11-14 yrs 
15-18 yrs 
0.8 
0.8 
1.2 
1.3 
2.7 (2.0-3.5) 
3.0 (2.2-3.0) 
2.7 (2.1-3.7) [11-18yrs]† 
 
 
0 (0) 
 
 
1.42 
 
 
8 (3) 
Niacin (mg) 11-14 yrs 
15-18 yrs 
8.0 
9.0 
15 
18 
41.7 (33.9-44.2) 
66.1 (59.7-66.1) 
43.6 (38.6-62.9) [11-18yrs]† 
 
 
0 (0) 
 
 
35.9 
 
 
0 (0) 
Vitamin B12 
(µg) 
11-14 yrs 
15-18 yrs 
0.8 
1.0 
1.2 
1.5  
6.0 (5.9-9.7) 
7.6 (5.9-7.6) 
6.0 (5.9-9.7) [11-18yrs]† 
 
 
0 (0) 
 
 
4.0 
 
 
2 (1) 
Vitamin D (µg)  - - 2.9 (1.9-6.1) - 2.2 - 
NDNS, National Diet and Nutrition Survey; CD, coeliac disease; IQR, interquartile range 
*p<0.05, dietary intakes significantly different to RNI values; †p<0.05, dietary intakes significantly different 
compared to NDNS data (one-sample Wilcoxon test) 
-Vitamin D does not have an established LRNI 
a
DoH (1991); 
b
Bates et al. (2012); 
c
NDNS interquartile range data is unavailable 
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5.3.3 Factors associated with adherence to the gluten-free diet 
5.3.3.1 Biagi adherence questionnaire 
All 39 teenagers completed the Biagi adherence questionnaire. Twenty-three of the 
teenagers (59%; 16 girls, 7 boys) were categorised as adherent to the GFD (scoring 
between three and four in the Biagi questionnaire). Sixteen participants (41%; 16 
girls) scored less than three and were classified as non-adherent. The distribution of 
scores relating to adherence levels; split by gender, is shown in figure 13.  
 
Figure 13 Distribution of reported adherence to the gluten-free diet (GFD) in girls 
and boys with coeliac disease measured using the Biagi adherence questionnaire 
Scoring: 0- non-adherent, I- following the GFD with major errors, II- following the GFD with a few 
errors, III- following the GFD with minor errors, IV- strictly adherent 
Non-adherent = Biagi score between 0 and II, Adherent = Biagi score between III and IV 
 
Of the non-adherent teenagers, 11 (68.8%) stated that they consumed gluten 
intentionally 4-10 times a year or more regularly and 12 (75%) stated that they 
consumed gluten unintentionally 4-10 times per year or more (10/12 of these cases 
also consumed gluten intentionally). The remaining three adolescents stated that they 
both intentionally and unintentionally consumed gluten <4 times per year.  
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5.3.3.2 Revised Global Coeliac Assessment Scale (r-GCAS) 
All participants completed the r-GCAS. Findings for each binary demographic 
subscale are presented in Table 27. Both being male and being a member of a coeliac 
disease support group were significantly positively associated with adherence to the 
GFD (p<0.01). Other binary demographic variables including race, level of 
education, symptom presentation, obtaining GF products on prescription and having 
additional food intolerances/allergies or other medical conditions were not correlated 
with GFD adherence. Median (IQR) age of adherent participants was 13.0 (12.0-
13.8) years, compared to 14.6 (12.9-15.3) years for non-adherent adolescents (ns). 
Additionally, the median (IQR) length of time adherent participants had been 
diagnosed for (6.0 [3.7-8.1] years) was longer compared to non-adherent teenagers 
(4.0 [1.8-10.9] years), although neither age nor length of diagnosis was associated 
with adherence (r=0.21; p=0.190 and r=-0.18; p=0.273, respectively; Spearman’s 
rank test).   
A greater proportion of non-adherent teenagers purchased their own lunch on the 
majority of weekdays (6/16, 37.5%) compared to adherent teenagers (3/26, 11.5%; 
p=0.01; Fisher’s exact test). Similarly, significantly more non-adherent teenagers 
purchased snacks themselves during the week (7/16, 43.8%) and at weekends (9/16, 
56.3%) in comparison to adherent participants (2/26, 7.7% and 5/26 19.2%, 
respectively; p<0.01 and p=0.04, respectively; Fisher’s exact test).   
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Table 27 Association between dichotomous demographic variables and adherence to 
the gluten-free diet  
Demographic factors N adherent* to the 
GFD (%) 
P-value 
Gender:  
             Male 
             Female 
 
7/7 (100) 
16/32 (50.0) 
 
0.03
a 
Race: 
             White 
             Other 
 
23/38 (60.0) 
0/1 (0.0) 
 
0.41 
Education: 
             Primary 
             Secondary or above 
 
6/8 (75.0) 
17/31 (54.8) 
 
0.43 
Oslo classical CD 
Non-classical CD 
19/28 (67.9) 
4/11 (36.4) 
0.15 
Support group membership 
No support group membership 
17/23 (73.9) 
6/16 (37.5) 
0.02
b 
Presence of other food intolerance/allergy
c 
Absence of other food intolerance/allergy
c 
3/5 (60.0) 
20/34 (58.8) 
1.00 
Additional medical problem
d 
No additional medical problem
d 
3/6 (50.0) 
20/33 (60.6) 
0.67 
Obtains prescription items 
Does not obtain prescription items 
21/33 (63.6) 
2/6 (33.3) 
0.21 
* Non-adherent = Biagi score between 0 and II, Adherent = Biagi score between III and IV 
ap<0.05; Fisher’s exact test 
bp<0.05; Pearson chi-square test 
cMainly lactose intolerance 
dMainly asthma, type 1 diabetes mellitus and eczema  
Responses for a number of questions associated with following a GFD in the r-
GCAS were significantly associated with adherence (Table 28). There was a strong 
positive association between adherence to the GFD and the teenager’s ability to 
follow the diet at home (p<0.01, Table 28). Adherence was also strongly positively 
associated with the teenager’s ability to follow a GFD on holiday abroad and in the 
UK (p<0.01 and p<0.0001, respectively, Table 28). However, avoidance of holidays 
abroad and within the UK was not related to GFD adherence (r=0.29, p=0.07 and 
r=0.15, p=0.36). The adolescent’s ability to follow a GFD on long train and car 
journeys was moderately positively correlated with GFD adherence (p<0.05, Table 
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28). Only thirteen (33.3%) of the participants strongly agreed that they were able to 
follow a strict GFD when at airports and flying, however this factor was not 
associated with overall adherence rating (r=-0.187, p=0.25).  
Table 28 Factors associated with GFD adherence* (n=39) 
Factor  Correlation 
coefficient (r) 
p-value
a 
Ability to follow GFD at home 0.45 0.004 
Ability to follow GFD on holiday abroad 0.48 0.005 
Ability to follow GFD on holiday in the UK 0.56 <0.0001 
Ability to follow GFD on a long car or train journey 0.34 0.034 
Ability to follow GFD at social events/parties/dating 0.45 0.005 
Ability to follow GFD at special events e.g. weddings 
and birthdays 
0.38 0.018 
Never checking food labels to see whether a product 
is GF 
-0.59 <0.0001 
Inclined to eat gluten-containing foods when GF 
options are unavailable  
-0.60 <0.0001 
Belief that Coeliac UK support groups had been 
helpful in learning about CD and the GFD 
0.44 0.010 
Belief that avoiding gluten is important because of 
feelings of guilt 
-0.36 0.038 
GFD = gluten-free diet, CD = coeliac disease, GF = gluten-free 
*GFD adherence based on Biagi scores ranging from 0 to 4 
ap<0.05; Spearman’s rank test 
 
Two teenagers categorised as ‘strictly adherent’ commented that they would rather 
go without food than risk eating food that contained gluten when dining out: 
“I won't eat if there is no gluten-free food. So when I eat out places I often go 
hungry.”  
“In restaurants/cafes where I am not guaranteed gluten-free foods I choose 
not to eat at all. It's the same whilst abroad. I never swerve from my diet.” 
Non-adherent teenagers, on the other hand, noted the difficulties surrounding the 
poor availability of GF foods. One girl mentioned,  
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“There are hardly any cafes like Costa and Pret that have GF products.” 
Whilst another girl remarked about the lack of food choice at her school, stating: 
“My school doesn't have any foods that are gluten-free, except for some 
packets of crisps.”  
Twenty-one adolescents (53.9%) agreed that they avoided eating foods from cafes 
and coffee shops in order to maintain a GFD, and twenty (46.1%) avoided eating at 
restaurants or buying food from takeaways. However, avoidance of cafes and coffee 
shops or restaurants and takeaways were not correlated with adherence to the GFD 
(r=-0.71, p=0.67 and r=-0.83, p=0.62, respectively). There was a strong negative 
linear association (r=-0.60) between GFD adherence and being inclined to eat gluten-
containing foods when GF options are unavailable (p<0.0001, Table 28). A 
suggestion was made by one non-adherent boy to design a “Coeliac app” for mobile 
phones which would allow you to view a map of all the venues serving GF options in 
the surrounding area. 
Twenty-one  teenagers (51.3%) either “strongly agreed” or “somewhat agreed” to 
being able to follow a GFD at social events, parties and dating, whilst six (15.4%) 
participants avoided such occasions. Four (10.3%) participants disagreed that they 
would be able to follow a GFD at special events such as weddings and birthdays. 
One strictly adherent teenager commented that a parent prepared her food for social 
events beforehand: 
“Quite often my Mum will give me a packed lunch for parties.” 
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 Yet another child reported being purposefully uninvited to an event due to 
discriminative behaviour: 
“Some people don't understand why I need to follow a gluten-free diet, so I 
sometimes get left out. For example, one child's mother said I wasn't allowed 
to come to her child's birthday party because I was gluten-free.” 
The ability to follow a GFD at social events and at special occasions was both 
significantly related to better GFD adherence (p<0.01 and p<0.05, respectively). 
Thirty-one out of 39 patients (79.5%) strongly agreed that they would always inspect 
food labels to see whether a product is GF, and there was a strong inverse 
relationship (r=-0.59) between never checking labels on packaged food and 
adherence to the GFD (p<0.0001, Table 28). One non-adherent girl commented on 
her confusions regarding the statements on packaged food: 
“Sometimes I find it [labelling] hard…I’m not sure if 'may contain gluten' or 
'made in a factory handling gluten' means it’s acceptable (to eat) or not.” 
However, adherent adolescents still reported inadequacies with packaging: 
“It's really hard to know what products are gluten-free when they don't say 
anything. But they always say things about dairy, nuts etc. Which I think is 
really unfair.”   
Eight (22.2%) teenagers agreed that they always used the coeliac UK food and drinks 
directory when purchasing food themselves, and nine (29.7%) agreed that a parent or 
carer would use the directory, although these factors were not related to overall 
adherence (r=0.01, p=0.97 and r=0.12, p=0.47, respectively). 
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There was a positive correlation between GFD adherence and belief that Coeliac UK 
support groups had been helpful in learning about CD and the GFD (p<0.05, Table 
28). Only seven (21.9%) of the teenagers agreed that GPs had been helpful in their 
learning about CD and the GFD, whereas thirty-one (81.6%), and thirty-three 
(84.6%) of the participants considered gastroenterologists and dietitians, 
respectively, to have been valuable sources of education. There was not an 
association, however, with GFD adherence and belief that any particular health 
professional had been helpful in learning about CD and the GFD. Furthermore, there 
was no association between GFD adherence and frequency of clinical appointments 
with a gastroenterologist, dietitian or GP. 
In relation to questions regarding support from others, two of the patients who did 
not follow a strict GFD diet claimed to have sufficient knowledge of the diet 
themselves. There was a sense of defensiveness towards additional help from others 
and a nonchalant attitude toward occasional gluten exposure: 
“I find following the diet easy as I've been doing it for 11 years so I don't 
really need support.” 
“In everyday life eating wheat isn't usually a problem. I know most things 
that contain wheat. I occasionally eat wheat, but not too much.” 
 All but one teenager agreed that avoiding gluten-containing foods was important for 
their health and thirty-two (84.2%) participants agreed that a concern surrounding the 
long-term complications of CD is an important stimulus for avoiding gluten. One 
adherent girl expanded on this motivation: 
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“I want to be able to have babies when I am older, and I do not want to die 
early; that is why I follow the gluten-free diet.” 
Fifteen (45.5%) participants avoided gluten-containing foods due to feelings of guilt, 
and eighteen teenagers (47.4%) were motivated to follow a GFD because their family 
worried about them. Interestingly, five (14.3%) of the patients inaccurately believed 
that avoiding gluten was important because it will make their CD “disappear”. Of the 
motivations for gluten avoidance addressed in the r-GCAS, a belief that excluding 
gluten is important due to feelings of guilt was the only factor where there was an 
inverse correlation with GFD adherence, although this association was not strong 
(p<0.05, Table 28). 
5.3.3.3 Knowledge quiz  
There was not a significant difference between adherent and non-adherent teenagers 
median (IQR) scores in the knowledge quiz (12.5 [11.8-15.3] and 16.0 [11.8-17.0], 
respectively, p=0.11). Additionally, there was not a significant association between 
GFD adherence and scores on the knowledge quiz (r=0.12, p=0.47). With regards to 
answers to specific questions, eleven of the 16 (68.8%) non-adherent participants 
thought that semolina was GF and nine of 16 (56.3%) non-adherent teenagers 
thought pearl barley was GF. Eleven of the 16 (68.8%) participants thought that malt 
vinegar was not suitable to include in a GFD. Furthermore, eight (50.0%) adolescents 
who were classified as non-adherent did not think untreated CD increased risk of 
reproductive problems.   
Similar to non-adherent patients, over fifty per cent of the 23 adherent participants 
(17/23, 53.1%) incorrectly thought that semolina was GF and 17 (53.1%) thought 
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that buckwheat and malt vinegar contain gluten. A similar proportion non-adherent 
and adherent teenagers a thought that ‘wheat-free’ was the same as ‘gluten-free’ 
(4/23, 12.5% and 5/16, 31.3%, respectively; p=0.46, Fisher’s exact test). 
5.3.4 Generic health related quality of life 
Thirty-eight participants completed the KIDSCREEN-52 questionnaire (97.4% 
response rate). Sixteen of the respondents were non-adherent to the GFD (14 F, 2 M) 
and 22 were adherent (15 F, 7M). The Shapiro-Wilk test for normality identified that 
within four of the ten KIDSCREEN-52 dimensions both adherent and non-adherent 
data were not normally distributed (Autonomy, Parents, Relations and Home Life, 
Financial Resources and Social Acceptance [Bullying]). Furthermore, non-adherent 
data was not normally distributed for the Social Support and Peers domain, whilst 
adherent data was not normally distributed for the School Environment domain 
(Shapiro-Wilk test). Thus all data were analysed using non-parametric statistics and 
are presented as medians and IQR.  
Adherent teenagers with CD had significantly higher HRQoL scores in the Moods 
and Emotions, Parents, Relations and Home Life and School Environment domains 
compared to the standard UK population (p<0.05, r>0.5; Table 29). Although 
adherent adolescents additionally had higher scores for the Physical Well-being, 
Psychological Well-being, Self Perception, Social Support and Peers, Autonomy and 
Social Acceptance (Bullying) dimensions, these did not reach statistical significance 
(all p>0.05, Table 29). Median Financial Resources scores were not significantly 
different for both adherent teenagers with CD and healthy controls (Table 29). 
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Non-adherent participants were observed to have lower HRQoL values compared to 
teenage controls in five out of ten domains; namely Physical Well-being, 
Psychological Well-being, Moods and Emotions, Autonomy and Social Support and 
Peers, however the difference was only significant between groups in the Physical 
Well-being and Self Perception domains (p<0.05, r>0.50; Table 29). 
Compared to adolescents who were non-adherent to the GFD, adherent teenagers 
were found to have higher HRQoL scores in all dimensions of the KIDSCREEN-52, 
excluding the Financial Resources domain, for which there were no significant 
differences (Table 29). However, the differences were only statistically significant 
for the dimensions Physical Well-being, Moods and Emotions and Self Perception 
(all p<0.05, Table 29). 
A greater proportion of non-adherent teenagers (6/16 [38%]) had low Self Perception 
scores compared to adherent teenagers (1/22 [5%] p<0.05; Table 30). For all other 
domains the proportion of each group with scores below the normal range was 
similar (Table 30). 
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Table 29 Comparison of median (IQR) HRQoL scores (KIDSCREEN-52 dimensions) between adherent (n=22) and non-adherent (n=16) 
CD teenagers with CD (11-18 years) and a standard UK population (12-18 years) (The KIDSCREEN Group 2010) 
 
Kidscreen-52 Domain Adherent teenagers Non-adherent teenagers Standard UK population P-value
a 
P-value
b 
P-value
c 
 n Median IQR n Median IQR n Median IQR    
Physical Well-being 22 52.4 47.1-60.6 16 45.9 41.5-49.6 930 49.9 44.7-56.2 0.18  0.04* 0.02* 
Psychological Well-being 22 51.8 45.1-57.6 16 45.1 40.7-53.2 930 49.6 43.6-55.1 0.34 0.15 0.08 
Moods and Emotions 22 54.0 48.6-57.4 16 45.4 42.9-51.5 921 47.1 42.0-52.1 0.004* 0.76 0.01* 
Self Perception 22 55.4 47.8-69.8 16 43.2 39.5-50.7 931 51.7 46.0-59.7 0.20 0.004* 0.002* 
Social Support and Peers 22 54.9 47.5-64.9 16 47.5 44.0-54.9 911 48.4 43.0-55.2 0.88 0.88 0.27 
Autonomy 22 48.7 46.4-53.2 16 46.0 43.6-50.8 933 47.2 41.9-53.2 0.11 0.96 0.16 
Parents, Relations and 
Home Life 
22 58.5 47.5-65.9 16 48.4 43.0-55.2 900 47.4 40.5-54.6 0.002* 0.57 0.11 
Financial Resources 22 49.3 49.3-62.9 16 49.3 49.6-62.9 910 49.3 43.5-61.8 0.18 0.38 0.10 
School Environment 22 56.4 45.7-73.8 16 50.4 41.2-58.9 894 46.7 40.9-52.1 0.003* 0.18 0.55 
Social Acceptance 
(Bullying) 
22 53.5 37.6-58.8 16 48.1 39.3-58.9 952 48.1 38.3-58.9 0.78 0.79 0.80 
HRQoL = Health related quality of life. IQR = Interquartile range 
a
Between scores of adherent teenagers and standard UK population (One-sample Wilcoxon signed-rank test) 
b 
Between scores of non-adherent teenagers and a standard UK population (One-sample Wilcoxon signed-rank test) 
c
Between scores of adherent and non-adherent participants (Mann-Whitney U Test) 
*P<0.05 
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Table 30 Proportion of adherent (n=22) and non-adherent (n=16) CD teenagers with 
low HRQoL scores (KIDSCREEN-52 dimensions) 
 Adherent Non-adherent  
Kidscreen-52 Domain N N (%) with low 
values
a 
N % with low 
values
a 
Significance  
(Chi-Square) 
Physical Well-Being 22 3 (14) 16 4 (25) 0.372 
Psychological Well-Being 22 3 (14) 16 4 (25) 0.372 
Moods and Emotions 22 2 (9) 16 2 (13) 0.735 
Self Perception 22 1 (5) 16 6 (38) 0.010* 
Autonomy 22 3 (14) 16 5 (31) 0.243 
Parent Relation and Home 
Life 
22 3 (14) 16 3 (19) 0.682 
Social Support and Peers 22 4 (18) 16 4 (25) 0.698 
Financial Resources 22 4 (18) 16 3 (19) 1.000 
School Environment 22 2 (9) 16 4 (25) 0.217 
Bullying 22 6 (27) 16 4 (25) 1.000 
HRQoL = Health related quality of life 
a
Low values are defined as scores below the normal threshold (mean of the general UK population -
0.5*SD) (The KIDSCREEN Group 2010) 
*p<0.05, Chi square test. Scores of adherent teenagers are significantly different from non-adherent 
teenagers 
 
5.3.5 Disease specific health-related quality of life 
The same thirty-eight patients, as mentioned in section 5.3.3, additionally completed 
the CDDUX tool, which assesses disease specific HRQoL. For the three subscales 
‘Communication’, ‘Having CD’ and ‘Diet’, there was no difference in median scores 
between adherent and non-adherent teenagers (all p>0.05; figure 14). Furthermore, 
median (IQR) overall scores for the CDDUX instrument (68 [58-78] and 68 [63-77], 
adherent and non-adherent participants, respectively) were not significantly different 
between groups (p=0.67).  
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Figure 14 Health related quality of life of adherent (n=22) and non-adherent (n=16) 
adolescents (11-18 years) with coeliac disease (CD) as assessed by the CD-specific 
CDDUX questionnaire. Box and whisker plot showing median, IQR and range. The 
questionnaire is divided into three subscales: ‘Communication’ (3 items), ‘Having CD’ (3 items) and 
‘Diet’ (6 items). Higher scores denote better HRQoL. ns = median scores of adherent and non-
adherent participants not significantly different; Mann-Whitney U test. 
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Chapter 6: Discussion  
This PhD research comprises three studies to look at current and retrospective 
epidemiological trends in paediatric CD in Scotland and the management of newly 
diagnosed children, but also dietary practices, adherence to the GFD and HRQoL in 
adolescents with CD. 
6.1 Study 1: The incidence and management of childhood coeliac disease 
in Scotland- the Scottish Paediatric Surveillance Unit (SPSU) coeliac 
project 
This first pan-Scottish study captured 91 new cases of paediatric CD between 
01/09/2009 and 31/08/2010 utilising an effective capture-recapture prospective 
surveillance method. Accurate age-sex standardisation of incidence rates allowed us 
to compare national figures with separate countrywide studies and to make regional 
comparisons with regards to incidence. To our knowledge, this is the first study that 
has controlled for cases diagnosed due to a lower threshold to test i.e. actively 
screened cases or those with non-classical presentations. The findings suggest that 
the incidence of childhood CD in Scotland differs from other European countries 
(Dydensborg et al. 2012; Olsson et al. 2008b). Furthermore, and most interestingly, 
there is evidence of regional variation in the incidence of paediatric CD within 
Scotland - clinicians in the East diagnosed approximately double the number of cases 
per head of population compared to clinicians in the West and North over the year. 
Since the age-sex adjusted incidence rate of cases diagnosed through targeted 
screening was over twice as high in the East and more CD serological tests were 
requested in the region it is likely that CD education in primary and secondary care 
  
242 
(leading to better awareness of conditions associated with CD in practice) played a 
role in the higher rate observed. However, approximately twice as many cases were 
also detected on the basis of a classical presentation in the East; indicative of a true 
geographical difference in CD. 
6.1.1 The incidence of paediatric CD in Scotland 
The study demonstrates a childhood (<16 years) age-sex standardised incidence of 
10.0/100,000/year, as determined by prospective data collection between 01/09/2009 
and 31/08/2010. Although separate regional and single-centre studies have collected 
data on the number of newly diagnosed cases over a similar time frame, these reports 
present crude figures only, and thus cannot be compared with the national Scottish 
incidence data (Balamtekin et al. 2010; Bhattacharya et al. 2009; Saadah 2011). 
Furthermore, the Scottish incidence rate cannot be compared to The Netherlands 
national data, as studies calculated incidence per 1000 live births (George et al. 
1997a; Steens et al. 2005). However, a much higher national childhood (<16yrs) 
incidence of 44/100,000/year was reported in Sweden in 2003, utilising a similar 
active prospective surveillance method to that employed in the current study (Olsson 
et al. 2008b). Since epidemiological research conducted in Sweden in the 1990s 
suggested an epidemic pattern of CD was occurring in children less than two years of 
age (Olsson et al. 2008b) clinician awareness of CD throughout Sweden is likely to 
be high. Thus, the higher rate reported may be attributed to a lower threshold to test.  
Population screening, however, has revealed that the estimated prevalence of CD is 
also higher in Swedish children compared to children born in the UK (1:34 vs. 1:100, 
respectively) (Bingley et al. 2004; Mylus et al. 2009). Furthermore, the UK 
prevalence may be overestimated since a biopsy was not performed to confirm 
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diagnosis in the screening study conducted.  Reasons for such large variation in case 
ascertainment between Scotland and Sweden may therefore lie in genetic, 
environmental or lifestyle differences as well as thresholds to test. 
Dydensborg et al. (2012) observed a lower national incidence of paediatric CD (<18 
years) in Denmark (6.9/100,000/year) for the year 2009. The reported case 
ascertainment may be lower than that observed in the current study due to 
inaccuracies in the retrospective data collection methods utilised in the Danish study. 
The date of diagnosis was taken as the date each new case was registered with the 
DNPR, although authors observed a considerable delay in the registration of newly 
diagnosed patients, implying that as many as one out of three cases diagnosed in 
2009 may not have been registered until 2010 (Dydensborg et al. 2012). Thus, the 
incidence in Denmark may be higher than reported.  
Interestingly, children in Sweden are reported to have a very low level of 
deprivation. Research commissioned by UNICEF compared twenty-one developed 
countries, including the UK and Sweden, in relation to well-being indicators 
(countries were ranked from 1 [very high well-being] to 21 [very low well-being] for 
each indicator) (UNICEF 2007). Sweden was identified as having the highest well-
being in terms of income, health and overall deprivation whereas the UK scored 
fourth from the bottom on ‘material well-being’ and was ranked 12th on ‘health and 
safety’. Superior socio-economic position has previously been associated with a 
higher risk for CD (Kondrashova et al. 2008; Wingren et al. 2012). A lower infection 
rate in less deprived populations such as Sweden could play a role in the higher 
incidence and prevalence of CD, since the ‘hygiene hypothesis’ proposes that lack of 
early childhood exposure to infections or certain micro-organisms such as 
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mycobacteria may repress the development of the immune system and give rise to 
autoimmune disease (Rautava et al. 2004). The underlying mechanisms relating to 
this are poorly understood, however it is thought that T-helper cells (Th1/Th2 cells) 
and associated cytokines are responsible (Rautava et al. 2004). Conversely, a large 
Swedish study (data obtained on 3,392 infants) reports that neonatal infections may 
increase CD risk (OR 1.52, 95% CI 1.19-1.95) adjusting for multiple maternal 
variables including maternal age, birth weight, maternal smoking habits and parity 
(Plot and Amital 2009), thus contradicting the “hygiene hypothesis”. Infections such 
as campylobacter have been shown to alter the permeability of the intestinal barrier 
and this action has been proposed to initiate the onset of CD in genetically 
predisposed individuals (Keenan and Day 2013). Further research is required to more 
clearly understand the role of microbiota and infections in CD pathogenesis.   
As previously discussed, specific infant feeding practices may influence CD 
development (Section 2.2.2). It has been suggested that practices such as length of 
time breastfed (>90 days), breastfeeding at time of gluten introduction and 
introducing infants to gluten between four and six months of age may be protective 
in relation to acquiring CD (Akobeng et al. 2006; Auricchio et al. 1983; Carlsson et 
al. 2006; Falth-Magnusson et al. 1996; Greco et al. 1988; Ivarsson et al. 2002; Norris 
et al. 2005; Peters et al. 2001; Silano et al. 2008). Statistics on the length of 
breastfeeding in Scotland, Sweden and Denmark are not consistent with findings that 
longer breastfeeding may be protective. Population survey data collected in 2005 
(OECD 2012) found that ~50-60% of infants in Sweden and Denmark were breastfed 
(not exclusively) for at least six months and that a greater percentage of children in 
Sweden (43%) were still breastfed after one year, compared to just 10% of children 
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in Denmark. Despite this there is a considerably higher prevalence of CD in Swedish 
children. Additionally, only 24% of children (n=2110) in Scotland were breastfed 
(not exclusively) for at least six months over the same time-period (Health and Social 
Care Information Centre & IFF Research 2012); again disputing the benefit of longer 
breastfeeding with regards to CD development. Differences between the three 
countries in relation to timing of gluten introduction and breastfeeding at time of 
gluten introduction are not known and will requires further exploration to ascertain 
whether a relationship between such practices and CD incidence exists. 
In addition to early nutrition and infant infections, further environmental factors have 
been proposed to influence CD incidence including mode of delivery at birth. Using 
prospectively recorded data from 1969-2008 a US study found a small increased risk 
for CD in children following elective caesarean delivery (OR 1.16, 95% CI 1.05-
1.28) (Marild et al. 2012), and in Germany retrospective surveillance identified 
similar patterns with higher caesarean rate delivery associated with greater CD risk 
(OR 1.83, 95% CI 1.18-2.85) (Decker et al. 2011). It is thought that microbial 
exposures in the birth canal could play a significant role in initial bowel colonisation 
and lack of exposure, such as in the case of an infant delivered via caesarean section, 
may impact immune response and mucosal barrier function, thus increasing CD risk 
(Marild et al. 2012). In spite of these findings, caesarean rates in Scotland, Sweden 
and Denmark were relatively comparable between 2006 and 2010 at 25%, 17% and 
21%, respectively (Gibbons et al. 2010; Information Services 2011). Therefore, it is 
unlikely that mode of delivery at birth was a major influence in the differences in 
incidence observed between the three countries. 
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The incidence of childhood CD in Scotland was lower compared to reports from 
Sweden and higher in comparison to Denmark. It is uncertain whether this variation 
lies in genetic or environmental differences between countries or thresholds to test. 
We recommend that in future research authors define incident cases according to the 
strict ‘Oslo’ criteria (Ludvigsson et al. 2012) to ensure a standard comparison of case 
detection across countries/studies. Country comparisons in relation to environmental 
factors that may be associated with CD risk such as childhood infections, timing of 
gluten introduction and mode of delivery at birth should be studied in more detail. If 
significant disparities are observed between countries with varying incidence rates, 
these findings may be used to develop primary CD prevention strategies.  
6.1.2 Clinical presentation and primary reasons for diagnosis  
The majority of children were diagnosed endoscopically in a paediatric setting as per 
1990 ESPGHAN guidance (Walker-Smith et al. 1990). The most frequent symptoms 
reported in the current study were predominantly gastro-intestinal (abdominal pain 
[n=54], diarrhoea [n=27], FTT [n=29] and bloating [n=19]), although nearly a third 
of children experienced fatigue. These findings are similar to that reported in a recent 
single-centre cohort study, examining 42 newly diagnosed children (<16 years) in 
South Wales (Hurley et al. 2012) and are consistent with the current NICE and 
BSPGHAN guidance on symptoms associated with CD (Coeliac Working Group of 
BSPGHAN 2005; NICE 2009). 
In terms of the children’s primary reason for diagnosis, nearly half (41/91, 45.1%) 
were diagnosed because of a low threshold test for CD i.e. were actively screened 
(22/91, 23.1%) or presented with non-classical symptoms (19/91, 20.9%), whereas 
54.9% (50/91) were diagnosed on the basis of classic symptoms. These results 
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indicate vast improvements in the awareness of CD’s varied presentation and 
associated conditions since early UK reports, where virtually all paediatric cases 
presented classically (Kelly et al. 1989; Logan et al. 1986). Our results are similar to 
those of the Welsh study of 1999-2004, where 26% (13/50) of cases (0-16 years) 
were diagnosed through targeted screening (Ravikumara et al. 2006) and a 
retrospective case series of children (<16 years) diagnosed in Athens, Greece, in 
which 36.2% of CD cases diagnosed between 1997 and 2007 presented atypically 
(with non-classical symptoms/or were actively screened) (Roma et al. 2010). 
However, it should be mentioned that in contrast to the current study, Roma et al. 
defined ‘non-classical’ cases as those children presenting with abdominal pain, short 
stature, constipation, vomiting, anaemia, or a combination of these symptoms. 
Additionally, McGowan et al. (2009) reported that just 19% (39/199) of the CD cases 
(0-17 years) detected between 2000 and 2006 at their hospital in Southern Alberta, 
USA, presented classically. However, ‘classical’ CD was defined on the basis of 
diarrhoea with FTT or weight loss of >10%, and thus these observations can not 
accurately be compared with the current data as will likely be an underestimate of the 
true incidence. 
Just over 15% of the children in our dataset had concomitant TIDM. Savilahti et al. 
(2010) observed a comparable proportion of children with TIDM (18.8%) in their 
retrospective study of newly diagnosed CD cases in Helsinki, Finland between 2000 
and 2005. However, in Hurley and Colleagues Welsh report, just two of the 42 
children (4.8%) diagnosed between 1996 and 2005 had associated TIDM (Hurley et 
al. 2012). The incidence of TIDM is very similar across different regions of the UK 
(Soltesz et al. 2007), and thus the higher diagnosed percentage of children with co-
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existing TIDM in the current study may partly be attributed the publication of NICE 
guidelines in 2009 which suggest serological testing should be offered to all children 
and adults with T1DM (NICE 2009). However, very few children are included in the 
Welsh report, and thus figures may not be representative of the wider population. In 
contrast, nearly 40% (56/143) of North American children (1-17 years) with CD 
detected at a single-centre in Wisconsin between 1986 and 2003 had concomitant 
TIDM (Telega et al. 2008). Again, the yearly incidence rate of TIDM in the UK and 
North America is relatively comparable: approximately 20.0/100,000 population 
(Soltesz et al. 2007). Authors of the study carried out in Wisconsin stated that 
screening of all children at increased risk for CD was standard clinical practice at 
their centre (Telega et al. 2008). Therefore, it is likely that such robust screening 
practices influenced the diagnosis of so many children with associated TIDM. 
Although NICE clinical guidelines suggest serological testing should be offered to 
individuals with associated conditions and to those with family history of CD in a 
first-degree relative, it is not certain whether this is routine practice in Scotland. 
However, the ethical and economic impact of screening asymptomatic patients 
should be considered and this is discussed in more detail in Section 6.2.1.  
The second most common additional medical condition reported in the SPSU study 
was asthma, affecting 8.8% of all children. However, the prevalence of childhood 
asthma in the general UK population is ~14% (Lenney 2012). As such, the current 
findings do not propose an increased risk of CD in children with asthma, or vice 
versa. 
Although CD is associated with being underweight, and seven of 74 (9.5%) children 
in our study had a low BMI according to joint RCPCH and SACN guidelines (<2
nd
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centile) (SACN and RCPCH 2012) it is of interest that ten children (13.5%) were at 
risk of overweight (BMI 85
th
-94
th
 centile) and four children (5.4%) were at risk of 
obesity (BMI >=95
th
 centile). Three of the children at risk of obesity presented with 
classic symptoms of CD, and the other child was detected on the basis of having 
associated TIDM. Very few papers report overweight or obesity in childhood CD, 
however it has been shown to be a relativity common presentation in adults (Dickey 
and Kearney 2006). It is possible that obesity is being observed in CD patients for a 
number of reasons; the prevalence of obesity in children is rising in general (The 
Scottish Government 2012b) and children are being captured at an older age with 
more subtle, non-classical symptoms (see Section 6.1.4). As such, a lower percentage 
of children at diagnosis have symptoms associated with weight loss such as 
diarrhoea. One American study reported a similar prevalence of obesity (5%) (BMI 
>95
th
 percentile) at time of diagnosis in 142 children (1-17 years) detected at a 
tertiary care centre (Venkatasubramani et al. 2010). However, authors do not state 
how many of the children were overweight. After one year on a GFD four of the 
obese children had a lower BMI z-score and two of the children’s BMI z-scores had 
increased (Venkatasubramani et al. 2010). Nonetheless, the study was under-
powered to detect true differences in BMI after commencing a GFD and weight loss 
could also reflect regular input from a registered dietitian or healthcare team.  
6.1.3 Regional variation in the incidence of paediatric CD in Scotland 
We revealed striking differences in the incidence of paediatric (<16 years) CD 
between Scottish regions. Double the number of cases per head of population were 
diagnosed in the East of Scotland (16.3/100,000/year) compared to the West 
(8.1/100,000/year) and North (7.7/100,000/yr). This may in part be due to under-
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reporting in the North and West; however, an effective capture/recapture technique 
was employed to highlight cases that had not initially been forwarded to the register. 
Importantly, biopsy proven cases in the East in the years either side of the study 
(2008-09, 2010-11) were similar (n=33 and n=40, respectively) (RHSC, Edinburgh. 
2012), demonstrating that the incidence observed in the East was not an anomaly. 
Furthermore, previous retrospective data from the East demonstrated an average 
yearly incidence rate of 6.27/100,000/year between 2000 and 2004 (Gillett et al. 
2009b) compared with 2.38/100,000/year recorded in the West between 2002 and 
2008 (Buchanan et al. 2009), further validating the differences observed in the 
current study. 
Despite variation in the number of CD cases between regions, there was uniformity 
between GI networks with regard to the proportion of under 2-year-olds diagnosed, 
median age at diagnosis and gender ratios. Although epidemiological studies 
conducted in Sweden and The Netherlands have previously reported regional 
variation in the incidence of paediatric CD (George et al. 1997a; Olsson et al. 
2009b), this is the first study that has controlled for cases diagnosed due to a lower 
threshold to test i.e. actively screened cases or those with a non-classical presentation 
of CD. Interestingly, in the current study, the incidence of classical cases and those 
diagnosed on the basis of active screening was over twice as high in the East, 
compared to the West and North. These results indicate that practitioner awareness of 
at-risk groups in the East may play a role in the greater incidence observed, but does 
not fully explain the difference in case ascertainment. A greater incidence of classical 
cases in the East suggests that there may be a true difference in the incidence of CD 
between regions. 
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Between 01/09/2009 and 31/08/2010 it was observed that significantly more 
serological tests for CD (Anti-tTG or Anti-EMA) were carried out in the East 
compared to the North and West per head of population (p<0.0001), although it is 
not certain how many of these tests were due to previously diagnosed children 
undergoing follow-up serology to measure adherence to the GFD. However, test 
requests from primary care will likely have been due to suspicion of new CD cases, 
and in contrast to the West, significantly more tests were requested by GPs in the 
East (p<0.0001) (data on the proportion requested from GPs in the North was 
unavailable). Evidence of more screen-detected cases and more CD serology requests 
from GPs in the East region suggests that CD education of clinicians in primary and 
secondary care may play a significant role in the higher case ascertainment. 
The current study did not aim to determine potential variation in genetic or 
environmental factors between the three geographical areas. In Sweden, genetic 
differences were attributed, in part, to regional disparity in incidence rates. However, 
unlike Sweden, where 16% of the population have foreign origins (Statistics Sweden 
2012), Scotland is genetically very stable; approximately 99% of the Scottish 
population are national descendants (General Register Office for Scotland 2012), and 
thus it is unlikely that heritable variances have affected regional CD incidence rates 
in Scotland.  
Local population statistics on areas of severe deprivation in Scotland may provide at 
least a partial explanation for the disparity in childhood CD incidence rates. The 
health board areas ‘Glasgow and Clyde’ and ‘Ayrshire and Arran’, both situated in 
the West of Scotland are home to around 80% of the most deprived populations in 
the country in terms of health (The Scottish Government 2011). Therefore, it is 
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possible that the “hygiene hypothesis” may be a contributory factor in the 
geographical variation of childhood CD incidence between the East and West of 
Scotland since, as previously discussed, superior socio-economic position has been 
associated with a higher risk for CD (see Section 6.1.1). However, this does not 
explain the disparity in incidence between the East and North of Scotland, given that 
health deprivation levels in these areas are similar (The Scottish Government 2011).  
It is of interest that recent data on births in Scottish hospitals showed that a higher 
proportion of births between 2009 and 2010 in the North and West of Scotland were 
delivered via C-section compared to the East (27.9%, 25.8% and 21.5%, 
respectively) (Information Services 2011), further contesting the unfavourable 
association between CD development and caesarean delivery. Although Scottish 
Government statistics on regional infant feeding practices are limited since they only 
concentrate on the percentage of children who are initially breastfed and those still 
breastfed after 6-8 weeks, these figures do not correspond with the hypothesis that 
longer breastfeeding provides protection. In fact, data collected between 2010 and 
2011 found that a lower proportion of children were breastfed at 6-8 weeks in the 
West (32%), compared to the East (42%) and North (47%) of Scotland (Information 
Services Division Scotland 2012). However, this data gathered is relatively crude and 
data on practices that may be key in this hypothesis such as weaning practices or 
exclusivity of breastfeeding are not available. 
6.1.4 Demographic characteristics 
The male to female gender ratio in the current study was 1:2, in line with studies 
from several populations (Bottaro et al. 1993; Cook et al. 2004; Dydensborg et al. 
2012; Hurley et al. 2012; Ivarsson et al. 2003; Murray et al. 2003; Rawashdeh et al. 
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1996; Roma et al. 2009; Savilahti et al. 2010; Stenhammar et al. 1987; Stone et al. 
2005; Telega et al. 2008). Female predominance is seen in most autoimmune 
conditions (Whitacre 2001), although reasons for such gender differences are not 
clear. During the apparent epidemic of paediatric CD in Sweden, Ivarsson et al. 
(2003) observed a larger rise in the incidence of CD in girls as compared to boys, 
suggesting that girls may be genetically more vulnerable to environmental exposures 
involved in CD development than boys, such as introducing gluten into the diet 
before four months of age. 
Median age at diagnosis (90 months; [IQR 50-129]) and the percentage of under 2-
year-olds diagnosed (7.7%) was in keeping with findings of many recent single-
centre studies from the UK and abroad (Balamtekin et al. 2010; Ravikumara et al. 
2006; Savilahti et al. 2010; Stone et al. 2005). This is in contrast to an earlier report 
of paediatric CD (≤15yrs) in the Lothian region of Scotland, where most children 
diagnosed between 1960-1974 were less than two years of age (~65%, n=79) (Logan 
et al. 1986). Many longitudinal studies have shown a steady rise in age at 
presentation over the last twenty years and with less typical symptoms (Alessio 
2005; Kelly et al. 1989; Magazzu et al. 1994; McGowan et al. 2009; Roma et al. 
2009; Steens et al. 2005; Telega et al. 2008; Westerbeek et al. 2005). Our work 
supports these findings, since a significantly higher number of older children (≥6yrs) 
were diagnosed with non-classical presentations compared to younger children 
(<6yrs) (p<0.05). The current clinical presentation of CD compared to older studies 
may reflect better awareness of non-classical or extra-intestinal presentations in 
recent years. Still, we cannot exclude the possibility that more children are 
developing CD at a later age due to changes in environmental stimuli or gene-
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environment interactions. After the Swedish Government revised its policy on infant 
feeding in 1995 to reduce the risk of CD (i.e. to introduce gluten-containing foods 
gradually at four to six months whilst still being breastfed and to reduce the gluten 
content of milk-cereal drinks) an initial decline in CD incidence was observed 
(Olsson et al. 2008b). Recently, Ivarsson and colleagues (2013) confirmed this 
association since they found that children (n=90,512) born after the change in policy 
consumed significantly less flour from milk and cereal based follow-on formula and 
(p<0.0001) and a higher proportion were breastfed at time of gluten introduction 
(p<0.001) compared to children born prior to the change in policy (n=117,997). 
However, after the initial decline researchers observed that CD was rising again, 
albeit in older children (Olsson et al. 2008b). These findings suggest that infant 
feeding practices may just delay CD onset due to milder symptoms, rather than 
prevent CD. 
The major limitation of the SPSU study is the short time frame of data capture. As 
such, it is possible that the regional disparity in CD incidence observed is simply an 
anomaly. Due to lack of funding it was not feasible to collect incidence data over two 
years as originally proposed. However, as previously discussed (see Section 6.1.3), 
incidence was similar in the East region for the years either side of the study, and 
findings from previous single-centre reports also infer that paediatric CD incidence 
rates are lower in the West compared to the East of Scotland (Gillett et al. 2009b; 
Buchanan et al. 2009). Nonetheless, continuation of national prospective data 
collection is necessary to confirm our initial conclusions.    
In summary, this study is the first in the UK to observe a ‘real-world’ paediatric CD 
incidence on a national scale. There has been a rise in case-ascertainment compared 
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to earlier studies, an older age at presentation and an increase in targeted screening. 
Although uniformity between regional networks was seen in relation to age and 
gender ratios of newly diagnosed children, there was a stark difference in incidence. 
Evidence of more screen-detected cases and more serology requested from GPs in 
the East region suggests that CD education in primary and secondary care may have 
played a role. However, an environmental influence cannot be excluded since more 
classical cases of CD were also diagnosed in the region. The findings of twice as 
many cases per head of population in the East region may have a negative impact on 
patients in terms of their ability to adhere to the GFD and HRQoL if secondary care 
healthcare practitioners have high caseloads and limited time to follow-up each 
patient. Thus, extra funds to support this higher caseload will need to be accounted 
for or more creative ways to manage and support patients developed such as group 
sessions with families or teenagers, perhaps with the presence of support groups. 
6.1.5 Dietetic practice 
Although the SPSU study did not continue for a second year as originally proposed, 
data on the dietetic management of paediatric CD cases diagnosed in SE Scotland 
between 10/09/2010 and 31/08/2011 were collected. As such, the dietetic data was 
not aligned with clinical data and this limits the interpretations that can be made. It is 
not clear from pro-formas whether the children seen by a dietitian after endoscopy 
rather than on the day of endoscopy were given any advice from a healthcare 
professional regarding the GFD prior to their first appointment. However, anecdotal 
evidence from clinicians at RHSC, Edinburgh (where all endoscopies in the region 
are conducted) suggests that children followed-up in district general hospitals rather 
than the regional centre are unlikely to have received any advice or support from a 
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dietitian prior to their first formal dietetic appointment. Additionally, it is not known 
if the children seen in the district general hospital were also seen separately by a 
paediatrician on the day of their dietetic appointment.  
Thirty-seven pro-formas were completed in total. A dietitian first saw the majority of 
cases in the regional clinic (25/37, 68%); all remaining patients were managed in the 
district general clinic (12/37, 32%). There was not a significant difference in the 
median age or gender ratio of children treated at the regional clinic or those seen in 
the district general clinic. Most treatment recommendations, including BSG 
guidelines (BSG 2002) and the newly published Coeliac UK and BSPGHAN 
guidelines on the management of children with CD state that a healthcare team 
approach such as in the case of the regional clinic; involving a gastroenterologist and 
dietitian, is necessary for the management of CD patients (Coeliac Working Group of 
BSPGHAN and Coeliac UK 2013). This is due to the different areas of expertise 
each HCP can provide. A dietitian is the most qualified HCP to assess nutritional 
status, nutritional intake and provide education and advice regarding the GFD (Case 
2005; Sanders et al. 2005; Stuckey et al. 2009), whereas a gastroenterologist is best 
placed to assess each patient’s clinical state, evaluate any persisting symptoms, 
assess for long-term complications and advise about genetic risks (Stuckey et al. 
2009). Nonetheless, there is little evidence to support the effectiveness or advantage 
of either a multi-disciplinary team approach or dietetic-led approach (such as in the 
case of the district general clinic) on health outcomes such as adherence to the GFD, 
nutritional status or HRQoL. Neither the type of clinic nor the teenagers feelings 
regarding support from different HCPs were associated with adherence to the GFD in 
the cross-sectional study (Section 5.3.3.2), although this may be due to the study 
  
257 
being under-powered to detect significant associations. Nonetheless, a similar high 
proportion of adolescents found both a gastroenterologist (81.6%) and dietitian 
(84.6%) to have been helpful in their learning about CD and the GFD, supporting the 
input from both professionals. A study of adult patients (n=99) with CD in the UK 
found that after one years follow-up in a dietetic-led clinic the number of participants 
adherent to the GFD (as assessed by a qualified dietitian) increased from 54 to 65 
(p=0.037) and the number of patients achieving recommended calcium intakes 
significantly increased from 47 to 77 (p<0.0001) (Wylie et al. 2005). All patients in 
the study agreed that the clinic worked well, however authors do not elaborate on the 
protocols of the clinic and there were potentially differences in advice depending on 
the patient’s age, additional comorbidities or time since diagnosis. Furthermore, the 
results may not be applicable to children.   
Nearly all of the children treated at the regional clinic (n=22, 88%) were first seen by 
a dietitian on the day of their upper GI endoscopy (UGIE) and were advised to start a 
GFD, whereas all children treated at the district general clinic received their initial 
appointment with a dietitian after the date of endoscopy (p<0.0001). This is likely to 
be attributed to the fact that the district clinic does not take place at the hospital 
where UGIE is performed. The NIH consensus panel on CD advise that consultation 
with a dietitian is essential at both time of diagnosis and at follow-up (Thompson 
2005) and the Coeliac Working Group of BSPGHAN and Coeliac UK (2013) advise 
a child should been seen by a paediatric dietitian within 1-2 weeks of diagnosis. It 
has been suggested that a delay in referral could lead to unnecessary confusion and 
frustration attributed to the patient or their family acquiring inaccurate information 
from outside sources (Case 2005). Median (IQR) time to follow-up in the district 
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general clinic was 37 (20-68) days, therefore some children and their families did not 
meet with a dietitian for over two months after endoscopy. However, this may have 
been influenced by the length of time taken to histologically confirm the biopsies as 
CD by regional pathologists. Other potential reasons for a delay in the initial dietetic 
appointment could be due to patient non-attendance or understaffing at the district 
general hospital. Such children may have nutritional deficiencies that require rapid 
correction such as IDA and could experience a reduced HRQoL if they do not 
commence the diet immediately. Furthermore, if symptoms and histological damage 
do not resolve initially this may potentially increase risk of future complications such 
as osteoporosis or fertility difficulties.  
A paediatric GI specialist (PGIS) dietitian saw all but one patient at the regional 
clinic (n=24, 96%), whereas 10 cases (83.3%) treated at the district general clinic 
were seen by a general paediatric dietitian (p<0.0001). Sanders and colleagues 
(2005) recommend that a dedicated coeliac specialist dietitian should be based in 
every hospital to provide empowerment, empathy and rigorous dietary advice. These 
suggestions were based on the evidence that many difficulties and issues are 
experienced by patients when following a GFD, and chefs and the general public 
have poor knowledge of CD and the GFD (Sanders et al. 2005; Sverker et al. 2005). 
However, there is an absence of research to suggest such specialist input is necessary 
in relation to health outcomes or adherence to the GFD, and it is not known whether 
general paediatric dietitians managing patients in the current study had a specialist 
interest in CD or not, although it is likely that they were experienced in GF issues. 
Focus group interviews conducted in Sweden with adolescents (15-18 years) 
identified that teenagers adhered to the GFD, in part, because of knowledge of the 
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long-term health outcomes of untreated CD and non-adherence was associated with a 
lack of knowledge of these health outcomes (Olsson et al. 2009a). As such, 
management by a dietitian with specific CD knowledge is likely to be important in 
terms of empowering the patient to effectively follow a GFD, although there is no 
reason why a paediatric gastroenterologist or general paediatric dietitian with an 
interest in CD could not provide reliable information and support. Such input is 
suggested in new guidance (Coeliac Working Group of BSPGHAN and Coeliac UK 
2013). 
Dietitians observed a number of nutritional areas of concern in the first appointment, 
namely IDA (n=6, 16%), low calcium intake (n=10, 27%), poor appetite/low energy 
(n=4, 11%), weight loss/poor weight gain (n=3, 8%) and fussy eating (n=3, 8%). 
However, it was unsure from the questionnaire how these were assessed (e.g. diet 
history, haematological assessment, general questioning). Collecting the clinical data 
may have helped to clarify how particular areas of concern were established. In 
relation to anthropometry, weight was measured in 34 patients (91.9%), although 
height was only recorded in 19 patients (51.5%). Therefore, BMI could only be 
assessed in 19 cases. Such anthropometric shortfalls have similarly been observed in 
the management of patients with IBD (Lomer 2009). Although weight is a good 
assessment of growth in children, and a short-term measure of nutritional status 
(since it can change rapidly), weight alone cannot determine underweight or 
overweight (Zemel 2013). BMI is a good indicator of energy status and can reflect 
under-nutrition or over-nutrition (SACN and RCPCH 2012; Zemel 2013). Thus, BMI 
should be assessed in conditions that affect absorption of nutrients, such as CD, to 
monitor recovery and track normal growth. Additionally, since a number of children 
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were classed as overweight or obese at diagnosis it will be important to assess 
whether initiation of the GFD reduces or exacerbates over-nutrition in these patients. 
Although BSG, BSPGHAN and new BSPGHAN and Coeliac UK guidelines state 
that growth should be assessed in children with CD (BSG 2002; Coeliac Working 
Group of BSPGHAN and Coeliac UK 2013; Coeliac Working Group of BSPGHAN 
2005) they do not provide guidance on how growth should be monitored i.e. utilising 
SACN and RCPCH guidance on underweight and overweight which may be why 
such information was only collected in approximately half of appointments. 
As previously noted, the main nutritional concerns observed in the regional clinic at 
time of diagnosis were IDA, low calcium intake, weight loss/poor weight gain and 
fussy eating. To improve iron status and calcium intakes, dietitians at the regional 
clinic mainly contacted the patient’s GP to suggest a prescription of nutritional 
supplementation, and advised patients to start the GFD to improve weight.  Similarly, 
in the district general clinic IDA and low calcium intakes were two of the most 
common concerns described. However, it is of interest that dietitians at the district 
general clinic did not arrange nutritional supplementation, but provided advice on 
dietary sources of iron and calcium. Although studies have not specifically looked at 
the effects of nutritional supplementation in CD, dietitians have recommended that 
comorbid conditions such as osteoporosis and reproductive disorders related to 
nutritional deficiencies could be reduced with vitamin or mineral therapy (Kupper 
2005) and BSG guidelines state that rapid correction of nutritional deficiencies with 
supplementation should be implemented (BSG 2002). However, in a study of iron-
deficient women of childbearing age in Australia (n=44), Patterson et al. (2001) 
found that although dietary supplementation led to a greater increase in mean (SD) 
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serum ferritin levels in the short term (after 12 weeks) compared to increasing dietary 
sources of iron (9.0±3.9g/L to 24.8±10.0g/L vs. 8.9±3.1g/L to 11.0±5.9gL, 
respectively), making dietary changes was associated with longer-term 
improvements in iron status (after 6 months). It is uncertain why differences in 
practice exists between the regional and district general clinic, however 
supplementation arrangement in the regional clinic may be due to direction from the 
accompanying gastroenterologist. Follow-up data on biochemistry or bone mineral 
density should be collected to help inform HCPs of the best mode of practice to treat 
micronutrient deficiencies or low intakes in children with CD.  
In-line with most guidance (BSG 2002; Coeliac Working Group of BSPGHAN 
2005) the majority of dietitians at the first appointment provided education to new 
patients and their families on the diet-disease link, advised about the GFD, 
prescription products and provided education on potential cross-contamination of 
foods and the importance of calcium. However, there were some differences in 
relation to certain areas of education provided between the regional and district 
general clinics. In a significantly greater proportion of appointments at the regional 
clinic education was provided on the inclusion of oats in the GFD, codex wheat 
starch, family screening and food labels (p=0.006, p=0.003, p=0.005 and p=0.02, 
respectively). Previous research in adults has shown that understanding food 
labelling is associated with better adherence to the GFD (Butterworth et al. 2004) 
and in Study 3 we observed that never checking food labels was negatively 
associated with GFD adherence in Scottish teenagers (r=-0.60, p<0.0001) (Section 
5.3.3.2). Furthermore, Joint Coeliac UK and BSPGHAN guidelines state that in the 
first dietetic appointment children should be established on a GFD and oats should 
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also be excluded since around 5% of CD cases are sensitive (experiencing 
histological damage) (Coeliac Working Group of BSPGHAN and Coeliac UK 2013). 
Uncontaminated oats should then be considered once baseline wellness is achieved. 
As such, children managed in the district general clinic may be at greater risk of 
initial poor adherence and sustained intestinal damage if they are not educated on 
such issues. Dietitians may not have covered certain factors due to limited time in the 
appointment or because of not wanting to overwhelm or confuse families with 
information initially. The combined input and knowledge of the dietitian and 
gastroenterologist in the regional clinic may have led to a broader range of issues 
being covered in the first appointment. However, it is not certain whether 
children/their families understand all the information they are initially provided with 
or whether the correct dietary changes are made, hence the need to collect further 
follow-up data in newly diagnosed patients.  
In a substantial proportion of initial appointments at both the regional and district led 
clinic dietitians did not provide education to patients and their families regarding 
following the GFD on holidays (18/24 regional, 7/11 district general) or at parties 
(10/24 regional, 4/9 district general). These could be referred to as situations in life 
when adherence may seem difficult, and are therefore deemed important issues to 
address according to BSG and BSPGHAN treatment guidelines (BSG 2002; Coeliac 
Working Group of BSPGHAN 2005). Nonetheless, in the first appointment dietitians 
may have limited time to cover all the important aspects of the GFD, especially if 
they are not deemed pertinent by the patient at the time. In the current Scottish cross-
sectional study adolescent adherence to the GFD was significantly associated with 
being able to follow the GFD on holiday abroad (r=0.48, p=0.005) and in the UK 
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(r=0.56, p<0.0001), throughout a long car or train journey (r=0.34, p=0.034) and at 
special events (r=0.45, p=0.005) (see Section 5.3.3.2). Therefore, this is where extra 
support should be focused (as detailed in Section 6.5) and the dietetic e-reporting 
should be continued to ascertain whether this information is provided in subsequent 
appointments; 6-12 months after diagnosis.  
In all appointments the family was advised to join Coeliac UK, which is 
recommended in both BSG and BSPGHAN guidance (BSG 2002; Coeliac Working 
Group of BSPGHAN 2005). Support group membership has been associated with 
stricter adherence to the GFD (as determined by intestinal biopsy) in UK adults 
(n=66) (OR 2.94, 95% CI 1.72-5.26) (Butterworth et al. 2004) and a similar positive 
association between adherence to the GFD and Coeliac UK membership was 
observed in the current study in Scottish teenagers (p=0.02) (as detailed in Section 
5.3.3.2). However, very few families seen in the district general clinic were provided 
with information on their ‘Local Coeliac UK Group’ (2/11 vs. 20/25, respectively, 
p<0.01). These groups provide additional support for patients by means of cookery 
demonstrations, arranging talks from medical experts and setting up food fairs 
(Coeliac UK 2013a), which may help to increase a patient’s HRQoL and adherence 
to the GFD. Activities involving solely children and adolescents with CD (such as 
GF camps) have been found to improve indices such as well-being, self-perception 
and emotional outlook in Italian children (Bongiovanni et al. 2010), although the 
long-term outcomes of such activities on measures of health requires further 
investigation. Furthermore, it was identified in Olsson and colleagues (2008) focus 
group study that adherent teenagers in Sweden received more emotional support 
from family and friends in relation to following a GFD compared to non-adherent 
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teenagers. Local groups of individuals diagnosed with the same condition may be 
able to provide such emotional support.  
Although certain information and education may not have been provided in the initial 
dietetic appointment, it was planned that 23 of 25 (92%) children would be followed-
up after three months in the regional clinic and 10 of 12 (83%) children seen in the 
district general clinic would be seen again in six weeks - in-line with recent 
guidelines which state that children should be followed-up at 3-6 month intervals in 
the first year (Coeliac Working Group of BSPGHAN and Coeliac UK 2013). This 
may account for the extent of information provided in the first appointments, 
especially in the district general clinic, as such prompt follow-up allows for children 
and their families to improve their knowledge of CD and the GFD and to clarify any 
misunderstandings or concerns they have about the GFD as quickly as possible.  
To summarise, the results uncover various differences in practice between the 
regional and district general clinics in SE Scotland in terms of the timing of the 
initial appointment, the type of dietetic input received (PGIS or general paediatric 
dietitian), the treatment of nutritional deficiencies/poor dietary intakes, as well as 
education provided. However, whether this translates to differences in HRQoL, 
adherence to the GFD or nutritional well-being requires further investigation and 
patient follow-up. Future management guidelines need to be standardised to ensure 
any inequalities in practice are minimised and the nutritional status of patients is 
monitored appropriately.   
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6.2 Discussion for Study 2: Trends in paediatric coeliac disease in 
Southeast Scotland from 1990-2009: a retrospective audit of cases 
To our knowledge, this is the largest dataset of paediatric coeliac disease cases in the 
UK to date (n=266). Although other national and international studies have captured 
a longer time period (Cook et al. 2004; Hurley et al. 2012; Olsson et al. 2008b; 
Ravikumara et al. 2006; Roma et al. 2009; Stevens et al. 1987), we feel that 20 years 
has yielded sufficient numbers to observe trends in disease incidence and primary 
reasons for diagnosis. The use of age-sex standardisation and Poisson regression 
models to detect true trends in CD incidence rate over time is unique and the 
extraction of data from multiple sources to enable cross-checking of information in 
this study has resulted in the most complete data set possible.  
This retrospective regional cohort study has shown a steady and sustained rise in 
incident paediatric CD, with a dramatic 6.4-fold increase in adjusted incidence 
observed between the epochs 1990-1994 and 2005-2009. Although similar linear 
trends have been reported from Wales (Hurley et al. 2012; Ravikumara et al. 2006), 
The Netherlands (George et al. 1997b; Steens et al. 2005), Greece (Roma et al. 2009) 
and North America (McGowan et al. 2009; Telega et al. 2008),
 
we uniquely show 
that approximately half the rise in the current cohort was attributed to children 
presenting with the strict Oslo classification of classical symptoms; namely FTT, 
diarrhoea, muscle wasting, poor appetite and/or abdominal distension. (Ludvigsson 
et al. 2012). Moreover, this statistically significant rise is independent of cases 
diagnosed through targeted screening or detected on the basis of non-classical 
presentation - implying a true rise in the incidence of childhood CD. 
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6.2.1 Trends in the incidence of childhood CD over time 
The mean age-sex standardised incidence of paediatric CD rose 6.4-fold from 
1.60/100,000/year in epoch 1, to 11.81/100,000/year in epoch 4 (p<0.01). Although 
the incidence of cases diagnosed on the basis of a non-classical presentation rose by 
1566%, from a mean of 0.09/100,000/year in epoch 1 to 1.41/100,000/year in epoch 
4 (p<0.05) and the incidence of cases diagnosed through active screening of ‘at-risk’ 
conditions or family history of CD increased 1170%, from 0.17/100,000/year to 
2.04/100,000/year (p<0.001), there was still an independent 2.5-fold rise in the 
incidence of classically presenting cases of paediatric CD-rising from 
1.51/100,000/year in epoch 1 to 5.22/100,000/year in epoch 4 (p<0.01); defined 
according to the strict Oslo criteria (which are seen as the gold standard for 
phenotypic description of coeliac disease) (Ludvigsson et al. 2012). It is unlikely that 
children with such visible symptoms will have been detected solely due to better 
awareness of CD in practice, better diagnostic practices or improvements in 
serological screening tools. Therefore, the rise in classical cases suggests that a true 
increase in CD incidence is evident in SE Scotland. 
This is the first study, to our knowledge, providing evidence for a true rise in the 
incidence of Oslo classical CD cases, in children or adults. A number of population 
screening studies have shown a rising prevalence of cases with a serological 
diagnosis of CD, which may support the current findings. Rubio-Tapia and 
colleagues in the United States performed anti-tTG assays on frozen sera of 9,133 
young men (18-49 years) from a historical cohort (1948-1954) and compared 
percentage positivity to that of 7,210 similarly aged men from a present day cohort 
(2006-2008). Over a fourfold increase in prevalence was observed over the 50 years 
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from 0.2% to 0.9% (Rubio-Tapia et al. 2009). However, the historical group 
comprised individuals originating from varying regions of the USA who therefore 
may have been exposed to different environmental factors that may play a role in CD 
development, whereas the present day cohort all originated from the same 
geographical area (Upper Midwest). Such differences between the two cohorts may 
have influenced the disparity in serological prevalence rates. Also, it cannot be said 
whether a similar rise would have been observed in females. Similarly, Finnish 
researchers used Anti-EMA serological tests to reveal almost a 200% rise in the 
prevalence of adult CD (>30 years) from 1.03% in 1978-80 to 1.99% in 2000-01 
(p=0.004), although again, the two cohorts were recruited from geographically 
distinct regions. Additionally, it is not certain in either of the above studies how 
many were true CD cases since biopsies to confirm diagnosis were not performed.  
Childhood screening for CD in Estonia suggests a true rise in paediatric CD may be 
evident. A prevalence of 0.34% (95% CI 0.09-0.88%) biopsy proven CD cases was 
observed in 1160 randomly selected schoolchildren (aged 9 or 15 years) in 2004 after 
screening with Anti-tTG antibodies (Ress et al. 2007). Findings were in contrast to 
an earlier screening study carried out in Estonia in the early 1990s where an absence 
of CD cases in 478 schoolchildren (aged 9, 12 or 15 years) was reported (Uibo et al. 
1996). Nonetheless, the comparability between studies is limited since they were 
conducted in different geographical areas where differences in infant feeding 
practices, childhood infection rates and other environmental factors may be apparent. 
It is worthy of note that anti-gliadin antibody tests were used to detect CD in the 
earlier study which are known to be inferior compared to anti-tTG and anti-EMA 
tests in terms of sensitivity and specificity for CD (NICE 2009). Additionally, the 
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number of children screened in the study by Uibo and colleagues (1996) was 
substantially lower; suggesting the true prevalence of CD may have been under-
reported in the earlier research. 
Other immune conditions, including multiple sclerosis, TIDM, inflammatory bowel 
disease (IBD) and asthma, have also demonstrated a rise in frequency over the last 
few decades, with a significant and ongoing rise in incidence of pediatric-onset 
inflammatory IBD in Scotland demonstrated over the last 40 years (Bach 2002; 
Henderson et al. 2012). Unlike CD, where children may present asymptomatically or 
with very subtle symptoms, IBD almost always presents with chronic symptoms of 
rectal bleeding, abdominal pain, diarrhoea, and growth failure (Henderson et al. 
2012). Therefore, it is felt that better accrual of children with milder symptoms is not 
a sufficient explanation for the rise. A decrease in the incidence of childhood 
infections such as measles, rubella, whooping cough and tuberculosis have been 
noted over a matched time period in Scotland and other developed countries (Health 
Protection Scotland 2013). As such, the ‘hygiene hypothesis’ as previously described 
(see Section 6.1.1) may therefore account for the associated rise in autoimmune and 
allergic conditions such as CD. Studies have shown that individuals residing in more 
deprived and urban areas have a greater risk of infection (Hawker et al. 2003; 
Spencer et al. 1996; Woodward et al. 2000), however we found no difference 
between SIMD and urban/rural indices in children with CD and the general SE 
Scotland population over time.  
Gene-environmental interactions or epigenetic changes occurring in response to 
foetal or postnatal environment may have contributed to the rising trend in incident 
cases, as genetic mutation alone would not explain such rapid changes over the time 
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period studied. For example, activation of interleukin-15 has long been described as 
a necessary step in the development of CD in genetically susceptible individuals 
(Kupfer and Jabri 2012). Proposed mechanisms for this are specific infectious agents, 
such as adenovirus, acting as a trigger, or the introduction of gliadin itself to the gut 
(Plot and Amital 2009). In terms of historical changes in infant feeding practices in 
Scotland there has been a notable shift towards later introduction of solid foods, with 
91% of mothers introducing solids before four months of age in 1995 compared to 
60% of mothers in 2005 (only 2% of mothers in 2005 waited until six months before 
introducing solids) (The Scottish Government 2011). The Scottish statistics do not 
detail when gluten-containing foods were specifically introduced into the diet. The 
data imply that wheat-based foods may have been introduced at a younger age in 
1995 compared to 2005 but this detail is not known, and thus firm conclusions 
cannot be drawn. This observation potentially contradicts the results of a large 
prospective study which identified that children (n=1560) exposed to gluten in the 
first three months of life had a 5-fold increased risk of acquiring CD autoimmunity, 
compared to those exposed at four to six months (HR 5.17, 95% CI 1.44 to 18.57) 
(Norris et al. 2005). Children in the study by Norris et al. were only followed-up for 
a mean (SD) of 4.8 (2.9) years. Therefore, it could be argued that earlier gluten 
exposure merely leads to earlier appearance of CD. The on-going European multi-
centre PreventCD project aims to addresses this (Hogen Esch et al. 2010). The study 
has involved screening two groups of children for CD, born before and after national 
changes in infant feeding recommendations as well as randomising at risk children to 
receive gluten or placebo at 4-6 months of age as part of a longitudinal case-control 
study. The findings of this study will be of great importance in terms of primary 
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prevention strategies as to whether feeding practices at this early stage in 
development influence CD risk. 
Although breastfeeding initiation rates post-partum rose from 50% to 74% from 1990 
to 2010 in Scotland, there has been no significant rise in those still breastfeeding at 
6-8 weeks (The Scottish Government 2011). Data on longer duration of 
breastfeeding over the twenty-year period are unavailable. However, between the 
years 1980 and 2000 the percentage of children breastfed at 3 months rose in a 
number of European countries including Denmark, Spain, Greece and The 
Netherlands (Yngve and Sjostrom 2001) coinciding with a rise in the incidence of 
childhood CD in these countries (Dydensborg et al. 2012; Lopez-Rodriguez et al. 
2003; Roma et al. 2009; Steens et al. 2005). These parallel trends suggest that longer 
breastfeeding may not be associated with a decreased risk for CD, as previously 
hypothesised (Akobeng et al. 2006). Moreover, as more children were diagnosed 
with CD in these countries more mothers may have been encouraged to breastfeed. 
Nonetheless, it is not known whether the positive linear trend in paediatric CD 
incidence observed in other European countries was attributed to a true rise in 
numbers, better screening interventions or improved awareness of non-classical 
presentations.  
As previously discussed (see Section 6.1.1) delivery via C-section has been proposed 
to increase CD risk. Interestingly, combined emergency and elective caesarean rates 
increased by 78% between 1990 and 2010 in Scotland from 14.2% to 25.3% of all 
births (Information Services 2011). It will be of interest to try to collect data on each 
child’s mode of delivery at birth in the current study and compare to the general 
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population to ascertain whether an association between CD and caesarean delivery 
exists. Such information could inform primary prevention strategies for CD. 
It cannot be dismissed that a lower threshold to test in children with non-classical 
symptoms and in those with associated conditions (T1DM and Down syndrome) or 
family history of CD has equally contributed to the rising trend in incidence 
observed. However, we should strive to continue improving the diagnostic process if 
the paediatric prevalence of 1% shown in some UK screening studies is accurate 
(Bingley et al. 2004). The clinically diagnosed prevalence of paediatric (<16 years) 
CD in SE Scotland at the end of 2004 was just 0.05% of the childhood population 
(Gillett et al. 2009a). Although the incidence of childhood CD in the region 
approximately doubled from the epoch 2000-2004 to the epoch 2005-2009, this still 
infers that the diagnosed prevalence of paediatric CD in SE Scotland is only around 
0.1%. Testing children with a working diagnosis of IBS who frequently present with 
the non-classical symptoms described above could help to improve diagnosis since a 
subset have been shown to have undiagnosed CD in a number of screening studies 
(El-Matary et al. 2004; Korkut et al. 2010) and current NICE guidelines advise that 
CD screening should be offered in such cases (NICE 2009). Additionally, population 
screening could help uncover undiagnosed cases, however the cost-effectiveness and 
its ethical justification are debatable (Kumar 2003).  
One economic analysis comparing the cost of undiagnosed CD with diagnosed CD 
has been conducted in the UK, involving 3,646 CD cases (mean age 38.9 years) and 
32,973 controls matched for age, gender, smoking status, BMI and Charlson 
comorbidity score (Violato et al. 2012). Primary healthcare costs were calculated for 
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approximately five years before and after CD diagnosis. Average annual primary 
healthcare costs increased by 91% (£310; 95% CI £299-£320) after CD diagnosis 
and for patients with CD the cost to the NHS was just over twice as much compared 
to controls (mean difference post diagnosis £354; 95% CI £347-£361). Authors 
identified that earlier diagnosis (between 0 and 18 years) was associated with fewer 
expenses compared to diagnosis at an older age (over 46 years), although reasons for 
this were not expanded upon. As such, capturing CD at an early age may help to 
reduce healthcare costs in the UK. However, it has to be taken into account that 
secondary healthcare costs were not considered in the study such as dual-energy X-
ray absorptiometry or blood tests and patients were followed up for a relatively short 
period after diagnosis, limiting the results observed. Since undiagnosed CD has been 
associated with various co-morbidities (see Section 3.1) a study comparing 
healthcare expenditure between diagnosed and undiagnosed cases is warranted as the 
cost of osteoporosis, infertility or malignancy may result in greater expenditure to the 
NHS than prescriptions for GF products and follow-up costs associated with 
diagnosis. Currently, there is no evidence to suggest individuals detected through 
screening programs are at higher risk of mortality compared to the general 
population and papers have demonstrated conflicting evidence as to whether 
diagnosing asymptomatic cases increases quality of life in the long-term. Ukkola and 
colleagues (2011) found that perception of health decreased following CD diagnosis 
in asymptomatic patients, however Viljamaa et al. (2005) identified good long-term 
adherence to the GFD diet in 53 screen-detected patients diagnosed for 14 years; 
furthermore, subjects quality of life and bone mineral density was comparable to a 
general healthy population. These variations in results suggest that mass screening of 
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asymptomatic populations should not be implemented until it can be economically 
and ethically justifiable. 
The rise in cases does not appear to be subsiding. This is likely to have implications 
on the amount of time health-care practitioners have to support and care for CD 
patients if their caseloads continue to rise. Thus, increased financial provision to 
maintain/improve the care and support patients currently receive should be 
considered, or as previously suggested (see Section 6.1.4) more innovative ways to 
manage a higher caseload should be considered. In addition, the demand for GF 
foods will also be increasing. Therefore, pressure needs to be placed on the food 
industry, food retailers, and eateries to improve the availability and choice of GF 
options to help patients maintain a strict GFD and an HRQoL similar to the general 
population. 
6.2.2 Patient demographics 
Of the 266 children diagnosed over the twenty years in the current study, 61% were 
female, and the male to female ratio of the newly diagnosed cases did not change 
significantly over the study period. Additionally, and as expected, the median (IQR) 
age at diagnosis rose from 29 (16-24) months in Epoch 1 to 90 (54-130) months in 
Epoch 4 (p<0.0001). This female predominance and rise in age at diagnosis was also 
seen at a national level (discussed previously in Section 6.1.4).  
Although the proportion of children under two years of age at diagnosis decreased 
over the 20 years from 42% of cases in Epoch 1 to 5% of cases in Epoch 4 
(p<0.0001) the crude number of children under two years of age remained stable 
despite the incidence increasing – implying that the true rise in incident cases was 
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restricted to children >2 years of age. The subsiding proportion of children less than 
two years of age is likely to be attributed to the fact that CD is no longer considered 
to be a condition solely associated with early childhood. Additionally, as seen in the 
current dataset and similar epidemiological studies, children presenting with classical 
or GI symptoms tend to be significantly younger (Balamtekin et al. 2010; 
Bhattacharya et al. 2009; Dydensborg et al. 2012; Ravikumara et al. 2006; Telega et 
al. 2008; Westerbeek et al. 2005). This suggests that younger children have 
continually been easier to detect in practice, and thus rates have not changed 
substantially. Children presenting non-classically and those identified through 
targeted screening were significantly older at diagnosis in the present study 
(p<0.0001) and of course these phenotypes have become more prolific in recent 
years as clinical awareness has improved. However, it is interesting that the median 
(IQR) age of classical cases rose significantly from 26 (16-53) months in Epoch 1 to 
81 (48-121) months in Epoch 4. This trend has not been observed previously and it 
may reflect a change in the disease pathogenesis in more recent years due to 
environmental or epigenetic influences. It is possible that the classical cases in Epoch 
4 have more subtle histopathological changes than those in Epoch 1, although testing 
this theory will require independent analysis and Marsh-Oberhuber grading by an 
experienced pathologist of all biopsies taken over this time period, and this was 
beyond the scope of this thesis. 
6.2.3 Haematology 
The most striking finding with regards to blood results between 2005 and 2009 was 
that just over 50% of children whose bloods were tested were iron deficient (defined 
by serum ferritin <20µg/L for boys and <15 µg/L for girls) at diagnosis, and over 
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25% were anaemic (defined by low Hb levels). It should be taken into consideration 
that ferritin is also a positive acute phase protein and levels are raised in response to 
infection or inflammation (Thurnham et al. 2010). As such, the number of children 
with iron-deficiency at diagnosis may actually be higher than reported. A similar 
high prevalence of iron deficiency and anaemia at CD diagnosis was recently 
described by Savilahti et al. (2010) in 197 children (<16 years) identified in Finland; 
with 42.5% of patients classified iron deficient and 23.5% anaemic. However, MCV, 
iron concentration and serum transferrin saturation were used to assess iron status in 
the Finnish study and these are less sensitive to changes in hepatic iron stores than 
serum ferritin (Goddard et al. 2011). Thus, the proportion of children who were 
classified as iron deficient in this study may differ slightly to that reported.  In the 
National Diet and Nutrition Survey of young people aged 4-18 years only 13% of 
boys (n=550) and 14% of girls (n=426) in the general UK population were found to 
have definitively low serum ferritin levels and 2% of boys (n=616) and 4% of girls 
(n=565) had low serum Hb levels (Gregory et al. 2000b) (The most recent NDNS 
only reports ferritin and Hb levels for children aged 11-18 years (Bates et al. 2012)). 
Although it is possible that some children included in the NDNS had undiagnosed 
CD, iron deficiency and anaemia appears to be much higher in untreated CD cases 
compared to the general population; this is likely to reflect limited iron absorption 
related to villous damage. Joint Coeliac Working Group for BSPGHAN and Coeliac 
UK guidelines (2013) state that micronutrient status and iron intakes should be 
monitored post-diagnosis, although as previously discussed (see Section 6.1.5) they 
do not provide guidance on how to treat iron-deficiency or anaemia which may result 
in inequalities in management. 
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Low vitamin B12 and folate levels were not a predominant feature in relation to 
diagnosis in the current study, affecting 1.5% and 11.1% of children, respectively.  
The findings in relation to folate are in contrast to a retrospective incidence study 
conducted in Southwest Spain where 21.5% of newly diagnosed children (n=157 <14 
years) with CD experienced folate deficiency (Lopez-Rodriguez et al. 2003). The 
lower percentage of children with a low serum folate result in this Scottish report 
may be attributed to the fact that we were unable to attain 52% of the patients’ folate 
results around the time of diagnosis due to changes in the computerised system as 
outlined above. The low number of children deficient in vitamin B12 is expected 
since absorption of the vitamin occurs primarily in the ileum (Bender 2005), which 
has been shown to be largely unaffected in patients with CD (Dickey and Hughes 
2004).  
Ferritin and Hb should be measured as a matter of routine – if not at the time of 
measuring tTG then certainly at the time of biopsy to assess current iron status and 
monitor improvements after the patient commences a GFD. Furthermore, clinicians 
should consider measuring ferritin in conjunction with the acute phase proteins C-
reactive protein and α1-acid glycoprotein in order to correct ferritin concentrations 
and reduce underestimation of iron deficiency associated with inflammation 
(Thurnham et al. 2010). If low iron levels are not managed appropriately soon after 
diagnosis school-age children may be at increased risk of poor cognition and 
physical work capacity, and girls may be at-risk of adverse pregnancy outcomes if 
intakes continue to be poor into adulthood (SACN 2010). Furthermore, in the cross-
sectional adolescent study approximately a third of girls following a GFD for over a 
year had iron intakes below the LRNI, putting them at risk of deficiency (see Section 
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6.3.1). As such, standardised guidelines for the management of poor iron status in 
children with CD should be devised to reduce risk of adverse health consequences. 
6.3 Discussion for Study 3: Adherence to the Gluten-Free Diet in a 
Scottish Adolescent Population 
In this multi-centre, cross-sectional study we aimed to compare dietary intakes and 
behaviours of adolescents with CD to age-matched controls (NDNS rolling 
programme data 2008/09-2010/11) representative of the population as a whole. The 
NDNS method of data collection to assess dietary intakes was replicated in the 
current study for accurate comparison across groups. A validated questionnaire was 
utilised to measure each teenager’s adherence to the GFD and a questionnaire and 
quiz based on tools previously developed in the United States (Leffler et al. 2008), 
outcomes of Swedish adolescent focus group discussions (Olsson et al. 2008a) and 
professional experience from a regional paediatric CD clinic were used to determine 
factors associated with adherence. Furthermore, validated generic and CD specific 
questionnaires were employed to compare HRQoL between adherent and non-
adherent adolescents and healthy controls. All data collection tools and the overall 
protocol were piloted in a subgroup of UK teenagers with CD to ensure the face and 
content validity of tools and feasibility of the study.  
Results of the cross-sectional study in Scottish adolescents suggest teenagers with 
CD have similar dietary concerns to age-matched controls following a gluten-
containing diet including high intakes of SFA and NMES and low intakes of NSP 
and iron. However, it is of interest that SFA and NMES intakes in teenagers with CD 
were significantly higher compared to controls. The findings also indicate that 
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adherence to the GFD is associated with a number of factors including gender, being 
a member of a CD support group, feelings of guilt in relation to consuming gluten 
and the ability to the follow the GFD at social and special events and when 
travelling. In addition, adolescents classified as non-adherent to the GFD were found 
to have significantly poorer physical well-being and self perception HRQoL indices 
compared to adherent teenagers and healthy controls.  
6.3.1 Estimated dietary energy and nutrient intakes 
Both teenage boys and girls with CD had significantly higher median (IQR) energy 
intakes compared to NDNS controls (2322 kcals [2022-2910] kcals vs. 1916 kcals 
and 1889 [1603-2324] kcals vs. 1617 kcals; p<0.05 and p<0.01, respectively). 
Similar findings have previously been observed in UK adults (Robins et al. 2008c; 
Wild et al. 2010). In girls, the extra energy consumed appears to be attributed to 
higher consumption of all macronutrients (including SFA and NMES) since median 
intakes of all macronutrients were significantly higher compared to the NDNS 
population (p<0.05). Conversely, boys were only found to have significantly higher 
protein intakes compared to NDNS controls (p<0.05), although due to the small 
sample of boys included this may not be reflective of the wider population. 
Furthermore, the higher energy and nutrient intakes in the CD population could 
reflect that these teenagers may have previously completed diet diaries as part of 
dietetic follow-up and thus have a better awareness of the methodology, their dietary 
habits and are less likely to under-report. 
Despite lower energy intakes in the NDNS population, 34% of boys and 38% of girls 
were either overweight or obese (BMI >85
th
 percentile). Therefore, Scottish 
teenagers following a strict GFD may be at an even greater risk of overweight or 
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obesity since their energy intakes were significantly higher. However, the teenagers’ 
physical activity levels are not known and the sample may be too small to represent 
the full population. Additionally, findings from studies comparing BMI in adults and 
children with CD to control populations do not support this theory (Bardella et al. 
2000; Barera et al. 2000; Cheng et al. 2010; Haapalahti et al. 2005; McFarlane et al. 
1995; Rea et al. 1996). However, a number of limitations in methodologies are 
evident. In three of the studies unreliable measures of adherence (EMA, AGA and 
subjective review) may have confounded results (Barera et al. 2000; McFarlane et al. 
1995; Rea et al. 1996) and in one study adherence was not assessed at all (Cheng et 
al. 2010). As such, a number of patients’ villous atrophy may have persisted, causing 
poor absorption of nutrients and possible weight loss. Furthermore, only two of the 
studies compared the percentage of patients that were overweight and obese (WHO 
guidance) to controls (Cheng et al. 2010; Kabbani et al. 2012). Research by Kabbani 
and colleagues (2012) in American adults (n=679, mean [SD] age 51.9 [15.5] years) 
appears to be the most reliable to date, in which a lower percentage of adherent 
patients (assessed by expert dietetic evaluation) were overweight (BMI 26-29.9) or 
obese (BMI ≥30) compared to age-sex matched population data (p<0.0001). 
However, data collected in American adults will likely differ from UK teenagers 
because of differences in dietary practices and the availability and type of GF food 
between these countries. Moreover, no study has compared anthropometric 
measurements specifically in teenagers with CD to a healthy control population, and 
this requires further investigation before sufficient conclusions can be drawn with 
regards to the effect of the GFD on weight status. 
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Despite apparent dietary restrictions with a GFD, the adolescents with CD followed 
similar trends to the general UK population in relation to macronutrients; consuming 
a significantly greater percentage of energy from SFA and NMES compared to 
DRVs (p<0.0001). However, the teenagers with CD were found to consume an even 
higher proportion of energy from SFA and NMES compared to NDNS controls 
(14.0% vs. 12.6% and 19.3% vs. 15.7%, respectively), and this difference was 
statistically significant (p<0.05 and p<0.01, respectively). Furthermore, when taking 
absolute grams into consideration teenage girls with CD consumed approximately 
30g more NMES per day compared to controls (p<0.05). Interestingly, in adults with 
CD in the UK (n=48) percentage energy derived from total fat was significantly 
lower in the CD group compared to NDNS controls (p<0.05) (Kinsey et al. 2008). 
However, the authors do not look specifically at energy derived from SFA, limiting 
the results observed. Ohlund et al. (2010) report findings similar to the current study, 
with children (4-17 years) consuming 14.5% of their daily food energy from SFA 
and 14.7% from sucrose (total NMES intakes were not stated). Furthermore, these 
intakes were even higher compared to healthy age-sex matched controls, although 
significance was not reported, limiting the conclusions drawn. Unlike previous 
studies in children and young adults with CD, we report the types of foods 
contributing to energy intake. This helped to determine differences in food choice 
between teenagers with CD and controls. Adolescents with CD consumed 
approximately twice as much energy from milk and milk products compared to 
NDNS controls (17% vs. 9%, p<0.0001), particularly more semi-skimmed milk and 
cheese (p<0.01 and p<0.0001, respectively). Less energy was consumed from cereal 
and cereal products (p<0.0001) and more energy from sugar, preserves and 
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confectionery (p<0.01). It is likely that the higher consumption of dairy produce, 
especially cheese influenced SFA intakes, and preference for carbohydrates high in 
added sugars over more complex carbohydrates lead to higher NMES intake in the 
CD group. 
The differences in SFA intakes between 11- to 18-year-olds in the general population 
and those following a GFD may be attributed to dietitians and clinicians promoting 
foods rich in calcium to CD patients (discussed previously in Section 6.1.5), since 
undiagnosed CD has been associated with increased risk for osteoporosis (see 
Section 3.1.1) and 10 of 37 newly diagnosed patients in the dietetic e-reporting study 
were identified as having low calcium intakes. The richest sources of calcium are 
milk and milk products (Department of Health 1991). However, results of the current 
study suggest that to reduce SFA intakes in adolescents with CD health professionals 
should emphasise consumption of low-fat dairy products such as milk and yogurt, 
rather than those high in SFA such as cheese, cream and ice cream. In relation to 
higher NMES intake, this may be due to sugars, preserves and many confectionery 
products being naturally GF compared to a limited number of cereal products 
(Coeliac UK 2010). As such, they may be considered convenient and safe options for 
adolescents with CD; especially since both adherent and non-adherent teenagers 
were found to experience difficulties interpreting food labels to determine whether a 
product is GF (this is discussed further in Section 6.3.2). Results of a recent survey 
by Singh and Whelan (2011) may further help to explain the disparity in NMES 
intakes. It was observed that out of 20 GF versions of standard products sweet 
biscuits were the most readily available in regular UK supermarkets. Furthermore, 
whole cake was the fifth most available GF food item; above plain flour, bread rolls 
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and savoury crackers. Abernethy and Bannerman (2011) observed similar results in 
their survey of Supermarkets in Scotland. Food items high in sugar and fat were 
more readily available in all Supermarkets (accounting for urban and rural localities 
and low and high SES areas) compared with other food groups. Therefore, teenagers 
may consume more energy from NMES due to a greater availability of GF products 
high in these added sugars. 
High intakes of SFA may increase risk of cardiovascular disease and type 2 diabetes 
(WHO & FAO 2003) whereas NMES intakes in Scottish children and adolescents (3-
17 years) are positively associated with dental caries (Masson et al. 2010). Thus, GF 
food manufacturers should be lobbied to increase the availability of GF products of 
higher nutritional quality; particularly snack foods. Furthermore, it should be 
recommended that macronutrient as well as micronutrient intakes are assessed at 
follow-up, advice regarding the potential impact of following a GFD on SFA and 
NMES intakes provided and naturally occurring and manufactured GF foods low in 
SFA and NMES promoted to improve the quality of macronutrient intakes in this 
population. Currently, joint Working Group of BSPGHAN and Coeliac UK 
guidelines (2013) only recommend that intakes of calcium and iron and be 
monitored. 
Similar to NDNS data, adolescents with CD consumed significantly less NSP than 
the RNI (p<0.05). However, median NSP intakes were significantly higher in boys 
and girls with CD compared to boys and girls in the NDNS (p<0.05 and p<0.001, 
respectively). This was unexpected since the majority of research in adults and 
children has shown NSP or dietary fibre intakes to be lower in those following a 
GFD compared to reference populations (Grehn et al. 2001; Hopman et al. 2009; 
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Kemppainen et al. 1995; Ohlund et al. 2010; Wild et al. 2010). Just one American 
adult study observed comparable results to ours (Thompson et al. 2005). The reason 
for higher NSP intakes in teenagers with CD could simply be due to the greater 
energy intake in the CD population compared to the NDNS population. Additionally, 
it was found that the participants consumed more energy from high fibre foods such 
as wholemeal bread and fruit compared to controls (p<0.05 and p<0.01, 
respectively). Data on foods contributing to NSP intake support this since a greater 
percentage of the NSP intake in adolescents with CD was derived from cereals and 
cereal products and fruit (ns and p<0.05, respectively). Fruit is naturally GF which 
will likely have influenced the higher consumption; however the preference for 
wholemeal bread in the CD group is interesting. This may be due to bread being the 
most commonly availably GF prescription product in the UK, and the second most 
available GF product in food stores within the UK (Singh and Whelan 2011) or 
attributed to input from a registered dietitian on the important role of NSP in the diet. 
Additionally, due to substantial developments in GF food science in the last few 
years, manufacturers have brought out a variety of high-fibre GF breads and pastas 
which may partially explain the difference in our findings compared to older 
research. 
Similar to outcomes of adult research from the UK (Kinsey et al. 2008; Wild et al. 
2010) our results suggest that teenagers consumed a higher proportion of energy 
from protein compared to the DRV of 15% of total energy and to the general 
adolescent population (p<0.05). Both boys and girls consumed approximately 20g 
more protein per day compared to NDNS controls. Again, greater consumption of 
milk and milk products may play a role in the higher dietary intake of protein.  
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The results indicate that girls’ iron intakes from food sources were significantly 
lower compared to the RNI (9.3mg vs. 14.8mg, p<0.05); this was still evident when 
accounting for iron intakes from food and supplement sources (9.6mg vs. 14.8mg, 
p<0.05). However, the girls following a GFD actually had higher median iron intakes 
compared to girls in the NDNS (9.3mg vs. 8.2mg, p<0.05). These results are in 
contrast to findings in young populations from Sweden and The Netherlands, where 
iron intakes were lower in CD groups compared to control subjects (Hopman et al. 
2009; Ohlund et al. 2010). However, this may be due to variation in data collection 
methods between cases and controls in the aforementioned studies or differences in 
dietary practices between Scotland and other European countries. Moreover, neither 
study reports the proportion of teenagers with iron intakes below the LRNI (or 
country equivalent), limiting their results.  
Approximately a third of girls following a GFD in the current study had iron intakes 
below the LRNI, similar to NDNS data. This is of concern since it is assumed that 
the LRNI will meet the needs of very few individuals (2.5% of the population group) 
(Department of Health 1991) and suggests intakes less than this indicate a risk of 
deficiency (the adverse effects of iron deficiency have previously been discussed in 
Section 6.2.3). Furthermore, teenagers with CD may have experienced a prolonged 
period of iron-deficiency prior to diagnosis (see Section 6.2.3), and thus the need for 
adequate iron intake following diagnosis is of paramount importance. It has been 
identified that by substituting grains and other complex carbohydrates usually 
included in a Western GFD such as white rice, potatoes and corn with alternative 
carbohydrates such as GF oats, high fibre brown rice bread and quinoa the iron and 
fibre nutrient levels in the diet may increase significantly (p<0.001) (Lee et al. 2009). 
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Health professionals should encourage the inclusion of such grains in the diet of 
adolescents with CD, as well as enriched GF products and naturally rich sources of 
iron. Future studies should also assess iron status in teenagers strictly adherent to a 
GFD to establish the true prevalence of deficiency. If a large proportion of diagnosed 
adolescents are found to be iron deficient on further study, policy to introduce the 
fortification of GF flours with iron may be advocated. However, a recent SACN 
review questions the impact iron fortification has on population intakes and the 
bioavailability of the iron added to flour (SACN 2012).   
The boys and girls with CD did not appear to be at a disadvantage compared to 
NDNS controls in relation to any other micronutrients. Furthermore, median intakes 
were above RNI values for all other micronutrients, including iron in boys. Although 
14% of girls had calcium intakes below the LRNI, this was not significantly different 
compared to NDNS data and was reduced by half when calcium supplementation 
was taken into consideration. Additionally, girls had significantly higher calcium 
intakes compared to NDNS controls. The results of research by Wild et al. (2010) 
suggest similar differences in relation to calcium intakes between adults with CD and 
controls, although Kinsey, Burden and Bannerman (2008) report the contrary in UK 
adults. The teenagers in our study all receive regular appointments with dietitians 
who, as highlighted previously, provide education on the importance of calcium as a 
matter of routine (see Section 6.1.5) and this is clearly reflected in the teenagers’ 
food choices and intakes. Adults, on the other hand, may receive less regular dietetic 
support (Nelson et al. 2007) and their requirements for calcium are higher than the 
RNI for the general population (Lewis and Scott 2007). Therefore, adults may find 
meeting the dietary targets more challenging. 
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In summary, the results suggest that adolescents with CD in Scotland have similar 
dietary concerns to the general teenage population in the UK. Their intakes were of 
concern regarding the distribution from different macronutrients, with SFA and 
NMES intakes exceeding DRVs and intakes of these nutrients in their peers 
following a gluten-containing diet. This may be attributed to a number of factors 
such as a greater availability of GF products high in sugar and fat compared to other 
food groups, over consumption of dairy products high in SFA due to concerns about 
meeting calcium requirements or choosing to consume more simple carbohydrates 
such as preserves and confectionery as a seemingly more convenient and safe option 
compared to more complex carbohydrates. Furthermore, the teenager NSP intakes 
fell below the RNI and similar to teenage girls in the general population, the results 
imply that many girls with CD have iron intakes below the LRNI. Further research is 
required to establish whether teenagers following a GFD are at increased risk of 
overweight/obesity or nutritional deficiencies compared to the general population. 
However, the results suggest that GF food manufacturers should be lobbied to 
increase the availability of healthy snack products, dietitians should monitor both 
macro- and micronutrient intakes at follow-up and they should encourage 
consumption of more complex alternative carbohydrates and low fat dairy products 
as a way to reduce SFA and NMES and increase iron and NSP intakes. 
6.3.2 Factors associated with adherence and non-adherence to the gluten-free diet 
Approximately 40% (n=16) of the adolescents with CD in the current study were 
classified as non-adherent to the GFD as assessed by the validated Biagi 
questionnaire (Biagi et al. 2009; Biagi et al. 2012). It is difficult to accurately 
compare adherence rates in the current study with previous teenage studies that did 
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not utilise validated measures of adherence. Kumar et al. (1988) reported a similar 
proportion of non-adherence in UK teenagers (12-20 years) over twenty-five years 
ago (45/102 patients, 44.1%). However, due to the self-report method employed it is 
likely that strict adherence was overestimated. Furthermore, substantial 
developments have been made in the last 25 years with regards to the awareness of 
CD and the long-term problems associated with the untreated condition; the 
availability, aesthetics and range of GF products on the market and the management 
of patients (see Section 3.5), limiting the comparisons that can be made between the 
two studies. Recently, the same Biagi tool was used to measure adherence to the 
GFD in 141 adults living in Italy and it was found that just 17.7% of participants 
were classified as non-adherent (Biagi et al. 2012). Similarly in the UK, it was 
identified that 13 out of 55 (23.6%) white Caucasian adults with CD were non-
adherent to the GFD (i.e. they had partial or total villous atrophy on duodenal 
biopsy) (Butterworth et al. 2005). Lower incidence of non-adherence in adult studies 
may highlight the different attitudes towards a GFD experienced by older 
populations. Length of diagnosis does not appear to play a role in the difference since 
adolescents in the current study had been diagnosed for a median (IQR) of 5.8 (3-10) 
years, whereas adults in the study by Butterworth et al. (2005) had been diagnosed 
for a shorter length of time (27 [15-73] months). The high proportion of non-
adherence in Scottish teenagers further highlights the importance of research into 
factors associated with adherence in this age group. 
To our knowledge, this is the first adolescent study that has sought to distinguish 
between intentional and unintentional non-adherence. The majority of non-adherent 
teenagers reported both intentionally and unintentionally consuming gluten-
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containing foods between four and ten times per year. Identifying factors associated 
with intentional or unintentional adherence to the GFD was not one of the objectives 
of the current study and would be limited due to sample size. However, this has 
recently been explored in adults. Questionnaire data was collected from 287 patients 
with biopsy confirmed CD living in both rural and urban areas of North East England 
(Hall et al. 2013). Authors found that intentional non-adherence was independently 
associated with low self-efficacy (OR 0.59, 95% CI 0.41-0.85) and high perceived 
tolerance to gluten-containing foods (OR 1.73, 95% CI 1.33-2.25). It should be 
mentioned that just 23.3% of adults in the study by Hall et al. (2013) were under 
regular follow-up with a dietitian. Since the majority of teenagers (84.6%) in the 
current study found dietitians to be a valuable source of education in their learning of 
CD and the GFD and studies suggest that lack of dietetic input may led to feelings of 
frustration and confusion through seeking information from unreliable sources, low 
self-efficacy and perceived tolerance to gluten in the aforementioned study may be 
associated with this lack of dietetic support. Nonetheless, the results are limited by 
the fact that an unreliable self-report method was used to determine adherence. 
Male gender and being a member of a CD support group were the only two binary 
demographic variables in the current study significantly associated with superior 
adherence. However, the findings in relation to gender may be biased since just 
seven of the 39 participants were boys and it may be that those who are more 
adherent to the GFD are willing to participate in research (Hall et al. 2009; Leffler et 
al. 2008). In contrast to our findings, Ljungman and Myrdal (1993) found dietary 
adherence to be higher in Swedish teenage girls (12-17 years) with CD compared to 
boys (12-17 years) when at home, at school and when out with friends. Nonetheless, 
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statistical analyses were not performed to determine significant differences and it is 
not clear from the paper how adherence was measured, limiting the results reported. 
Conversely, in a large survey of 1743 adults from 17 states in the USA, females 
reported a slightly higher degree of intentional non-adherence compared to males, 
especially when out with friends (58% vs. 67%) (Lee et al. 2012). However, 
significance is not stated in the paper, limiting interpretation of results. Zarkadas et 
al. (2013) observed that a larger percentage of men compared to women with CD 
were accepting of the GFD after diagnosis (65.2% vs. 55.0%, p<0.01). Even after a 
substantial time following the GFD a greater proportion of women felt frustrated, 
overwhelmed, isolated, anxious, sad and depressed about having to follow the dietary 
regime (Zarkadas et al. 2013). Such emotions may have a negative impact on 
adherence and lead to a poorer HRQoL, although it is not certain if adolescent girls 
feel similar emotions.  
It is unsurprising that belonging to a CD support group was associated with better 
adherence to the GFD and there was a strong positive correlation between adherence 
and belief that Coeliac UK had been helpful in learning about CD and the GFD 
(r=0.44, p<0.05). Although this has not previously been reported in adolescent 
research, such correlations have been observed in a number of adult studies from the 
UK and the United States (Butterworth et al. 2005; Hall et al. 2013; Leffler et al. 
2008). Moreover, in a large survey (n=5912) of Canadian adults with CD, 90.4% 
rated information from support groups as very good or excellent (Zarkadas et al. 
2013). In a recent UK survey (n=1291) it was found that 56% of the general public 
and 23% of chefs are not aware of CD (Simpson et al. 2011). Considering this, it is 
important that patients have access to reliable and up-to-date information about 
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managing their condition, such as that offered by Coeliac UK. In the dietetic e-
reporting study it was found that in all appointments dietitians advised children and 
their families to join Coeliac UK in the first meeting. The charity provides online 
advice, information and resources to assist in the management of CD. Focus group 
research in UK adolescents (n=157, 11-19 years) identified that many teenagers use 
the internet as their primary health information source, generally regard the 
information as salient and feel that it offers a stigma-free environment (Gray et al. 
2005). Moreover, the teenagers discussed that online communities provide both 
empathy and privacy when accessing information. These attributes are likely to have 
a positive impact on adolescent management of long-term conditions such as CD. 
Coeliac UK also hosts local events for people with CD such as cooking 
demonstrations and meetings with medical experts. Such events may help to increase 
knowledge, skills and confidence. In addition, meeting other young people with CD 
provides an opportunity to share experiences and may reduce feelings of isolation. 
However, as previously discussed (see Section 6.1.5) there are inconsistencies in 
initial dietetic appointments with regards to informing patients about local Coeliac 
UK support groups and this should be highly encouraged in practice to aid adherence 
and possibly HRQoL. 
A significantly greater proportion of non-adherent teenagers purchased their own 
lunch and snacks during the week compared to adherent teenagers in the study 
(p<0.05 and p<0.01, respectively). This assumes that non-compliant adolescents 
receive less control in relation to food acquisition or are more confident to purchase 
food themselves, but more likely to make mistakes. Teenagers may face difficulties 
following a strict GFD when buying food themselves due to various reasons. Firstly, 
  
291 
adolescents may not read labels on packaged food or may misinterpret them. Non-
adherence was strongly associated with never checking food labels in the current 
study (r=-0.59, p<0.0001) and teenagers commented on the inadequacies of labelling 
on packaged products, making them difficult to interpret. Olsson et al. (2008a) 
observed similar themes in relation to non-adherence in focus group discussions with 
Swedish teenagers. Non-compliers expressed that they were fed up with checking 
food labels, informing others of their condition and asking if products were GF 
(Olsson et al. 2008a). Additionally, 47 out of 73 children with CD (median [IQR] age 
9.4 [5-14.5] years) in a study conducted in Greece agreed that they found it difficult 
to determine if a food was GF from its labelling (Roma et al. 2010) meaning they 
may avoid packaged foods or potentially eat something that is gluten-containing. 
Secondly, as one participant mentioned, there may be a lack of GF lunch and snack 
options available at the school. Therefore, teenagers may opt for gluten-containing 
foods or purchase food from outside sources where they may unintentionally 
consume gluten. Thirdly, by purchasing food themselves the teenager’s CD is likely 
to become visible to others i.e. friends. As such, adolescents may try to hide their 
condition by purchasing ‘regular’ foods. In Olsson and colleagues (2009) study of 
the stigma associated with CD in Swedish adolescents it was identified that 
differences in the appearance of GF foods and their poor availability amplified this 
visibility in a negative way. Furthermore, it has been recognised that an action may 
be repressed during adolescence if it does not relate to normative peer group 
behaviour (McDonagh and Kaufman 2009). As such, teenagers may choose to 
purchase similar foods to their friends in order to ‘fit in’. Teenagers should not be 
discouraged from purchasing their own food; however school caterers and smaller 
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retailers should be urged to supply or increase the availability of GF foods to help 
reduce deviance. Health professionals should dedicate time during follow-up to focus 
on interpreting whether a product is GF from its food label, or online tools could be 
developed to help adolescents better understand labelling. Additionally, there is a 
need to increase the awareness and acceptance of the CD and the GFD in the general 
population to reduce teenagers’ feelings of being different or stigmatised due to 
differences in dietary practices. 
There is evidence in the current study that better adherence to the GFD is associated 
with the teenagers ability to follow a GFD at social and special events. Similar 
findings have been observed in adults living in New England, USA (Leffler et al. 
2008). Strict adherence during such occasions may be attributed to the adolescent or 
their parents taking personal control of preparing GF foods as highlighted in 
Olsson’s qualitative teenage research (Olsson et al. 2008a). Conversely, Chauhan et 
al. (2010) identified that dietary non-adherence was more common in children whose 
parents were reluctant to discuss their child’s condition with others. Adherent 
teenagers seem to possess a higher degree of self-restraint with regards to consuming 
gluten-containing foods. This is evident in both Olsson’s focus group interviews and 
the results of our study, since we observed a strong negative association between 
adherence and being inclined to eat gluten-containing foods when GF options are 
unavailable (r=-0.60, p<0.0001) – these situations are likely to occur more often at 
social gatherings. To avoid being made visible, excluded/uninvited to an event or to 
avoid feelings of guilt (due to other people making an extra effort), teenagers may 
not disclose their condition before attending social and special occasions. In turn, this 
may result in deviance from the GFD when GF foods are unavailable. Furthermore, 
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some non-adherent adolescents in the current study appeared to be very complacent 
in relation to following the diet and not concerned about occasionally consuming 
gluten. Therefore, when at parties and out with friends adherence to the GFD may 
not be seen as a priority for these youths if their main goal is to fit in. Such findings 
suggest that adolescents and their parents should be encouraged to explain and 
address the importance of following a GFD with friends, family and members of the 
public to empower others to either provide GF options at social and special events or 
have a better understanding of why teenagers/their parents are providing food 
themselves. Additionally, both HPCs and support groups should provide information 
and support on being prepared for events where it is not guaranteed that GF options 
will be available. 
In adult studies, difficulties and dilemmas with following the GFD when on holiday 
and travelling have consistently been raised (Lee et al. 2012; Roma et al. 2010; 
Zarkadas et al. 2006; Zarkadas et al. 2013). The results of our study suggest that non-
adherence in teenagers is associated with a poor ability to follow the GFD when on 
holiday abroad and in the UK and during long car or train journey. Leffler and 
colleagues (2008) observed similar associations in American adults with CD. As 
with social and special events good pre holiday planning and good organisation is 
more likely to result in better adherence. Adaptive strategies noted in adults studies 
include taking pre-prepared food when travelling, researching local restaurants 
before visiting another area/country, taking translated information on how to explain 
the GFD and contacting local coeliac societies prior to visiting another country 
(Rashid et al. 2005; Zarkadas et al. 2006; Zarkadas et al. 2013). Therefore, non-
adherence may occur when travelling due to lack of preparation. Kiosks and smaller 
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shops at train stations/on trains are unlikely to stock many GF items and adolescents 
in the current study commented on the poor availability of GF items in cafes and 
coffee shops. In addition, language barriers and foreign labelling may impede strict 
adherence to a GFD when abroad. Coeliac UK provides online material specifically 
on following a GFD when travelling within the UK and abroad (Coeliac UK 2013b). 
Healthcare professionals should encourage patients to access this information prior to 
travelling and should also conduct their own research to provide tailored information 
and support for patients on GF options that will be available both en route and at 
their destination and how to prepare for journeys when purchasing GF foods may be 
limited.  
The majority of teenagers agreed that concern of the long-term health problems 
associated with CD was an important motivation for avoiding gluten. Olsson et al. 
(2008a) observed that non-compliant teenagers in Sweden were more likely to have a 
lack of knowledge about the importance of the GFD for long-term health, although 
this was not the case in the current study. Instead, adolescents who avoided gluten 
because of feelings of guilt were more likely to be non-compliant, however only a 
modest association was observed (r=-0.36, p<0.05). A similar modest association 
between intentional non-adherence and feelings of guilt when consuming gluten has 
been observed in UK adults (r=-0.27, p<0.001) (Hall et al. 2013). It is uncertain 
whether a sense of guilt arises from consuming gluten itself which teenagers know 
may negatively impact current or future health status or the anticipated 
disappointment from significant others such as parents. A negative relationship 
between family conflict and treatment adherence during adolescence has previously 
been observed (Shaw 2001). Therefore, if a parent or carer frequently expresses their 
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disapproval in relation to non-adherence this may inadvertently result in the teenager 
deviating from the GFD more often. Such behaviour could be addressed by 
developing support group sessions for the parents/carers of teenagers with CD in 
which alternative coping and support strategies are discussed. 
Knowledge was not significantly associated with adherence to the GFD. This is in 
contrast to the aforementioned study by Roma et al. (2010) which investigated 
factors associated with adherence to the GFD in Greek children. Only 19.4% of non-
adherent children in the study were found to have sufficient knowledge of CD 
(defined as answering 12 out of 15 questions in a knowledge quiz correctly) 
compared to 80.6% of compliant children (p<0.001). However, an invalid self-report 
measure of adherence was utilised, limiting the findings observed. During 
adolescence more social and psychological factors may start to become significant in 
relation to adherence, overriding whether the teenager has a good knowledge of CD 
and the GFD. As previously discussed, teenagers may choose to stray from the GFD 
when at social or special events or when buying food themselves because of anxiety 
about not conforming to the norm or feeling visible in public.  
To summarise, non-adherence was prevalent in Scottish teenagers with the majority 
of non-compliant adolescents both intentionally and unintentionally consuming 
gluten. We identified that a number of factors correlated with adherence to the GFD. 
In contrast to previous teenage studies the results suggest that male gender may be 
associated with better adherence. Findings may be biased due to low numbers, 
however psychological and social differences between sexes at this formative stage 
could play a role in adherence abilities. Being a member of a support group such as 
Coeliac UK was also associated with superior adherence. The privacy and empathy 
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provided by online support groups may be an important factor in adherence to the 
GFD during adolescence and healthcare professionals should emphasise joining the 
both the online communities and local support networks to aid adherence. Teenagers 
who purchased their own food were more likely to be non-adherent. This may be 
related to poor interpretation of food labels, poor availability of GF foods within 
schools or anxiety about being made visible if GF items are purchased with friends. 
As such, dietitians should prioritise informing teenagers on how to interpret food 
labels and mobile apps could be developed to improve labelling and ingredient 
knowledge. Additionally, schools should be encouraged to increase provision of GF 
alternatives. Non-adherence was additionally associated with poor ability to follow 
the GFD at social and special events and when on holiday and travelling. Under these 
circumstances prior preparation may play a key role in improving adherence and 
there is a real need to empower the friends and family of teenagers with CD as well 
as the general population to improve their acceptance and knowledge of the GFD. 
Lastly, the results suggest that teenagers who avoid gluten because of feelings of 
guilt have a greater tendency to not adhere. Feeling guilty about consuming gluten 
may be related to anticipated parental disappointment which has previously been 
shown to have a negative effect on adherence to medical regimes. This could be 
addressed through development of support groups for parents of teenagers with CD.  
6.3.3 Health-related quality of life 
Very few studies have assessed the HRQoL of teenagers with CD (Errichiello et al. 
2010; Gray and Papanicolas 2010; Kolsteren et al. 2001; Wagner et al. 2008). To the 
best of our knowledge, this is the first study in the UK to compare HRQoL indicators 
of adherent and non-adherent adolescents to the general population and between 
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adherent and non-adherent teenagers. Interestingly, the results suggest that adherent 
teenagers actually have better HRQoL scores compared to the general population in 
relation to mood and emotions, home and school life. This contrasts with findings 
from Mazzone and colleagues (2011) who observed that Italian children (n100, 10.4 
± 2.7 years) following a strict GFD exhibited more behavioural and emotional 
problems such as separation anxiety, general anxiety and somatic complaints 
compared to age and sex-matched controls (Mazzone et al. 2011). Nonetheless, the 
single-centre design and self-report method used to assess adherence in this 
particular study limit the results reported. Outcomes of focus group interviews with 
Swedish teenagers (Olsson et al. 2008a) provide a parsimonious explanation of the 
observations noted in the current study since strict adherence was related to better 
emotional support from family and friends. Additionally, Errichiello et al. (2010) 
identified ‘school integration’ (measured using a 25-point Likert scale where higher 
scores are related to better participation in social and play activities at school and 
more friendships) as the only factor that predicted good or poor adherence to the 
GFD in adolescents and young adults with CD (14-30 years). Each degree of 
improved school integration predicted 56% less transgression from the diet, although 
the method of assessing adherence (a 24-hour dietary recall method and diet history 
to quantify gluten consumption over the last 30 days) has not been validated, and 
may therefore be an unreliable predictor of adherence. It is interesting that family, 
peer and school support in relation to following a GFD were not associated with 
teenage adherence to the GFD in the r-GCAS, nor were any emotions with being 
diagnosed such as stress, anger, anxiety or happiness. However, questions regarding 
support and emotional state unrelated to following a GFD were not posed in the 
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questionnaire and the study may have been under-powered to detect true 
associations.  
Although the current findings suggest that non-adherent teenagers and controls have 
similar emotional, home and school life HRQoL scores, non-compliant adolescents 
had poorer physical well-being and self-perception scores (p<0.05). Similarly, in 
Italian and Austrian adolescents with CD non-adherence was associated with a 
reduced physical health (Errichiello et al. 2010; Wagner et al. 2008). This does not 
seem to be dependant on severity of symptoms since nine non-adherent cases in the 
current study presented with Oslo classical symptoms at diagnosis and seven 
presented with non-classical symptoms. Prospective follow-up studies in adults and 
children with CD have observed significant improvements in physical HRQoL 
indicators after GFD commencement (Casellas et al. 2008; Gray and Papanicolas 
2010; Nachman et al. 2010). As such, it is likely that adherence affects physical 
health, rather than vice versa. Poor adherence may lead to more symptomatic 
complaints such as abdominal pain and diarrhoea, or poor micronutrient status; both 
of which could lead to the reduced physical health observed in the current study.  
Non-adherent teenagers not only had a significantly lower self-perception compared 
to the general population, a greater proportion had a definitively ‘low’ self-
perception score compared to adherent teenagers. This has not previously been 
observed in CD patients, although in diabetic patients similar outcomes have been 
reported (Wichowski and Kubsch 1997). Self-perception is often considered to be a 
component of self-esteem (Cornwell and Schmitt 1990). In the case of CD, an 
adolescent’s confidence and opinion of themselves may be hindered due to feeling 
different from their peers or experiencing stigma in public when buying GF food or 
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talking about their condition with others (Olsson et al. 2009a). Furthermore, 15.4% 
(n=6) of teenagers in the current study reported avoiding social events, parties and 
dating, one child commented that she was purposefully uninvited to an event because 
of her condition, 45.5% (n=15) of participants avoided gluten because of feelings of 
guilt and 47.4% (n=18) because their family worried about them. Disregarding the 
dietary restrictions associated with CD may help teenagers to combat stigmatisation 
and to test rules and limits imposed by parents or health professionals. Alternatively, 
poor adherence to the diet may contribute to a low perception of one’s self and a lack 
of confidence, particularly if the patient continues to unintentionally consume gluten. 
As discussed in Section 6.3.2 empowering the general population as well as schools, 
catering staff and local and national food establishments to have a better 
understanding of what constitutes a GFD and why it is important for individuals with 
CD could help to reduce stigmatisation on a population level, thus improving 
adherence and HRQoL. Whereas support group sessions could help parents of 
teenagers with CD to understand how to address the difficulties adolescents 
encounter with regards to following a GFD at this challenging stage of physical, 
psychological and social development. To identify whether non-adherence affects 
self-perception, or whether an inherent low self-perception leads to non-adherence, a 
prospective follow-up study comparing HRQoL at diagnosis and again at subsequent 
time points is required. Nonetheless, it is important that health-care professionals 
assess HRQoL in addition to adherence to the GFD at follow-up to ascertain whether 
certain teenagers require additional professional and emotional support. 
There was not a significant difference in the scores obtained in the CDDUX between 
compliant and non-compliant teenagers. This proposes that all teenagers (whether 
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adherent or non-adherent) experience similar feelings in relation to adherence, 
dietary restrictions, discussing and explaining the condition to others, being offered 
gluten-containing food and thinking about gluten foods. In all three subscales of the 
questionnaire participants reported a ‘good’ disease specific HRQoL (median score 
between 60 and 80) as defined by Van Doorn et al. (2008). In two previous studies 
that utilised the CDDUX, children where found to have ‘bad’ to ‘neutral’ scores in 
all three domains of the questionnaire (van Doorn et al. 2008; van Koppen et al. 
2009). These studies, however, were conducted in The Netherlands, where the 
CDDUX was developed and validated. Therefore, the CDDUX may not be truly 
indicative of disease-specific HRQoL in UK teenagers and validation of this tool or a 
new measure for use in the UK is required. Additionally, our study may be under-
powered to be able to detect any difference if one exists (see Section 6.4 for further 
detail). 
In summary, in our sample the results indicate that strict adherence is associated with 
a superior HRQoL compared to non-adherent teenagers and the general population. 
This may reflect strong family and peer-group support, in addition to better school 
integration. Conversely, non-adherent teenagers reported poorer physical health and 
self-perception. It is likely that adhering to the GFD improves physical health, 
although it is uncertain whether low self-perception is a cause or effect of non-
adherence and this will require further study. However, the findings suggest that in 
practice HCPs should monitor HRQoL alongside adherence at follow-up to 
determine whether adolescents with CD require additional professional and 
emotional support. Furthermore, population education such as workshops or 
presentations in schools or with food industry professionals could help to improve 
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knowledge and acceptance of CD and the GFD in society and reduce the 
stigmatisation teenagers experience when trying to follow a strict GFD. 
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6.4 Limitations 
In the retrospective study, it is possible that some children may not have been 
captured if they were diagnosed in adult services (although we expect these numbers 
to be minimal). This was controlled for between 1990 and 1999 by cross-checking 
biopsy records with the regional serology database to identify whether any serology 
positive children had been biopsied in general hospitals. This information, however, 
was not gathered for the epochs 2000-2004 and 2005-2009, inferring that the 
complete extent of the already significant accrual may in fact represent an 
underestimation. Another possibility is that documentation of symptoms in the 
clinical notes may have been incomplete e.g. only one major symptom noted and this 
is a potential limitation of our study when classifying by number of symptoms. We 
hope however to have controlled for this at least in part by further defining classical 
cases according to the Oslo criteria, where a single major symptom is sufficient for 
categorisation (Ludvigsson et al. 2012), and a rise is still seen. 
It is important to note that the rising trend in classical CD cases in SE Scotland may 
not be representative of the country as a whole. Buchanan et al. (2009) observed a 
similar rise in numbers in the West of Scotland, from 1995 to 2008. However, it is 
not certain if this increase is attributed to a true increase in numbers or a lower 
threshold to test. Continuation of the prospective SPSU project will allow for 
accurate estimation of changes in incidence across Scotland. 
A final limitation of the retrospective study is that we did not collect data on each 
patient’s migration status. Over the period of our study there has been a trend 
towards net migration gain from overseas in the Scottish population as a whole, 
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including populations genetically at-risk of CD (The Scottish Government 2012a). 
An apparent rising incidence of classic CD in older children, when the total numbers 
diagnosed over 20 years is only 266, may potentially result from the immigration of 
older children whose diagnosis has previously been missed. However, for the 0-16 
age group net migration is minimal, with the lowest number of migrants aged 
between 10 and 16 years (The Scottish Government 2012a). As such, we do not think 
this will have significantly influenced the rise in older classical cases. 
Regarding the dietetic data, it should be acknowledged that some of the pro-formas 
completed in the district general clinic were completed retrospectively. This was 
attributed to a member of staff on long-term leave of absence and completing the 
forms on return. As such, this may have lessened the reliability of such data if advice 
that was given in the clinic was not reported in case notes.  
A number of limitations should be discussed in relation to the adolescent cross-
sectional study. Firstly, we did not meet our pre-calculated sample size of 26 
participants per group (adherent and non-adherent adolescents). However, adherent 
teenagers were still identified as having better HRQoL indices for the domains 
‘physical well-being’, ‘moods and emotions’ and ‘self perception’ compared to non-
adherent teenagers, rejecting the null hypothesis. The multi-centre study design and 
recruitment of participants through hospital databases, rather than support groups, 
increases the likelihood that the data is more representative of the wider population. 
Still, those teenagers and their families with a greater interest in their condition and 
who are perhaps more adherent to the GFD are more likely to participate which 
could mean the views of non-adherent adolescents are not accurately represented. 
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Recruiting teenagers from RHSC Yorkhill in Glasgow may have helped to increase 
numbers, as this tertiary centre covers the largest population area in Scotland. 
Nonetheless, a local research team at the hospital were aiming to recruit a similar 
teenage population for a separate study, and thus authorisation for us to recruit from 
this site was not approved. 
A limitation of estimating nutrient intakes using diet diaries is that they are prone to 
social desirability bias through participants under-reporting, under-eating or even 
over-reporting (Briefel et al. 1997). However, they are a widely accepted tool for 
estimating dietary intakes and utilised in national and international studies such as 
the NDNS and the European Prospective Investigation into Cancer and Nutrition 
(EPIC) study (Bates et al. 2012; Cade et al. 2004). The relative validation of the 4-
day diet diary used in the most recent NDNS and the current study is discussed in 
Section 4.3.6.5. To effectively minimise bias young participants were verbally 
encouraged to complete the diary as honestly as possible and requested not to alter 
their current dietary routine. It was also stressed that what participants consumed was 
not being judged. Furthermore, diet diaries were checked with the participant at the 
end of the study for completeness and household measures were converted into 
weights. The strength of the current study in comparison to the majority of previous 
reports (Grehn et al. 2001; Kinsey et al. 2008; Ohlund et al. 2010; Wild et al. 2010) 
is that the same measure of dietary assessment was used to collect data in both the 
CD and control populations, allowing for a standardised comparison across groups. 
Additionally, due to a lack of GF food items in WinDiets (2005) and limited 
nutritional analyses available from GF food manufacturers, incomplete data for many 
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GF products (particularly in relation to micronutrients) was used when estimating 
dietary intakes. Therefore, the estimated micronutrient intakes calculated for the CD 
group may be under-estimates. This is a particularly important limitation to consider 
with regards to the high proportion of girls with estimated iron intakes below the 
LRNI. However, very few manufacturers of staple GF foods such as bread and pasta 
claimed to fortify their products or use fortified flour within their products. As such, 
unfortified GF products where full nutritional information was available from 
manufacturers were used as substitutes in the database for items with limited 
nutritional information.  
Finally, as previously discussed, the CDDUX may have limited use in UK teenagers 
due to development in The Netherlands (van Doorn et al. 2008). There may be 
differences between The Netherlands and the UK in terms of CD treatment, the 
availability and type of GF foods as well as social values and norms and thus it is 
important that similar, country specific measures are developed. Another limitation 
of the CDDUX is that only members of a coeliac society were interviewed in the 
development stage of the questionnaire. As highlighted in the current study and other 
reports (Butterworth et al. 2005; Hall et al. 2013; Leffler et al. 2008), being a 
member of a CD support group is associated with better adherence to the GFD. 
Therefore, the outcomes of the focus group discussions used to formulate the 
questionnaire may not be representative of the overall coeliac population and some 
important issues associated with non-adherence may have been missed such as 
difficulties following the diet on holiday, when travelling and at social and special 
events. Nonetheless, the CDDUX is available in English and is currently the most 
reliable and valid instrument to assess CD-specific HRQoL in the UK. 
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Chapter 7: Conclusions 
The findings of this PhD thesis combine to improve our knowledge of childhood CD 
epidemiology and its clinical management in Scotland. The work provides a greater 
understanding of the nutritional, physical and psychosocial health of adolescents 
living with CD in Scotland and the factors or issues that are associated with 
adherence to a strict GFD. As such, recommendations for clinical practice, coeliac 
support organisations, industry, and further research can be proposed. 
In terms of clinical management, evidence of a dramatic 6.5-fold rise in the incidence 
of childhood CD in Scotland between 1990 and 2009; related to both better accrual 
of cases and a true rise in numbers is likely to put a strain on the amount of time 
HPCs have to support and follow-up patients. This may be especially pertinent in the 
Southeast of Scotland where twice as many cases were diagnosed per head of 
population between 01/09/2009 and 31/08/2010 compared to the West and North. As 
highlighted in the adolescent cross-sectional study, patients find input from dietitians 
and gastroenterologists extremely valuable sources of education. Therefore, it is 
imperative that such support is not compromised by increasing numbers. Financial 
provision to manage a rising or higher caseload should be considered. Alternatively, 
more innovative ways to manage children and teenagers could be devised, such as 
group sessions or series of educational workshops in collaboration with external 
support groups such as Coeliac UK. Moreover, prospective longitudinal research is 
warranted to investigate the many potential causal factors (environmental or 
epigenetic) implicated in a true rise in numbers and regional differences in incidence 
before primary prevention strategies can be implemented. 
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While it is encouraging that more children are being diagnosed in practice due to 
better awareness of CD, it is still vital that HCPs have a low threshold to test, since a 
large proportion of cases remain undiagnosed. Although continuation of the SPSU 
study is required to confirm results, our initials findings suggest that clinicians in the 
East may have a better awareness of the risk factors associated with CD compared to 
practitioners in the West and North of Scotland. Education programmes or courses 
for primary care practitioners and the general public on the signs, symptoms and at-
risk conditions related to CD should be encouraged to help reduce potential 
inequalities in diagnosis. Results of the current study also suggest that practitioners 
should not dismiss CD in clinically overweight or obese children and that serum 
ferritin should be measured in conjunction with acute phase proteins (C-reactive 
protein or α1 glycoprotein) to reduce underestimation of iron deficiency associated 
with inflammation. Population screening, however, should not be implemented until 
it is ethically and economically justifiable. 
Differences in the dietetic management of newly diagnosed children were observed 
between regional and district general clinics, however the findings do not infer the 
best mode of practice in terms of improved health outcomes. Further research is 
necessary to determine whether particular management techniques, such as timing 
and frequency of follow-up, individual versus group based counselling or treating 
micronutrient deficiencies with supplements or dietary advice are associated with 
adherence to the GFD, better health indices including nutritional status and HRQoL. 
Continuation of the dietetic e-reporting study will allow us to see whether 
information that is not addressed in initial appointments is covered in subsequent 
clinics. Although Coeliac UK and ESPGHAN have recently published new CD 
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management guidelines these are not informed by outcome-based research and 
details on how to assess nutritional status in patients are not specified. Such research 
could help to establish standardised evidence-based management guidelines to ensure 
any inequalities in practice are minimised and nutritional status is appropriately 
assessed. 
The results of the adolescent cross-sectional study should be interpreted with caution 
due to low participation and incomplete nutritional data on a number of GF products 
that participants consumed. However, in terms of informing dietetic practice the 
results suggest that when managing adolescents, dietitians should assess 
macronutrient as well micronutrient intakes, since teenagers had higher estimated 
intakes of SFA and NMES compared to DRVs and many had low NSP intakes as 
well as low iron – these nutritional concerns are common in the general adolescent 
population. Dietitians should not only focus on trying to increase iron and calcium 
intakes as this may be detrimental to other nutrient intakes such as increased 
saturated fat from dairy products. Furthermore, to improve dietary adherence the 
results imply that dietitians should provide greater awareness, information and 
support in relation to joining local and national support groups (particularly online 
communities), interpreting food labels, prior preparation before travelling, holidays 
or attending social and special events and encourage teenagers to discuss their 
condition and dietary requirements with friends, family and the general population to 
improve public acceptance and knowledge. Additionally, since non-adherence was 
associated with lower scores of physical health and self-perception, a dietitian or 
gastroenterologist should assess teenagers HRQoL at follow-up to identify whether 
patients require additional clinical, emotional or psychological support – as, although 
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diet is the cornerstone of CD treatment, food serves numerous social, psychological 
and emotional functions, besides providing the body with adequate nutrition. 
Collecting such information would also align with the governments push for the 
collection and reporting of PROMs. Nonetheless, future research is needed involving 
a larger sample size to identify independent predictors of adherence during 
adolescence. Additionally, a prospective follow-up study, comparing HRQoL before 
and after diagnosis is required to identify whether non-adherence to the GFD predicts 
a poor HRQoL or vice versa.     
As well as affecting clinical management, the rise in CD incidence will increase the 
demand for GF foods. Adolescents in the current research experienced difficulties 
following a GFD in particular situations, such as when travelling or buying food 
themselves, possibly due to poor availability of GF options or difficulties reading 
food labels. Similar findings have been reported elsewhere. Thus, food 
manufacturers, local and national food retailers and eateries should be lobbied to 
increase the availability and choice of GF options, and clear front of pack labelling 
on packaged food should be advised to help improve adherence to the GFD and 
potentially HRQoL in coeliac populations. Additionally, manufacturers should be 
encouraged to develop GF products low in added sugars and SFA to assist 
individuals in achieving a healthy balanced diet. Although a sizable number of 
teenage girls in our cross-sectional study had estimated iron intakes below the LRNI, 
further research is required to ascertain whether the low intakes translate to iron 
deficiency associated with following a GFD. Only then should the mandatory 
fortification of GF flours with iron be considered. 
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With regards to rising numbers and improving adolescent adherence to the GFD and 
HRQoL, coeliac support organisations such as Coeliac UK will likely play a pivotal 
role. Local groups, along with patients can help to increase the awareness and 
acceptance of CD and the GFD in the general population by providing educational 
sessions or workshops at places such as schools about what constitutes a GFD and its 
importance for the health of individuals. Empowerment on this level could reduce 
stigmatisation, help others to better cater for those following a GFD and prevent 
adolescents from feeling the need to hide their condition or conform to the norm in 
social situations. Support groups and HCPs could also develop educational sessions 
or support tools (such as online resources or booklets) for parents and carers of 
teenagers with CD which address the challenges adolescents face when following a 
GFD diet at this unique stage of physical, social and psychological development; 
thus allowing parents to more effectively support their child’s needs. Furthermore, 
more innovative ways to facilitate learning and improve adherence and HRQoL in 
adolescent populations such as mobile apps, online educational videos or GF camps 
could be developed or implemented by such organisations. 
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382 
 
Appendix 4.12: Email of consent to use and amend NDNS 4-day diet 
diary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
383 
 
Appendix 4.13: Revised NDNS 4-day diet diary 
 
 
 
 
  
384 
 
 
 
 
 
 
  
385 
 
 
 
 
 
 
  
386 
 
 
 
 
 
 
  
387 
 
 
 
 
 
 
  
388 
 
 
 
 
 
 
  
389 
 
 
 
 
 
 
  
390 
 
 
 
 
 
 
  
391 
 
 
 
 
 
 
  
392 
 
 
  
  
393 
Appendix 4.14: Diet diary substitutions 
 
Food item Substitutions Comments/Justification 
Cereal and cereal products   
Eat Natural almond, apricot and 
yogurt bar 
Chewy cereal bar  
GF cereal flakes Cornflakes Unspecified brand 
GF flours (exact ingredients or 
nutritional information 
unknown) 
Corn flour Any nutrients the flour 
was fortified with were 
added to the database 
separately 
Nature Valley cereal bar (oats 
and honey) 
Oat based biscuits Oats = main ingredient 
Nairn’s oat bakes Oat cakes  
Chocolate Stars (GF breakfast 
cereal) 
Coco pops Rice flour = main 
ingredient 
Rice mac and cheese (Amy’s 
Kitchen) 
White rice 
Cheese sauce 
 
Cheese rice cakes Rice cakes  
Choc chip rice cakes Rice cakes 
Milk chocolate 
 
Trufree chocolate finger biscuits Rice crispie cakes Rice flour = main 
ingredient 
GF pastas (exact ingredients or 
nutritional information 
unknown) 
Rice noodles 
Corn pasta 
Depending on which grain 
was the main ingredient 
Mrs Crimble’s cheese crackers Corn and starch based 
snacks 
Corn and potato flour = 
main ingredients 
Scotch pancakes (GF) Corn cakes  These are American 
versions of pancakes 
where cornmeal is the 
main ingredient 
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High fibre crackers (Glutafin) Rice cakes (brown rice and 
buckwheat) 
Rice flour = main 
ingredient 
Chocolate and orange ‘no 
wheat’ biscuits 
Rice crispie cakes Rice flour = main 
ingredient 
Tesco free from chocolate 
digestives 
Oat based biscuits Oats = main ingredient 
GF crisp breads Rice cakes (brown rice and 
buckwheat) 
Rice flour = main 
ingredient 
GF breads (exact ingredients or 
nutritional information 
unknown) 
Brown or white GF bread 
(where exact nutritional info 
was available) e.g. Juvela 
breads 
Any nutrients the 
individual bread was 
fortified with were added 
to the database separately 
Milk and milk products   
Vienetta Choc-ice  
Cheese Strings Processed cheese  
Sour cream and chive dip Sour cream  
Cadbury’s Flake chocolate 
yogurt 
Yogurt, plain 
Milk chocolate 
 
White Magnum ice cream Choc-ice  
Meat and fish products   
Marks and Spencer’s ginger, 
lime and coriander chicken 
Chicken breast marinated 
with garlic and herbs 
 
Turkey ham (Bernard 
Matthews) 
Ham, canned Similar pork content 
Fish fingers (GF) Cod, baked 
GF white bread 
Same ratio as recipe 
Coarse pork pate Liver pate  
Fruit, vegetables and potatoes   
Craisens (dried cranberries) Raisins  
Mandarins Satsumas  
  
395 
Rocket Spinach  
Passata Chopped tomatoes  
Plum tomatoes Cherry tomatoes  
Tomato and chilli pasta sauce Sauce, tomato base  
Kohlrabi Cabbage Belongs to the same 
brassica family 
Potato smiles Potato waffles  
Sugar, preserves and 
confectionery 
  
Haribo Starmix Foam sweets  
Lollies Boiled sweets  
Milky Way Magic Stars Milk chocolate  
Aero Bubbles Milk chocolate  
Sesame Snaps Candies (sesame crunch)  
Moam Strips Chew sweets  
Cadbury’s chocolate eclairs Chocolate covered caramels  
Cadbury’s Roses Chocolate covered caramels  
Werther’s Original Butterscotch  
Dolly Mixture Jelly sweets  
Choc/orange macaroon Macaroon  
White Toblerone White chocolate  
Candy floss Sugar, white  
Chocolate truffles Chocolate filled and fancy  
Fruitellas Chew sweets  
Rainbow Drops Marshmallow  
Petits Filous chocolate dessert Chocolate mousse  
Daim Bar Chocolate covered caramels  
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Nestle Nut Bar Snickers  
Haribo Tangfastics Fruit gums/jellies  
Cadbury’s Curly Wurly Chocolate covered caramels  
Toffee sauce Ice cream sauce  
Nutella Chocolate spread  
Savoury snacks   
Trufree pretzels Maize and rice flour snacks  
Pringles Potato chips made from 
dried potatoes 
 
Wotsits Corn snacks  
Walkers French Fries Puffed potato products  
Pom Bears Puffed potato products  
Cheese puffs Corn snacks  
Mrs Crimble’s Cheese Bites Puffed potato products  
Non-alcoholic beverages   
Irn Bru Carbonated fruit drink 
‘ready to drink’ 
Similar calories and sugar 
content 
Pomegranate tea Green tea  
Diet Irn Bru Diet Cola  
Lemon and lime water Bottled water  
Mint hot chocolate Hot chocolate  
Strawberry slushy Carbonated fruit drink 
‘ready to drink’ 
 
Cranberry/raspberry juice from 
concentrate 
Grape juice  Cranberry juice was in 
database, although many 
nutrients missing 
7up Lemonade  
Apple tango Lemonade  
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Lacto Free milk Semi-skimmed milk Lacto Free milk is made 
from cow’s milk 
Fanta Lemonade  
Miscellaneous    
Fajita seasoning Poultry seasoning  
Fish sauce Soy sauce  
Fresh stock made from ham on 
the bone 
Chicken stock  
Vanilla essence Vanilla extract  
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Appendix 4.15: Adolescent study sample size calculation 
 
 
399 
 
Appendix 4.16: Ethical approval letter (QMU Research Ethics 
Committee) for conduct of the adolescent pilot study
 
  
  
400 
Appendix 6.1: Additional medical conditions previously diagnosed in 
children newly diagnosed with CD between 01/09/2009 and 31/08/2010 
 
Additional medical 
conditions 
Frequency of cases % of cases 
TIDM 14 15.4 
Asthma 8 8.8 
Eczema 4 4.4 
Lactose intolerance 3 3.3 
Adenotonsillar 
hypertrophy 
1 1.1 
Asperger’s syndrome 1 1.1 
Cervical neck abscesses 1 1.1 
Down syndrome 1 1.1 
Dyslexia 1 1.1 
Body dysmorphic disorder 1 1.1 
Eating disorder* 1 1.1 
Epilepsy 1 1.1 
Hirschsprung’s disease 1 1.1 
Hypermobile joints 1 1.1 
Hypothyroidism 1 1.1 
Language delay 1 1.1 
Seizures 1 1.1 
Selective mutism 1 1.1 
Trisomy 21 1 1.1 
West syndrome 1 1.1 
Cow’s milk allergy 1 1.1 
Egg allergy 1 1.1 
Nut allergy 1 1.1 
T1DM = Type 1 diabetes mellitus; *specific disorder not stated in questionnaire 
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Appendix 6.2: SPSS output; Chi-Square and Fisher’s exact tests to 
observe any differences in the proportion of newly diagnosed CD cases 
with different BMI classifications between tertiary GI networks  
 
 Tertiary GI Network Chi-Square and Fisher’s 
exact test analysis 
BMI 
Classification 
East (E) West (W) North (N) E vs. W E vs. N N vs. W 
Freq. % Freq. % Freq. %    
Obese 3 11.5 0 0.0 1 3.1 P=0.316 P=1.000 P=1.000 
Overweight 2 7.7 5 31.3 3 9.4 P=0.717 P=0.465 P=0.138 
Low BMI 4 15.4 1 6.3 2 6.3 P=0.393 P=0.633 P=1.000 
 
